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Abstract 
The class of furanocembranoid diterpenes is a huge, still growing family of marine natural 
products.[1] [2] Their interesting biological activities and complex molecular architectures, 
accompanied by their limited availability make them challenging synthetic targets. The vast 
majority of the family’s constituents can be divided in three different classes, depending on their 
rearranged carbon-skeletons: pseudopteranes, gersolanes and furanocembranoids. Among each 
other, they mainly differ in their degrees of oxygenation and oxygenation patterns.  
A well known member of the latter family is Providencin (1). It was first isolated and subsequently 
structure elucidated in 2003 by Rodriguez et al..[3] The cyclic diterpene has some very interesting 
structural features. Its highly oxygenated hexacyclic structure is based on a previously undescribed 
bicyclo[12.2.0]hexadecane ring system. It bears nine stereogenic centers and its cyclobutanol 
subunit is four-fold substituted. Due to the highly strained ring system, the butenolide moiety is in 
a perpendicular orientation to the furan moiety, which makes the total synthesis of this molecule 
considerably difficult. To this day, no total synthesis has been published. 
Herein several approaches with decreasing the molecule’s ring strain are reported. The stepwise 
opening of rigid motifs should facilitate the crucial step of the macrocyclization. Four different, 
well established macrocyclization techniques were tested in two different synthetic series 
(cyclobutane- and isopropenyl-series): Ring closing metathesis,[4] Horner-Wadsworth-Emmons 
conditions,[5] macrolactonization,[6] and (transition) metal mediated carbon-carbon-bond forming 
reactions.[7] [8] The fragments of each approach were synthesized in a stereoselective and 
convergent manner. 
The cyclobutane series exhibits this structural motif already in the starting material (±-cis-
bicyclo[3.2.0]hept-2-en-6-one; 180), whereas in the isopropenyl series (R)-(-)-Carvone (359) was 
used. The latter one is a chiral pool starting material and therefore, allows the total synthesis of 
diterpenes starting with a cyclic monoterpene.  
The metathesis approaches in the cyclobutane, as well as in the isopropenyl series gave the most 
promising results and yielded highly advanced intermediates in the synthesis of Providencin (1). 
Since Providencin (1) is the only depicted member of the cembranoid family bearing a cyclobutane 
moiety in this position, the cyclobutane series is perfect for the synthesis of (1). In contrast, the 
isopropenyl series offers a flexible approach to the carbon-skeleton of numerous members of this 
family. Overall, most promising key intermediate 213 was synthesized in a 21-linear-steps 
sequence and provided access to a possible total synthesis of Providencin (1). Furthermore, the 
14-step-synthesis of key intermediate 369 disclosed the biomimetic synthesis of Providencin (1) en 
route with numerous other natural products, such as Iopholide (57), Iophodiol A/B and Bipinnatin 
E (58).  
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Zusammenfassung 
Furanocembranoide Diterpene sind eine riesige, stets wachsende Klasse mariner Naturstoffe.[1] [2] 
Sowohl ihre interessanten biologischen Eigenschaften und ihre komplexen molekularen 
Architekturen, als auch ihre begrenzte Verfügbarkeit, machen sie zu herausfordernden 
synthetischen Zielen. Die Mehrheit der Vertreter dieser Klasse lässt sich in drei Hauptgruppen 
unterteilen, die sich im Wesentlichen durch ihre umgelagerten Kohlenstoffgerüste unterscheiden: 
Pseudopterane, Gersolane und Furanocembranoide. Innerhalb dieser drei Klassen unterscheiden 
sich deren Vertreter hauptsächlich durch ihren Oxidationsgrad und ihr Oxidationsmuster. 
Providencin (1) ist ein bekannter Vertreter der Furanocembranoide. Es wurde im Jahr 2003 von 
Rodriguez et al. isoliert und charakterisiert und besitzt einige seltene Strukturmotive, wie sein, 
bisher literatur-unbekanntes, hoch oxigeniertes Bicyclo[12.2.0]hexadecan-Skelett.[3] Des Weiteren 
besitzt Providencin (1) neun stereogene Zentren und eine vierfach substituierte Cyclobutan-
Einheit. Wegen der hohen Ringspannung, die das Molekül aufweist, weichen Furan und Butenolid 
Untereinheit in eine zueinander orthogonale Position aus, welche die Totalsynthese von 
Providencin (1) erschweren. Bis heute ist keine Totalsynthese literaturbekannt.  
Im Folgenden werden mehrere Zugänge präsentiert, welche die Ringspannung des Moleküls 
sukzessive herabsetzen. Die schrittweise Öffnung rigider Strukturmotive ermöglicht eine höhere 
Flexibilität und deshalb eine Erleichterung der schwierigen Makrozyklisierung. Dazu werden vier 
gut etablierte Makrozyklisierungsmethoden in zwei Syntheseserien (Cyclobutan- und Isopropenyl-
Serie) verwendet: Ringschlussmetathese,[4] Horner-Wadsworth-Emmons Bedingungen,[5] Makro-
laktonisierung und (Übergangs-)metall vermittelte Kohlenstoff-Kohlenstoff-Bindungs-
knüpfung.[6] [7] [8] Die Fragmente der einzelnen Ansätze wurden stereoselektiv synthetisiert. 
Ausgangsmaterial für die Cyclobutan-Serie war (±)-cis-Bicyclo[3.2.0]hept-2-en-6-on (180), welches 
den gewünschten viergliedrigen Ring bereits besitzt. Für die Isopropenyl-Serie wurde (R)-(-)-
Carvon (359) als optimales Startmaterial gewählt.  
Sowohl in der Cyclobutan-, als auch in der Isopropenyl-Serie erwies sich der Metathese Zugang als 
zielführend. Dadurch konnten hoch funktionalisierte, weit fortgeschrittene Zwischenstufen 
synthetisiert werden, wie zum Beispiel Verbindung 213 in einer 21-Stufen Sequenz oder 
Verbindung 369 in einer 14-Stufen Sequenz. Da Providencin (1) unter den furanocembranoiden 
Diterpenen der einzige Vertreter ist, der eine Cyclobutan-Untereinheit an dieser Position aufweist, 
ermöglicht die Cyclobutan-Serie lediglich die maßgeschneiderte Synthese von (1). Der Isopropenyl-
Ansatz ermöglicht jedoch die Synthese zahlreicher weiterer Vertreter dieser Naturstoffklasse, wie 
zum Beispiel Iopholide (57), Iophodiol A/B und Bipinnatin E (58). 
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1 Introduction 
1.1 Background 
Natural products play an important role in the discovery of new drugs, but in many cases they can 
only be isolated from nature in very small quantities. If preliminary standardized screenings 
against various harmful cell-lines (cancer, malaria, HIV,...) show satisfying cytotoxic activity (IC50-
values), these natural products have to be synthesized in larger quantities. Therefore, the 
stereoselective total synthesis of complex natural products is a major challenge in organic 
chemistry. Its great advantage is that specific modifications in the NP’s carbon/heteroatom 
skeleton can be done with ease, thus increasing the molecules’ activity.[9] 
Terpenes are an important class of natural products with a large structural diversity (Figure 1). 
Until now more than 30.000 different representatives of this class are known.[10] By reason of their 
high oxygenation degrees and their numerous stereogenic centers they are interesting and 
challenging synthetic targets for organic chemists. 
 
Figure 1: Different types of complex terpene structures: Providencin (1), a marine diterpene; Paclitaxel (A), one of the 
most important anti cancer drugs; Eleutherobin (B), a potent anti cancer drug. 
 
1.2 Biosynthesis of terpenes 
Terpenes can be divided – according to their number of carbon atoms – in hemi-, mono-, sesqui-, 
di-, sester-, tri- and tetraterpenes, with a C5, C10, C15, C20, C25, C30 and C40-carbon skeleton, 
respectively. All terpenes possess a common denominator: they are built up by head-to-tail or tail-
to-tail linkage of C5-isoprenyl-units, where the isopropyl part of 2-methylbutane (isoprene) is 
defined as the head and the ethyl residue as the tail. This rule is called the isoprene rule and was 
found by Ruzicka and Wallach in 1959.[11] The resulting C-C-double bonds always have a trans 
configuration.  
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In nature, two different biogenetic pathways are known to synthesize terpenes: On the one hand 
the acetate-mevalonate pathway (Figure 2) and on the other hand the activated acetaldehyde-
glyceraldehyde-3-phosphate pathway (Rhomer-pathway, non-mevalonate-pathway, Figure 
3).[12] [13] Both of them result in the same C5-intermediates isopentenyl-pyrophosphate (7, IPP) and 
dimethyl-allyl-pyrophophate (8, DMAPP). 
1.2.1 Acetate-Mevalonate-Pathway (MVA-pathway) 
In this case, acetyl-coenzyme A (Ac-CoA, 2) is the biogenetic precursor of terpenes. Two 
equivalents of Ac-CoA (2) are coupled to acetoacetyl-CoA (3), similar to the Claisen 
condensation.[14] Following the pattern of an aldol reaction, acetoacetyl-CoA (3) reacts with 
another equivalent of Ac-CoA (2) as a nucleophile. The resulting hydroxy-methyl-glutaryl-CoA 
(HMG-CoA, 4) is enzymatically reduced (HMG-CoA-reductase) to (R)-mevalonic acid (MVA, 5). 
Mevalonic acid 5 is then converted to the corresponding pyrophosphate 6 by an ATP-dependent 
kinase. This intermediate is subsequently decarboxylized and dehydrated to IPP (7), which can be 
isomerized by an Mg2+-dependent isomerase to DMAPP (8) (Figure 2). 
 
Figure 2: Scheme of the biogenesis of IPP (7) and DMAPP (8) via the mevalonate pathway. 
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1.2.2 The Rhomer Pathway (MEP-pathway)[13] 
Following the non-mevalonate pathway, pyruvate (9) and glyceraldehyde (11a) are the biogenetic 
precursors of IPP (7) and DMAPP (8). In the first step, pyruvate (9) is attacked by the vitamin B1 
derivate thiamine pyrophosphate (TPP, 19), forming a reversible adduct 10. After irreversible 
decarboxylation an Umpolung-reaction takes place and the former electrophilic ketone becomes 
nucleophilic (11), attacking glyceraldehyde-3-phosphate on C1 to yield 12. After regeneration of 
TPP (19) by a retro aldol reaction, compound 13 (1-deoxyxylulose-5-phosphate, DXP) is generated. 
An acyloin rearrangement of 13 results in the formation of 2C-methyl-D-erythritol-4-phosphate 
(MEP, 14). Repeated phosphorylation yields MEcPP (16), a cyclic diphosphate, which is then 
reduced via a yet unknown mechanism to IPP (7) and DMAPP (8) (Figure 3). 
 
Figure 3: Scheme of the biogenesis of IPP and DMAPP via the non-mevalonate pathway. 
The electrophilic allylic CH2-group of DMAPP (8) and the nucleophilic methylene group of IPP (7) 
are connected by a head-to-tail linkage to the monoterpenoid geranyl phosphate (20, C10) by an 
Alder-Ene-like reaction.[15] Using the same mechanism again nature elongates geranyl phosphate 
(20) once more to farnesylphosphate (21, C15). 
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After another elongation using the same pathway, the C20-skeleton of geranyl-
geranyldiphosphate (22, GGPP, C20) is finished. This intermediate is the basis for the synthesis of 
all diterpenes, such as Providencin (1) and Sarcofuranocembranolide A (75).Further chain 
elongation of geranyl-geranylphosphate (22) leads to the formation of sester-terpenes (23, C25). 
Tail-to-tail dimerization of two farnesyl subunits furnishes the squalene skeleton (25, C30), which 
is the starting material for the cationic cyclization to the steroid skeleton. Further, enzyme-based 
oxidations provide the large variety of different steroid based hormones, needed in living 
organisms. Repeated addition of further isoprene units to 23 lead to the formation of 
polyterpenes (24) and finally to gutta-percha, a natural polymer (Figure 4).[10] 
 
Figure 4: Biosynthesis of the carbon-skeleton of diterpenes. 
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1.3 Structure, Isolation and Biological Activity 
In 1962, Dauben et al. re-characterized a hydrocarbon, which they called cembrene.[16] Actually it 
was first isolated in 1951 by Haagen-Smit, Wang and Mirov.[17] The compound showed a molecular 
mass of 272 g/mol, which upon catalytic hydrogenation yielded a different product with a 
molecular mass of 280 g/mol, indicating the presence of four double bonds. Further analysis with 
NMR, IR and UV-VIS spectroscopy showed the presence of a conjugated diene system and five 
vinylic protons. Furthermore the double bonds seemed to be trans configured. Nevertheless the 
authors concluded that, “Although no information is available with regard to the stereochemistry 
of the trisubstituted double bonds, from a study of models the structure written containing one cis 
bond appears to be more favored than an all trans structure”.[16] Furthermore, conducting 
oxidative degradation experiments they only found bi-functional products, concluding that the 
structure had to have a 14-membered macrocycle (32a) (Figure 5). 
 
Figure 5: Originally proposed structure of cembrene (32a) and correct structure of cembrene (32b). 
In 1960 Drew et al. showed a revised structure by crystallographic analysis.[18] Instead of an 
originally proposed 7,8 cis-double bond the authors could show that cembrene exhibits a 4,5 cis 
configured double bond (32b) (Figure 5). This was the cornerstone of the cembrene-skeleton with 
its characteristic 2,3-4,5-7,8-11,12 double bond positions (Figure 6).  
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In 1966, Moore et al. reported a termite trail pheromone.[19] The very same diterpene was re-
isolated in 1972 by A. J. Birch and coworkers and was given the name neocembrene-A (30, 
cembrene-A).[20] It features a slightly rearranged carbon skeleton in terms of the double bond 
positions and geometry. According to its double bond positions (3,4-7,8-11,12-15,16), the carbon 
skeleton of neocembrene-A is name giving for the neocembrene-skeleton (26) (Figure 6).  
 
Figure 6: Skeletons of different 14-membered macrocyclic diterpenes. Dashed lines stand for mutable double bond 
geometry. The all trans configuration is most likely. 
A very recent publication of Keasling et al. revealed the gene of the neocembrene synthase in 
Euphorbiaceae plants.[21] In contrast to the well known casbene synthase (EC 4.2.3.8), which is 
responsible for the formation of the dimethylcyclopropane subunit of casbenes (28), this enzyme 
catalyzes the selective formation of the isopropenyl group present in the neo-cembrene family 
(26). 
Furanocembranoids, pseudopteranes and gersolanes represent a huge family of diterpenoids, 
which have been isolated exclusively from marine sources. All possess a (slightly rearranged) neo-
cembrene or a casbene skeleton. Due to their attractive molecular architectures combined with 
considerable bioactivities, they have gained the interest of both, natural product chemists and 
synthetic chemists. 
The vast majority of furanocembranoids, pseudopteranes and gersolanes have been isolated from 
gorgonian corals, which are also known as sea whips or sea fans. They can be found in the oceans 
all over the world, especially in the tropics and subtropics. The habitus of these corals is usually 
erect and flattened or whiplike and bushy. A colony of these polyps can be several feet in height 
and brightly colored, often purple, red or yellow. 
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Further information concerning the phylogeny of gorgonian octocorals is depicted in Figure 7. 
 
Figure 7: (a) phylogeny of gorgonian octocorals; (b) Phenotype of pseudopterogorgia kallos.
[22]
 
Little is known about the complete biosynthesis of this class of molecules, especially about the 
enzymes responsible for the oxidation reactions. Some speculations assume that the cytochrome 
P450 complex is involved in these oxidative transformations. But, it is clearly shown that the 
biosynthesis of these molecules starts with geranyl-geranyldiphosphate (22, GGPP), which is 
derived from DMAPP (8) and IPP (7) as shown above (Figure 4).[1] 
1.3.1 Cationic GGPP cyclizations 
The numbering of the carbon atoms in the following descriptions of the different types of cationic 
cyclizations depends on the particularly formed carbon skeletons and therefore, differs for each 
substance class.[10] In general, type A cyclizations form a macrocyclic carbon skeleton, whereas 
type B cyclizations form numerous smaller cycles. Type A – type B cyclizations form in the first step 
a macrocyclic core, which is then constricted to multiple smaller rings. Type B – type A cyclizations, 
respectively, generate in the first step several smaller carbo cycles and adjacently form an 
additional carbo cycle. 
Type A Cyclizations:[12] 
After generation of a stabilized cation at C15 and subsequent formation of a carbon-carbon single 
bond between C1 and C2 the 14-membered macrocycle of furanocembranoids is finished by a 
type-A cyclization (29). Onto abstraction of a proton on C16 a new carbon-carbon double is formed 
and the positive charge on C15 is equalized, finishing the biosynthesis of the simplest member of 
the neo-cembrene family: cembrene-A (30). The 14-membered macrocycle is called neo-cembrene 
skeleton and it is the base for the biosynthetical formation of furanocembranoids. 
  
(b) 
8 
 
As depicted in Figure 8 different reaction pathways can be figured out, leading to different carbon 
skeletons. A [1,3]-hydride shift (31) and subsequent proton abstraction would lead to the 
cembrene skeleton (32b), mentioned above. In contrast, -proton abstraction would lead to the 
formation of a cyclopropane ring – boosted by the Thorpe-Ingold effect – and therefore to the 
formation of the casbene skeleton (33) (Figure 8).[23] 
 
Figure 8: Biosynthetic cationic type A cyclizations of GGPP (cembrene-A features a neocembrene skeleton). 
Type A – Type B Cyclizations:[12] 
The formation of two different carbon-skeletons is described by this type of cyclization reaction: 
the taxane-skeleton (39) and the fusicoccane-skeleton (36). The formation of the fusicoccane-
skeleton (36) starts with formation of a stabilized carbo cation on C1, which immediately cyclizes 
to C14. The formed 4,14-cyclocembrene-skeleton (35) is the basis for numerous natural products. 
Further proton promoted cyclization of C10 to C6 forms the fusicoccane-core (36), which consists 
of a 5-8-5-membered, tricyclic ring system. The formation of the taxane-skeleton (39) is induced 
by the generation of a stabilized carbo cation on C4. Two bond forming reactions between 5,15 
and 1,14 result in the formation of the verticillane-skeleton (38), which can be further cyclized to 
the taxane-skeleton (39) by the generation of a 8,13-single bond (Figure 9). This carbon skeleton is 
the basis of one of the most potent anti cancer drug Paclitaxel (A, Figure 1). 
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Type B – Type A Cyclizations:[12] 
The formation of the 4,5- and 9,10-single bonds to intermediates 40, 43 and 46 (depending on the 
transition state) are the initial steps in these types of cyclizations. The formed substituted decaline 
core can now undergo various rearrangements. Double Wagner-Meerwein rearrangement (C3 to 
C5 and C20 to C9) and double [1,2]-hydride shift (C5-H to C10-H and C9-H to C8-H) provide bicyclic 
intermediate 41.[24] Compound 41 has a new nomenclature according to Figure 9. SN
2’ attack of C11 
to C12 furnishes the eight-membered cycle of the pleuromutilin-core (42), which is completed by a 
[1,5]-hydride shift (C14-H to C10-H). The formation of the primarane-skeleton (44) is carried out 
starting from 43, by a SN
2’ attack of C17 to C13 furnishing 44. Once again, compound 44 has a new 
nomenclature. Attack of C16 to C8, Wagner-Meerwein rearrangement (C12 to C15) and a final 
[1,2]-hydride shift (C17-H to C13-H) complete the biosynthesis of the kaurane-skeleton (45),[24] 
which is again the starting material for the rearrangement to the giberellane-skeleton (Figure 9). 
 
Figure 9: Different types of cationic GGPP-cyclizations, affording different carbon-skeletons. 
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Type B Cyclizations:[12] 
Classic type B cyclizations are in fact the initial step of the type B – type A cyclization. The 
formation of the 4,5- and 9,10-single bonds result in the formation of intermediate 46. Proton 
abstraction on C17 leads to the formation of 47, the labdane-skeleton. This carbon skeleton can 
undergo double Wagner-Meerwein rearrangement (C19 to C5 and C20 to C9) and double [1,2]-
hydride shift (C5-H to C10-H and C9-H to C8-H) to the clerodane-skeleton (48) upon proton 
abstraction on C3 (Figure 9).[24] 
 
1.3.2 Furanocembranoids 
The first family of marine derived diterpenes discussed in this thesis is the family of 
furanocembranoids. Furanocembranoids possess a 14-membered carbon-macrocycle (30), 
accompanied by a furan (C3-C6) and a butenolide (C10-C12; C20) moiety, hence they are referred 
as “furanocembranolides” in older literature. Furthermore, furanocembranoids very often show 
similar substitution patterns among themselves and their congeners (Figure 10, Figure 11): 
 C2 often is hydroxylated 
 C18 can attain all possible oxidation states 
 The 7,8 double bond often undergoes oxidation and subsequent transformation 
 The 11,12 double bond of the butenolide often undergoes epoxidation 
 C13 is often oxidized, usually bearing an acetoxy group 
 
 
Figure 10: Common structural motives in furanocembranoids, including oxygenation pattern. 
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In terms of their established configurations, furanocembranoids are typically (R)-configured at C1. 
The double bond at 7,8 can be both (E)- or (Z)-configured. Interestingly, the corresponding 
epoxides appear to stem only from the (E)-configured alkenes, which could be an indication of the 
inherent instability of the other epoxides in the presence of the furan ring. (Z)-configured epoxides 
undergo rearrangements and epoxide-opening reactions to yield a tertiary alcohol at C8 (Figure 
11).[1] 
 
Figure 11: Representative members of the (furano)cembranoid family. 
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1.3.2.1 Providencin 
Providencin (1) is a naturally occurring cytotoxin isolated from the Caribbean gorgonian octocoral 
Pseudopterogorgia kallos (Bielschowsky, 1918) by Rodriguez and coworkers.[3] The sea plume was 
collected near Providencia Island (Old Providence) located in the southwestern Caribbean Sea, 
among the oceanic islands, atolls and banks of the San Andrés and Providencia Archipelago, off the 
Nicaraguan shelf.  
 
Figure 12: ORTEP diagram of Providencin with 30% probability of ellipsoids. 
1.07kg of sun dried animal specimens were frozen, cut in small pieces and extracted with a 1:1 
mixture of CH2Cl2 and methanol to result 166 g of crude extract. This was portioned between 
hexanes, CHCl3 and EtOAc. The chloroform soluble material was purified by repeated silica gel and 
size exclusion chromatography to yield 20 mg (0.0019% w/w dry weight) of pure Providencin. 
Structure elucidation was performed by 1H NMR, 13C NMR, DEPT, 1H-1H-COSY, HMQC, HMBC, two 
dimensional NOESY, HREIMS, IR and single-crystal X-ray analysis (Figure 12). Providencin was 
isolated as an amorphous colorless solid with an optical rotation of []20D=+7.9° (c = 1.2, CHCl3). Its 
highly oxygenated hexacyclic structure is based on a previously undescribed bicyclo[12.2.0] 
hexadecane ring system.[3] 
Providencin (1) shows modest in vitro cytotoxic activity against MCF-7 (breast cancer), NCI-H460 
(nonsmall lung cancer) and SF-268 (CNS cancer). 
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Biosynthetically, Providencin seems to stem from Bipinnatin E (58, Figure 13). Via a Norrish type II 
reaction a proton in -position to the furan moiety is abstracted and a stabilized benzylic radical is 
generated. After formation of an alkoxy radical both radicals recombine to the cyclobutanol ring, 
generating the final structure of Providencin (1).[1]  
 
Figure 13: Speculative biosynthesis of Providencin. 
This biosynthetic proposal is corroborated by the findings of Pattenden et al., who published in 
2006 the synthesis of a model system of the eastern part of Providencin (1). Starting from 
intermediate 68 bearing an isopropenyl group at C1, they were successful in oxidizing the allylic 
position on C17 (69), using SeO2. Thus, they were able to install a structural motif, similar to that of 
Bipinnatin E (58). After irradiation with a 400W medium pressure Hg-lamp, they could isolate the 
desired cyclobutanol model system (70) in modest yield. Therefore, the group was able to show an 
experimental proof for the proposed biosynthetic pathway (Scheme 1).[25] 
 
Scheme 1: Experimental corroboration of the proposed biosynthetic pathway of Providencin (1), by Pattenden et al. 
Structurally, Providencin (1) shows some really challenging motifs. Due to the high ring strain the 
butenolide moiety is in a perpendicular position to the furan. The four-fold substituted 
cyclobutane ring, nine stereogenic centers and the high oxygenation degree make it a demanding 
target. 
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1.3.2.2 Sarcofuranocembranolide A 
Sarcofuranocembranolide A (75) is a furanocembranoid with a rearranged unique 
8,19-bisnorfuranocembrenolide carbon skeleton featuring a 13-membered macrocycle. It was 
isolated by Namikoshi et al. by the methanolic extraction of wet Sarcophyton sp. (Manado, North 
Sulawesi, Indonesia) together with 6 other cembrane-type natural products.[26] The crude extract 
was concentrated and purified by SiO2, Sephadex LH-20 and Hypersil ODS column 
chromatographies followed by HPLC to yield 3.6 mg of pure Sarcofuranocembranolide A (75). 
Structure elucidation was performed by 1H NMR, 13C NMR, 2D NMR, HRFABMS and IR. An X-ray 
analysis is not available. 
A structural specialty of Sarcofuranocembranolide A (75) is the contracted 13-membered carbon-
macrocycle. The authors propose two different mechanisms for the ring contraction: an acyloin 
like and a semi pinacol like. Following the acyloin like pathway, the double bond first is 
dihydroxylated, followed by the oxidation of the secondary alcohol to the corresponding ketone 
(71). After an acyloin like rearrangement to intermediate 72 and deacetylation the carbon skeleton 
of Sarcofuranocembranolide A (75) is completed.[27] Following the semipinacol like pathway, the 
initiating step is an allylic oxidation at C9, followed by a dihydroxylation at C7 and C8. Now triol 73 
undergoes a semipinacol like rearrangement furnishing intermediate 74.[28] Deacetylation 
furnishes the carbon-skeleton of Sarcofuranocembranolide A (75) (Figure 14). 
 
 
Figure 14: Speculative biosynthetic rearrangements to form 13-membered macrocycle of Sarcofuranocembranolide A. 
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1.3.3 Pseudopteranes 
Pseudopteranes exhibit a slightly rearranged carbon-skeleton compared to the 
furanocembranoids. The 14-membered macrocycle is ring contracted to a 12-membered 
macrocycle accompanied by the formation of a second isopropenyl moiety (76).[1] 
Rodriguez et al. showed that upon irradiation the furanocembrane skeleton of Bipinnatin J (52) 
rearranged to the pseudopterane skeleton of Kallolide A (77) via a photochemically allowed 
suprafacial [2s + 2s] 1,3-allyl shift. Thermally, this process is also Woodward-Hoffmann allowed, 
but would proceed under inversion of configuration. Upon irradiation, the 9,10--bond of 52 
migrates suprafacially to C7 with concomitant reorganization of the -system. The configuration at 
C10 remains unchanged during the migration of the butenolide moiety (Figure 15).[29] 
 
Figure 15: [1,3]-pericyclic rearrangement from furanocembranoid Bipinnatin J to pseudopteranes Kallolide A. 
 
What remains to be investigated is whether these results represent a special case or reflect the 
general biosynthesis of pseudopteranes. Like in every living organism it is possible that these 
arrangements are, at least in some cases, enzyme mediated or occur in presence of a special 
binding protein. 
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1.3.4 Gersolanes 
Gersolanes possess a ring contracted 13-membered macrocyclic carbon skeleton. But unlike in the 
pseudopterane family, the ring contraction leads to the formation of an addition cyclopropane ring 
(78).[1] 
As in the case above, Rodriguez and coworkers published the experimental proof of the 
photochemically allowed cembrane – gersolane skeletal isomerization. The authors postulate an 
antarafacial [2a + 2a] [1,2]-group transfer. Upon irradiation, the 9,10--bond of 52 migrates 
antarafacially to C7 and C8 with retention of configuration at C10 (79). Curiously, they observed an 
inversion of configuration at C2 selectively, which indicates the ease of formation of a “benzylic” 
carbo-cation in this position. Interestingly, they furthermore found traces of the oxidized furan 
product 81, which is due to the formation of 1O2 under these photochemical conditions (Figure 
16).[29] It remains to be investigated, if this photo rearrangement is the general biosynthetic 
pathway. 
 
Figure 16: [1,2]-pericyclic rearrangement from furanocembranoid Bipinnatin J to gersolanes Pinnatin A & C. 
 
1.4 Selected Syntheses of Marine Diterpenes 
The following syntheses of diterpenoids were particularly selected with regard to their structural 
relationship to Providencin (1) and Sarcofuranocembranolide A (75). The aim was to present an 
overview of syntheses using modern synthetic chemistry methods for the construction of a 
diterpenoid carbon framework. 
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Since Providencin (1) as well as Sarcofuranocembranolide A (75) exhibit an unique structure 
(cyclobutane and 13-membered macrocycle, respectively) only structurally related compounds can 
be presented. Due to the high ring strain in (E)-configured cembranes, most of the shown 
examples possess a (Z)-double bond geometry. 
1.4.1 Dauben’s Synthesis of Cembrene[30] 
Dauben’s approach was based on the findings of Mirov and Roberts/Rowland who showed that 
isocembrol upon treatment with mild acids stereospecifically yielded cembrene (32b).[31] This 
methodology was used in the last step for the introduction of the unstable diene system of 
cembrene (32b). Starting with 82, the authors planned a nucleophilic addition – deprotection 
sequence yielding 83. A reduction – protection – reduction sequence finally led to 84, representing 
one of the two fragments of the convergent synthesis. The other fragment was synthesized 
starting from acetol THP ether by addition of vinyl lithium to yield 85. Treatment of Intermediate 
85 with ethyl orthoacetate under acidic conditions gave the Claisen rearranged product 86.[32] 
After introduction of the -keto phosphonate both fragments (87 and 84) were coupled by a HWE 
reaction giving >95% the trans isomer.[33] Reduction of the enone and acetylation yielded 
allylacetate 88. Now the stage was set for double THP deprotection, introduction of the allyl 
bromides and Ni(CO)4 mediated macrocyclization, yielding 89. Reductive removal of the acetate, 
oxidation, methyl addition and acidic alcohol elimination yielded cembrene (32b) (Scheme 2). 
 
Scheme 2: First total synthesis of the 14-membered macrocyclic core of cembrenes. 
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1.4.2 Wender’s Synthesis of (-)-(3Z)-Cembrene A[34] 
In 1985 Wender and Holt published a very short and atom economic approach to (3Z)-Cembrene 
A. Starting from (+)-Carvon (90) and by the addition of two isoprene units the authors were able to 
synthesize the target in only eight steps. In the first step methanol was added to the isopropenyl 
group under acidic conditions, affording the Markownikoff product.[35] Deprotonation with LDA 
and quenching with TfOCl afforded chloroketones 91. Now the authors planned a tandem 1,2-
addition – semi pinacol sequence,[28] which worked perfectly. First the 1,2 attack of 1-lithio-2-
methyl-1,3-butadiene (91a) to the carbonyl moiety (92), followed by addition of lithium 
isopropenyl acetylide (92a). Upon warming up the molecule smoothly underwent semi pinacol 
rearrangement and addition of the alkynylide to the transiently liberated carbonyl (93).[28] 
Subsequent addition of LAH to the reaction mixture gave intermediate 94, which was treated with 
18-crown-6 and KH to induce an anion accelerated [5,5]-sigmatropic rearrangement to compound 
95. Now the ketone was reduced under Luche conditions and the excessive 1,2 disubstituted 
double bond was reduced using Adam’s catalyst.[36] [37] After acetylation the hydroxyl group was 
removed using Birch conditions.[38] Treatment with AcOMs yielded (-)-(3Z)-Cembrene A (96) in a 
very elegant way (Scheme 3). 
 
Scheme 3: Pericyclic formation of the 14-membered macrocycle 95. 
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1.4.3 Donohoe’s Synthesis of (-)-(Z)-Deoxypukalide[39] 
Donohoe et al. synthesized a terpene starting from a terpene. The elegant synthesis used perillyl 
alcohol (97) as starting material, which was converted to its TIPS ether and then carefully 
ozonolyzed at the more electron rich double bond. The resulting aldehyde was treated with the 
vinyl alane of methylpropionate to give Morita-Baylis-Hillman adduct 98 in 48% overall yield.[40] 
Treatment of 98 with acrolein dimethyl acetal in presence of PPTS gave a diene which was 
subjected to an olefin metathesis reaction using Grubbs 2nd generation catalyst (GH2) to provide 
furan 99 after treatment with PPTS. Olefination with methyl-Wittig-ylid, cleavage of the TIPS-ether 
and subsequent TEMPO oxidation of the resulting primary alcohol to the corresponding carboxylic 
acid gave intermediate 103 in 90% yield. Furthermore, (S)-glycidol (100) was converted into its 
TBS-ether and the epoxide was opened with deprotonated TMS-acetylene. After deprotection to 
101 and carbo alumination at elevated temperature the resulting (Z)-vinyl iodide was obtained. 
This intermediate was treated with trisyl imidazole (Hicks-Fraser-Reid reaction) to give the epoxide 
which was then converted to the corresponding allyl alcohol by a protocol developed by 
Alcaraz.[41] [42] The resulting allylic alcohol was finally re-protected providing 102 in an excellent 
overall yield. After Negishi coupling of fragment 102 and 103, the silyl group was cleaved.[43] The 
secondary alcohol was used for a macro lactonization according to Shiina and the butenolide 
moiety was closed by a metathesis reaction (Scheme 4).[44] [45] 
 
Scheme 4: Donohoe’s macrolactonization strategy.  
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1.4.4 Trauner’s Synthesis of Bipinnatin J[46] 
In 2005 Trauner et al. published a protecting group free total synthesis of racemic Bipinnatin J (52). 
Starting from 3-butyn-1-ol (105) the authors performed a carbo-alumination reaction followed by 
an oxidation with Dess-Martin-Periodinane (DMP). To the resulting aldehyde 106 methyl 
propiolate was added to afford a propargylic alcohol, which was subsequently converted with allyl 
alcohol by a Ru-catalyzed Trost enyne reaction to aldehyde 107 in 52% yield.[47] Now the stage was 
set for chain elongation by a Wittig olefination.[48] The resulting aldehyde was immediately 
reduced with NaBH4 to afford allylic alcohol 108, which represents the southern fragment of the 
convergent synthesis. The northern fragment was synthesized from 3-methyl-furfural (109). In a 
single step the authors were able to lithiate position 5 (110) and subsequently transform this 
species to the corresponding stannyl furfural 111 in 85% yield by the addition of Me3SnCl. Both 
fragments were combined by a Stille cross coupling reaction in 92% yield.[49] After transforming the 
primary allylic alcohol in its bromide 112 by a modified Appel reaction using NBS and PPh3,
[50] the 
stage was set for the final key step of the synthesis: the transformation of 112 by a Nozaki-
Hiyama-Kishi reaction to Bipinnatin J (52) in 59% yield.[51] Remarkably, almost only a single 
diastereoisomer (d.r. > 9:1) was formed, which was explained by the rigidity of 113 and the 
defined six-membered transition state of the reaction (Scheme 5). 
 
Scheme 5: Trauner’s protecting group free synthesis of Bipinnatin J (52).  
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1.4.5 Pattenden Synthesis of (+)-Intricarene[52] 
In 2006 Pattenden presented a stereoselective synthesis of Intricarene (119). In fact this total 
synthesis made use of the actuality that Bipinnatin J (52) could be transformed in a biomimetically 
manner into Intricarene, so two total syntheses actually were presented. As the starting material 
compound 114 was used. Donhoe et al. made use of its enantiomer two years later for the 
synthesis of Deoxypukalide (104).[39] Compound 114 was transformed into the corresponding 
epoxide 115, which was attacked by the sodium-enolate of 115a in a non stereo specific way. After 
closure of the lactone and elimination of the selenium-species a Stille coupling with 3-methyl-
furfurylstannane (111) was performed.[49] Hydroxy-bromide exchange and subsequent NHK ring 
closure completed the synthesis of Bipinnatin J (52).[51] An Achmatowicz-type reaction and 
acetylation afforded intermediate 117, which formed upon treatment with base 1,3-dipol 118.[53] 
This underwent a [5+2] cycloaddition to Intricarene (119) in overall 10% yield (Scheme 6). 
 
Scheme 6: Pattenden’s [5+2] cycloaddition approach to Intricarene 119. 
 
1.4.6 Marshall’s Synthesis of Kallolide A[54] 
This landmark synthesis was published in 1998. It started with TBS-protected pent-4-yne-1-ol 
(120), which was C1 chain elongated at C5. The resulting primary alcohol was protected and the 
TBS group was cleaved. After an oxidation, (E)-selective Wittig olefination, reduction sequence 
allylic alcohol 121 was obtained,[48] which was transformed first into its chloride by an Appel 
reaction and then to the corresponding allylstannane by lithiation and adjacent transmetalation.[50] 
Intermediate 122 represented the southern fragment of the convergent synthesis. The northern 
fragment was synthesized starting from 123.  
22 
 
Conversion with Me3SnLi gave allene 124, which was reacted with benzoyl protected 
glycolaldehyde. After oxidation and basic allene formation (125), aromatization was performed 
under AgNO3 catalysis. Seven steps were needed to transform 126 into 127. BF3
.OEt2 mediated 
fragment coupling furnished the syn SN
2’ product, which was converted to 128. A Finkelstein 
reaction,[55] subsequent reduction of the ester and a Williamson’s macro-etherification were 
conducted.[56] Intermediate 129 was treated with n-BuLi and smoothly underwent a [2,3]-Wittig 
rearrangement. The resulting propargylic alcohol was mesylated. Pd2dba3 mediated CO insertion in 
the presence of TMSCH2CH2OH gave the allenic ester, which had to be cis/trans isomerized with 
PPh3. TBAF mediated silyl deprotection followed by an oxidative butenolide formation afforded 
intermediate 131, which only had to be isomerized at the C2 position. This was performed via a SN
1 
mechanism, according to findings of Abramson et al. (Scheme 7).[57] 
Scheme 7: Marshall’s synthesis of Kallolide A using extensive allene chemistry.  
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1.4.7 Trauner’s Syntheses of Coralloidolides A, B, C and E[58] 
In 2010 Trauner et al. published biomimetic skeleton rearrangements of Bipinnatin J furnishing the 
Coralloidolide series. Interestingly, the Coralloidolides were the first furanocembranoids found in a 
Mediterranean organism, in contrast to most other members of the family, which are of Caribbean 
origin. Bipinnatin J (52) was reduced with Et3SiH and CF3CO2H to Rubifolide (51). Scheffer-Weitz 
conditions led to Coralloidolide A (53).[59] Subsequent oxidation with mCPBA gave Coralloidolide E 
(132). Under Lewis acidic conditions Coralloidolide E (132) rearranged to Coralloidolide B (59), 
whereas under basic aldol conditions it gave Coralloidolide C (61). The authors report that both 
transformations were challenging. Therefore a careful screening of reagents was necessary to 
provide selective conversions (Scheme 8). 
 
Scheme 8: Trauner’s biomimetic transformations in the Coralloidolide-series. 
  
24 
 
1.4.8 Paquette’s Synthesis of Acerosolide[60] 
In 1993 Paquette et al. published the first total synthesis of a 14-membered furanocembranoide. 
Starting from acetonide protected glyceraldehydes (134) the authors were able to synthesize furan 
136 in a very short and concise sequence. After Swern oxidation,[61] isopropenyl-Grignard addition 
and acetylation (137), a Pd-mediated Tsuji-Trost reaction afforded allyl stannane 138 in an 
inconsequential mixture of double bond isomers.[62] This intermediate was reacted with aldehyde 
139 to give compound 141 as a single double bond isomer via chair like transition state 140. Now 
the stage was set for the acidic closure of the butyrolactone. After introduction of two phenyl-
selenium groups, one in -position of the furan, the other in -position of the lactone, the mixed 
acetal next to the furan was oxidatively deprotected using AgClO4. Now, the second selenium 
group was oxidatively eliminated with NaIO4 to yield compound 142. Intermediate 142 was 
reduced and brominated. After a Pd-mediated Stille cross coupling 143 was obtained in satisfying 
yield.[49] Deprotection-bromination and deprotection followed by oxidation gave the 
macrocyclization precursor, which was cyclized under NHK conditions via transition state 144.[51] A 
final oxidation step completed the synthesis of Acerosolide (145) ( Scheme 9). 
 Scheme 9: Paquett’s synthesis of Acerosolide. 
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1.4.9 Pattenden’s Synthesis of Bis-Deoxylophotoxin[63] 
Pattenden’s approach started with (R)-(-)-epichlorhydrin (146). TMS-acetylene selectively opened 
the epoxide. The formation of a Schlosser-Fouquet product was not observed.[64] Carboalumination 
provided (E)-vinyl iodide 147. Construction of the butyrolactone and introduction of the phenyl 
selenyl ether furnished selenolactone 148. The eastern fragment was synthesized 
enantioselectively using diastereoselective Evans’ auxiliary induction.[65] Therefore, 149 was 
alkylated with 2-bromomethyl-3-furoate in satisfying yield. After reductive cleavage of the 
auxiliary and tosylation of the resulting alcohol (150), the ethylester was reduced with DIBAL-H to 
the corresponding alcohol. Now the stage was set for C1-elongation with n-Bu4NCN, protection of 
the furanoic primary alcohol to yield 151. A two step reduction protocol of the cyanide to the 
corresponding alcohol, treatment with n-BuLi and Me3SnCl and subsequent oxidation finished the 
eastern fragment 152. Both fragments were coupled in an aldol reaction and the phenylselenium 
ether was oxidatively eliminated. An intramolecular Stille reaction under the conditions described 
by Farina et al. (addition of AsPh3) led to the desired macrocycle 153,
[66] that was further 
acetyleated, deprotected and oxidized to bis-Deoxylophotoxin (154) (Scheme 10).  
 
Scheme 10: Pattenden’s auxiliary based synthesis of bis-Deoxylophotoxin. 
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1.4.10 Myer’s Synthesis of (±)-7,8-Epoxy-4-basmen-6-one[67] 
Starting with commercially available neryl acetone (155) the authors presented the total synthesis 
of racemic 164 in 1993, isolated from tobacco. After the addition of lithium acetylide to 155, the 
resulting propargylic alcohol was mesylated and treated with the dianion of methyl acetoacetate. 
Diethyl chloro phosphate was added, resulting in vinyl phosphate 156. Conjugate methyl addition, 
saponification, conversion into the acid chloride and macrocyclization by conditions developed by 
Kato et al. finally yielded 157.[68] Conjugate reduction, treatment with DBU and subsequent 
reduction using methanolic SmI2 led to 158. After epimerization with DBU and reduction of the 
ketone, the resulting secondary alcohol was acylated with m-(trifluoromethyl)benzoyl chloride. 
Irradiation of intermediate 159 and subsequent isomerization of the resulting double bonds led to 
161, via a 5-exo-trig pathway. The stereochemistry at C11 was inverted. Therefore, the authors 
had to oxidatively cleave the double bond, selectively protect the methyl ketone as its 
dithioacetale, perform a Knoevenagel condensation with benzaldehyde and,[69] finally, perform the 
epimerization at C11 via the silylenolether 162. A deprotection, McMurry coupling,[70] epoxidation, 
glycol-cleavage sequence was necessary furnishing intermediate 163. Installation of a final double 
bond yielded the desired 7,8-Epoxy-4-basmen-6-one (164) (Scheme 11). 
 
Scheme 11: Myer’s radical transannular cyclization of a modified neocembrene skeleton.  
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1.5 Mechanisms of the Key Furan Cyclizations 
In the following, a short overview and substrate scope of the used key furan cyclization is 
presented. The generation of a furan moiety is always accompanied with the generation of rigidity, 
but also the generation of aromatization energy. By a detailed discussion of the pertinent 
mechanism, a deeper understanding of the reactions’ success or failure is obtained. 
The Wipf Cyclization:[71] 
This protocol is based on the fact, that alkynyl ketone enolates undergo a thermal SN
2’ O-alkylation 
to provide the desired vinyl furans. Starting materials 165 are easily obtained by the alkylation of 
-keto esters with the corresponding propargylic iodides. The initial step is the basic enolization of 
the carbonyl to 166. The newly formed enolate 166 attacks the propargylic carbonate via a SN
2’-
mechanism, forming fulvenoid structure 167. During this process CO2 and ethanol is liberated, 
which is an enormous entropic advantage. Furthermore, 167 smoothly forms the heteroaromatic 
compound 168, due to liberation of the aromatization energy. An alternative mechanism takes 
place, if a Pd-catalyst is used. Starting with a Tsuji-Trost like formation of a Pd-allene species 
169,[62] followed by a nucleophilic attack of the enolate of -keto ester (170), intermediate 172 is 
formed. This can tautomerize to furan 168 (Scheme 12).  
 
Scheme 12: Mechanism of the Wipf furan cyclization, (a) base mediated; (b) Pd-mediated. 
As long as the substrates are base stable, or do not possess any functional groups, able to perform 
oxidative addition reactions (Pd-catalyst), this is a very versatile and useful method for the 
construction of vinyl furan moieties. Although this method facilitates the construction of 2,3,5-
trisubstituted vinyl furans, it has a major disadvantage: the outcome of the geometry of the 
benzylic double bond cannot be controlled externally and is just substrate controlled.  
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The Krische Cyclization:[72] 
The Krische protocol is based on the postulate that -acyloxy butynoates 173 react with 
stoichometric amounts of triphenylphosphine to allenic esters 176, which, upon treatment with 
catalytic amounts of triphenylphosphine (or transition metal catalysts) react further to the 
substituted furans 179. The starting material 173 is easily obtained by nucleophilic addition of 
propiolates to aldehydes, followed by an esterification with the desired carboxylic acid. The 
reaction starts with a conjugate addition of triphenylphosphine to the propiolate subunit. The 
newly formed nucleophile attacks the carbonyl moiety of the ester functionality and forms 
intermediate 174. Compound 174 rearranges intermediately to betaine structure 175, which upon 
elimination of triphenylphosphineoxid, releases allenic ester 176. Conjugate addition of a catalytic 
amount of triphenylphosphine leads to intermediate 177, which can cyclize to phosporylide 178. 
After a [1,2]-hydride shift, elimination of triphenylphosphine and aromatization to a 2,3,5-
trisubstituted furan (179) the sequence is finished (Figure 17). Furan cyclization proceeds most 
efficiently for substrates that embody electron deficient -acyloxy moieties, but work as well for 
other substrates. 
 
product 
 
yield 72% 81% 91% 77% 
product 
 
yield 83% 86% 83% 71% 
Figure 17: Mechanism of the Krische cyclization and selected examples.  
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2 Results and Discussion 
Providencin 
Providencin (1) drew our attention due to its complex molecular architecture and the ambition of 
accomplishing the first total synthesis of this amazing diterpene. From an organic chemist’s point 
of view, the challenging hexacyclic structure of Providencin (1) and its very high degree of 
oxygenation (carbon/oxygen ratio = 2.3/1) make it an interesting synthetic target. Furthermore, 
possible medicinal applications require a larger amount of 1, than the 20 mg batch isolated from 
the Caribbean gorgonian octocoral Pseudopterogorgia kallos.[3] 
The main challenge of the synthesis of this molecule was the closure of the highly strained 13-
membered macrocycle. Due to the high steric rigidness of the carbon skeleton (furan moiety in 
close proximity to the cyclobutane, butenolide moiety and “benzylic” epoxide) and the known high 
Prelog strain of 13-membered macrocycles,[73] macrocyclization techniques with a large entropic 
or enthalpic driving force were needed.[4, 6, 74] Therefore, either the metathesis reaction or the 
HWE reaction was chosen as the main strategy for macrocyclization.[5] 
Another synthetic challenge was the regioselective installation of the 2,3,5-trisubstituted furan 
moiety. Many synthetic methodologies are known for the synthesis of furans,[75] but most of them 
either often require harsh reaction conditions, which are not suitable for highly functionalized 
molecules, or, build up the furan core from a linear, 1,4-dioxosubstituted alkyl chain. The second 
reason makes a convergent synthesis nearly impossible, thus, the methods presented by Wipf et 
al. and Krische et al. attracted our interest.[71-72] 
2.1 Cyclobutane Series (cBu) 
The idea of the cyclobutane series was the early introduction of the cyclobutane moiety into the 
molecule, since thermal or photochemical methods for the installation of a cyclobutane moiety 
often prove to be too harsh for highly functionalized molecules. Therefore, a starting material, 
already containing the desired moiety was chosen: (±)-cis-bicyclo[3.2.0]hept-2-en-6-one (180) 
(Scheme 13). 
 
Scheme 13: Starting material of the cBu-series.  
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2.1.1 General Retrosynthetic Analysis 
The first scissions of the retrosynthetic analysis were identical for all approaches of the cBu-series. 
Starting with the removal of the allylic alcohol and the exo-methylene group on the cyclobutane 
moiety, leading to intermediate 181, molecule degradation was continued by the reductive 
removal of the epoxides, which finally led to key intermediate 183. The further systematic 
degradation of intermediate 183 differed mainly in the construction of the furan moiety and is 
described below (Scheme 14). 
 
Scheme 14: Retrosynthetic simplification of Providencin (1) to key intermediate 183. 
 
2.1.2 Wipf’s Furan Cyclization Approaches 
All these approaches shared the palladium or base mediated furan closure developed by Wipf and 
coworkers,[71] where -keto ester 195 was alkylated by different propargylic iodides. This method 
provided a very convergent approach, since complexity could be introduced through a simple 
alkylation reaction. 
2.1.2.1 Ring Closing Metathesis Attempts 
The intramolecular metathesis reaction provides many advantages, like an exothermic reaction 
profile, an increase of entropy and a high functional group tolerance. These convincing 
characteristics make it a promising choice for the macrocyclization reaction. Nevertheless, there 
are limitations, like hardly any possibilities for controlling the geometry of the formed double 
bond. 
 
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2.1.2.1.1 7,8 Metathesis Approach 
This approach is the most convergent one and has many advantages: The furan moiety, the 
butenolide moiety, as well as the cyclobutane moiety are already in place and only minor 
modifications have to be done after closing the strained macrocycle.  
Retrosynthetic Analysis:  
The simplification of key intermediate 183 started with the opening of the 14-membered carbo 
macrocycle at 7,8, followed by the cleavage of the 12,13 single bond, resulting in two equally large 
fragments 184 and 185. Compound 184 could be further simplified to -keto ester 195, which 
could be derived from racemic (±)-cis-bicyclo[3.2.0]hept-2-en-6-one (180). The other fragment 185 
could be simplified to (R)-glycidol (186), which is a cheap, chiral, and readily available starting 
material (Scheme 15). 
 
Scheme 15: Retrosynthetic analysis of key intermediate 183 to commercially available starting materials. 
Synthesis: 
The synthesis started with racemic (±)-cis-bicyclo[3.2.0]hept-2-en-6-one (180), that was reduced 
with NaBH4 at low temperature using the open-book-effect to achieve a d.r. of >95:5. The resulting 
secondary alcohol was acetylated with chloro acetic acid anhydride yielding intermediate 189, 
which was subjected to enzymatic chiral resolution using Lipase SAM II. The desired (1S,5R,6S)-
isomer stayed untouched and was saponified using aqueous LiOH. Esterification of an analytical 
sample with (S)-Mosher’s chloride and analysis by 19F-NMR showed an e.e. of 98%.[76] Primary 
alcohol 190 was protected as its TIPS-ether 187 and subjected to ozonolysis followed by reductive 
work up with NaBH4. This completed the synthesis of key intermediate 191 (Scheme 16). 
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Scheme 16: Diastereoselective synthesis of intermediate 191. 
The less hindered primary alcohol of diol 191 is converted to its MMTr-ether. Since both hydroxy 
moieties only have minor steric differences, this reaction proved to be troublesome in terms of 
regioselectivity. Figure 18 shows the used conditions and its results. Thereby, -42 °C proved to be 
the optimal temperature. Lower temperatures only resulted in dramatically longer reaction times, 
and higher temperatures resulted in worse regioselectivity. The correctness of the regiochemistry 
was approved by NOESY and HMBC experiments. Double-MMTr protected diol (192) was 
deprotected with CSA, thus recovering diol 191 (Figure 18). 
 
base NEt3 NEt3 NEt3 NEt3 py py py py 
temperature r.t. 0 °C -42 °C -78 °C r.t. 0 °C -42 °C -78 °C 
equivalents 193 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
equivalents 188 1.0 1.6 3.7 3.8 1.0 1.7 4.1 4.2 
Figure 18: Selectivities for the mono-MMTr-protection of 188 and synthesis of key intermediate 195. 
With 188 in hands, the stage was set for the oxidation of primary alcohol 188 to the corresponding 
aldehyde,[77] using IBX as oxidizing agent.[78] Epimerization at C1 with K2CO3 (194) and C2-
elongation was performed by a Reformatzky reaction and an aldol reaction,[79] but the latter gave 
worse yields (quantitative vs. 83%). The resulting secondary alcohol moiety was again oxidized 
with IBX,[78] giving key intermediate, -keto ester 195 in very high yield (Figure 18). 
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The short synthesis of the side chain 188 was accomplished in two steps. But-2-yne-diol (196) was 
converted to its mono-methyl carbonate 197, using methyl chloroformate, followed by an 
iodination of the remaining primary propargylic alcohol under modified Appel conditions (Scheme 
17).[50] 
 
Scheme 17: Synthesis of the side chain. 
Deprotonation of -keto ester 195 with NaH and subsequent alkylation with 198 furnished the 
furan cyclization precursor 199. Unfortunately, the standard Wipf cyclization emerged difficultly 
and the yields never exceeded 45%. After some optimization, the yield could be improved to 78%, 
95% based on recovered starting material, respectively (Figure 19). Finally, rather simple base 
catalysis (K2CO3) yielded vinylfuran 200 in acceptable yields. At this stage, the MMTr-group was 
cleaved and the resulting primary alcohol was oxidized with IBX to the corresponding aldehyde 
201. This sequence made the northern fragment 201 accessible in a very concise manner (Figure 
19). 
 
reagent 
Pd(OAc)2 
K2CO3 
THF 
Pd(OAc)2 
K2CO3 
CH3CN, H2O 
Pd(OAc)2 
K2CO3 
dioxane, µW 
Pd(OAc)2 
K2CO3 
THF, µW 
Hg(OAc)2 
 
benzene 
Hg(OTf)2 
 
benzene 
yield 42% 34% 35% 37% up to 40% Up to 40% 
reagent 
AgOTf 
 
benzene 
AgIO4 
 
acetone 
Ag(O2CCF3)2 
 
CaCO3 
AgNO3 
CaCO3 
acetone 
K2CO3 
 
DMF, µW 
K2CO3 
 
DMF 
yield 31% decomp. 14% 27% 65% 78% 
Figure 19: Optimization of the furan cyclization and completion of the northern fragment 201. 
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The synthesis of the southern fragment started with the tosylation of (R)-glycidol (186). The 
resulting (S)-configured tosylate was further converted by a Cu(I)-mediated epoxide opening 
reaction into secondary homoallylic alcohol 202. The formation of the enantiomeric Schlosser-
Fouquet product was not observed,[64] probably due to the fact that vinyl cuprates are soft 
nucleophiles, which preferentially attack soft electrophiles, according to the HSAB concept. 
Secondary alcohol 202 was transformed to its corresponding epoxide, which subsequently was 
opened by the in situ generated dianion of phenyl selenyl acetic acid (203), yielding seco acid 204. 
Highly diluted Steglich esterification using diisopropylcarbodiimide (DIC) yielded the southern 
fragment 185 (selenolactone) in high yields as an inconsequential mixture of diastereo isomers 
(d.r. = 1.5:1) (Scheme 18).[80] 
 
Scheme 18: Synthesis of the southern fragment 185. 
With both fragments in hand, the stage was set for fragment combination. This was accomplished 
by an aldol reaction, using LDA as the non-nucleophilic base. Subsequent oxidative selenoether 
elimination furnished butenolide 205, which was the direct metathesis macrocyclization precursor. 
After some unsuccessful attempts, RCM using Grubbs’ 2nd generation catalyst afforded the desired 
macrocycle in acceptable yields. Unfortunately, the geometry of the formed 7,8 double bond was 
(Z)-configured. Among other catalysts, only the Grubbs-Hoveyda 2nd generation catalyst showed 
conversion, but in lower yields. The C13-diastereoisomer could easily be separated by silica gel 
column chromatography at that stage. Acylation with acetic anhydride gave allylic acetate 206 in 
quantitative yield (Figure 20). 
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catalyst G1 G2 GH2 G1 G2 GH2 
solvent () CH2Cl2 CH2Cl2 CH2Cl2 benzene benzene benzene 
result s.m. (205) s.m. (205) s.m. (205) s.m. (205) 46% 39% 
Figure 20: Macrocyclization of 205 and further conversion to 207. 
The next step in the ongoing synthesis of Providencin (1) was the installation of the epoxide at the 
electron poor double bond of the butenolide. Surprisingly, classical Scheffer-Weitz conditions with 
ensuing acetylation gave unexpected epoxy-ketone 210 (Scheme 19). But NaOCl as oxidizing agent 
smoothly provided the desired epoxide 207 as single diastereoisomer (Figure 20).[81] 
 
Scheme 19: Unexpected ketone formation during epoxidation. 
Although the macrocycle was closed, the double bond geometry and so the geometry of the in 
future installed benzylic epoxide was inverted. Therefore, many attempts for double bond 
inversion were performed. Methods using radical mechanisms are summarized in Figure 21. 
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reagent I2 I2, h (vis) Ph2Se2 I2 I2, h (vis) Ph2Se2 
solvent () CH2Cl2 CH2Cl2 THF CH2Cl2 CH2Cl2 THF 
s.m. 206 206 206 207 207 207 
result s.m. (212) s.m. (212) s.m. (212) s.m. (213) s.m. (213) s.m. (213) 
reagent I2 I2, h (vis) Ph2Se2 I2 I2, h (vis) Ph2Se2 
solvent () CH2Cl2 CH2Cl2 THF CH2Cl2 CH2Cl2 THF 
s.m. 210 210 210 211 211 211 
result s.m. (214) s.m. (214) s.m. (214) s.m. (215) s.m. (215) s.m. (215) 
Figure 21: Unsuccessful radical double bond isomerization conditions. 
Unfortunately, these radical conditions proved to be ineffective. To overcome these problems, a 
different strategy was applied, starting with a hydroboration of the undesired (Z)-olefin 207. The 
general idea was a syn addition and an anti elimination following an E2-mechanism. This should 
invert the double bond geometry, but all attempts to yield the desired borated product 216 failed 
under standard conditions (Scheme 20). 
 
Scheme 20: Attempted double bond inversion by hydroboration/elimination sequence. 
Apart from these attempts for double bond geometry inversion, many other different strategies 
were tested by Gaich,[82] like a bromohydrin strategy, a Corey-Winter strategy,[83] and many others. 
Unfortunately, these experiments did not deliver the desired (E)-double bond either. 
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Scheme 21: (a) Successful double bond inversion by irradiation of 207; (b) Spectroscopic evidence for (E)-double bond 
geometry. 
(Photo)isomerization of carbon-carbon double bonds is a well known synthetic tool,[84] but due to 
the disappointing results of the initial isomerization experiments this approach was abandoned for 
a while. But life is a double edged sword. In 2010 Pattenden and coworkers published a UV-light 
mediated double bond isomerization on a member of the furanocembranoid family (Z-(+)-
Deoxypukalide).[85] Inspired by their promising results, the advanced intermediate 207 was 
irradiated with a 100W UV-bulb. To our delight, we observed a smooth conversion to the highly 
strained (E)-macrocycle 213, which showed a rotational barrier and therefore coexisted as a 
mixture of multiple atropisomers. Figure 22 shows the evolution of a clean NMR-spectrum at 
elevated temperatures. Careful 2D-NMR experiments (COSY, HSQC, HMBC, NOESY) clearly showed 
successful isomerization of the 7, 8 double bond (Scheme 21). 
 
Figure 22: Temperature dependence of the NMR-spectra of atropisomers 213.  
H5 H7 H11 
H10 
H11 
H15 
OMe 
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2.1.2.1.2 9,10 Metathesis Approach 
This approach shares some ideas with the first one, but has some major advantages. The 
stereoselective introduction of the secondary 13-alcohol using auxiliary based chemistry and the 
independency of the outcome of the 9,10 double bond geometry after macrocyclization by 
metathesis. Nevertheless, many compromises have to be taken, like the removal of the allylic 
halogen after halolactonization and the late stage introduction of the butenolide 11,12 double 
bond.  
Retrosynthetic Analysis: 
The first retrosynthetic simplification of key intermediate 183 was the opening of the southern 
butenolide, resulting in the free carboxylic acid 219. The next step was the opening of the 14-
membered macrocycle between 9,10 yielding triene 220. Scission of the 12,13 single bond and 
opening of the furan gave an alkylated -keto ester, which could be further simplified to 195 and 
221 (Scheme 22). 
 
Scheme 22: Retrosynthetic analysis of the 
9,10
 metathesis approach. 
Synthesis: 
Deprotonated literature known PMB-protected propargylic alcohol 222a was added to the 
carbonyl moiety of methyl-vinyl-ketone (MVK).[86] The formation of a 1,4-addition product was not 
observed. The resulting tertiary alcohol 223 was transformed to its corresponding benzoate, using 
the protocol developed by Vedejs et al.[87] Oxidative cleavage of the primary PMB-ether yielded 
224 and subsequent transformation to the propargylic iodide using Appel conditions gave 
alkylation fragment 221 in high overall yield (Scheme 23).[50] 
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Scheme 23: Synthesis of the alkylation side chain 221. 
In analogy to the 7,8 metathesis approach, -keto ester 195 was deprotonated with NaH and 
alkylated with propargylic iodide 221 giving intermediate 226. Furan cyclization of 226 proofed to 
be troublesome. Under standard, as well as slightly modified Wipf conditions yields never 
exceeded 15% of a mixture of double bond isomers (E/Z = 4/1).[71] A possible reason could be the 
formation of a completely conjugated diene system, which is predisposed for Pd-coordination, 
activation and further (unselective) transformation. But with 227 in hands, the stage was set for 
the acid catalyzed liberation of the primary alcohol and subsequent oxidation to the corresponding 
aldehyde 228 using IBX as oxidizing agent (Figure 23). 
 
reagent Pd(OAc)2, dppf, K2CO3 Pd(OAc)2, dppf, K2CO3 K2CO3 
solvent CH3CN THF DMF 
result decomposition decomposition 15% yield (E/Z = 4/1) 
Figure 23: Furan cyclization and completion of the northern fragment 228. 
In this approach, secondary alcohol 231a should be generated stereoselectively using Evans’ aldol 
methodology. Therefore, (4S,5R)-4-methyl-5-phenyloxazolidin-2-one was acylated with pent-4-
enoic acid in a Steglich esterification using DIC.[80] Using Bu2BOTf two possible syn aldol adducts 
can be generated,[65] but using the chiral induction of the EPHOX-auxiliary additional, aldol product 
231a could be generated via transition state 230 as a single diastereomer (Scheme 24). 
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Scheme 24: Transition state of the boron aldol and therewith generated stereochemistry. 
With the bulky auxiliary still in place, 231a, b was subjected to a ring closing metathesis reaction 
using different ruthenium based catalysts and substitution patterns on C13-OH (Figure 24). 
Unfortunately none of the applied conditions led to the desired macrocycles 232a, b, instead a 
homodimerization at the 10,10a-double bond took place, most likely due to a precoordinating 
effect of the heteroatoms of the auxiliary towards the metathesis catalysts.  
 
catalyst G1 G1 G2 G2 G3 G3 
solvent () CH2Cl2 benzene CH2Cl2 benzene CH2Cl2 benzene 
s.m. 231a 231a 231a 231a 231a 231a 
result s.m. s.m. s.m. homodimer s.m. homodimer 
catalyst G2 G2 G3 G3 GH2 GH2 
solvent () CH2Cl2 benzene CH2Cl2 benzene CH2Cl2 benzene 
s.m. 231b 231b 231b 231b 231b 231b 
result s.m. homodimer s.m. homodimer s.m. homodimer 
Figure 24: (a) Unsuccessful attempts for the macrocyclization; (b) Structures of used metathesis catalysts. 
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Since the macrocyclization attempts of 231a and 231b only led to homodimerization, hydrolytic 
cleavage of the auxiliary was carried out prior to further RCM attempts. Therefore, standard 
conditions using the nucleophilicity enhancing -effect of lithium-hydroperoxide were applied.[88] 
With the free alcohol moiety of 231a, the ring opened product 233 was obtained, whereas with 
the TBS-protected alcohol 231b no reaction to compound 234 was observed (Scheme 25). Any 
attempts to remove the auxiliary by the addition of thiolates failed.[89] Methanolysis did not lead to 
the formation of the desired product either.[90] 
 
Scheme 25: Hydrolytic auxiliary cleavage attempts of 231a, b. 
2.1.2.1.3 10,11 Metathesis Approach 
Similar to the second approach, this approach benefits from the stereoselective introduction of 
the secondary C13 alcohol by an Evans-type auxiliary methodology and the independency of the 
10,11 double bond geometry, generated by metathesis-macrocyclization. Furthermore, the -
lactone is closed by a 5-endo halolactonization, generating a secondary alkylhalide, which can be 
subsequently eliminated to the corresponding butenolide double bond by sterically demanding 
pyridine bases.[91] [92] Besides, the troublesome diene, generated by Wipf’s furan cyclization 
strategy and the allyl halide, generated by halolactonization in the former approach (218), are 
avoided. 
Retrosynthetic Analysis: 
The first retrosynthetic step was the anti-Markovnikoff addition of hydrogen iodide to key 
intermediate 183. After retro-halolactonization, the next step was the scission of key intermediate 
235 at the 10,11 carbon-carbon bond. Further simplification was achieved by the opening of the 
14-membered macrocycle at 10,11 yielding triene 236. Scission of the 12,13 bond and opening of 
the furan gave alkylated -keto ester, which could be further simplified to 195 and 237. Compound 
237 again, could be derived from N-acetylmorpholine (238) (Scheme 26). 
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Scheme 26: Retrosynthetic analysis of the 
10,11
 metathesis approach. 
Synthesis: 
THP-protected propargylic alcohol 222b was deprotonated with LiHMDS and added to 
N-acetylmorpholine (238). The formed hemiaminal gave methylketone 239 upon aqueous workup. 
The hard nucleophile allyl magnesium bromide was added to the carbonyl moiety of 239 and the 
resulting tertiary alcohol was benzoylated using the protocol developed by Vedej.[87] The resulting 
tertiary benzoate 240 was treated with DOWEX 50x4 to liberate the primary propargylic alcohol, 
which was subsequently transformed to the corresponding propargylic iodide 237 by modified 
Appel conditions (Scheme 27).[50] 
 
Scheme 27: 5-step synthesis of the side chain fragment. 
Readily available -keto ester 195 was deprotonated with NaH and subsequently alkylated with 
237. The resulting compound 241 was cyclized under basic conditions to vinylfuran 242,[71] which 
was again deprotected with PPTS and oxidized using IBX as oxidizing agent to provide northern 
fragment 243 in very good overall yield (Scheme 28). 
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Scheme 28: Alkylation, furan closure and completion of the northern fragment. 
Like in the former approach, the secondary alcohol should be generated stereoselectively using 
Evans’ aldol chemistry. Therefore, (4S,5R)-4-methyl-5-phenyloxazolidin-2-one was acylated with 
crotonic acid chloride, according to literature.[93] -Deprotonation with NEt3 and Bu2BOTf provided 
the (Z)-enolate, which reacted, due to the chiral auxiliary in -position over transition state 245 in 
a highly diastereoselective way to syn aldol product 246 (Scheme 29). 
 
Scheme 29: Transition state of the boron aldol and therewith generated stereochemistry. 
With the macrocyclization precursor 246 in hands, the stage was set for the synthesis’ key step: 
the RCM reaction. First tries with the auxiliary still in place only led to the C10-C10 homodimerized 
product, even when using different substitution patterns at C13-OH (246a, b). The change to 
fluorinated solvents, which should increase the power of the used catalysts, had no effect on the 
formed products.[94] Reductive or hydrolytic cleavage of the auxiliary and subsequent metathesis 
once again led to the dimerized products,[88] probably again due to an effect of precoordination of 
the metathesis catalyst by the alcohol moieties in 247 and 249. Therefore, both alcohols were 
protected as their silyl ethers to prevent this phenomenon and the resulting precursor 248 was 
subjected to a ring closing reaction. But in these cases as well, only the C10-C10 homodimers 
(homo 246-249) could be detected (Figure 25). 
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catalyst (solvent) G2 (C6H6) G2 (C6H6) G2 (C6H6) GH2 (C6H6) G2 (C6F6) 
s.m. 246a 246b 247 247 247 
result homodimer homodimer homodimer homodimer homodimer 
catalyst (solvent) G2 (C6H6) GH2 (C6H6) G2 (C7H8) G2 (C6F6) G2 (C6H6) 
s.m. 248 248 248 248 249 
result homodimer homodimer homodimer homodimer homodimer 
Figure 25: 
10, 11
 Metathesis experiments and their outcome. 
During the macrocyclization attempts shown in Figure 25, it could be observed, that the molecule 
avoided macrocyclization and rather underwent homodimerization. Therefore, the introduction of 
a rigid ring system, to make the unreactive olefin more accessible towards the metathesis reaction 
was plausible. Thus, an acetonide was installed and tricycle 254 was subjected to RCM reaction. 
Unfortunately, this idea proved to be unsuccessful as well and only the C10-C10-homodimer was 
formed (Figure 26). 
 
catalyst (solvent) G2 (benzene) GH2 (benzene) G3 (benzene) 
result homodimer homodimer homodimer 
Figure 26: Generation of another 
10,11
 metathesis precursor and cyclization attempts. 
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2.1.2.1.4 11,12 Metathesis Approach 
This approach should make use of the 11,12-double bond generated by olefin metathesis to build 
up the butenolide structure. But it is noteworthy to mention, that, unlike in the auxiliary based 
approaches, the outcome of the double bond geometry is essential. An (E)-geometry is needed, to 
build up the butenolide successfully. Another advantage is the fixed (E)-geometry of the 7,8-
double bond, that is generated by the Wipf method.[71] 
Retrosynthetic Analysis: 
The first retrosynthetic simplification of this approach was the opening of the butenolide lactone, 
leading to intermediate 256. The ester was reduced to its corresponding allylic alcohol and the 
macrocycle was opened giving triene 257, which was further simplified by the removal of the 
mono substituted double bond at C11. Finally, the scission of the 12,13-carbon bond led to the 
removal of allyl alcohol in the south-east and to intermediate 258. The furan moiety was opened 
and the -keto ester dealkylated to 195. The propargylic moiety of the side chain was removed, 
leading to a methyl ketone, which was derived from L-(-)-malic acid (Scheme 30). 
 
Scheme 30: Retrosynthetic analysis of the 
11,12
 metathesis approach. 
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Synthesis: 
L-(-)-Malic acid was converted to its dimethyl ester, which was chemoselectively reduced to the 
corresponding diol 260.[95] [96] Both alcohol moieties in 260 were protected as their TBS-ethers and 
subsequently converted to the Weinreb amide derivative,[97] which was further transformed to 
methyl ketone 261 by the addition of methyl magnesium bromide (Scheme 31). 
 
Scheme 31: Stereoselective synthesis of methyl ketone 261. 
Deprotonated 222a was subsequently added to methyl ketone 261. The formed tertiary alcohol 
was obtained in a diastereo enriched way (d.r. = 4:1). Due to the loss of this stereo center during 
the following furan closure, the mixture was used and therefore converted to the corresponding 
benzoates 262 using the Vedejs protocol.[87] After oxidative cleavage of the PMB protecting group 
using DDQ, the primary alcohol was transformed into the corresponding propargylic iodide 259 by 
an Appel-reaction (Scheme 32).[50] 
 
Scheme 32: Completion of the side chain 259. 
After deprotonation with NaH, well established -keto ester 195 was alkylated with propargylic 
iodide 259. The resulting product 263 was then cyclized to vinyl furan 258 (E/Z = 4/1) using the 
methodology of Wipf.[71] Unfortunately, to the best of our knowledge, there is no possibility of 
controlling the double bond geometry by external methods, like ligand design. Only substrate 
dependent sterical parameters have an influence on the (E/Z)-ratio (Scheme 33). 
 
Scheme 33: Alkylation of 195 and furan closure by Wipf‘s method.
[71]
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Furthermore, both TBS-protecting groups were cleaved by pyridine buffered hydrogen fluoride 
and the resulting primary alcohol was tosylated chemoselectively by the method developed by 
Martinelli and coworkers.[98] The resulting mono-tosylate 264 was transformed to allylic alcohol 
265 by a slightly modified procedure of Alcaraz.[42] In this one pot reaction the epoxide was first 
closed and then re-opened by a sulfur ylide. Aldehyde 266 was generated by cleavage of the 
MMTr-group by solvolysis in HFIP and subsequent oxidation with IBX (Scheme 34). 
 
Scheme 34: Installation of vinyl alcohol 265 and synthesis of aldehyde 266. 
Further chain elongation was performed by a Cr(II)/Ni(II) NHK-coupling of 266 and 407b in a 
diastereo enriched manner (d.r. = 2:1).[8, 51] The resulting compound 267a was subsequently 
subjected to ring closing metathesis either with a free primary alcohol moiety (267b) or a TES-
protected one (267a) (Figure 27). Unfortunately, none of the conditions applied led to the 
formation of the desired macrocycle 268a, b. 
 
catalyst (solvent) G2 (C6H6) GH2 (C6H6) G3 (C6H6) G2 (C6H6) GH2 (C6H6) G3 (C6H6) 
s.m. 267a 267a 267a 267b 267b 267b 
result s.m. s.m. s.m. s.m. s.m. s.m. 
Figure 27: 
11, 12
 Macrocyclization attempts of different precursors. 
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2.1.2.2 Horner Wadsworth Emmons Macrocyclization Attempts 
Since the massive strain of the 13-membered macrocycle so far prevented the formation of the 
sterically more demanding (E)-double bond in any position, a macrocyclization strategy is chosen, 
that can influence the outcome of the double bond geometry. Compared to the ring closing 
metathesis, where the geometry of the formed double bond is one of the last unsolved 
problems,[99] the HWE reaction is capable of controlling the outcome of the double bond 
geometry, by choosing the appropriate stereo-electronical substituents on the phosphonate 
moiety.[5, 100] 
2.1.2.2.1 11,12 Horner Wadsworth Emmons Approach (cBu) 
This approach releases strain by the removal of the butenolide moiety and thus, generating more 
degrees of freedom by ring opening. Due to these benefits the closure of the desired macrocycle 
should be facilitated. Installation of the butenolide moiety should be performed at a later 
synthetic stage. 
Retrosynthetic Analysis: 
The first retrosynthetic scission was the opening of the ester of the butenolide moiety. Removal of 
the former ester-carbonyl and substitution with a vinyl halide led to intermediate 269. Further ring 
opening, removal of dimethyl methylphosphonate and sequential reduction of the carbonyls to 
the corresponding alcohols led to known intermediate 258 (Scheme 35). 
 
Scheme 35: Retrosynthetic analysis of the 
11, 12
 HWE approach. 
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Synthesis: 
Parts of the synthesis, like the preparation of 258 were already described in the 11,12-metathesis 
approach, within this approach, compound  258 was converted to aldehyde 270 by the selective 
cleavage of a MMTr-ether by solvolysis in hexafluoroisopropanol and subsequent oxidation of the 
resulting alcohol moiety to the corresponding aldehyde 270. Both TBS-silyl ethers are stable under 
these mild conditions. Dimethyl methylphosphonate was converted to its Li-enolate (331a) using 
n-butyllithium as base and subsequently added to aldehyde 270.[101] The resulting secondary 
alcohol was directly transformed to -keto phosphonate 271 by oxidation with IBX (Scheme 36). 
 
Scheme 36: Installation of the -keto phosphonate 271. 
Chemoselective cleavage of the primary TBS-ether and subsequent oxidation to the corresponding 
aldehyde led to macrocyclization precursor 272, which smoothly underwent macrocyclization 
using lithium hexafluoroisopropanolate as base. The formation of the 7,8 (Z)-configured double 
bond isomer proceeded much faster than the formation of the (E)-configured double bond isomer 
(273), most probably caused by the high ring strain in the 13-membered macrocycle. The stage 
was set for the -halogenation of the enone system (274). Unfortunately, all of the conditions 
applied led either to decomposition of the molecule or to recovered starting material (Figure 28). 
 
conditions py, CCl4
[102] NEt3, CH2Cl2 DMAP, THF
[103] 
result s.m. s.m. decomposition 
Figure 28: Closure of macrocycle 273 and -halogenation attempts. 
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2.1.2.2.2 12,13 Horner Wadsworth Emmons Approach 
Since the 11,12-HWE approach smoothly gave macrocycle 273, but made further C12-
functionalization impossible, a slightly modified approach was designed. Here, the same 
macrocyclization strategy should be used, but the butenolide carbonyl group should already be in 
place. Sharpless asymmetric dihydroxylation (SAD) should introduce the desired secondary C13-
hydroxy group in a diastereoselective way and subsequent dehydratation should generate the 
butenolide double bond.  
Retrosynthetic Analysis: 
Markovnikov type addition of water to the butenolide double bond in 183 led to intermediate 275, 
which was further simplified by the removal of the acetyl group and the vicinal diol. Opening of 
the butenolide led to intermediate 276, which after opening of the macrocycle, was further 
deduced to intermediate 277. Degradation of the -keto phosphonate moiety led once again to 
well established key intermediate 258 (Scheme 37). 
 
Scheme 37: Retrosynthetic analysis of the 
12,13
-HWE approach. 
Synthesis: 
TBS-ether 258 was chemoselectively cleaved by the use of NH4F. The resulting primary alcohol 
moiety in 278 was subsequently converted to the corresponding iodide 279 under Appel 
conditions (Scheme 38).[50] 
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Scheme 38: Chemoselective deprotection and iodination of 258. 
Commercially available triethyl phosphonoacetate (280) was deprotonated with NaH and alkylated 
with primary iodide 279 in high yields. The resulting -keto phosphonate 277 was treated with the 
standard deprotection/oxidation reagents PPTS and IBX to afford macrocyclization precursor 281 
(Scheme 39). 
 
Scheme 39: Installation of the -keto phosphonate and synthesis of the macrocyclization precursor. 
Various macrocyclization conditions were carried out, but unfortunately, none of them were 
successful. Starting from gentle (modified) Masamune-Roush conditions,[104] covering previously 
applied lithium hexafluoroisopropanolate and NaH, up to K2CO3 in boiling toluene: None of them 
led to the formation of the desired macrocycle 276 (Figure 29). 
 
base, additive DBU, LiCl DIPEA, LiCl BuLi, HFIP NaH Ba(OH)2
.8H2O K2CO3 
solvent CH3CN CH2Cl2 THF THF THF toluene 
result s.m. s.m. s.m. s.m. s.m. s.m. 
Figure 29: Applied macro-olefination conditions. 
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2.1.2.3 Miscellaneous Macrocyclization Attempts 
These approaches do not have a unique macrocyclization strategy in common, but the general 
idea in these approaches is the use of relatively large (transition) metals to precoordinate the two 
endings of the particular macrocyclization precursor followed by a nucleophilic addition to a 
carbonyl center. 
2.1.2.3.1 Furan-Butenolide-12,13 Approach 
Encouraged by the power of SmI2-mediated reactions and the easy accessibility of the starting 
materials,[7] this approach was started. The advantages are the well established route for the 
synthesis of the northern fragment and the rather short and straight synthesis of the southern 
fragment. Furthermore, the cross metathesis reaction, used for the fragment combination, offers a 
simple variation of the participating building blocks and thus, an easy variation of functional 
groups. 
Retrosynthetic Analysis: 
The first retrosynthetic scission of 183 in this approach was the removal of the acetate group and 
the subsequent opening of the macrocyclic carbon skeleton. Compound 282 was further simplified 
by the degradation of the 7,8-double bond yielding the two building blocks 283 and 200 (Scheme 
40). 
 
Scheme 40: Retrosynthetic analysis of the furan-butenolide 
12,13
 approach. 
Synthesis: 
This approach started with literature known MMTr-protected (R)-glycidol 284. Commercially 
available hard nucleophile isopropenyl magnesium bromide was transformed into its 
corresponding cuprate by the addition of Cu(I). With this in situ generated species, glycidol 284 
was selectively opened and the resulting secondary alcohol protected as its TBS-ether to yield 285. 
Chemoselective solvolysis of the MMTr-ether with HFIP generated the free primary alcohol 
moiety, which was subsequently transformed to the corresponding aldehyde 286 by an IBX 
oxidation.  
 53 
 
-Bromo-phosphonate (Ando’s variant,[105] 286a) was deprotonated with NaH and aldehyde 286 
was added. The resulting -bromo enone was subsequently deprotected and cyclized under acid 
catalysis. Using this sequence, butenolide 283 was obtained in a high overall yield (Scheme 41). 
 
Scheme 41: Short 6-step synthesis of intermediate 283. 
Finally, the stage was set for the fragment combination by a cross metathesis reaction. It is well 
known, that every cross metathesis needs its own special conditions and that a general receipt for 
the selective generation of a cross metathesis product does not exist.[106] Thus, many different 
parameters were varied. When G2 or GH2 in refluxing benzene was used 282 could be isolated. 
When refluxing toluene was used, the yields were even better, but it had to be put up, that the 
amount of 1,1-disubstituted olefin 283 had to be raised. However, the yields never exceeded 21% 
(Figure 30). 
 
catalyst G2 G2 G2 GH2 GH2 GH2 
solvent () CH2Cl2 benzene toluene CH2Cl2 benzene toluene 
200 / 283 1 / 3 1 / 3 1 / 4 1 / 3 1 / 3 1 / 4 
result s.m. 12% 21% s.m. 15% 21% 
Figure 30: Applied cross metathesis conditions; synthesis of 282. 
The product 282 of the cross metathesis was deprotected under acidic conditions with pyridine 
buffered pTsOH. The resulting primary alcohol was oxidized under Swern conditions,[61] yielding 
macrocyclization precursor 287 in modest yield. SmI2 mediated nucleophilic attack to the freshly 
generated aldehyde did not show any conversion,[107] [108] whereas the supplementary addition of 
HMPA led to the formation of a complex product mixture.[109] HPLC analysis identified six different 
products, but all of them only in trace amounts.  
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Standard NHK-coupling conditions did not form the desired macrocycle 288 either and heating the 
reaction to 75 °C only led to decomposition of the starting material 287 (Figure 31).[8, 51] 
 
reagent SmI2 SmI2 / HMPA CrCl2 / NiCl2 CrCl2 / NiCl2 
solvent (temp.) THF (-78 °C) THF (-78 °C) DMF (r.t.) DMF (75 °C) 
result s.m. (287) decomposition s.m. (287) decomposition 
Figure 31: Synthesis of precursor 287 and attempted macrocyclization. 
 
2.1.2.3.2 Furan-12,13 Approach 
The leading thought of this approach is the release of ring strain of the 13-membered macrocycle, 
by the selective opening of the butenolide moiety and thus, generating more degrees of freedom, 
which should ease the closure of the macrocycle. Advantages are the correct geometry of the 7,8 
double bond and the closed furan moiety already in place.  
Retrosynthetic Analysis: 
The retrosynthetic degradation started with the opening of the butenolide moiety of 183 and 
continues with the oxidative cleavage of the 11,12-double bond of 289. Further reduction of the 
resulting aldehyde to the corresponding primary alcohol led to well established key intermediate 
258 (Scheme 42). 
 
Scheme 42: Retrosynthetic analysis of the furan 
12, 13
 approach. 
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Synthesis: 
Well established primary alcohol 278 was oxidized with IBX to the corresponding aldehyde, that 
was subsequently (E)-selectively olefinated by the use of the -brominated derivative of Ando’s 
phosphonate 286a.[105] [110] The resulting -bromo enone 289 was subjected to acidic MMTr-ether 
cleavage conditions and the resultant primary alcohol was oxidized to aldehyde 290, using IBX as 
the oxidizing reagent (Scheme 43). 
 
Scheme 43: (E)-selective Ando’s olefination and synthesis of macrocyclization precursor 290.
[110]
 
Aldehyde 290 constituted the macrocyclization precursor, which should lead to macrocyclic 
compound 291 under (transition) metal catalysis. Unfortunately, the idea of releasing strain was 
not fruitful, because none of the applied conditions, whether SmI2 nor Cr(II)/Ni(II) led to the 
formation of the desired macrocycle 291 and thus, one step closer to Providencin (1) (Figure 
32).[107] 
 
reagent SmI2 SmI2 / HMPA CrCl2 / NiCl2 
solvent THF (-78 °C) THF (-78 °C) DMF (r.t.) 
result decomposition decomposition s.m. 
Figure 32: Attempted macrocyclization conditions. 
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2.1.2.3.3 12,13 Approach 
Unfortunately, the idea of releasing strain by opening of the butenolide moiety was not fruitful 
and did not lead to the formation of the desired macrocycle 291. Therefore, another rigid element 
of the 13-membered macrocycle is opened: the furan moiety. Aromaticity means planarity and 
this automatically leads to rigidity. By opening of the furan moiety much strain is released and thus 
the closure of the carbon macrocycle should be simplified. Late stage furan closure by the Wipf 
methodology should be both,[71] enthalpically and entropically favored and therefore, should work 
with ease. 
Retrosynthetic Analysis: 
The first step in the retrosynthetic analysis was the scission of the C6-O bond to open the furan 
moiety, leading to intermediate 292. Subsequent opening of the macrocycle gave intermediate 
293. This was further simplified by lactone hydrolysis which led to intermediate 295. In 295 
another rigid ring system was opened and thus, flexibility should be enhanced. Furthermore, -
bromo acrylic ester could be reduced to allylic silyl ether 294, which should boost the electron 
density in the vinyl bromide and therefore, should ease the oxidative addition of the (transition) 
metal, which should alleviate the macrocyclization. Intermediates 293-295 were built up by 
alkylation of 195 with the corresponding propargylic iodides (298, 300, 304) (Scheme 44). 
 
Scheme 44: Retrosynthetic analysis of the 
12, 13
 approach. 
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Synthesis: 
Bis TBS-ether 262 was chemoselectively converted to the corresponding free alcohol by the weak 
fluoride donor ammoniumfluoride. The resulting primary alcohol was gently oxidized by the use of 
IBX to aldehyde 296. (E)-selective olefination with -brominated Ando‘s phosphonate (286a) 
yielded compound 297,[105] [110] which was treated with pTsOH. Under these conditions, three 
reactions took place in a row: First, cleavage of the TBS-ether, second, closure of the butenolide 
moiety and third, cleavage of the PMB-ether. Treatment of the resulting primary alcohol under 
modified Appel conditions led to propargylic iodide 298 (Scheme 45).[50] 
 
Scheme 45: Short 5-step synthesis of side chain 298. 
Described -keto ester 195 was enolized with NaH and alkylated with 298. The resulting alkylated 
species 293 was transformed to 299 by a two step procedure, known from previous approaches. 
Finally 299 represented the finished macrocyclization precursor. Interestingly, Wipf’s furan 
cyclization methodology of precursor 293 to furan 282 was not applicable and only led to 
complete degradation.[71] This made the synthesis of 282 by this short and convergent route 
impossible (Scheme 46). Nevertheless, furan 282 could be obtained by CM, described in chapter 
2.1.2.3.1. 
 
 
Scheme 46: Synthesis of macrocyclization precursor 299; Attempted furan closure by Wipf‘s conditions.
[71]
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Within this approach, macrocyclization precursor 299 was used for further synthesis. The stage 
was set for one of the key steps and vinyl bromide 299 was treated with various (transition) metals 
to form macrocycle 292. But whether SmI2, nor Cr(II)/Ni(II) mediated the desired transformation to 
macrocycle 292.[7] On the one hand side, the reason could be the remaining strain caused by the 
butenolide and the cyclobutane, on the other hand, it could be due to the electron deficiency of 
the vinyl bromide, anticipating in the oxidative insertion of the transition metal (Figure 33). 
 
reagent SmI2 SmI2 / HMPA CrCl2 / NiCl2 
solvent THF (-78 °C) THF (-78 °C) DMF (r.t.) 
result decomposition decomposition s.m. (300) 
Figure 33: Attempted (transitions) metal mediated macrocyclization. 
Thus, the concept was reinvestigated and it was decided to open two rigid rings, to ease the 
macrocyclization: the furan moiety and the butenolide moiety. Therefore, another alkylation 
substrate had to be synthesized. In fact, only the butenolide cyclization step had to be spared out 
and the PMB-ether 297 could directly be oxidatively cleaved and further be transformed to the 
corresponding propargylic iodide 300. Again, -keto ester 195 was deprotonated with NaH and 
subsequently alkylated with 300, furnishing compound 295 (Scheme 47). 
 
Scheme 47: Alkylation of 195 with 300. 
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As for the other approaches, a two step deprotection/oxidation sequence led to the 
macrocyclization precursor 301. The ring strain is reduced to a minimum and so expectations were 
high. But, much to our regret, none of the applied conditions led to the formation of the desired 
macrocyclic compound 302. If this approach should work, the enhancement of the electron 
density in the vinyl bromide should be conducive (Figure 34). 
 
 
reagent SmI2 SmI2 / HMPA CrCl2 / NiCl2 
solvent THF (-78 °C) THF (-78 °C) DMF (r.t.) 
result decomposition decomposition s.m. 
Figure 34: Synthesis of macrocyclization precursor 301 and attempted macrocyclization. 
Thus, an alkylation fragment had been synthesized, where the ester was replaced by a protected 
allylic alcohol. Therefore, intermediate 297 was reduced with DIBAL-H. As the tertiary benzoylic 
ester was not stable under these conditions and was reduced as well, it had to be reinstalled. For 
this reason, the resulting primary alcohol was converted to its TBS-ether and afterwards Vedejs‘ 
protocol was applied to re-install the tertiary benzoate 303.[87] Subsequent appliance of the well 
established deprotection/iodination sequence led to alkylation fragment 304 (Scheme 48). 
 
Scheme 48: 5-step synthesis of side chain 304. 
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Application of the known three step sequence to intermediate 195 – alkylation, deprotection and 
oxidation – resulted in the formation of the desired macrocyclization precursor 305 (Scheme 49). 
 
Scheme 49: Alkylation of 195 and completion of macrocyclization precursor 305. 
Compound 305 was subjected to many different cyclization conditions, but to our disappointment, 
none of them led to the formation of the desired macrocycle 306. Unfortunately, two different 
extremes could be observed: either no reaction occurred or due to too many functional groups 
decomposition was observed (Figure 35). 
 
reagent SmI2 SmI2 / HMPA CrCl2 / NiCl2 CrCl2 / NiCl2 CrCl2 / NiCl2 
solvent THF (-78 °C) THF (-78 °C) DMF (r.t.) DMF (40 °C) DMF (75 °C) 
result decomposition decomposition s.m. (305) s.m. (305) decomposition 
Figure 35: Attempted cyclization of 14-membered carbacycle 306. 
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2.1.3 Krische’s Furan Cyclization Approaches 
The common key intermediate of these approaches is the phosphine mediated furan closure 
developed by Krische and coworkers,[72] where a carboxy methyl substituted propargylic ester is 
transformed to a 2,3,5-trisubstituted furan moiety. The big advantage of this method is the 
preparation of the corresponding starting materials. Forming an ester bond is by far easier, than 
forming a carbon-carbon bond, thus the crucial step of macrocyclization can be accomplished by 
rather simple, well established macrolactonization techniques.[6] Krische describes a large number 
of different substrates,[72] which smoothly undergo furan cyclization. Since the shown examples 
are rather simple and do not have many functional groups, a model substance is synthesized. 
Starting from 3,3-dimethyl allyl alcohol (307), oxidation and nucleophilic addition of 327 gave 
propargylic alcohol 308. A Steglich esterification with cyclobutane carboxylic acid yielded 
cyclization precursor 309 in high yields,[80] which was subsequently subjected to Krische’s 
conditions (Figure 19).[72] Unfortunately, the suggested conditions did not lead to the formation of 
the desired heterocycle 310, maybe due to the high steric demand of the phosphine substituents 
and leading to a decreased nucleophilicity. Therefore, these phosphines (PPh3, P(o-Tol)3) were 
replaced by more nucleophilic alkyl phosphines (P(n-Bu)3, P(n-Oct)3). To our delight precursor 309 
underwent furan cyclization to 310 in good yields under these modified Krische conditions (Figure 
36). 
 
phosphine PPh3 PPh3 P(o-Tol)3 P(o-Tol)3 
solvent (°C) EtOAc (110 °C) EtOAc (µW, 110 °C) C6H6 (r.t.) C6H6 (110 °C) 
result s.m. (309) s.m. (309) s.m. (309) s.m. (309) 
phosphine P(n-Bu)3 P(n-Bu)3 P(n-Oct)3 P(t-Bu)3 
solvent (°C) EtOAc (110 °C) C6H6 (110 °C) EtOAc (110 °C) EtOAc (110 °C) 
result 62% 60% 45% s.m. (309) 
Figure 36: Synthesis and cyclization of the of the Krische method model substrate 310.
[72]
 All reactions were 
performed in a sealed tube. 
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2.1.3.1 Macrolactonization Attempts 
Macrolactonization is a well established synthetic technique in the total synthesis of natural 
products. Many different carboxyl activating reagents are published, thus, offering a large 
variation of possible condition. Using Krische’s method, Providencin precursor 183 can be 
simplified to a molecule containing two lactones, both suitable for macrolactonization. Although, 
the Krische furan closure strategy offers the formation of a macrolactone,[72] it does not solve the 
problem of high ring strain of the Providencin (1) core.  
2.1.3.1.1 Northern Lactone-Butenolide Approach 
Having many structural motifs already installed, means more rigidity in the molecule. But, 
functionalization after ring closure implies working on a more complex molecule, which increases 
the danger of side reactions. Thus, a powerful macrolactonization reagent can probably overcome 
the ring strain and saves post functionalization. This approach makes use of the early installation 
of the cyclobutane, the 7,8 (E)-double bond and the butenolide moiety and closes the macrocycle 
and the furan moiety in one of the last steps. 
Retrosynthetic Analysis: 
Opening of the furan in 183 led to macrolactones 311a, b. After ester hydrolysis, seco compounds 
312a, b were obtained, that were further simplified by the removal of the propargylic ester. The 
scission of the 12,13 bond divided the compounds in two equally large fragments 313 and 316a, b. 
Compound 313 was further simplified by the degradation of selenolactone 313 to epoxide 314, 
which could be obtained from vinyl iodide 315 and tosylated (R)-glycidol (393). Esters 316a, b were 
reduced to alcohol 188, which could be derived from bicycloketone 180 (Scheme 50). 
Scheme 50: Retrosynthetic analysis of the northern lactone butenolide approach.  
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Synthesis: 
But-2-yn-1-ol (317) was subjected to a hydrostannylation reaction yielding the corresponding 
stable vinyl stannane,[111] which was subsequently transformed to its vinyl iodide 315 by the 
addition of I2. Installation of a primary TBS protecting group under standard conditions resulted in 
the formation of the precursor of a copper mediated addition-elimination cascade reaction. TBS-
protected 315 was lithiated with t-BuLi and low order cuprate 2-thienyl(cyano)copper lithium was 
added.[112] The formed high order cuprate acts as a soft nucleophile and attacks tosylated (R)-
glycidol 393 on the epoxide side. The formation of a Schlosser-Fouquet product was not 
observed.[64] The in situ formed alcoholate substituted the tosylate in a SN
2 reaction and formed 
the epoxide 314. Using the already in chapter 2.1.2.1.1 established dianion methodology of phenyl 
seleno acetic acid 203 and subsequent carbodiimin esterification formed desired selenolactone 
313 in a short synthetic sequence (Scheme 51).[80] 
 
Scheme 51: Stereoselective synthesis of selenolactone 313. 
Aldehyde 194 was oxidized to the corresponding carboxylic acid under Pinnick conditions. Two 
different esters were synthesized, a PMB-ester (316a) and a t-Bu-ester (316b). Both of them 
should be feasible to be deprotected orthogonally to the methyl ester of fragment 312a, b. For the 
installation of the PMB-ester, Steglich conditions were applied, which unfortunately, did not work 
for the t-Bu series.[80] t-Butanol was sterically too demanding for this kind of reaction, therefore 
the Yamaguchi method was used.[113] In both cases esterification worked in high yields and 
delivered fragment 316a and 316b, respectively. A two step deprotection-oxidation sequence 
finally yielded the northern fragments 319a, b (Scheme 52). 
 
Scheme 52: Synthesis of the northern fragment 319a-b.  
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Fragment 313 was converted to its Li-enolate, using LDA and added to aldehydes 319a, b, 
respectively. The resulting mixtures of diastereo isomers (d.r. = 3:1) were treated under oxidative 
conditions. Subsequent elimination of the seleno phenyl ether generated the butenolide double 
bond. The newly formed secondary alcohols 320a, b were converted into the corresponding 
TBDPS-ether in the PMB-series and to the MEM-ether in the t-Bu-series. Chemoselective 
deprotection of the primary allylic alcohol with NH4F yielded intermediates 321a, b (Scheme 53). 
 
Scheme 53: Fragment combination and installation of different protecting groups. 
Primary alcohols 321a, b were oxidized with IBX and lithiated methyl propiolate (327) was added. 
Now, the stage was set to liberate the carboxylic acids 322a, b. Many different conditions were 
applied, but only one provided the desired seco compound 322a. All others led, due to harsh 
reaction conditions, to decomposition of precursors 312a, b (Figure 37). 
 
reagent  TFA  SiO2 
solvent neat CH2Cl2 quinoline toluene 
s.m. 312b 312b 312b 312b 
result decomposition decomposition decomposition s.m. 
reagent DDQ CAN TFA TFA/Et3SiH 
solvent CH2Cl2/buffer CH3CN/H2O CH2Cl2 CH2Cl2 
s.m. 312a 312a 312a 312a 
result decomposition decomposition 88% yield 87% yield 
Figure 37: Different deprotection conditions for PMB- and t-Bu-esters.  
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Seco compound 322a was subjected to a variety of different macrolactonization conditions. 
Unfortunately, none of them led to the formation of the desired macrolactone 311a. Whether the 
well established Yamaguchi conditions,[113] nor the method developed by Shiina et al.,[44] nor 
carbodiimine methods were successful (Figure 38). 
 
reagent 
 
conditions 
DMAP 
(Yamaguchi)[113] 
DMAP 
(Shiina)[44] 
DMAP 
(Steglich)[80] 
DMAP.HCl 
(Keck)[114] 
solvent benzene toluene CH2Cl2 CHCl3 
result decomposition s.m. s.m. decomposition 
Figure 38: Macrolactonization attempts for precursor 322a. 
 
2.1.3.1.2 Northern Lactone-Horner Wadsworth Emmons Approach 
In the previous approach the structural motif of the butenolide was already installed. Within this 
approach, ring strain is reduced by the removal of the butenolide moiety. Combination of two 
fragments should be performed by a HWE reaction, generating a vinyl halide. This HWE reaction 
has to be (Z)-selective in case the halide is introduced by the phosphonate. This means, that the 
halide and the secondary alcohol moiety have to be on the same side of the double bond. If the 
halide is introduced in a later stage, the outcome of the double bond geometry is not important. 
Macrolactonization should be performed in the northern part of the molecule, with the 
cyclobutane in place. Furthermore, the (E)-geometry of the 7,8 double bond is already predefined. 
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Retrosynthetic Analysis: 
The furan moiety of crucial intermediate 183 was opened and macrolactone 311c was received. 
Saponification of the lactone, reduction of the carboxylic acid and removal of the butenolide 
carbonyl yielded intermediates 324a, b, that were further simplified by an oxidative cleavage of 
the 11,12 double bond resulting in the formation of 325a, b and 193, two building blocks similar in 
size. Scission of the 5,6 single bond in 325a-b and removal of the southern C3-glycidol-subunit in 
326 finally yielded building block 315 (Scheme 54). 
 
Scheme 54: Retrosynthetic analysis of the northern lactone HWE approach. 
Synthesis: 
Vinyl iodide 315 was converted to its TES-ether under standard conditions and lithiated by the 
addition of t-BuLi. The formation of the corresponding high order cuprate was carried out by the 
addition of 2-thienyl(cyano)copper lithium.[112] This soft nucleophile attacked MMTr-protected (R)-
glycidol 284 on the epoxide side. The formed secondary alcohol 326 was converted to the 
corresponding TBS-ether and the primary silyl ether was chemoselectively cleaved with NH4F. The 
resulting primary allylic alcohol 328 was oxidized using IBX as the oxidizing reagent and lithiated 
methyl propiolate (327) was subsequently added to finish the synthesis of 329 (Scheme 55). 
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Scheme 55: 6-step synthesis of intermediate 329. 
The secondary alcohol 329 was either converted to its Troc-carbonate 325a or its TES-ether 325b. 
A final deprotection-oxidation sequence yields the western fragments 330a-b (Scheme 56). 
 
Scheme 56: Installation of different protecting groups and completion of the fragment synthesis. 
Mono-MMTr-ether 193 was oxidized with IBX and lithiated dimethyl-methyl phosphonate (331a) 
was added. The resulting -hydroxy phosphonate 331 was oxidized to the corresponding -keto 
phosphonate, which was subjected to HWE-olefination under various conditions. Every base used 
resulted in the formation of the desired (E)-configured double bond 324a, but using LiHMDS as the 
base gave the best results (Figure 39). 
 
base K2CO3, 18-crown-6 KHMDS LiHMDS 
solvent (temp.) THF (-10 °C) THF (-78 °C) THF (-78 °C) 
yield 34% (E only) 39% (E only) 55% (E only) 
Figure 39: Installation of -keto phosphonate and applied HWE conditions. 
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With the desired enone 324a in hands, the stage was set for the introduction of the necessary 
halogen in -position of the ketone. Literature provided a large variety of different methods for 
the introduction of -halo enones,[115] [102] [103] but all of them starting with an unsubstituted 
Michael-system had one in common: the use of halogen and base. Unfortunately, all of the applied 
conditions were unsuccessful and did not form the desired -halo enone 332 (Figure 40). Apart 
from that, Luche reduction of the C13 carbonyl of 324a to provide the corresponding allylic alcohol 
440 was successful,[36] but would only delay the problem of halide introduction to a later stage of 
the synthesis. Treatment of 324a under acidic conditions for the attempted cleavage of the MMTr-
ether led to the formation of cyclic acetal 333 (Scheme 57). 
 
conditions py, CCl4
[102] NEt3, CH2Cl2 DMAP, THF
[103] 
result s.m. (324a) s.m. (324a) decomposition 
Figure 40: Attempted introduction of the -iodine moiety. 
 
Scheme 57: Undesired closure of a methyl acetal under acidic conditions. 
Since the introduction of the halide at the 11,12 double bond was an unsolvable problem, the 
halide should be introduced at an earlier stage by a brominated -keto phosphonate. Therefore, 
-hydroxy phosphonate 331 was oxidized with IBX and deprotonated with NaH, followed by 
trapping of the enolate with bromine.[116] Substrate 334 was again enolized with different bases 
and subjected to HWE reaction conditions. Unfortunately, only the undesired (E)-isomers 335a, b 
could be isolated, most probably due to the high steric demand of the bromine atom (Figure 41). 
The loss of the TBS-protecting group (335b) may be explained by Lewis acidic activation of the TBS-
silyl ether via transition state 334a.  
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base KOt-Bu, 18-crown-6 KOt-Bu KHMDS LiHMDS 
solvent (temp.) THF (-10 °C) THF (0 °C) THF (-78 °C) THF (-78 °C) 
R= TBS (335a) TBS (335a) TBS (335a) H (335b) 
yield 27% (E only) 70% (E only) 35% (E only) 63% (E only) 
Figure 41: Installation of an -bromo-enone by HWE conditions. 
Due to the variation of the stereoelectronical properties of the phosphonate substituents, it 
should be possible to influence the outcome of the geometry of the formed double bond. In 1983 
Still and Gennari reported on a (Z)-selective variation of the classical HWE reaction.[100] The two 
ethoxy substituents on the phosphorous atom were replaced by two trifluoroethoxy substituents 
and these electron withdrawing groups, together with a strong base formed exclusive (Z)-olefins. 
The synthesis of such substrates was a bit more complex, due to the high lability of 
di(trifluoroethyl) methyl enolates. Classical addition to an aldehyde and subsequent oxidation to 
the corresponding -keto phosphonate was not practical. 
Thus, mono-MMTr ether 188 was converted to its corresponding TBDPS-ether and the liberated 
primary alcohol 336 was oxidized stepwise to the corresponding carboxylic acid 337. The 
carboxylic acid was transformed to its acid chloride using Ghosez’ reagent (338) and lithium 
di(trifluoroethyl) methyl phosphonate was added to smoothly provide -keto phosphonate 339 
(Scheme 58).[117] 
 
Scheme 58: Synthesis of the Still Gennari -keto phosphonate. 
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Compound 339 was deprotonated with NaH, followed by trapping of the enolate with bromine. 
The brominated Still-Gennari phosphonate 340 was again enolized with different bases and 
subjected to HWE reaction (Figure 42). Once again and independently of the installed substituents 
on the phosphonate, only the undesired (E)-isomer 341 was formed, most probable due to the 
high steric demand of the bromine, which overruled the stereo electronical control of the 
phosphonate. 
 
base KOt-Bu KHMDS LiHMDS 
solvent (temp.) THF (-78 °C) THF (-78 °C) THF (-78 °C) 
yield 26% (E only) 29% (E only) 46% (E only) 
Figure 42: Applied conditions for the Still Gennari phosphonate. 
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Other (Z)-selective vinyl halide attempt:[118] 
Since the introduction of a halide in -position of the C13-carbonyl was not practicable by the 
methods used, a completely new structural motif was designed. Compound 345 should be 
converted to 346, using a Au(I) mediated method developed by Zhang.[118] According to the 
authors, this methodology was highly (Z)-selective and proceeds via a [3,3]-sigmatropic shift of the 
acetyl-group (modified Meyer-Schuster rearrangement;[119] 342, 343a). The authors also presented 
several different examples, but with less functional groups. Nevertheless, these conditions were 
applied to precursor 345, which was prepared by a four step sequence from established material 
193. To our disappointment, these conditions did not lead to the formation of the desired (Z)-vinyl 
iodide either 346 (Scheme 59). 
 
Scheme 59: (a) Au(I) mediated [3,3]-sigmatropic rearrangement and (b) Attempted (Z)-selective -iodination. 
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2.1.3.1.3 Southern Lactone Approach 
The other approaches using Krische’s method for furan cyclization seem to collapse due to high 
steric demand and rigidity of several functional groups (bromine, butenolide). Therefore, this 
approach uses the upper ester as linkage between two equally large fragments. The southern 
(butenolide) lactone is used as connection point for the macrocyclization.  
Retrosynthetic Analysis: 
The furan moiety of crucial intermediate 183 was opened to macrolactone 311d, followed by the 
opening of the 11,12 double bond of the butenolide by a formal cross metathesis with ethylene. 
Saponification of the macrolactone led to intermediate 347. Another saponification of the 
northern lactone and after removal of methyl propiolate led to fragments 348 and 349. Compound 
348 could be further simplified to epoxide 314 and the eastern fragment could be degraded to 
well established mono-MMTr-ether 193 (Scheme 60). 
 
Scheme 60: Retrosynthetic analysis of the southern lactone approach. 
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Synthesis: 
Epoxide 314 was treated with trimethyl sulfur ylide, generated in situ by the treatment of 
trimethyl sulfur iodide with n-BuLi, and the resulting secondary allylic alcohol was converted to its 
MMTr-ether 348. Cleavage of the remaining primary silyl ether with diluted hydrogen fluoride and 
subsequent oxidation with IBX yielded aldehyde 350. Finally, addition of lithiated methyl 
propiolate (327) finished the synthesis of the western fragment 351 (Scheme 61). 
 
Scheme 61: 5-step synthesis of western fragment 351. 
The eastern fragment of this approach was synthesized from well established alcohol 193, which 
was oxidized to its corresponding aldehyde in the first step. Diastereo enriched (d.r. = 3.5:1) 
Cr(II)/Ni(II) catalyzed NHK reaction with 407a yielded secondary alcohol 352.[8, 51] This intermediate 
was converted to its MEM-ether under standard conditions and finally the primary MMTr-ether 
was cleaved chemoselectively by solvolysis in HFIP,[120] which completed the synthesis of 
compound 353 (Scheme 62). 
 
Scheme 62: Successful NHK-coupling and synthesis of 353.
[51]
 
Oxidation of 353 using IBX as oxidizing agent and basic epimerization of the carbon center in -
position of the carbonyl resulted in the formation of aldehyde 354, which was oxidized under 
Pinnick conditions to the corresponding carboxylic acid. Now, with both fragments in hand, the 
stage was set for fragment combination. Therefore, Steglich esterification conditions were used,[80] 
finally leading to advanced intermediate 347. Even though, secondary MEM-protected alcohol was 
previously not introduced in a stereospecific way, it was possible to separate the diastereo isomers 
at this stage (Scheme 63).  
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Scheme 63: Steglich esterification of oxidized 354 (349) and 351. 
Primary, allylic TBS-ether 347 was cleaved chemoselectively with NH4F and the resulting primary 
alcohol was oxidized stepwise to the corresponding carboxylic acid 355. Cleavage of the secondary 
MMTr-ether yielded the seco acid, which was the direct precursor for macrolactonization. Like in 
other macrolactonization approaches, many different reagents and conditions were applied, but, 
unfortunately, none of them led to the formation of the desired macrocycle 356 (Figure 43). 
 
reagent 
 
conditions DMAP (Shiina)[44] DMAP (Yamagucchi)[113] DMAP.HCl (Keck)[114] 
solvent toluene toluene CHCl3 
result s.m. s.m. decomposition 
Figure 43: Installation of the seco acid and attempted macrolactonization conditions. 
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To proof the usability of the Krische method on highly functionalized molecules,[72] compound 347 
was subjected to these conditions. To our disappointment, the reaction resulted in the formation 
of a complex mixture of products, probably due to the presence of four allylic ethers/esters, all of 
them capable to undergo a SN
2’-like reaction with good nucleophiles like alkyl phosphines. 
Nevertheless, trace amounts of the desired product 267c could be isolated after intensive 
chromatographic separations (Scheme 64). 
 
Scheme 64: Application of Krische conditions to highly advanced intermediate 347.
[72]
 
 
2.1.3.2 Ring Closing Metathesis Attempts 
The RCM macrocyclization strategy in the Krische series has an exclusive advantage: The degrees 
of freedom of the non-closed furan moiety and the enthropically favored formation of ethylene 
during the macrocyclization reaction.  
2.1.3.2.1 11,12 Metathesis Approach 
This approach is quite similar to the one described in chapter 2.1.3.1.3 and many related 
intermediates can be used. In fact, all degrees of freedom stay the same, only the macrocyclization 
strategy is different: A metathesis reaction, instead of a lactonization should be used. 
Retrosynthetic Analysis: 
The furan moiety of crucial intermediate 183 was opened and macrolactone 311d was received. 
Furthermore, the butenolide lactone was opened, followed by the cleavage of the double bond of 
the butenolide by a formal cross metathesis with ethylene. After saponification of the northern 
ester moiety, the two fragments 349 and 351 were obtained, both known from former approaches 
(Scheme 65). 
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Scheme 65: Retrosynthetic analysis of the 
11,12
 metathesis approach. 
Synthesis: 
Intermediates 357a-c were subjected to a macro RCM reaction using different metathesis 
catalysts, different substitution patterns on various alcohols and different solvents (Figure 44). 
Unfortunately, in most cases only starting material was recovered, in the case of 
hexafluorobenzene (C6F6) was used as solvent,
[94] the formation of a large variety of products could 
be observed and removal of both protecting groups R1 and R2 (R1=R2=H) resulted in the formation 
of a homodimer.  
 
catalyst G2 G2 G2 G2 G2 
solvent () CH2Cl2 C6H6 C6F6 C6H6 C6H6 
s.m. 357a 357a 357b 357b 357c 
result s.m. s.m. decomposition s.m. homodimer 
Figure 44: Attempted macrocyclization conditions for the synthesis of 358a-c. 
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2.2 Isopropenyl Series (iPr) 
Inspired by the biosynthesis proposed by Pattenden and Trauner,[25] [1] a biomimetic approach is 
designed. The main idea behind the iPr-series is the late stage introduction of the cyclobutanol 
moiety and thus, increasing the degrees of freedom of the molecule. For this reason the 
macrocyclization should proceed much easier, or metathesis reaction results at least in the partial 
formation of the desired 7,8 (E)-double bond. The isopropenyl unit on C1 is a common structural 
motif in furanocembranoids. Therefore, a synthesis was planned using a monoterpene ((R)-(-)-
Carvone, 359) as starting material and converting it in a multistep sequence to the Providencin (1) 
(Scheme 66). 
 
Scheme 66: Starting material of the iPr-series. 
2.2.1 Wipf’s Furan Cyclization Approaches 
All these approaches share the palladium or base mediated furan closure developed by Wipf and 
coworkers.[71] Therein, -keto ester 362 is alkylated by different propargylic iodides. This method 
offers a very convergent approach, since complexity can be introduced through a simple alkylation 
reaction. 
Retrosynthetic Analysis: 
The first scission in the simplification of Providencin (1) was between C2 and C17. The opening of 
the cyclobutanol moiety resulted in the generation of an -substituted crotyl aldehyde 58 
(Bipinnatin E), which was further simplified by reduction to compound 57 (Iopholide). Removal of 
both epoxides resulted in the formation of 360, which is a key intermediate in the synthesis of 
Providencin (1) (Scheme 67). 
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Scheme 67: Retrosynthetic degradation to key intermediate 360. 
 
2.2.1.1 Ring Closing Metathesis Attempts 
As the RCM reaction is a very powerful tool in organic synthesis it is widely used for the closure of 
(strained) macrocycles. Due to its high functional group tolerance, it is one of the most popular 
reactions and should be suitable for ring closure in this special case as well. 
2.2.1.1.1 7,8 Metathesis Approach 
Although, macrocyclization by a RCM reaction in the cBu-series resulted in the exclusive formation 
of the (Z)-configured 7,8-double bond, the generation of more degrees of freedom and therefore 
minor ring strain (by cyclobutane opening) increases the possibility of an (E)-double bond 
formation. 
Retrosynthetic Analysis: 
The first retrosynthetic simplification of intermediate 360 was the opening of the strained 
macrocycle and the cleavage of the 12,13-single bond, resulting in the northern and a southern 
fragments 361 and 185. The latter one was already known from former approaches, the northern 
one could be further simplified by opening of the furan moiety and dealkylation to -keto ester 
362, which was obtained by oxidative degradation of (R)-(-)-Carvone (359) (Scheme 68). 
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Scheme 68: Retrosynthetic analysis of the 
7,8
 metathesis approach. 
Synthesis: 
Inspired by the work of Theodorakis et al.,[121] Scheffer-Weitz epoxidation of the electron poorer 
double bond of commercially available (R)-Carvone (359), followed by subsequent acidic epoxide 
opening resulted in the formation of diol 363. Double Malaprade reaction,[122] elimination of acetic 
acid and subsequent one pot esterification and acetalization yielded key intermediate 364 
(Scheme 69). 
 
Scheme 69: 4-step synthesis of intermediate 364, starting from (R)-(-)-Carvone. 
Careful reduction of ester 364 with sterically demanding DIBAL-H to the corresponding aldehyde 
and subsequent chain elongation by an aldol reaction formed secondary alcohol 365 as an 
inconsequential mixture of diastereo isomers. Oxidation to the corresponding -keto ester using 
IBX as oxidizing agent and subsequent alkylation with well established propargylic iodide 198 
yielded intermediate 366. Conducting the oxidation reaction under Swern conditions,[61] the 
undesired -chlorinated product 365a was obtained, which could be reductively converted to 
365b with Copper/Zinc couple.[123] Subsequent alkylation with 198 furnished 366 (Scheme 70). 
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Scheme 70: 4-step synthesis of intermediate 366 and undesired -chlorination (365a) using Swern conditions.
[61]
 
Furan cyclization precursor 366 was treated with K2CO3 and smoothly underwent cyclization to 
furan 367. Treatment of 367 with 50% aqueous TFA liberated the aldehyde and finished the 
synthesis of the northern fragment 361 (Scheme 71). 
 
Scheme 71: Furan cyclization and completion of the northern fragment 361. 
Selenolactone 185 was deprotonated with LDA and subsequently added to the northern fragment 
361. Oxidative elimination of the seleno phenyl ether to the corresponding butenolide yielded 
macrocyclization precursor 368a. Unfortunately, any attempts to close the macrocycle with the 
free alcohol at C13 in place failed but the 7,7-homodimer was obtained. Acetylation of the free 
alcohol with acetic acid anhydride yielded 368b and subsequent macrocyclization smoothly 
yielded macrocycle 369. Careful 2D-NMR experiments revealed once again, that only the 
undesired (Z)-isomer was formed (Figure 45). 
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catalyst G2 G2 G2 G2 GH2 
solvent () CH2Cl2 C6H6 CH2Cl2 C6H6 C6H6 
s.m. 368a 368a 368b 368b 368b 
result homodimer homodimer s.m. (368b) 43% yield 38% yield 
Figure 45: Fragment coupling and successful macrocyclization to 369. 
 
2.2.1.2 Horner Wadsworth Emmons Macrocyclization Attempts 
As the HWE reaction is a well established method for the formation of small, medium-sized and 
large rings, it should be used in this approach. The affinity of phosphor to oxygen, the 
enthropically auspicious formation of a phosphoric acid derivative and the possibility to influence 
the geometry of the formed double bond (unlike in the metathesis reaction) make it an excellent 
choice for macrocyclization. 
2.2.1.2.1 11,12 Horner Wadsworth Emmons Approach (iPr) 
This approach is designed as a proof of principle, to assure the usability of the conditions applied 
in the cBu-series in the iPr-series. Like in the cBu-series, macrocyclization works smoothly and 
macrocycle 370 is formed in high overall yield. 
Retrosynthetic Analysis: 
The first retrosynthetic scission was the removal of the butenolide carbonyl, leading to 
intermediate 370. Oxidative ring opening at the 11,12 position to 371, further opening of the furan 
moiety and de-alkylation led to well established fragments 362 and 259 (Scheme 72). 
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Scheme 72: Retrosynthetic analysis of the 
11,12
 HWE approach. 
Synthesis: 
-Keto ester 362 was enolized by the addition of NaH and subsequently alkylated with propargylic 
iodide 259. The resulting intermediate was treated with K2CO3 and smoothly underwent furan 
cyclization to product 371 according to the Wipf‘s protocol.[71] Differentiation between the silyl-
ethers and the dimethyl acetal proofed to be troublesome. But after some ineffective 
experiments, LiBF4 in wet CH3CN smoothly generated the free aldehyde,
[124] which was 
subsequently converted to the -keto phosphonate 373 using the Gilbert-Seyferth-reagent 372 in a 
tin mediated Roskamp reaction (Scheme 73).[125] [126]  
 
Scheme 73: Furan closure and installation of the -keto phosphonate 373 by a Roskamp reaction. 
Chemoselective cleavage of the primary silyl-ether of 373 with NH4F and subsequent oxidation 
under Swern-conditions to the corresponding aldehyde yielded macrocyclization precursor 374.[61] 
Already in chapter 2.1.2.2.1 successfully applied macrocyclization conditions (LiHFIP) finally 
furnished the desired macrocycle 370 in acceptable yield (Scheme 74). 
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Scheme 74: Successful macrocyclization of 374 to 370 by a HWE reaction. 
 
Sarcofuranocembranolide A 
The aim to archive a total synthesis of Sarcofuranocembranolide A (75) resulted from the 
promising results of the synthesis of Providencin-precursors 206 and 369. The geometry of the 
formed 7,8 double bond is not essential, due to its planned reduction to the corresponding alkane 
in a later stage. The syntheses of both, northern fragment 361 and southern fragment 378 are very 
similar to the ones of the Providencin (1) approaches.  
Retrosynthetic Analysis: 
The first retrosynthetic scission was the removal of the benzylic ketone. FGA led to substructures 
376a, b, which was ring opened and thus, led to intermediate 377a, b. Scission of the 11,12-bond 
led to the two main fragments of the synthesis 361 and 378 (Scheme 75). 
 
Scheme 75: Retrosynthetic analysis of Sarcofuranocembranolide A (75). 
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Synthesis: 
The following sequence was performed according to Enders et al..[127] Butan-1,4-diol (379) was 
converted to its mono TBS-ether and the remaining free alcohol was oxidized using IBX as the 
oxidizing agent. Addition of vinyl magnesium bromide to aldehyde 380 generated a racemic 
secondary allylic alcohol, which was deracemized by Amano lipase PS in the presence of vinyl 
acetate. The desired enantiomer was obtained as free alcohol 381 (Scheme 76). 
 
Scheme 76: Synthesis and enzymatic resolution of 381. 
Optically active secondary allylic alcohol 381 was acetylated with acetic acid anhydride and the 
primary TBS-ether was cleaved with PPTS, which resulted in the formation of compound 382. A 
two step oxidation procedure using IBX and the Pinnick protocol furnished acid 383.[128] Basic 
hydrolysis of the acetate and carbodiimine mediated lactonization finally yielded lactone 384 
(Scheme 77). 
 
Scheme 77: Closure of the -butyrolactone 384. 
Introduction of the phenyl seleno ether in 384 proofed to be troublesome. The formed mono 
selenated product 378 had an increased pKa-value of the remaining -proton, thus leading to a 
second enolization and selenation. Intercepting the formed lithium enolate with TMS-Cl and 
forming the TMS-enolether provided the mono selenated product 378 as single product after 
addition of phenyl selenyl bromide. Compound 378 was deprotonated with LDA and added to 
aldehyde 361. Oxidative elimination of the seleno phenyl ether resulted in the formation of 
butenolide 377a, which was subjected to ring closing metathesis. Unfortunately, none of the 
applied conditions led to the formation of the desired macrocycle 376a. 
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Thus, secondary C12-alcohol was acetylated with acetic anhydride and once again subjected to 
ring closing metathesis. To our disappointment, these conditions also did not lead to the formation 
of desired macrocycle 376b. In 2005 Forman and coworkers reported,[129] that the addition of 
(substituted) phenols could increase the activity of metathesis catalysts, but unfortunately this 
variation was not fruitful for this substrate 377b (Figure 46). 
 
catalyst G1 G2 GH2 G2 
solvent CH2Cl2 CH2Cl2 CH2Cl2 C6H6 
s.m. 377a 377a 377a 377a 
result s.m. s.m. s.m. s.m. 
catalyst G1 G2 GH2 G2 
solvent toluene toluene toluene DCE 
s.m. 377a 377a 377a 377a 
result s.m. s.m. s.m. s.m. 
catalyst G2 GH2 G1 (+ 4-MeO-Ph-OH) G2 (+ 4-MeO-Ph-OH) 
solvent toluene toluene toluene toluene 
s.m. 377b 377b 377b 377b 
result s.m. s.m. s.m. s.m. 
Figure 46: Fragment combination and attempted macrocyclization by RCM. 
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Etherification: 
Model studies for the installation of the C12-ethyl ether were carried out on substrate 385a and 
385b. None of the applied conditions led to the formation of the desired ethyl ether. In some 
cases only starting material could be recovered, in others the deprotonation of the C12-alcohol led 
to the formation of a complex product mixture (Figure 47). 
 
reagent Ag2O NaH, Et-I NaH, Et-I KOtBu, Et-I NaH, Et2SO4 
solvent EtI THF DMF DMF THF 
s.m. 385a 385a 385a 385a 385a 
result s.m. decomp. decomp. decomp. decomp. 
reagent KOH, Et2SO4 
BuLi, DMSO, 
EtI[130] 
Et3OBF4,
[131] 
proton sponge 
NaH, EtI KOtBu, EtI 
solvent CH3CN THF CHCl3 DMF DMF 
s.m. 385a 385a 385a 385b 385b 
result s.m. decomp. s.m. decomp. decomp. 
reagent Ag2O, EtI KHMDS, EtI 
BuLi, DMSO, 
EtI[130] 
NaH, Et2SO4 
Et3OBF4,
[131] 
proton sponge 
solvent Et2O THF THF THF CHCl3 
s.m. 385b 385b 385b 385b 385b 
result s.m. decomp. decomp. decomp. s.m. 
Figure 47: Attempted installation of an ethyl ether at C12-OH. 
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3 Conclusion and Outlook 
The aim of this Ph.D. research was the synthesis of highly strained furanocembranoid macrocycles. 
The 14-membered macrocyclic carbon skeleton is the common structural motif of this class of 
natural products and therefore, a fast and elegant synthesis of a suitable key intermediate could 
provide access to a large variety of different constituents of furanocembranoids. Providencin (1) is 
an extraordinary member of this family, since it exhibits an unique bicyclo[12.2.0]hexadecane ring 
system. The 13-membered carbo skeleton of Sarcofuranocembranolide A (75) is unique as well, 
due to its ring contracted, and even more strained carbon framework. Therefore, tailor-made 
macrocyclization precursors had to be prepared. 
Two synthetic series, the isopropenyl-series (iPr) and the cyclobutane-series (cBu) were 
synthesized. Within these series two different methologies for the closure of the common furan 
moiety were established: the Wipf cyclization and the Krische cyclization.[71] [72] Due to the unique 
cyclobutane moiety, the cBu series is only suitable for the construction of Providencin (1) 
precursors, while the iPr-series is suitable for the synthesis of Iopholide (57), Bipinnatin E (58) and 
Providencin (1). 
As necessary and practical possible, all intermediates were synthesized in a stereospecific way 
using modern synthetic methods. Within the cBu-series, key intermediate 213 was synthesized in a 
21-linear-steps sequence and provided access to a possible total synthesis of Providencin (1), while 
within the iPr-series the 14-steps-synthesis of key intermediate 369 disclosed the biomimetic 
synthesis of Providencin (1) (Figure 48). Interestingly, metathesis reaction exclusively yielded the 
7,8-(Z)-isomer of the desired macrocyclic compound 183, most probably due to the high ring 
strain of the formed carbon skeleton. But subsequent photoisomerization produced the desired 
macrocycle 213. Besides these synthetic achievements, only the Horner-Wadsworth-Emmons 
approaches were able to close the desired macrocycle, just to collapse later on due to other 
reasons. Every other approach preceded smoothly until macrocyclization. At this stage, these 
approaches turned out to be not suitable for the total synthesis of Providencin (1) or related 
compounds. 
Although the successful closure of strained furanocembranoid macrocycles was a challenging goal 
to achieve, the successful total synthesis of Providencin, Bipinnatin E and/or Iopholide would 
extend the scope of the synthesized intermediates. As presented in Figure 48, only a few steps are 
missing. Starting from intermediate 213, an epoxidation of the 7,8-double bond, followed by 
subsequent TIPS-ether cleavage and oxidation should lead to an intermediate, which only has to 
be olefinated and allylically oxidized to furnish Providencin (1).  
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On the other hand, intermediate 369, is only three steps away from Iopholide (57), which could be 
converted to Bipinnatin E (58) by allylic oxidation and subsequently to Providencin (1) by a Norrish 
Type II photocyclization. 
 
Figure 48: Missing steps from key intermediates 213 and 369 to Providencin (1), Iopholide (57) and Bipinnatin E (58), 
respectively. 
Since Sarcofuranocembranolide A (75) is the only member of furanocembranoids, which exhibits a 
13-membered, ring contracted macrocyclic carbon framework, intermediate 377a is only suitable 
for the total synthesis of this molecule. This intermediate was synthesized in a 12-steps linear 
sequence, but macrocyclization using different metathesis catalysts was not successful, most 
probable due to the highly strained macrocycle in 376a (Figure 49). 
 
Figure 49: Missing steps to complete the total synthesis of Sarcofuranocembranolide A (75).  
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4 Experimental Section 
4.1 General Methods 
Solvents: 
All solvents were distilled prior to use, except THF, which was purchased from Sigma Aldrich 
(99.9%, H2O < 20ppm) or Acros Organics (99.85%, H2O < 50 ppm) and used without further 
purification. Et2O, benzene and toluene were dried with sodium. CH2Cl2 and CHCl3 were passed 
through an Al2O3-MgSO4 column or dried with P2O5. Acetone and hexane were dried using P2O5. 
DMF, DMSO, CH3CN, NEt3, iPr2NH, iPr2NEt, HMPA and 2,6-lutidine were dried with CaH2. Pyridine 
was distilled from potassium hydroxide and methanol was refluxed over magnesium turnings for 
several hours and then distilled. 
 
Synthetic Methods: 
All reaction vessels were dried by repeated heating under vacuum (hot gun) followed by purging 
with dry argon. Oxygen- and moisture sensitive reactions were carried out under a slight argon 
overpressure (balloon) and in anhydrous solvents. Sensitive solutions and liquids were transferred 
via a double tipped needle or syringe through rubber septa. All reactions were stirred magnetically 
unless otherwise noted. Solvents for palladium catalyzed reactions and metathesis reactions were 
degassed by the “pump-freeze-thaw” method (at least four cycles). 
 
Chemicals: 
All commercially available reagents were used without further purification unless otherwise 
stated. 
 
Chromatography: 
Thin-layer chromatography (TLC) 
All reactions were monitored using precoated Merck silica gel 60 F254 plates. UV active spots were 
detected at longwave UV (254nm) and shortwave UV (180 nm). For visualization, the following 
reagents were used: Anisaldehyde [anisaldehyde (6 g) in EtOH (250 mL) and conc. H2SO4 (25 mL)], 
Ceric(IV)sulfate [Ce(SO4)2 (0.1 g), phosphormolybdic acid (20 g) in H2SO4 (10%, 400 mL)] and 
Potassium permanganate [KMnO4 (2.5 g) in 1N NaOH (500 mL)]. 
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Column Chromatography 
Preparative column chromatography was performed with silica gel 60 from Merck (0.040 - 
0.063µm, 240 - 400 mesh), using as a rule of thumb 30-fold excess of silica gel based on the crude 
product weight. As a routine, conditioning of the column was performed by the “wet-packing” 
technique. Yields refer to chromatographically and spectroscopically pure compounds, unless 
otherwise stated. 
Analytic and preparative HPLC 
For the determination of diastereomeric ratios in analytic scale a Jasco System (PU-980 pump, UV-
975 UV detector, RI-930 RI detector) with a Nucleosil 50 column (5μm, 4mm x 241mm) at ambient 
temperature was used. Preparative HPLC was performed on a Dynamix System (SD-1 pump, UV-1 
UV-detector (λ = 254nm)) using a Supersphere 60 Si column (4μm, 25mm x 250mm, Merck) at 
ambient temperature. 
 
Spectroscopy: 
NMR-Spectroscopy 
All NMR spectra were measured on a Bruker Avance DRX-250, a Bruker Avance DRX-400, a Bruker 
AV400 or a Bruker DRX-600 at 250.13MHz (62.89MHz), 400.13 MHz (100.61MHz) or 600.13MHz 
(150.90MHz), respectively. Chemical shifts are given in ppm and were referenced to the solvent 
residual peak(s). CHCl3 (1H, = 7.26ppm; 13C, = 77.0ppm) or toluene (1H, = 7.09, 7.00, 
6.98ppm; 13C, = 137.9, 129.2, 128.3, 125.5, 20.4ppm). Data are reported as follows: chemical 
shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, bs = broad singlet), 
coupling constant J in Hz, integration. Assignments of proton resonances were confirmed, when 
possible, by correlated spectroscopy. 
Infrared-Spectroscopy 
Infrared spectra were recorded as thin films on an ATR-unit on a Perkin Elmer Spectrum 2000 FT-IR 
spectrometer or as thin films on a silicon plate on a Perkin Elmer Spectrum 1600-FT-IT. 
Mass-Spectroscopy 
Mass spectra were measured on a Micro mass, trio 200 Fisions Instruments. High-resolution mass 
spectra (HRMS) were performed on a Finnigan MAT 8230 with a resolution of 10000. 
 
Polarimetry: 
Optical rotations were measured on a P341 Perkin-Elmer polarimeter in a 10cm cell at 20 °C with 
589nm wavelength. The concentration c is given in g/100 mL. 
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Melting points: 
Melting points (mp) were determined on a Leica Galen III apparatus and are uncorrected. 
 
X-Ray Analysis: 
Single crystal diffractions were collected on a Bruker X8APEX II CCD diffractometer. The structure 
was solved by direct methods and refined by full-matrix least-squares techniques. Non-hydrogen 
atoms were refined with anisotropic displacement parameters. Hydrogen atoms were placed at 
calculated positions and refined as riding atoms in the subsequent least squares model 
refinements. Structure solution and refinement was performed with the SHELX program (G.M. 
Sheldrick, Program for crystal structure solution, Universität Goettingen, 1997). 
 
4.2 Providencin 
4.2.1 7,8 Metathesis Approach (cBu) 
 
(±)-cis-Bicyclo[3.2.0]hept-2-en-6-ol (387) 
 
An adapted procedure of Fairlamb et al. was used.[132] NaBH4 (3.5 g, 92.5 mmol, 0.5 eq.) was 
suspended in anhydrous MeOH (100 mL) and the solution was cooled to -78 °C. After the evolution 
of dihydrogen has ceased, a solution of (±)-cis-bicyclo[3.2.0]hept-2-en-6-one (20.0 g, 185.0 mmol, 
1.0 eq.) in anhydrous MeOH (50ml) was added dropwise over a period of 15 minutes. The reaction 
mixture was stirred at -78 °C for one hour, before it was allowed to warm to r.t. The same amount 
of Et2O (150 mL) and 50 mL of 2N HCl were added. The phases were separated and the organic 
phase was extracted three times with water. The combined aqueous phases were back-extracted 
three times with Et2O/hexane (1/1). The combined organic phases were washed with brine and 
dried over MgSO4. Careful evaporation (volatility of the product) gave 19.4 g (176.1 mmol, 95%) of 
387 as slightly yellow liquid, which was of perfect purity for further conversion. 
1H-NMR (250MHz, CDCl3):  = 5.85 (bs, 2H); 4.42 (m, 1H); 3.16 (m, 1H); 3.02 (m, 1H); 2.76 (m, 1H); 
2.69 (m, 1H); 2.40 (m, 1H); 1.68 (bs, 1H); 1.59 (ddd, J = 12.9, 4.5, 1.1Hz, 1H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C7H10ONa: 133.0629; found: 133.0627 
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(±)-cis-bicyclo[3.2.0]hept-2-en-6-yl 2-chloroacetate (189) 
 
Racemic 387 (14 g, 127 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (60 mL) and pyridine 
(15.4 mL, 191.0 mmol, 1.5 eq.) was added. The solution was cooled to 0 °C and a solution of chloro 
acetic acid anhydride (30.4 g, 178 mmol, 1.4 eq.) in anhydrous CH2Cl2 (60 mL) was added dropwise 
over a period of 30 minutes. After stirring the reaction mixture for one hour at 0 °C, MeOH was 
added and the solution was allowed to warm to r.t. CH2Cl2 was added and the mixture was washed 
several times with aqueous 1M HCl. After washing two times with water the organic phase was 
dried over MgSO4 and the solvent was removed under reduced pressure. The crude product was 
purified by silica gel column chromatography (hexane/EtOAc = 7/1) giving 21.1 g (113.1 mmol, 
89%) of 189 as colorless oil.  
1H-NMR (250MHz, CDCl3):  = 5.82 (bs, 2H); 5.28 (dt, J = 8.1, 5.9Hz, 1H); 4.05 (s, 2H); 3.32 (m, 1H); 
3.06 (m, 1H); 2.77 (m, 1H); 2.50 (m, 2H); 1.82 (m, 1H) 
HRMS (ESI) (m/z): [M]+ calcd. for C9H11ClO2: 186.0448; found: 186.0443 
 
(1S,5R,6S)-bicyclo[3.2.0]hept-2-en-6-yl 2-chloroacetate (388) 
 
Racemic 189 (23.8 g, 127.5 mmol, 1.0 eq.) was dissolved in 200 mL of a 1:1 mixture of 
MTBE/pentane. 300 mL of a pH=7-buffer (50mM KH2PO4) were added and the biphasic system was 
vigorously stirred at r.t. 150 mg of Lipase SAM II were added to start the enzymatic resolution. The 
pH of the mixture was monitored and adjusted to 7 by a Merck Titrino 702SM using 0.5M NaOH. 
The reaction was stopped after a consumption of 130 mL of 0.5M NaOH by the addition of 2M HCl. 
The pH was adjusted to 4 and the phases were separated. The aqueous phase was extracted two 
times with Et2O and the combined organic layers were dried using MgSO4. Solvents were removed 
under reduced pressure and the residue was purified using silica gel chromatography 
(hexane/EtOAc = 7/1) giving optically pure 388 as colorless oil (11.4 g, 61.1 mmol, 96%). 
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1H-NMR (250MHz, CDCl3):  = 5.82 (bs, 2H); 5.28 (dt, J = 8.1, 5.9Hz, 1H); 4.05 (s, 2H); 3.32 (m, 1H); 
3.06 (m, 1H); 2.77 (m, 1H); 2.50 (m, 2H); 1.82 (m, 1H) 
13C-NMR (63MHz, CDCl3):  = 167.1; 134.6; 132.8; 70.1; 41.6; 41.4; 41.1; 37.0; 33.0 
HRMS (ESI) (m/z): [M]+ calcd. for C9H11ClO2: 186.0448; found: 186.0451 
IR (film): 2941; 1758; 1414; 1349; 1311; 1286; 1186; 1047; 1001cm–1 
[]D
20: -19.6 (c=0.66; CHCl3) 
 
(1S,5R,6S)-bicyclo[3.2.0]hept-2-en-6-ol (190) 
 
11.4 g of 388 (61.1 mmol, 1.0 eq.) were dissolved in 80 mL of MeOH. A solution of LiOH.H2O (7.7 g, 
183.3 mmol, 3 eq.) in distilled water (40 mL) was slowly added at r.t. The reation mixture was 
allowed to stir at this temperature for 30 minutes. Et2O was added and the pH of the aqueous 
phase was adjusted to 6-7. The phases were separated and the aqueous phase was extracted two 
more times with Et2O. The combined organic extracts were dried over MgSO4 and the solvent was 
carefully removed in vacuo (volatility of the product!), yielding alcohol 190 as colorless oil (6.7 g, 
61.0 mmol, 99%). 
1H-NMR (250MHz, CDCl3):  = 5.85 (bs, 2H); 4.42 (m, 1H); 3.16 (m, 1H); 3.02 (m, 1H); 2.76 (m, 1H); 
2.69 (m, 1H); 2.40 (m, 1H); 1.68 (bs, 1H); 1.59 (ddd, J = 12.9, 4.5, 1.1Hz, 1H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C7H10ONa: 133.0629; found: 133.0632 
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((1S,5R,6S)-bicyclo[3.2.0]hept-2-en-6-yloxy)triisopropylsilane (389) 
 
Secondary alcohol 190 (6.5 g, 59 mmol, 1.0 eq.) was dissolved in anhydrous DMF (60 mL) and 
imidazole (9.6 g, 141.1 mmol, 2 eq.) was added in one portion. Under Ar-atmosphere, the mixture 
was cooled to 0 °C and a solution of triisopropyl chloride (TIPS-Cl, 13.6 g, 70.6 mmol, 1.2 eq.) in 
anhydrous DMF (20 mL) was slowly added at 0 °C. The reaction mixture was allowed to warm to 
r.t. overnight. 100 mL of hexane/Et2O (1/1) and 100 mL of saturated aqueous NH4Cl were added 
and the phases separated. The organic phase was extracted with water twice. The combined 
aqueous phases were back-extracted two times with a 1/1 mixture of hexane/Et2O and the 
combined organic layers were dried over MgSO4. Evaporation of the solvent yielded silylether 389 
(13.4 g, 50.2 mmol, 85%) as colorless oil, which was purified by silica gel column chromatography 
(hexane/EtOAc = 50/1). 
1H-NMR (250MHz, CDCl3):  = 5.80 (m, 2H); 4.53 (ddd, J = 7.8, 6.4, 2.1Hz, 1H); 3.13 (m, 1H); 2.96 
(m, 1H); 2.84 (m, 1H); 2.61 (m, 1H); 2.31 (m, 1H); 1.63 (m, 1H); 1.03 (bs, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C16H30OSi: 266.2066; found: 266.2054 
 
2-((1R,2R,4S)-2-(hydroxymethyl)-4-((triisopropylsilyl)oxy)cyclobutyl)ethanol (191) 
 
Bicycle 389 (12.0 g, 45 mmol, 1.0 eq.) was dissolved in a 4/1 mixture of CH2Cl2/MeOH (450 mL). 
The solution was cooled to -78 °C and ozone was bubbled through it until it turned blue. The ozone 
generator was turned off and dehumidified air was further bubbled through the solution until the 
blue color disappeared. MeOH (360 mL) and NaBH4 (6.8 g, 180 mmol, 4 eq.) were added and the 
reaction mixture was allowed to warm to r.t., where it was stirred for another 3h. The pH of the 
solution was adjusted to 4-5 with 1M HCl. The phases were separated and the aqueous phase was 
extracted with CH2Cl2 twice. The combined organic layers were dried with Na2SO4 and the solvent 
was removed in vacuo. The crude product was of sufficient purity for further conversion. Diol 191 
was obtained as white semi-solid (13.6 g, 45 mmol, quant.). 
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1H-NMR (250MHz, CDCl3):  = 4.33 (m, 1H); 3.78 (m, 1H); 3.63 (m, 2H); 2.74 (m, 2H); 2.62 (m, 1H); 
2.25 (m, 2H); 1.98 (m, 1H); 1.81 (m, 1H); 1.64 (m, 1H); 1.05 (bs, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C16H34O3Si: 302.2277; found: 302.2282 
[]D
20: +45.6 (c=0.69; CHCl3) 
 
((1R,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)methanol (188) and 
2-((1R,2R,4S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)ethanol (193) 
 
Diol 191 (17.2 g, 56.9 mmol, 1.0 eq.) was dissolved in 500 mL anhydrous CH2Cl2 and DMAP 
(348 mg, 2.8 mmol, 0.05 eq.) and pyridine (3.67 mL, 45.5 mmol, 0.8 eq.) were added. The reaction 
mixture was cooled to -42 °C using an acetonitrile/dry ice cooling bath. A solution of MMTr-Cl 
(12.3 g, 40 mmol, 0.7 eq.) in 100 mL of anhydrous CH2Cl2 was added dropwise to the solution of 
the diol at low temperature. The reaction mixture was stirred for two hours at -42 °C and 
consecutively quenched by the addition of sat. aq. NH4Cl solution. Under vigorous stirring the 
solution was allowed to warm to r.t. and the phases were separated. The aqueous phase was 
extracted twice with 100 mL CH2Cl2, respectively. The combined organic layers were dried with 
brine and MgSO4. Solvents were removed under reduced pressure and the crude product was 
purified using silica gel chromatography (hexane/EtOAc = 10/1 - 7/1 - 5/1 - 4/1 - 3/1). The first 
eluted product was the di-MMTr-protected diol 192 (2.4 g, 2.9 mmol, 7%). The second eluted 
product was the wrong regio isomer 193 (3.3 g, 5.7 mmol, 14%). The desired alcohol 188 was 
isolated as slightly yellow oil (16.4 g, 29 mmol, 73%), but the remaining unprotected diol (starting 
material 191) is still resting on the column. 
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Since the reaction produced a complex mixture of regio isomers, all had to be separated. As soon 
as the desired alcohol 188 was eluted, the di-MMTr-protected diol 192 was dissolved in 
CH2Cl2/MeOH (1/1, 30 mL) and PPTS (72 mg, 0.3 mmol, 0.1eq) was added. The reaction mixture 
was stirred at r.t. for 30 minutes. The solvents were removed under reduced pressure and the 
crude product was subjected to the same column chromatography described above. Now the 
elution was continued with pure EtOAc, first eluting MMTr-OH and then the diol 191. 
Major: 
1H-NMR (400MHz, CDCl3):  = 7.44 (m, 4H); 7.31 (m, 2H); 7.27 (m, 4H); 7.20 (m, 2H); 6.82 (m, 2H); 
4.26 (ddd, J = 6.6, 6.6, 6.6Hz, 1H); 3.79 (s, 3H); 3.64 (m, 1H); 3.58 (m, 1H); 3.22 (m, 1H); 3.05 (m, 
1H); 2.64 (m, 1H); 2.31 (m, 1H); 2.17 (m, 1H); 2.04 (m, 1H); 1.84 (bs, 1H); 1.80 (m, 1H); 1.69 (ddd, J 
= 11.1, 8.5, 6.6Hz, 1H); 0.97 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 158.4; 144.9; 136.3; 130.3; 128.5; 127.7; 126.7; 112.9; 86.3; 66.4; 
63.4; 63.1; 55.2; 40.6; 34.3; 32.5; 24.1; 18.0; 17.9; 11.9 
HRMS (ESI) (m/z): [M]+ calcd. for C36H50O4Si: 574.3478; found: 574.3465 
[]D
20: +17.9 (c=1.10; CHCl3) 
Minor: 
1H-NMR (400MHz, CDCl3):  = 7.45 (m, 4H); 7.32 (m, 2H); 7.30 (m, 4H); 7.24 (m, 2H); 6.85 (m, 2H); 
4.37 (ddd, J = 6.9, 6.9, 6.9Hz, 1H); 3.82 (s, 3H); 3.61 (m, 1H); 3.56 (m, 1H); 3.17 (dd, J = 9.2, 5.5Hz, 
1H); 3.02 (dd, J = 9.2, 5.5Hz, 1H); 2.69 (m, 1H); 2.62 (bs, 1H); 2.35 (m, 1H); 2.33 (m, 1H); 1.85 (m, 
1H); 1.71 (m, 1H); 1.52 (m, 1H); 1.07 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 158.5; 144.8; 135.9; 130.4; 128.4; 127.8; 126.9; 113.0; 86.1; 65.9; 
63.8; 62.7; 55.2; 43.0; 35.4; 29.1; 35.4; 26.4; 18.0; 17.9; 12.1 
HRMS (ESI) (m/z): [M]+ calcd. for C36H50O4Si: 574.3478; found: 574.3460 
[]D
20: +19.8 (c=1.42; CHCl3) 
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(1R,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarbaldehyde (390) 
 
Mono-MMTr-protected triol 188 (8.6 g, 14.9 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc 
(150 mL) and IBX (12.5 g, 44.6 mmol, 3 eq.) was added. The reaction mixture was refluxed until all 
starting material was consumed (approx. two hours). Now 150 mL of hexane were added and the 
suspension was filtered through a pad of celite 545 coarse. Removal of the solvents gave aldehyde 
390 (8.6 g, 14.9 mmol, quant.) as colorless oil.  
1H-NMR (400MHz, CDCl3):  = 9.66 (d, J = 2.3Hz, 1H); 7.41 (m, 4H); 7.27 (m, 6H); 7.21 (m, 2H); 6.81 
(m, 2H); 4.36 (m, 1H); 3.79 (s, 3H); 3.08 (m, 3H); 2.78 (m, 1H); 2.41 (m, 1H); 2.23 (m, 1H); 2.10 (m, 
1H); 1.75 (m, 1H); 0.97 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 202.9; 158.4; 144.8; 144.8; 136.1; 130.3; 128.4; 127.7; 126.7; 112.8; 
86.1; 65.2; 62.9; 60.4; 55.2; 43.7; 41.6; 31.3; 24.8; 17.9; 17.9; 11.9 
HRMS (ESI) (m/z): [M]+ calcd. for C36H48O4Si: 572.3322; found: 574.3307 
 
(1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarbaldehyde (194) 
 
7.6 g (13.3 mmol, 1.0 eq.) of aldehyde 390 were dissolved in as little anhydrous CH2Cl2 as possible. 
150 mL of anhydrous MeOH and 18.5 g (133 mmol, 10 eq.) of finely ground K2CO3 were added. The 
reaction mixture was stirred for one hour and afterwards filtered through a pad of celite. Et2O 
(100 mL) was added to the resulting solution. The pH of the solution was adjusted to 7 by the 
addition of 0.5M KHSO4 solution and the phases were separated. The organic phase was extracted 
twice with water and the combined aqueous phases were back-extracted with Et2O/hexane (1/1). 
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The combined organic layers were dried with MgSO4 and the solvent was removed under reduced 
pressure giving 7.6 g (13.3 mmol, quant.) of inverted aldehyde 194 as colorless oil, which was of 
excellent purity. 
1H-NMR (400MHz, CDCl3):  = 9.67 (d, J = 1.6Hz, 1H); 7.42 (m, 4H); 7.26 (m, 6H); 7.21 (m, 2H); 6.82 
(m, 2H); 4.38 (m, 1H); 3.80 (s, 3H); 3.16 (m, 2H); 2.82 (m, 2H); 2.53 (m, 1H); 2.09 (m, 2H); 1.86 (m, 
1H); 0.97 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 202.6; 158.4; 144.8; 136.0; 130.3; 128.4; 127.7; 126.7; 113.0; 86.2; 
65.9; 61.8; 60.4; 55.2; 46.0; 41.2; 31.3; 28.5; 17.9; 17.9; 12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C36H48O4Si: 572.3322; found: 574.3315 
[]D
20: +23.8 (c=0.61; CHCl3) 
 
Methyl-3-hydroxy-3-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)propanoate (391) 
 
The reaction was carried out under Barbier conditions. Aldehyde 194 (7.6 g, 13.3 mmol, 1.0 eq.), 
bromo acetic acid methyl ester (1.59 mL, 17.3 mmol, 1.3 eq.) and zinc powder (1.4 g, 21.2 mmol, 
1.6 eq.) were dissolved/suspended in anhydrous THF (60 mL). Local heating with a hot gun started 
the reaction, the solution turned green and started to reflux. After cessation of boiling the reaction 
mixture was heated at 40 °C for 30 minutes. The reaction mixture was quenched by the addition of 
saturated aqueous NH4Cl. The phases were separated and the pH of the aqueous phases was set 
slightly acidic by the addition of 0.5M KHSO4. The aqueous phase was extracted twice with Et2O 
and the combined organic phases were dried with brine and MgSO4. Removal of the solvent under 
reduced pressure and silica gel chromatography (hexane/EtOAc = 5/1 to 4/1; important to remove 
zink-impurities, which inhibit the following IBX oxidation!) yielded 391 (8.6 g, 13.3 mmol, quant.) 
as an inconsequential mixture of diastereo isomers. 
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1H-NMR (250MHz, CDCl3):  = 7.43 (m, 4H); 7.27 (m, 8H); 6.81 (m, 2H); 4.40 (m, 1H); 3.89 (m, 1H); 
3.79 (s, 3H); 3.68 (s, 3H); 3.09 (m, 2H); 2.72 (m, 1H); 2.31 (m, 2H); 2.05 (m, 3H); 1.79 (m, 3H); 1.00 
(m, 21H) 
13C-NMR (100MHz, CDCl3):  = 173.5; 173.2; 158.4; 144.9; 136.1; 130.3; 128.4; 127.3; 126.6; 113.0; 
86.4; 86.1; 70.9; 70.1; 66.2; 62.4; 61.9; 55.2; 51.7; 41.0; 40.7; 40.4; 40.2; 39.3; 33.4; 32.0; 29.1; 
28.8; 18.0; 12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C39H54O6Si: 646.3690; found: 646.3681 
 
Methyl-3-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)-3-oxopropanoate (195) 
 
Secondary alcohol 391 (8.6 g, 13.3 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (130 mL) and 
IBX (11.2 g, 39.8 mmol, 3 eq.) was added. The suspension was heated to reflux for three hours. 
Now the suspension was cooled to r.t. and 130 mL hexane were added. The slurry was filtered 
through a pad of celite and the solvents were removed under reduced pressure. The crude 
product was purified by silica gel column chromatography (hexane/EtOAc = 5/1). -keto ester 195 
was obtained as a viscous slightly yellow oil (8.4 g, 13.0 mmol, 98%). 
1H-NMR (400MHz, CDCl3):  = 7.41 (m, 4H); 7.26 (m, 8H); 6.81 (m, 2H); 4.41 (m, 1H); 3.78 (s, 3H); 
3.66 (s, 3H); 3.28 (m, 2H); 3.16 (m, 2H); 2.95 (ddd, J = 9.2, 4.5, 4.5Hz, 1H); 2.78 (m, 1H); 2.51 (dddd, 
J = 11.7, 4.3, 4.0, 3.3Hz, 1H); 2.11 (m, 2H); 1.83 (m, 1H); 1.00 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 203.9; 167.5; 158.5; 144.6; 136.0; 130.2; 128.4; 127.8; 126.8; 113.0; 
86.3; 65.5; 62.0; 55.1; 52.2; 47.5; 45.6; 42.8; 33.0; 28.7; 17.8; 11.9 
HRMS (ESI) (m/z): [M]+ calcd. for C39H52O6Si: 644.3533; found: 644.3527 
[]D
20: +26.4 (c=0.60; CHCl3) 
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Methyl-6-((ethoxycarbonyl)oxy)-2-((1S,2R,3S)-2-(2-((4-
methoxyphenyl)diphenylmethoxy)ethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)hex-
4-ynoate (199) 
 
NaH (60% in mineral oil, 520 mg, 13.0 mmol, 1.0 eq.) was suspended in anhydrous THF (30 mL). 
The reaction mixture was cooled to 0 °C and a solution of -keto ester 195 (8.4 g, 13.0 mmol, 
1.0 eq.) in anhydrous THF (60 mL) was added. The reaction was stirred at 0 °C for 20 minutes and 
afterwards warmed to r.t. within 10 minutes. Then it was re-cooled to 0 °C and a solution of 
propargylic iodide 198 (3.3 g, 12.4 mmol, 0.95 eq.) in anhydrous THF (40 mL) was added 
uninterruptedly at 0 °C. The reaction mixture was stirred at this temperature for 20 minutes and 
then warmed to r.t. within 20 minutes before it was quenched with saturated aqueous NH4Cl. Et2O 
was added and the phases separated. The pH of the aqueous phase was adjusted to 6 with 0.5M 
KHSO4 and it was extracted twice with Et2O. The combined organic layers were dried with MgSO4 
and the solvent was removed under reduced pressure. Silica gel column chromatography 
(hexane/EtOAc = 7/1) yielded alkylated -keto ester 199 as slightly yellow oil (9.5 g, 12.2 mmol, 
98%). 
1H-NMR (600MHz, CDCl3):  = 7.42 (m, 4H); 7.28 (m, 6H); 7.21 (m, 2H); 6.82 (m, 2H); 4.61 (m, 1H); 
4.56 (m, 1H); 4.40 (m, 1H); 3.79 (s, 3H); 3.77 (s, 3H); 3.58 (m, 4H); 3.16 (m, 2H); 3.07 (m, 1H); 2.86 
(m, 1H); 2.66 (m, 2H); 2.49 (m, 1H); 2.15 (m, 2H); 1.81 (m, 1H); 0.99 (m, 21H) 
13C-NMR (150MHz, CDCl3):  = 205.1; 204.1; 168.4; 168.3; 158.5; 158.4; 144.8; 144.7; 144.6; 135.9; 
130.3; 128.4; 128.3; 127.8; 127.7; 126.8; 126.7; 113.0; 86.2; 84.6; 75.5; 75.1; 65.4; 61.9; 61.8; 55.7; 
55.5; 55.3; 55.1; 55.0; 52.6; 52.5; 45.8; 45.0; 42.4; 42.0; 33.3; 33.1; 28.9; 28.8; 18.1; 17.9; 17.8; 
17.6; 11.9 
HRMS (ESI) (m/z): [M]+ calcd. for C39H52O6Si: 770.3850; found: 770.3843 
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Methyl-2-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)-5-vinylfuran-3-carboxylate (200) 
 
Alkylated -keto ester 199 (9.5 g, 12.2 mmol, 1.0 eq.) was dissolved in anhydrous DMF (120 mL) 
under an Ar-atmosphere and finely ground anhydrous K2CO3 (11 g, 79.3 mmol, 6.5 eq.) was added. 
The reaction flask was sealed and the reaction mixture was heated to 90 °C (oil bath temperature 
100 °C) for two hours. Stirring was stopped, the suspension was allowed to cool to r.t. and the 
suspended K2CO3 was allowed to settle down. The supernatant was decanted and remaining K2CO3 
was washed four times with Et2O (4x40 mL). The combined organic layers were quenched with 
0.5M KHSO4 and the pH was adjusted to 6. The phases were separated and the aqueous phase was 
washed 4 times with Et2O/hexane (1/1). The combined organic layers were dried with MgSO4 and 
the solvents were removed under reduced pressure. The crude product was purified by silica gel 
chromatography (hexane/EtOAc = 10/1) yielding pure vinyl furan 200 (6.8 g, 9.8 mmol, 80%). 
1H-NMR (400MHz, CDCl3):  = 7.34 (m, 4H); 7.19 (m, 8H); 6.75 (d, J = 8.95Hz, 2H); 6.45 (s, 1H); 6.42 
(dd, J = 17.5, 11.3Hz, 1H); 5.64 (dd, 17.5, 0.8Hz, 1H); 5.19 (dd, J = 11.3, 0.8Hz, 1H); 4.66 (m, 1H); 
3.91 (m, 1H); 3.78 (s, 3H); 3.68 (s, 3H); 3.05 (m, 3H); 2.47 (m, 1H); 2.30 (m, 1H); 2.07 (m, 1H); 1.88 
(m, 1H); 1.03 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 164.3; 158.5; 150.7; 144.9; 136.2; 130.3; 128.4; 127.6; 126.5; 124.5; 
113.8; 112.9; 112.7; 108.8; 66.9; 61.5; 55.1; 51.1; 44.7; 36.4; 33.7; 29.1; 18.0; 12.1 
HRMS (ESI) (m/z): [M]+ calcd. for C43H54O6Si: 694.3690; found: 694.3692 
[]D
20: +16.4 (c=0.48; CH2Cl2) 
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Methyl-2-((1S,2R,3S)-2-(2-hydroxyethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-vinylfuran-
3-carboxylate (392) 
 
Vinyl furan 200 (6.8 g, 9.8 mmol, 1.0 eq.) was dissolved in 100 mL of a 4/1 mixture CH2Cl2/MeOH. 
PPTS (246 mg, 1.0 mmol, 0.1 eq.) was added and the reaction mixture was allowed to stir at r.t. 
until TLC analysis indicated full consumption of the starting material (approx. one hour). The 
reaction mixture was quenched with saturated aqueous NaHCO3. The phases were separated and 
the aqueous layer was extracted two times with Et2O. The combined organic layers were dried 
with MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 4/1) yielded free alcohol 392 as colorless viscous oil (3.9 g, 
9.1 mmol, 93%). 
1H-NMR (400MHz, CDCl3):  = 6.47 (s, 1H); 6.44 (dd, J = 17.5, 11.3Hz, 1H); 5.64 (dd, J = 17.5, 0.8Hz, 
1H); 5.20 (dd, J = 11.3, 0.8Hz, 1H); 4.79 (m, 1H); 3.91 (m, 1H); 3.80 (s, 3H); 3.72 (m, 2H); 2.80 (m, 
1H); 2.61 (m, 1H); 2.44 (m, 1H); 2.24 (t, J = 5.6Hz, 1H); 2.09 (m, 1H); 1.92 (m, 1H); 1.09 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 163.9; 151.0; 124.4; 112.9; 108.7; 66.7; 61.2; 51.4; 46.3; 35.9; 32.5; 
31.8; 18.0; 17.9; 12.1 
HRMS (ESI) (m/z): [M]+ calcd. for C23H38O5Si: 422.2489; found: 422.2483 
[]D
20: +25.4 (c=0.50; CHCl3) 
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Methyl-2-((1S,2R,3S)-2-(2-oxoethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-vinylfuran-3-
carboxylate (201) 
 
Primary alcohol 392 (3.9 g, 9.1 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (90 mL) and IBX 
(7.6 g, 27.3 mmol, 3 eq.) was added. The suspension was heated to reflux for three hours. Now the 
suspension was cooled to r.t. and 90 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed in vacuo. The crude product was purified 
by silica gel column chromatography (hexane/EtOAc = 5/1). Aldehyde 201 was obtained as viscous 
oil (3.7 g, 8.8 mmol, 97%). 
1H-NMR (400MHz, CDCl3):  = 9.79 (t, J = 1.5Hz, 1H); 6.48 (s, 1H); 6.44 (dd, J = 17.7, 11.3Hz, 1H); 
5.66 (dd, 17.7, 0.8Hz, 1H); 5.22 (dd, J = 11.3, 0.8Hz, 1H); 4.77 (m, 1H); 4.02 (m, 1H); 3.80 (s, 3H); 
3.21 (m, 1H); 2.97 (dd, J = 17.5, 1.5Hz, 1H); 2.66 (m, 2H); 2.37 (m, 1H); 1.07 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 201.8; 162.9; 157.4; 124.4; 113.1; 108.7; 66.6; 51.3; 43.1; 42.2; 35.8; 
33.2; 17.9; 12.1 
HRMS (ESI) (m/z): [M]+ calcd. for C23H36O5Si: 420.2332; found: 420.2321 
 
(S)-oxiran-2-ylmethyl 4-methylbenzenesulfonate (393) 
 
(R)-glycidol (186, 4.0 g, 54 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (50 mL) and NEt3 
(15 mL, 108 mmol, 2 eq.) and DMAP (330 mg, 2.7 mmol, 0.05 eq.) were added. The solution was 
cooled to 0 °C and kept under an Ar-atmosphere. Tosyl-chloride (9.8 g, 51.0 mmol, 0.95 eq.) was 
dissolved in anhydrous CH2Cl2 (50 mL) and was added dropwise to the solution of glycidol. The 
reaction mixture was stirred for 90 minutes. The reaction was quenched by the addition of 0.5M 
KHSO4. The phases were separated and the aqueous layer was extracted with CH2Cl2. The 
combined organic extracts were dried with brine and MgSO4 and the solvent was removed under 
reduced pressure. Purification by silica gel column chromatography (hexane/EtOAc = 2/1) yielded 
tosylated glycidol 393 (11.6 g, 50.8 mmol, 94%).  
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1H-NMR (400MHz, CDCl3):  = 7.81 (d, J = 8.3Hz, 2H); 7.36 (d, J = 8.3Hz, 2H); 4.25 (dd, J = 11.4, 
3.6Hz, 1H); 3.96 (dd, J = 11.4, 6.1Hz, 1H); 3.19 (m, 1H); 2.81 (t, J = 4.5Hz, 1H); 2.59 (dd, J = 4.8, 
2.5Hz, 1H); 2.45 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H12O4S: 228.0456; found: 228.0450 
 
(S)-2-hydroxy-4-methylpent-4-en-1-yl 4-methylbenzenesulfonate (202) 
 
CuI (2.4 g, 12.8 mmol, 0.2 eq.) was suspended in a flame dried three neck round bottom flask in 
anhydrous THF (40 mL) and the suspension was cooled to -78 °C. 268 mL of a 0.5M solution of 
isopropenylmagnesium bromide (134 mmol, 2.1 eq.) in THF were added and the suspension 
turned into a yellow solution. The reaction mixture was allowed to stir for 45 minutes at -78 °C 
until 60 mL of a solution of tosylated glycidol 393 (14.6 g, 63.8 mmol, 1.0 eq.) in anhydrous THF 
was added dropwise. The reaction mixture was allowed to stir at -78 °C for 30 minutes. Then it was 
allowed to warm to -40 °C within two hours until it was quenched with NH4Cl (no further warming, 
else the formed alcoholate eliminates the tosylate and forms the epoxide; volatile!). The biphasic 
mixture was allowed to warm to r.t. and Et2O and 25% aqueous NH3 were added. The phases were 
separated and the organic layer was repeatedly washed with a 3/1 mixture of NH4Cl/NH3. The 
combined aqueous extracts were back-extracted once with Et2O and the combined organic layers 
were dried with MgSO4. The solvent was removed under reduced pressure and the crude product 
was purified by silica gel column chromatography (hexane/EtOAc = 2/1) yielding tosylate 202 
(15.5 g, 57 mmol, 90%). 
1H-NMR (400MHz, CDCl3):  = 7.81 (d, J = 8.3Hz, 2H); 7.36 (d, J = 8.3Hz, 2H); 4.86 (s, 1H), 4.76 (s, 
1H); 4.00 (m, 3H); 2.46 (s, 3H); 2.18 (m, 2H); 2.06 (d, J = 3.8Hz, 1H); 1.73 (s, 3H) 
13C-NMR (100MHz, CDCl3):  = 145.0; 140.9; 132.8; 129.9; 129.3; 128.0; 114.2; 73.3; 70.4; 67.1; 
44.6; 41.4; 22.5; 22.3; 21.6; 20.8 
HRMS (ESI) (m/z): [M]+ calcd. for C13H18O4S: 270.0926; found: 270.0919 
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(5S)-5-(2-methylallyl)-3-(phenylselanyl)dihydrofuran-2(3H)-one (185) 
 
DIPA (25.2 mL, 180 mmol, 3.15 eq.) was mixed with anhydrous THF (130 mL) and the mixture was 
cooled to -10 °C when n-BuLi (2.5M in hexane; 68 mL, 171.0 mmol, 3 eq.) was added. The mixture 
was allowed to stir at -10 °C for 30 minutes. Consecutively, a solution of phenylselenyl acetic acid 
397 (30.7 g, 143 mmol, 2.5 eq.) in anhydrous THF (100 mL) was added. The reaction mixture was 
stirred at -10 °C for 20 minutes , then the cooling bath was removed and the reaction mixture was 
allowed to stir at r.t for 90 minutes (formation of dianion, precipitating). 
Meanwhile, NaH (60% in mineral oil, 2.3 g, 57 mmol, 1.0 eq.) was suspended in anhydrous THF 
(60 mL) at 0 °C. Tosylate 202 (15.5 g, 57 mmol, 1.0 eq.) dissolved in anhydrous THF (120 mL) and 
was added dropwise to the suspension of NaH at 0 °C. After 30 minutes the evolution of 
dihydrogen has ceased, the cooling bath was removed and stirring was continued for additional 30 
minutes. 
The suspension of the dianion was cooled to -78 °C and the suspension of the in situ generated 
epoxide was cannulated to the dianion. The reaction mixture was allowed to warm to r.t. slowly 
overnight. The reaction was quenched by the addition of NH4Cl and water. Et2O was added and the 
phases were separated. The aqueous phase was extracted twice with Et2O and the combined 
organic layers were dried with MgSO4. The solvent was removed under reduced pressure. The 
crude product was of sufficient purity for further conversion. 
The crude product 204 (18.2 g) was dissolved in anhydrous CH2Cl2 (600 mL) and DMAP (696 mg, 
5.7 mmol, 0.1 eq.) was added. The reaction was cooled to 0 °C and DIC (9.7 mL, 62.7 mmol, 
1.1 eq.) was added. The reaction mixture was stirred at 0 °C for 90 minutes. The solvent was 
removed under reduced pressure and the crude product was purified using silica gel 
chromatography (hexane/EtOAc = 7/1). Selenolactone 185 was obtained as orange oil (14.3 g, 
49 mmol, 85%) as an inconsequential mixture of diastereo isomers.  
1H-NMR (400MHz, CDCl3):  = 7.69 (m, 2H); 7.35 (m, 1H); 7.34 (m, 2H); 4.84 (s, 1H); 4.73 (s, 1H); 
4.42 (dddd, J = 7.0, 7.0, 6.8, 6.8Hz, 1H); 3.95 (dd, J = 6.5, 4.5Hz, 1H), 2.45 (dd, J = 14.3, 6.9Hz, 1H), 
2.36 (m, 1H), 2.23 (dd, J = 14.3, 6.1Hz, 1H), 1.71 (s, 3H) 
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13C-NMR (100MHz, CDCl3):  = 175.6; 140.1; 135.9; 129.9; 129.8; 129.2; 126.7; 113.9; 77.6; 43.2; 
36.9; 36.5; 22.7 
HRMS (ESI) (m/z): [M]+ calcd. for C14H16O2Se: 296.0316; found: 296.0301 
 
Methyl-2-((1S,2R,3S)-2-(2-hydroxy-2-((5S)-5-(2-methylallyl)-2-oxo-3-
(phenylselanyl)tetrahydrofuran-3-yl)ethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-
vinylfuran-3-carboxylate (394) 
 
DIPA (1.6 mL, 11.4 mmol, 1.3 eq.) was dissolved in anhydrous THF (30 mL) and the mixture was 
cooled to -10 °C when n-BuLi (2.5M in hexane; 4.2 mL, 10.6 mmol, 1.2 eq.) was added. The mixture 
was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
selenolactone 185 (2.9 g, 9.7 mmol, 1.1 eq.) in anhydrous THF (20 mL) was added dropwise. Upon 
completion, the reaction mixture was allowed to stir for 30 minutes. A solution of aldehyde 201 
(3.7 g, 8.8 mmol, 1.0 eq.) in anhydrous THF (30 mL) was added and the reaction mixture was 
stirred for one hour. The reaction was quenched by the addition of sat. aq. NH4Cl. After addition of 
Et2O, the phases were separated and the aqueous phase was neutralized by the addition of 0.5M 
KHSO4. The aqueous layer was extracted twice with Et2O and the combined organic phases were 
dried with MgSO4. Purification by silica gel chromatography (hexane/EtOAc = 10/1) yielded diene 
394 as colorless viscous oil (5.67 g, 7.9 mmol, 90%). 
1H-NMR (400MHz, CDCl3):  = 7.70 (m, 2H); 7.41 (m, 1H); 7.30 (m, 2H); 6.45 (s, 1H); 6.43 (dd, J = 
17.3, 12.5Hz, 1H); 5.65 (d, J = 17.3Hz, 1H); 5.20 (d, J = 12.5Hz, 1H); 4.81 (bs, 1H); 4.76 (dddd, J = 
9.0, 6.8, 6.8, 6.8Hz, 1H); 4.69 (bs, 1H); 4.16 (m, 1H); 3.91 (ddd, J = 9.1, 5.9, 5.8Hz, 1H); 3.86 (d, J = 
10.7Hz, 1H); 3.79 (m, 1H); 3.75 (s, 3H); 3.03 (m, 1H); 2.83 (m, 1H); 2.61 (m, 1H); 2.44 (dd, J = 14.5, 
7.0Hz, 1H), 2.35 (m, 1H), 2.22 (m, 2H), 2.20 (m, 1H); 2.18 (m, 1H); 1.65 (s, 3H); 1.11 (m, 21H) 
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13C-NMR (100MHz, CDCl3):  = 164.7; 163.8; 151.3; 140.5; 138.8; 130.9; 129.6; 126.1; 124.8; 113.4; 
114.1; 109.0; 76.3; 72.0; 67.5; 56.7; 45.5; 51.8; 43.6; 38.6; 36.1; 33.8; 32.3; 23.0; 18.4; 12.6 
HRMS (ESI) (m/z): [M]+ calcd. for C37H52O7SeSi: 716.2648; found: 716.2638 
 
Methyl-2-((1S,2R,3S)-2-(2-hydroxy-2-((S)-5-(2-methylallyl)-2-oxo-2,5-dihydrofuran-3-
yl)ethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-vinylfuran-3-carboxylate (205) 
 
Diene 394 (5.67 g, 7.9 mmol, 1.0 eq.) was dissolved in CH2Cl2 (80 mL) and 20 mL of sat. aq. NH4Cl 
were added. The biphasic mixture was cooled to 0 °C and 30% H2O2 (733 µL, 23.7 mmol, 3 eq.) was 
added. The reaction was stirred at 0 °C for one hour and then quenched by the addition of sat. aq. 
Na2S2O3. Phases were separated and the organic phase was extracted 4 times with water. The 
organic layer was dried with MgSO4 and the solvent was removed under reduced pressure. After 
silica gel chromatography (hexane/EtOAc = 2/1) butenolide 205 was obtained as colorless oil 
(4.4 g, 7.9 mmol, quant.) as an hardly separable mixture of diastereo isomers. 
Major: 
1H-NMR (400MHz, CDCl3):  = 7.24 (t, J = 1.6Hz, 1H); 6.47 (s, 1H); 6.42 (dd, J = 17.4, 11.3Hz, 1H); 
5.63 (d, J = 17.4Hz, 1H); 5.19 (d, J = 11.3Hz, 1H); 5.04 (tt, J = 6.9, 1.6Hz, 1H); 4.89 (bs, 1H); 4.83 (q, J 
= 6.9Hz, 1H); 4.79 (bs, 1H); 4.55 (d, J = 9.5Hz, 1H); 3.85 (m, 1H); 3.79 (s, 3H); 2.93 (m, 1H); 2.63 (m, 
1H); 2.41 (m, 3H); 2.25 (ddd, J = 14.5, 7.1, 3.0Hz, 1H); 2.08 (m, 1H); 1.77 (s, 3H); 1.08 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 172.0; 164.3; 163.0; 150.8; 148.1; 139.6; 137.7; 124.3; 114.3; 114.1; 
112.9; 108.7; 79.9; 66.7; 65.9; 51.5; 46.2; 41.3; 35.5; 35.3; 32.5; 29.6; 22.9; 17.9; 17.8; 17.8; 17.7; 
12.4; 12.1; 11.9; 11.8 
HRMS (ESI) (m/z): [M]+ calcd. for C31H46O7Si: 558.3013; found: 558.3010 
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Minor: 
1H-NMR (400MHz, CDCl3):  = 7.16 (t, J = 1.5Hz, 1H); 6.48 (s, 1H); 6.44 (dd, J = 17.5, 11.2Hz, 1H); 
5.64 (d, J = 17.5Hz, 1H); 5.21 (d, J = 11.2Hz, 1H); 5.03 (tt, J = 6.9, 1.4Hz, 1H); 4.90 (bs, 1H); 4.81 (bs, 
1H); 4.78 (q, J = 6.9Hz, 1H); 4.63 (m, 1H); 3.99 (m, 1H); 3.93 (d, J = 5.2Hz, 1H); 3.81 (s, 3H); 2.79 (m, 
1H); 2.64 (m, 1H); 2.39 (m, 5H); 2. 06 (m, 1H); 1.78 (s, 3H); 1.08 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 172.0; 164.3; 163.2; 150.8; 148.5; 139.8; 136.7; 124.4; 114.2; 114.1; 
113.0; 108.7; 80.0; 66.9; 66.1; 51.6; 45.5; 41.4; 35.7; 35.3; 34.1; 32.6; 22.9; 18.0; 17.8; 17.9; 12.1 
(1S,9S,11S,12R,14R,Z)-methyl 14-hydroxy-3-methyl-16-oxo-11-((triisopropylsilyl)oxy)-
17,19-dioxatetracyclo[13.2.1.15,8.09,12]nonadeca-3,5,7,15(18)-tetraene-7-carboxylate 
(395) 
 
Benzene was degassed with 5 pump and freeze cycles. Both diastereo isomers of diene 205 
(2.15 g, 3.85 mmol, 1.0 eq.) were dissolved in degassed benzene (2.4L; [1.6mM]) in a flame dried 
Schlenk flask and the reaction mixture was heated to reflux. Grubbs’ second generation 
metathesis catalyst (653 mg, 0.77 mmol, 0.2 eq.) was dissolved in 20 mL degassed benzene and 
was added via a syringe over a period of 15h using a syringe pump. After the addition was 
completed the solvent was removed under reduced pressure. Purification by silica gel column 
chromatography yielded macrocycle 395 as colorless oil (946 mg, 1.78mmopl, 46%) and its 
diastereo isomer (620 mg, 1.17 mmol, 30%). 
1H-NMR (400MHz, CDCl3):  = 6.83 (s, 1H); 6.39 (s, 1H); 6.07 (s, 1H); 4.92 (m, 1H); 4.73 (m, 1H); 
4.36 (dd, J = 5.9, 5.9Hz, 1H); 4.23 (ddd, J = 9.3, 9.3, 9.3Hz, 1H); 3.74 (s, 3H); 3.06 (dd, J = 11.7, 
11.7Hz, 1H); 2.69 (dd, J = 11.7, 4.5Hz, 1H); 2.55 (m, 1H); 2.33 (m, 1H); 2.19 (m, 1H); 2.12 (m, 1H); 
2.04 (m, 1H); 1.95 (s, 3H); 1.01 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 171.9; 164.4; 163.7; 152.5; 150.1; 143.4; 129.8; 117.5; 113.9; 111.8; 
79.1; 69.4; 67.3; 51.8; 41.3; 40.8; 38.6; 38.4; 33.3; 26.6; 18.4; 18.2; 17.5 
HRMS (ESI) (m/z): [M]+ calcd. for C29H42O7Si: 530.2700; found: 530.2712 
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[]D
20: +69.1 (c=0.42; CH2Cl2) 
 
(1S,9S,11S,12R,14R,Z)-methyl 14-acetoxy-3-methyl-16-oxo-11-((triisopropylsilyl)oxy)-
17,19-dioxatetracyclo[13.2.1.15,8.09,12]nonadeca-3,5,7,15(18)-tetraene-7-carboxylate 
(206) 
 
Macrocycle 395 (102 mg, 0.19 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (3 mL) and DIPEA 
(37 µL, 0.21 mmol, 1.1eq) and DMAP (2.4 mg, 0.02 mmol, 0.1 eq.) were added. The reaction 
mixture was cooled to 0 °C and Ac2O (18.9 µL, 0.2 mmol, 1.05 eq.) was added. The solution was 
allowed to stir at 0 °C for 45 minutes, then it was quenched by the addition of sat. aq. NH4Cl. 
Phases were separated and the aqueous phase was extracted twice with CH2Cl2. The combined 
organic layers were dried with MgSO4 and the solvent was removed under reduced pressure. 
Purification by silica gel chromatography yielded acetate 206 (109 mg, 0.19 mmol, quant.).  
1H-NMR (400MHz, CDCl3):  = 6.94 (d, J = 1.3Hz, 1H); 6.48 (s, 1H); 6.12 (s, 1H); 5.24 (dd, J = 12.0, 
5.2Hz, 1H); 4.97 (ddd, J = 11.6, 4.6, 1.3Hz, 1H); 4.46 (t, J = 5.9Hz, 1H); 4.18 (q, J = 9.4Hz, 1H); 3.82 
(s, 3H); 3.02 (dd, J = 11.9, 11.9Hz, 1H); 2.78 (dd, J = 11.9, 4.6Hz, 1H); 2.54 (m, 2H); 2.32 (dd, J = 
11.4, 9.5Hz, 1H); 2.24 (dt, J = 12.5, 5.2Hz, 1H); 2.09 (m, 1H); 2.03 (s, 3H); 2.00 (s, 3H); 1.08 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 170.7; 170.6; 163.6; 162.2; 158.2; 149.8; 129.4; 128.4; 117.1; 113.9; 
111.8; 78.0; 68.3; 67.0; 60.4; 51.5; 41.1; 40.5; 37.8; 36.4; 29.9; 26.1; 21.2; 18.0; 12.4; 12.1 
HRMS (ESI) (m/z): [M]+ calcd. for C31H44O8Si: 572.2805; found: 572.2793 
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(Z)-Pentacycle (207) 
 
Acetate 206 (95 mg, 0.17 mmol, 1.0 eq.) was dissolved in anhydrous pyridine (2 mL) and the 
solution was cooled to -15 °C. Now 1.4 mL aqueous NaOCl (5% chlorine) were added dropwise and 
the reaction mixture was stirred for 5 minutes at -15 °C before it was quenched by the addition of 
a 1/1 mixture Na2S2O3/NH4Cl at low temperature. The aqueous phase was extracted three times 
with EtOAc and the combined organic layers were dried with MgSO4. Solvents were removed 
under reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 4/1) 
yielded (Z)-pentacycle 207 as colorless oil (84 mg, 0.14 mmol, 84%). 
1H-NMR (400MHz, CDCl3):  = 6.50 (s, 1H); 6.20 (d, J = 1.3Hz, 1H); 4.78 (dd, J = 12.4, 4.8Hz, 1H); 
4.54 (dd, J = 12.4, 4.0Hz, 1H); 4.50 (m, 1H); 4.08 (q, J = 9.2Hz, 1H); 3.82 (s, 3H); 3.70 (s, 1H); 3.51 
(dd, J = 12.6, 12.6Hz, 1H); 2.87 (m, 1H); 2.57 (m, 2H); 2.45 (m, 1H); 2.31 (dd, J = 13.6, 4.8Hz, 1H); 
2.23 (m, 1H); 2.11 (s, 3H); 2.00 (d, J = 1.3Hz, 3H); 1.07 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 170.0; 168.3; 163.4; 161.8; 149.5; 129.2; 117.6; 113.9; 111.3; 75.8; 
67.8; 67.5; 65.3; 58.1; 51.6; 39.6; 38.0; 36.6; 36.0; 30.3; 29.7; 29.3; 25.5; 22.7; 21.0; 18.0; 17.9; 
12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C31H44O8Si: 588.2755; found: 588.2751 
[]D
20: +96.2 (c=0.90; CHCl3) 
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(E)-Pentacycle (213) 
 
(Z)-pentacycle 207 (10 mg, 17 µmol, 1.0 eq.) was dissolved in anhydrous, degassed CH3CN (2 mL) in 
a pyrex tube. The reaction mixture was irradiated with a 100W Hoenle Fe bulb for 30 minutes. 
Longer reaction times led to the formation of undesired side products. The solvent was removed 
under reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 4/1) yielded 
(E)-pentacycle 213 (3 mg, 5.1 µmol, 30%) as mixture of atropisomers. 
1H-NMR (600MHz, toluene-d8, 348.1K):  = 6.42 (d, J = 1.3Hz, 1H); 5.84 (s, 1H); 5.41 (d, J = 10.3Hz, 
1H); 4.40 (dd, J = 5.4, 5.4Hz, 1H); 4.06 (dd, J = 4.0, 2.5Hz, 1H); 3.88 (q, J = 9.2Hz, 1H); 3.52 (m, 2H); 
3.49 (s, 3H); 2.99 (m, 1H); 2.48 (dd, J = 12.3, 8.6Hz, 1H); 2.28 (dd, J = 13.9, 3.9Hz, 1H); 2.16 (m, 3H); 
1.73 (s, 3H); 1.60 (s, 3H); 1.08 (m, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C31H44O8Si: 588.2755; found: 588.2748 
 
Ethyl 2-(phenylselanyl)acetate (396) 
 
A procedure of Arrica and Wirth was used.[133] Diphenyldiselenide (10.0 g, 32 mmol, 1.0 eq.) was 
suspended in anhydrous EtOH (70 mL) and the mixture was cooled to 0 °C. Portionwise addition of 
NaBH4 (3.64 g, 96 mmol, 3 eq.) yielded the selenate which was accompanied by decolorization. 
The reaction mixture was stirred for 10 minutes at 0 °C. A solution of chloro acetic acid ethyl ester 
(8.4 mL, 80.1 mmol, 2.5 eq.) in anhydrous EtOH (30 mL) was added dropwise. The reaction mixture 
was allowed to stir for one hour until it was quenched by the addition of sat. aq. NH4Cl. After the 
addition of Et2O, the phases were separated and the aqueous phase was extracted twice with 
Et2O. The combined organic layers were dried with MgSO4 and the solvents were removed under 
reduced pressure. The excess of ethyl-chloro-acetate was removed in high vacuum yielding 396 
(15.6 g, 64 mmol, quant.) as colorless liquid. 
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1H-NMR (250MHz, CDCl3):  = 7.59 (m, 2H); 7.29 (m, 3H); 4.13 (q, J = 7.1Hz, 2H); 3.51 (s, 2H); 1.2 (t, 
J = 7.1Hz, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H12O2Se: 244.0003; found: 243.9995 
 
2-(phenylselanyl)acetic acid (397) 
 
A procedure of Arrica and Wirth was used.[133] 15.6 g (64 mmol, 1.0 eq.) of ester 396 were 
dissolved in EtOH (100 mL) and the solution was cooled to 0 °C. After the addition of 100 mL 30% 
KOH the reaction mixture was allowed to stir for 1h. Acidification (pH = 1-2) with concentrated HCl 
and extraction with Et2O, drying with MgSO4 and removal of the solvents under reduced pressure 
yielded pure 2-(phenylselanyl)acetic acid 397 (13.7 g, 64 mmol, quant.) as white (seldom slightly 
colored) crystals. 
1H-NMR (250MHz, CDCl3):  = 10.50 (bs, 1H); 7.60 (m, 2H); 7.31 (m, 3H); 3.52 (s, 2H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C8H8O2SeNa: 238.9587; found: 238.99578 
 
Ethyl-(4-hydroxybut-2-yn-1-yl) carbonate (197) 
 
But-2-yne-1,4-diol (196, 15 g, 174 mmol, 3 eq.) was dissolved in anhydrous CH2Cl2 (350 mL) and 
the solution was cooled to 0 °C. DIPEA (33.5 mL, 191.7 mmol, 3.3 eq.) and DMAP (708 mg, 
5.8 mmol, 0.1 eq.) were added to the solution before methyl chloro formate (4.49 mL, 58.1 mmol, 
1.0 eq.) was added dropwise via a syringe. The reaction mixture was stirred at 0 °C for two hours 
before it was allowed to warm to r.t. overnight. The solution was concentrated to ¼ of its original 
volume and Et2O and NaHCO3 were added. The phases were separated and the organic phase was 
washed three times with sat. aq. NaHCO3 before it was dried with brine and MgSO4. The solvent 
was removed under reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 
1/1) yielded propargylic carbonate 197 as colorless liquid (7.3 g, 50.7 mmol, 87%). 
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1H-NMR (250MHz, CDCl3):  = 4.77 (bs, 2H); 4.30 (d, J = 6.3Hz, 2H); 3.81 (s, 3H); 1.89 (t, J = 6.3Hz, 
1H) 
HRMS (ESI) (m/z): [M]+ calcd. for C6H8O4: 144.0423; found: 144.0420 
 
Ethyl-(4-iodobut-2-yn-1-yl) carbonate (198) 
 
Imidazole (10.5 g, 153.6 mmol, 3 eq.), PPh3 (26.9 g, 102.4 mmol, 2 eq.) and iodine (26.0 g, 
102.4 mmol, 2 eq.) were added to 220 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension 
was stirred at 0 °C for 20 minutes while it turned yellow. To this suspension a solution of 
propargylic carbonate 197 (7.37 g, 51.2 mmol, 1.0 eq.) in anhydrous CH2Cl2 (30 mL) was rapidly 
added. The reaction mixture was stirred for one hour. Then it was quenched by the addition of 
220 mL hexane. The precipitating triphenylphosphineoxide was filtered through a pad of celite and 
a solution of sat. aq. Na2S2O3 and NaHCO3 was added to the filtrate. The phases were separated 
and the organic phase was washed with Na2S2O3, NaHCO3 and brine before it was dried with 
MgSO4. After removal of the solvent under reduced pressure, purification by silica gel 
chromatography yielded propargylic iodide 198 (10.3 g, 38.4 mmol, 75%) as slightly yellow liquid.  
1H-NMR (250MHz, CDCl3):  = 4.75 (bs, 2H); 3.81 (s, 3H); 3.70 (bs, 2H) 
HRMS (ESI) (m/z): [M]+ calcd. for C6H7IO3: 253.9440; found: 253.9435 
 
 
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4.2.2 9,10 Metathesis Approach (cBu) 
 
PMB-propargyl ether (222a) 
 
A suspension of NaH (60% in mineral oil, 5.29 g, 132.2 mmol, 1.1 eq.) in anhydrous DMF (75 mL) 
was cooled to 0 °C and a solution of anisyl alcohol (16.6 g, 120 mmol, 1.0 eq.) in anhydrous DMF 
(20 mL) was added dropwise. Upon completion of the addition the reaction mixture was stirred for 
2.5 hours. A solution of propargylic bromide (10 mL, 132.2 mmol, 1.1 eq.) in anhydrous DMF 
(20 mL) was added dropwise and the solution was allowed to warm to r.t. overnight. By the 
addition of 0.5M KHSO4 the pH of the solution was adjusted to neutral and the slurry was extract 
three times with Et2O/hexane (1/1). The combined organic layers were dried with MgSO4 and the 
solvent was removed under reduced pressure. The excess of propargylic bromide was removed in 
high vacuum. PMB ether 222a (20.7 g, 117.5 mmol, 98%) was obtained as slightly orange liquid. 
1H-NMR (400MHz, CDCl3):  = 7.29 (d, J = 8.6Hz, 2H); 6.88 (d, J = 8.6Hz, 2H); 4.54 (s, 2H); 4.14 (d, J = 
2.4Hz, 2H); 3.80 (s, 3H); 2.47 (t, J = 2.4Hz, 1H) 
13C-NMR (100MHz, CDCl3):  = 159.5; 129.9; 129.3; 113.9; 79.8; 74.6; 71.2; 56.7; 55.3 
IR (film): 3288; 3001; 2937; 2907; 2837; 1612; 1585; 1513; 1464; 1442; 1386; 1352; 1302; 1250; 
1175; 1079; 1034; 820; 637cm–1 
 
HRMS (ESI) (m/z): [M]+ calcd. for C11H12O2: 176.0837; found: 176.0833 
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6-((4-methoxybenzyl)oxy)-3-methylhex-1-en-4-yn-3-ol (223) 
 
PMB ether 222a (9.7 g, 55 mmol, 1.0 eq.) was dissolved in anhydrous THF (150 mL) and the 
solution was cooled to -78 °C. After dropwise addition of LiHMDS (1M, 60 mL, 60 mmol, 1.1 eq.) 
the reaction mixture was allowed to stir for one hour. A solution of methyl vinyl ketone (MVK; 
4.24 g, 60 mmol, 1.1eq) in anhydrous THF (40 mL) was added dropwise. The reaction mixture was 
allowed to stir at -78 °C for two hours until it was quenched by the addition of sat. aq. NH4Cl. After 
the addition of Et2O the phases were separated and the pH of the aqueous phase was adjusted to 
5. 
The aqueous phase was extracted twice with Et2O and the combined organic layers were dried 
with MgSO4. Removal of the solvent under reduced pressure and purification by silica gel 
chromatography (hexane/EtOAc = 4/1) yielded allyl alcohol 223 (11.2 g, 45.7 mmol, 83%) as 
colorless oil.  
1H-NMR (250MHz, CDCl3):  = 7.28 (d, J = 8.6Hz, 2H); 6.88 (d, J = 8.6Hz, 2H); 5.99 (dd, J = 17.1, 
10.2Hz, 1H); 5.51 (d, J = 17.1Hz, 1H); 5.14 (d, J = 10.2Hz, 1H); 4.53 (s, 2H); 4.20 (s, 2H); 3.81 (s, 3H); 
2.06 (bs, 1H); 1.58 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C15H18O3: 246.1256; found: 246.1243 
 
6-hydroxy-3-methylhex-1-en-4-yn-3-yl benzoate (224) 
 
Allyl alcohol 223 (11.2 g, 45.7 mmol, 1.0 eq.) was dissolved in anhydrous THF (100 mL) and NEt3 
(19.3 mL, 137.1 mmol, 3 eq.) and benzoic acid anhydride (20.7 g, 91.4 mmol, 2 eq.) were added at 
r.t. The reaction mixture was cooled to 0 °C and MgBr2
.OEt2 (23.6 g, 91.4 mmol, 2 eq.) was added 
portionwise. The solution was allowed to warm to r.t. within 30 minutes. Water and Et2O were 
added and the phases were separated. The organic phase was washed with water and the 
combined aqueous phases were back-extracted with Et2O. The combined organic layers were dried 
with MgSO4 and the solvent was removed under reduced pressure. The crude product was used 
without further purification.  
116 
 
To a solution of crude tertiary benzoate (10.7 g, 30.5 mmol, 1.0 eq.) in CH2Cl2 (600 mL) were added 
100 mL of a pH=7-buffer (50mM KH2PO4). The vigorously stirred suspension was cooled to 0 °C and 
DDQ (10.4 g, 45.7 mmol, 1.5 eq.) was added portionwise. The suspension was allowed to stir 
overnight while it warmed to r.t. After addition of sat. aq. NaHCO3, the phases were separated and 
the organic phase was washed 6 times with H2O. The organic phase was dried with brine and 
MgSO4, and removal of the solvent in vacuo gave crude propargylic alcohol. Purification by silica 
gel chromatography gave alcohol 224 in quantitative yield (7 g, 30.5 mmol, quant.). 
1H-NMR (250MHz, CDCl3):  = 8.00 (m, 2H); 7.54 (m, 1H); 7.41 (m, 2H); 6.08 (dd, J = 17.1, 10.2Hz, 
1H); 5.63 (d, J = 17.1Hz, 1H); 5.27 (d, J = 10.2Hz, 1H); 4.36 (s, 2H); 2.96 (bs, 1H); 1.83 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C14H14O3: 230.0943; found: 230.0941 
6-iodo-3-methylhex-1-en-4-yn-3-yl benzoate (221) 
 
Imidazole (1.95 g, 28.7 mmol, 1.1 eq.), PPh3 (7.5 g, 28.7 mmol, 1.1 eq.) and iodine (7.0 g, 
27.4 mmol, 1.05 eq.) were added to 35 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension 
was stirred at 0 °C for 20 min, while it turned yellow. To this suspension a solution of propargylic 
benzoate 224 (6.0 g, 26.1 mmol, 1.0 eq.) in anhydrous CH2Cl2 (15 mL) was rapidly added. The 
reaction mixture was stirred for one hour. Then it was quenched by the addition of 60 mL hexane. 
The precipitating triphenylphosphineoxide was filter through a pad of celite and a solution of sat. 
aq. Na2S2O3 and NaHCO3 was added to the filtrate. The phases were separated and the organic 
phase was washed with Na2S2O3, NaHCO3 and brine before it was dried with MgSO4. After removal 
of the solvent under reduced pressure, purification by silica gel chromatography (hexane/EtOAc = 
4/1) yielded propargylic iodide 221 (7.5 g, 22.1 mmol, 85%) as slightly yellow liquid.  
1H-NMR (250MHz, CDCl3):  = 8.02 (m, 2H); 7.55 (m, 1H); 7.42 (m, 2H); 6.11 (dd, J = 17.1, 10.4Hz, 
1H); 5.65 (d, J = 17.1Hz, 1H); 5.30 (d, J = 10.4Hz, 1H); 3.77 (s, 2H); 1.82 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C14H13IO2: 339.9960; found: 339.9948 
 
  
 117 
 
8-methoxy-7-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarbonyl)-3-methyl-8-oxooct-1-en-4-yn-3-yl benzoate 
(226) 
 
NaH (60% in mineral oil, 124 mg, 3.1 mmol, 1.0 eq.) was suspended in anhydrous THF (10 mL). The 
reaction mixture was cooled to 0 °C and a solution of -keto ester 195 (2.0 g, 3.1 mmol, 1.0 eq.) in 
anhydrous THF (10 mL) was added. The reaction was stirred at 0 °C for 20 minutes and then 
warmed to r.t. within 10 minutes. Then it was re-cooled to 0 °C and a solution of propargylic iodide 
221 (844 mg, 2.48 mmol, 0.8 eq.) was added uninterruptedly at 0 °C. The reaction mixture was 
stirred at this temperature for 20 minutes and then warmed to r.t. within 20 minutes before it was 
quenched with saturated aqueous NH4Cl. Et2O was added and the phases separated. 
The pH of the aqueous phase was adjusted to 6 with 0.5M KHSO4 and it was extracted twice with 
Et2O. The combined organic layers were dried with MgSO4 and the solvent was removed under 
reduced pressure. Silica gel column chromatography (hexane/EtOAc = 5/1) yielded alkylated -
keto ester 226 as slightly yellow oil (1.8 g, 2.1 mmol, 99%). 
1H-NMR (250MHz, CDCl3):  = 7.98 (m, 2H); 7.53 (m, 1H); 7.40 (m, 6H); 7.23 (m, 8H); 6.80 (2H); 
6.04 (m, 1H); 5.54 (m, 1H); 5.21 (m, 1H); 4.40 (m, 1H); 3.78 (s, 3H); 3.57 (m, 4H); 3.13 (m, 2H); 2.74 
(m, 4H); 2.47 (m, 1H); 2.11 (m, 2H); 1.75 (s, 3H); 1.24 (m, 1H); 0.97 (m, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C53H64O8Si: 856.4370; found: 856.4364 
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Methyl-2-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)-5-(2-methylbuta-1,3-dien-1-yl)furan-3-carboxylate (227) 
 
Pd(OAc)2 (2.6 mg, 11.7 µmol, 0.05 eq.) and dppf (7.8 mg, 14.0 µmol, 0.06 eq.) were premixed in 
anhydrous THF (2 mL) at r.t. in a flame dried Schlenk-tube under Ar-atmosphere for 1h. The color 
of the reaction mixture turned from yellow to a deep red. After this period of time a solution of 
226 (200 mg, 0.23 mmol, 1.0 eq.) in anhydrous THF (3 mL) was added together with finely ground 
K2CO3 (211 mg, 1.52 mmol, 6.5 eq.). The reaction mixture was heated to reflux for four hours. It 
was quenched by the addition of 0.5M KHSO4 solution and the pH was adjusted to 7. The aqueous 
phase was extracted three times with Et2O. The combined organic layers were dried with MgSO4 
and removal of the solvent under reduced pressure yielded crude furan 227 (E/Z = 3/2). The crude 
product was dissolved in THF (5 mL) and Ph2Se2 (22 mg, 69 µmol; 0.3 eq.) was added. The reaction 
mixture was heated to reflux overnight. The solvent was removed under reduced pressure and 
purification by silica gel chromatography (hexane/EtOAc = 10/1 to 5/1) yielded pure furan 227 
(26 mg, 0.35 mmol, 15%) as an inseparable mixture of its double bond isomers (E/Z = 4/1).  
Major & minor: 
1H-NMR (400MHz, CDCl3):  = 7.34 (m, 4H); 7.20 (m, 8H); 6.75 (d, J = 8.8Hz, 2H); 6.54, 6.46 (s, 1H); 
6.48 (dd, J = 17.2, 11.0Hz, 1H); 6.18, 6.05 (s, 1H); 5.40, 5.34 (d, J = 17.2, 1H); 5.26, 5.15 (d, J = 
11.0Hz, 1H); 4.68 (m, 1H); 3.92 (m, 1H); 3.78, 3.77 (s, 3H); 3.70, 3.69 (s, 3H); 3.05 (m, 3H); 2.47 (m, 
1H); 2.34 (m, 1H); 2.12, 2.00 (s, 3H); 2.07 (m, 1H); 1.90 (m, 1H); 1.04 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 164.0; 163.7; 163.6; 158.3; 150.9; 150.7; 145.0; 144.9; 141.0; 136.2; 
134.9; 134.7; 133.6; 130.2; 129.5; 128.4; 127.7; 127.6; 126.7; 126.6; 126.5; 118.7; 116.6; 116.4; 
114.0; 113.7; 113.5; 112.9; 112.8; 110.9; 110.6; 85.9; 66.8; 61.5; 55.1; 51.2; 51.1; 44.7; 44.5; 36.4; 
33.5; 33.4; 29.2; 29.1; 20.3; 18.0; 14.2; 13.4; 12.1; 12.0; 11.9 
HRMS (ESI) (m/z): [M]+ calcd. for C46H58O6Si: 734.4003; found: 743.3995 
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Methyl-2-((1S,2R,3S)-2-(2-hydroxyethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-(2-
methylbuta-1,3-dien-1-yl)furan-3-carboxylate (398) 
 
Diene 227 (440 mg, 0.60 mmol, 1.0 eq.) was dissolved in 6 mL of a 4/1 mixture CH2Cl2/MeOH. PPTS 
(15 mg, 0.06 mmol, 0.1 eq.) was added and the reaction mixture was allowed to stir at r.t. until TLC 
analysis indicated full consumption of the starting material (approx. one hour). The reaction 
mixture was quenched with saturated aqueous NaHCO3. The phases were separated and the 
aqueous layer was extracted two times with Et2O. The combined organic layers were dried with 
MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 4/1) yielded free alcohol 398 as colorless viscous oil (260 mg, 
0.60 mmol, quant.). 
1H-NMR (250MHz, CDCl3):  = 6.55 (s, 1H); 6.48 (dd, J = 17.1, 10.6Hz, 1H); 6.18 (s, 1H); 5.34, (d, J = 
17.1Hz, 1H); 5.15 (d, J = 10.6Hz, 1H); 4.78 (m, 1H); 3.92 (m, 1H); 3.81, (s, 3H); 3.73 (m, 2H); 2.80 (m, 
1H); 2.60 (m, 1H); 2.47 (m, 1H); 2.23 (m, 1H); 2.13 (s, 3H); 2.07 (m, 1H); 1.90 (m, 1H); 1.08 (m, 21H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C26H42O5SiNa: 485.2699; found: 485.2687 
 
Methyl-5-(2-methylbuta-1,3-dien-1-yl)-2-((1S,2R,3S)-2-(2-oxoethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (228) 
 
Primary alcohol 398 (10 mg, 21.6 µmol, 1.0 eq.) was dissolved in anhydrous EtOAc (2 mL) and IBX 
(18 mg, 64.8 µmol, 3 eq.) was added. The suspension was heated to reflux for three hours. Now 
the suspension was cooled to r.t. and 2 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed in vacuo. The crude product was purified 
by silica gel column chromatography (hexane/EtOAc = 5/1). Aldehyde 228 was obtained as viscous 
oil (7 mg, 15.2 µmol, 70%).  
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1H-NMR (400MHz, CDCl3):  = 9.80 (t, J = 1.5Hz, 1H); 6.56 (s, 1H); 6.48 (dd, J = 17.5, 10.6Hz, 1H); 
6.20 (s, 1H); 5.35, (d, J = 17.1Hz, 1H); 5.15 (d, J = 10.6Hz, 1H); 4.78 (m, 1H); 4.00 (m, 1H); 3.81 (m, 
1H); 3.80, (s, 3H); 3.21 (m, 1H); 2.98 (ddd, J = 17.4, 8.1, 1.6Hz, 1H); 2.66 (m, 2H); 2.40 (m, 1H); 2.13 
(s, 3H); 1.06 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 201.8; 162.3; 151.3; 149.4; 140.9; 135.2; 134.8; 118.5; 116.4; 113.8; 
110.7; 66.5; 66.4; 51.4; 43.1; 42.2; 35.8; 32.9; 20.4; 17.9; 13.4; 12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C26H40O5Si: 460.2645; found: 460.2641 
 
(4S,5R)-4-methyl-3-(pent-4-enoyl)-5-phenyloxazolidin-2-one (229) 
 
4-Pentenoic acid (1.0 g, 10 mmol, 1.0 eq.), (4S,5R)-4-methyl-5-phenyloxazolidin-2-one (1.77 g, 
10 mmol, 1.0 eq.) and DMAP (122 mg, 1.0 mmol, 0.1 eq.) were dissolved in anhydrous CH2Cl2 
(50 mL) in an Ar-atmosphere. DIC (1.7 mL, 11.0 mmol, 1.1 eq.) was added to the reaction mixture 
and the solution was allowed to stir at r.t. overnight. The solvent was removed under reduced 
pressure and the crude reaction mixture was purified by silica gel chromatography (hexane/EtOAc 
= 4/1) yielding pure 229 (2.07 g, 8 mmol, 80%) as white crystals. 
1H-NMR (250MHz, CDCl3):  = 7.37 (m, 5H); 5.88 (m, 1H); 5.66 (d, J = 7.3Hz, 1H); 5.09 (dd, J = 17.2, 
1.5Hz, 1H); 5.02 (d, J = 10.4Hz, 1H); 4.76 (m, 1H); 3.07 (m, 2H); 2.44 (m, 2H); 0.89 (d, J = 6.7Hz, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C15H17NO3: 259.1208; found: 259.1200 
mp 70 – 71 °C 
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Methyl-2-((1S,2R,3S)-2-((2R,3S)-2-hydroxy-3-((4S,5R)-4-methyl-2-oxo-5-phenyloxazolidine-
3-carbonyl)hex-5-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-(2-methylbuta-1,3-dien-1-
yl)furan-3-carboxylate (231) 
 
Di-nbutyl boron trifluormethanesulfonate (1.0M in CH2Cl2, 1 mL, 2.2 eq.) and NEt3 (158 µL, 
1.13 mmol, 2.5 eq.) were added to a well stirred solution of 229 (235 mg, 0.91 mmol, 2 eq.) in 
anhydrous CH2Cl2 (8 mL) at 0 °C within 10 minutes. After complete addition, the reaction mixture 
was stirred for another 10 minutes at 0 °C and finally cooled to -78 °C. A solution of 228 (209 mg, 
0.45 mmol, 1.0 eq.) in anhydrous CH2Cl2 (7 mL) was added dropwise and the reaction was allowed 
to stir at -78 °C for two hours and an additional hour at 0 °C. The reaction mixture was quenched 
by the addition of 2 mL of a pH=7-buffer (50mM KH2PO4) and 2 mL of MeOH at 0 °C. Further, 
0.5 mL of H2O2 (30%) were added and the reaction was allowed to stir for 90 minutes at 0 °C. The 
organic layer was separated and the aqueous layer was extracted three times with CH2Cl2. The 
combined organic layers were dried with brine and MgSO4 and the solvents were removed under 
reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 2/1) yielded pure 
syn-aldol poduct 231 (133 mg, 0.18 mmol, 41%) as a colorless oil.  
1H-NMR (400MHz, CDCl3):  = 7.39 (m, 3H); 7.28 (m, 2H); 6.54 (s, 1H); 6.47 (dd, J = 17.3, 10.8Hz, 
1H); 6.19 (s, 1H); 5.86 (m, 1H); 5.57 (d, J = 7.2Hz, 1H); 5.33 (m, 1H); 5.32 (d, J = 17.3Hz, 1H); 5.13 (d, 
J = 10.8Hz, 1H); 5.03 (dd, J = 17.1, 1.7Hz, 1H); 4.95 (d, J = 10.3Hz, 1H); 4.76 (m, 2H); 4.13 (m, 1H); 
4.03 (m, 2H); 3.81 (s, 3H); 3.41 (m, 1H); 2.87 (m, 1H); 2.57 (m, 2H); 2.45 (m, 1H); 2.11 (s, 3H); 2.06 
(m, 1H); 1.88 (m, 1H); 1.09 (m, 21H); 0.83 (d, J = 6.6Hz, 3H) 
13C-NMR (100MHz, CDCl3):  = 175.3; 164.5; 163.3; 152.6; 151.1; 141.0; 135.5; 135.0; 133.3; 128.7; 
125.6; 118.5; 116.9; 114.1; 113.6; 110.7; 78.6; 70.9; 66.9; 55.0; 51.5; 47.4; 45.9; 45.8; 35.6; 33.2; 
32.9; 32.4; 18.0; 14.5; 13.4; 12.1 
HRMS (ESI) (m/z): [M]+ calcd. for C41H57NO8Si: 719.3853; found: 719.3848 
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4.2.3 10,11 Metathesis Approach (cBu) 
 
N-Acetylmorpholine (238) 
 
An adapted procedure of Yadav and Babu was used.[134] Acetic anhydride (5.19 mL, 55 mmol, 
1.1 eq.) and morpholine (4.36 mL, 50 mmol, 1.0 eq.) were mixed and cooled to 0 °C. Al2O3 (7.65 g, 
75 mmol, 1.5 eq.) was added (caution: extremely exothermic!) and the suspension was stirred for 
20 minutes. CH2Cl2 was added and the suspension was filtered through a pad of celite. Sat. aq. 
NaHCO3 was added and the phases were separated. The organic phase was extracted twice with 
NaHCO3 and afterwards dried with brine and MgSO4. Removal of the solvent under reduced 
pressure yielded pure N-acetylmorpholine 238 (6.46 g, 50 mmol, quant.) as colorless liquid.  
1H-NMR (400MHz, CDCl3):  = 3.62 (m, 4H); 3.56 (m, 2H); 3.41 (m, 2H); 2.04 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C6H11NO2: 129.0790; found: 129.0782 
 
5-((tetrahydro-2H-pyran-2-yl)oxy)pent-3-yn-2-one (239) 
 
THP-protected propargylic alcohol (27.45 g, 196 mmol, 3 eq.) was dissolved in anhydrous THF 
(50 mL) and the solution was cooled to -78 °C. n-BuLi (2.5M in hexane; 78.3 mL, 196 mmol, 3 eq.) 
was added and the reaction mixture was allowed to stir at -78 °C for 30 minutes. A solution of N-
acetylmorpholine 238 (8.43 g, 65 mmol, 1.0 eq.) in anhydrous THF (20 mL) was added and the 
reaction mixture was allowed to stir for four hours (-78 °C to -40 °C). The reaction mixture was 
quenched by the addition of sat. aq. NH4Cl and Et2O. The phases were separated and the pH of the 
aqueous phase was adjusted to neutral. The aqueous layer was extracted twice with Et2O and the 
combined organic layers were dried with brine and MgSO4. The solvent was removed under 
reduced pressure. Silica gel chromatography (hexane/EtOAc = 5/1) yielded pure yne-one 239 
(11.3 g, 62 mmol, 95%) as colorless liquid.  
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1H-NMR (400MHz, CDCl3):  = 4.80 (t, J = 3.2Hz, 1H); 4.41 (d, J = 1.8Hz, 2H); 3.82 (m, 1H); 3.55 (m, 
1H); 2.35 (s, 3H); 1.77 (m, 2H); 1.59 (m, 4H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H14O3: 182.0943; found: 182.0932 
 
4-methyl-7-((tetrahydro-2H-pyran-2-yl)oxy)hept-1-en-5-yn-4-ol (399) 
 
Ynone 239 (11.3 g, 62 mmol, 1.0 eq.) was dissolved in anhydrous THF (120 mL) and the solution 
was cooled to -78 °C. Allyl-MgBr (1M in THF, 81 mL, 81.0 mmol, 1.3 eq.) was slowly added and the 
reaction mixture was allowed to stir for two hours warming to -40 °C. The reaction was quenched 
by the addition of sat. aq. NH4Cl and Et2O was added. The phases were separated and the pH of 
the aqueous phase was adjusted to neutral. The aqueous layer was extracted twice with Et2O and 
the combined organic layers were dried with brine and MgSO4. The solvent was removed under 
reduced pressure. Silica gel chromatography (hexane/EtOAc = 5/1) yielded pure tertiary alcohol 
399 (11.5 g, 51.5 mmol, 83%) as colorless liquid.  
1H-NMR (400MHz, CD3OD):  = 5.92 (m, 1H); 5.13 (m, 1H); 5.09 (bs, 1H); 4.82 (m, 2H); 4.27 (d, J = 
1.5Hz, 2H); 3.84 (m, 1H); 3.51 (m, 1H); 2.40 (m, 2H); 1.77 (m, 2H); 1.55 (m, 4H); 1.41 (s, 3H) 
13C-NMR (100MHz, CD3OD):  = 134.7; 118.4; 116.6; 97.7; 90.6; 79.7; 67.7; 62.9; 54.8; 31.2; 29.2; 
26.3; 20.0 
HRMS (ESI) (m/z): [M]+ calcd. for C13H20O3: 224.1412; found: 224.1401 
 
4-methyl-7-((tetrahydro-2H-pyran-2-yl)oxy)hept-1-en-5-yn-4-yl benzoate (240) 
 
Tertiary alcohol 399 (3 g, 13.4 mmol, 1.0 eq.) was dissolved in anhydrous THF (100 mL) and NEt3 
(5.6 mL, 40.1 mmol, 3 eq.) and benzoic acid anhydride (6.1 g, 26.8 mmol, 2 eq.) were added at r.t. 
The reaction mixture was cooled to 0 °C and MgBr2
.OEt2 (6.9 g, 26.8 mmol, 2 eq.) was added 
portionwise. The solution was allowed to warm to r.t. within 30 minutes. Water and Et2O were 
added and the phases were separated.  
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The organic phase was washed with water and the combined aqueous phases were back-extracted 
with Et2O. The combined organic layers were dried with MgSO4 and the solvent was removed 
under reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded 
tertiary benzoate 240 (4.4 g, 13.4 mmol, quant.) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 7.98 (m, 2H); 7.50 (m, 1H); 7.39 (m, 2H); 5.92 (m, 1H); 5.16 (m, 2H); 
4.83 (bs, 1H); 4.30 (s, 2H); 3.81 (m, 1H); 3.73 (m, 1H); 3.48 (m, 1H); 2.79 (m, 2H); 1.76 (s, 3H); 1.73 
(m, 2H); 1.54 (m, 4H) 
HRMS (ESI) (m/z): [M]+ calcd. for C20H24O4: 328.1675; found: 328.1662 
 
7-hydroxy-4-methylhept-1-en-5-yn-4-yl benzoate (400) 
 
Tertiary benzoate 240 (5.9 g, 18 mmol, 1.0 eq.) was dissolved in MeOH (100 mL) and DOWEX 50x4 
(approx. 2.5 g) was added. The reaction mixture was stirred at r.t. for two hours and then filtered 
through a pad of celite 545 coarse. The solvents were removed in vacuo and the crude product 
was subjected to silica gel column chromatography (hexane/EtOAc = 4/1). Free propargylic alcohol 
400 (4.4 g, 18 mmol, quant.) was obtained as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 8.00 (m, 2H); 7.54 (m, 1H); 7.42 (m, 2H); 5.95 (m, 1H); 5.20 (m, 2H); 
4.33 (s, 2H); 2.81 (m, 2H); 1.78 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C15H16O3: 244.1099; found: 244.1084 
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7-iodo-4-methylhept-1-en-5-yn-4-yl benzoate (237) 
 
Imidazole (1.74 g, 25.5 mmol, 3 eq.), PPh3 (4.46 g, 17 mmol, 2 eq.) and iodine (4.32 g, 17 mmol, 
2 eq.) were added to 60 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension was stirred at 
0 °C for 20 minutes while it turned yellow. To this suspension a solution of propargylic benzoate 
400 (2.01 g, 8.5 mmol, 1.0 eq.) in anhydrous CH2Cl2 (20 mL) was rapidly added. The reaction 
mixture was stirred for one hour. Then it was quenched by the addition of 80 mL hexane. 
The precipitating triphenylphosphineoxide was filter through a pad of celite and a sat. aq. solution 
of Na2S2O3 and NaHCO3 was added to the filtrate. The phases were separated and the organic 
phase was washed with Na2S2O3, NaHCO3 and brine before it was dried with MgSO4. After removal 
of the solvent under reduced pressure, purification by silica gel chromatography (hexane/EtOAc = 
7/1) yielded propargylic iodide 237 (2.71 g, 7.7 mmol, 90%) as slightly yellow liquid.  
1H-NMR (400MHz, CDCl3):  = 8.00 (m, 2H); 7.55 (m, 1H); 7.43 (m, 2H); 5.95 (m, 1H); 5.22 (m, 2H); 
3.75 (s, 2H); 2.81 (m, 2H); 1.76 (s, 3H) 
13C-NMR (100MHz, CDCl3):  = 164.6; 136.3; 132.9; 132.0; 130.8; 129.8; 129.6; 128.3; 119.4; 85.1; 
82.7; 74.6; 45.8; 26.0; -18.9 
HRMS (ESI) (m/z): [M]+ calcd. for C15H15IO2: 354.0117; found: 354.0105 
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9-methoxy-8-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarbonyl)-4-methyl-9-oxonon-1-en-5-yn-4-yl benzoate 
(241) 
 
NaH (60% in mineral oil, 62 mg, 1.55 mmol, 1.0 eq.) was suspended in anhydrous THF (5 mL). The 
reaction mixture was cooled to 0 °C and a solution of -keto ester 195 (1 g, 1.55 mmol, 1.0 eq.) in 
anhydrous THF (5 mL) was added. The reaction was stirred at 0 °C for 20 minutes and then 
warmed to r.t. within 10 minutes. Then it was re-cooled to 0 °C and a solution of propargylic iodide 
237 (549 mg, 1.55 mmol, 1.0 eq.) was added uninterruptedly at 0 °C. The reaction mixture was 
stirred at this temperature for 20 minutes and then warmed to r.t. within 20 minutes before it was 
quenched with saturated aqueous NH4Cl. Et2O was added and the phases separated. The pH of the 
aqueous phase was adjusted to 6 with 0.5M KHSO4 and it was extracted twice with Et2O. The 
combined organic layers were dried with MgSO4 and the solvent was removed under reduced 
pressure. Silica gel column chromatography (hexane/EtOAc = 7/1) yielded alkylated -keto ester 
241 as slightly yellow oil (1.32 g, 1.52 mmol, 98%). 
 
1H-NMR (400MHz, CDCl3):  = 7.96 (m, 2H); 7.52 (m, 1H); 7.40 (m, 6H); 7.28 (m, 6H); 7.19 (m, 2H); 
6.81 (m, 2H); 5.88 (m, 1H); 5.16 (m, 2H); 4.40 (m, 1H); 3.78, 3.66 (m, 6H); 3.62 (d, J = 2.3Hz, 1H); 
3.54 (d, J = 2.3Hz, 1H); 3.13 (m, 3H); 2.72 (m, 3H); 2.47 (m, 1H); 2.11 (m, 2H); 1.80 (m, 1H); 1.73 (m, 
1H); 1.69 (m, 3H); 0.98 (m, 21H) 
13C-NMR (100MHz, CDCl3):  = 205.6; 168.7; 164.5; 158.4; 144.8; 136.0; 132.7; 132.4; 130.3; 129.5; 
128.4; 128.2; 127.8; 127.7; 126.7; 119.0; 116.1; 113.2; 113.0; 86.2; 82.1; 74.7; 65.8; 65.5; 65.3; 
61.8; 55.1; 52.4; 47.5; 46.0; 45.6; 44.9; 42.8; 42.2; 33.7; 33.0; 28.9; 26.4; 17.9; 12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C54H66O8Si: 870.4527; found: 870.4513 
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Methyl-2-((1S,2R,3S)-2-(2-hydroxyethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-(2-
methylpenta-1,4-dien-1-yl)furan-3-carboxylate (401) 
 
Alkylated -keto ester 241 (1.2 g, 1.38 mmol, 1.0 eq.) was dissolved in anhydrous DMF (28 mL) 
under an Ar-atmosphere and finely ground anhydrous K2CO3 (1.24 g, 8.95 mmol, 6.5 eq.) was 
added. The reaction flask was sealed and the reaction mixture was heated to 90 °C (oil bath 
temperature 100 °C) for two hours. The suspension was allowed to cool to r.t. and the suspended 
K2CO3 was allowed to settle down. The supernatant was decanted and remaining K2CO3 was 
washed four times with Et2O (4x40 mL). The combined organic layers were quenched with 0.5M 
KHSO4 and the pH was adjusted to 6. The phases were separated and the aqueous phase was 
washed 4 times with Et2O/hexane (1/1). The combined organic layers were dried with MgSO4 and 
the solvents were removed under reduced pressure. The crude product was purified by silica gel 
chromatography (hexane/EtOAc = 10/1 to 7/1) yielding pure vinyl furan 401a (920 mg, 1.23 mmol, 
89%) as an inseparable mixture of double bond isomers (E/Z = 2/1). 
Vinyl furan 401a (920 mg, 1.23 mmol, 1.0 eq.) was dissolved in 15 mL of a 4/1 mixture 
CH2Cl2/MeOH. PPTS (31 mg, 0.12 mmol, 0.1 eq.) was added and the reaction mixture was allowed 
to stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. two 
hours). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were 
separated and the aqueous layer was extracted two times with Et2O. The combined organic layers 
were dried with MgSO4 and the solvent was removed under reduced pressure. Purification by silica 
gel chromatography (hexane/EtOAc = 4/1) yielded free alcohol 401 as colorless viscous oil 
(580 mg, 1.22 mmol, 99%). 
(E)-isomer: 
1H-NMR (400MHz, CDCl3):  = 6.40 (s, 1H); 6.02 (s, 1H); 5.86 (m, 1H); 5.14 (m, 1H); 5.08 (m, 1H); 
4.73 (m, 1H); 3.90 (m, 1H); 3.80 (m, 3H); 3.71 (m, 2H); 2.90 (d, J = 6.7Hz, 1H); 2.77 (m, 2H); 2.58 (m, 
1H); 2.42 (m, 1H); 2.04 (s, 3H); 1.93 (m, 1H); 1.88 (m, 1H); 1.71 (m, 1H); 1.07 (m, 21H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C27H44O5SiNa: 499.2856; found: 499.2841 
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Methyl-2-((1S,2R,3S)-2-((2R,3S)-2-hydroxy-3-((4S,5R)-4-methyl-2-oxo-5-phenyloxazolidine-
3-carbonyl)pent-4-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-(2-methylpenta-1,4-dien-
1-yl)furan-3-carboxylate (246a) 
 
Primary alcohol 401 (580 mg, 1.22 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (12 mL) and 
IBX (1.02 g, 3.66 mmol, 3 eq.) was added. The suspension was heated to reflux for three hours. The 
suspension was cooled to r.t. and 12 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed under reduced pressure. The crude 
product was purified by silica gel column chromatography (hexane/EtOAc = 5/1). The aldehyde 
was obtained as viscous oil (580 mg, 1.22 mmol, quant.). 
(4S,5R)-3-((E)-but-2-enoyl)-4-methyl-5-phenyloxazolidin-2-one (244, 114 mg, 0.46 mmol, 1.0 eq.) 
was dissolved in anhydrous CH2Cl2 (2 mL) and the solution was cooled to -78 °C. 460 µL of a 1M 
solution Bu2BOTf (in CH2Cl2, 460 µL, 0.46 mmol, 1.0 eq.) were added dropwise. The reaction 
mixture was stirred for 30 minutes, then NEt3 (81 µL, 0.58 mmol, 1.25 eq.) was added. The 
reaction mixture was stirred for 20 minutes then it was allowed to warm to 0 °C and stirring was 
continued for 90 minutes. The solution was re-cooled to -78 °C and a solution of the previously 
prepared aldehyde (220 mg, 0.46 mmol, 1.0 eq.) in anhydrous CH2Cl2 (2 mL) was added dropwise. 
The reaction mixture was stirred at -78 °C for two hours and at -25 °C overnight, before it was 
quenched with pH=7-buffer (50mM KH2PO4). 600 µL of a 2/1 mixture MeOH/H2O2 (30% aqueous 
solution) were added and the reaction mixture was stirred for 10 minutes at r.t. Additional CH2Cl2 
was added and the phases were separated. The organic layer was extracted two times with water 
and brine. The solvent was removed in vacuo and purification by silica gel chromatography 
(hexane/EtOAc = 5/1 to 4/1) yielded pure aldol product 246a (331 mg, 0.46 mmol, quant.) as 
colorless oil. 
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(E)-isomer: 
1H-NMR (400MHz, CDCl3):  = 7.39 (m, 3H); 7.27 (m, 2H); 6.39 (s, 1H); 6.02 (s, 1H); 6.01 (dd, J = 
20.5, 8.6Hz, 1H); 5.83 (m, 1H); 5.61 (d, J = 7.2Hz, 1H); 5.31 (d, J = 15.9Hz, 2H); 5.09 (m, 2H); 5.08 
(m, 1H); 4.74 (m, 2H); 4.46 (m, 1H); 4.17 (m, 1H); 3.99 (m, 1H); 3.79 (s, 3H); 3.49 (d, J = 2.8Hz, 1H); 
3.15 (m, 1H); 2.87 (d, J = 6.7Hz, 1H); 2.57 (m, 1H); 2.40 (m, 1H); 2.04 (s, 3H); 1.86 (m, 2H); 1.07 (m, 
21H); 0.85 (d, J = 6.6Hz, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C41H57NO8SiNa: 742.3751; found: 742.3742 
 
Methyl-2-((1S,2R,3S)-2-((2R,3S)-2-((tert-butyldimethylsilyl)oxy)-3-((4S,5R)-4-methyl-2-oxo-
5-phenyloxazolidine-3-carbonyl)pent-4-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-(2-
methylpenta-1,4-dien-1-yl)furan-3-carboxylate (246b) 
 
Secondary alcohol 246a (70 mg, 0.1 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (1 mL) and 
the reaction mixture was cooled to 0 °C. After the addition of 2,6-lutidine (47.1 µL, 0.4 mmol, 
4 eq.) the solution was incubated at 0 °C for 5 minutes before TBS-OTf (46.5 µL, 0.2 mmol, 2 eq.) 
was added dropwise. The reaction mixture was stirred at 0 °C for 30 minutes and then quenched 
by the addition of sat. aq. NaHCO3. The phases were separated and the aqueous layer was 
extracted twice with CH2Cl2. The combined organic layers were washed with NH4Cl and brine. 
Drying with MgSO4, concentration in vacuo and purification by silica gel chromatography 
(hexane/EtOAc = 5/1) yielded pure 246b (85 mg, 0.1 mmol, quant.) as colorless oil.  
1H-NMR (400MHz, CDCl3):  = 7.39 (m, 3H); 7.28 (m, 2H); 6.43 (s, 1H); 6.04 (m, 2H); 5.85 (m, 1H); 
5.56 (d, J = 6.8Hz, 1H); 5.19 (d, J = 10.5Hz, 1H); 5.09 (m, 2H); 4.82 (m, 1H); 4.60 (m, 1H); 4.39 (m, 
1H); 4.22 (m, 1H); 3.94 (m, 1H); 3.71 (s, 3H); 2.89 (d, J = 6.6Hz, 1H); 2.80 (m, 1H); 2.47 (m, 2H); 2.13 
(m, 1H); 2.02 (s, 3H); 1.84 (m, 2H); 1.71 (m, 1H); 1.07 (m, 21H); 0.91 (s, 9H); 0.83 (d, J = 6.5Hz, 3H); 
0.16 (s, 3H); 0.12 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C47H71NO8Si2: 833.4718; found: 833.4715  
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(S)-2-((R)-1-((tert-butyldimethylsilyl)oxy)-2-((1R,2S,4S)-2-(3-(methoxycarbonyl)-5-(2-
methylpenta-1,4-dien-1-yl)furan-2-yl)-4-((triisopropylsilyl)oxy)cyclobutyl)ethyl)but-3-enoic 
acid (249) 
 
Compound 246b (60 mg, 72 µmol, 1.0 eq.) was dissolved in THF (1 mL) and the solution was cooled 
to 0 °C. A mixture of LiOH.H2O (3.9 mg, 92.8 mmol, 1.3 mmol) and 30% H2O2 (19 µL, 180 µmol, 
2.5 eq.) in water (300 µL) was added dropwise at low temperature. The reaction was allowed to 
stir at 0 °C overnight, before it was quenched by the addition of sat. aq. Na2S2O3 and Et2O. The 
phases were separated and the organic layer was washed twice with water before it was dried 
with brine and MgSO4. The solvent was removed in vacuo and purification by silica gel 
chromatography (hexane/EtOAc = 3/1) yielded pure carboxylic acid 249 (17 mg, 25 µmol, 35%) as 
colorless semisolid. 
1H-NMR (400MHz, CDCl3):  = 9.71 (bs, 1H); 6.41 (s, 1H); 6.00 (m, 2H); 5.85 (m, 1H); 5.21 (d, J = 
10.3Hz, 1H); 5.13 (d, J = 5.5Hz, 1H); 5.03 (m, 2H); 4.64 (m, 1H); 4.31 (m, 2H); 4.00 (m, 1H); 3.81 (s, 
3H); 2.90 (d, J = 6.7Hz, 1H); 2.83 (m, 1H); 2.65 (m, 1H); 2.56 (m, 1H); 2.33 (m, 1H); 1.99 (s, 3H); 1.88 
(m, 1H); 1.74 (m, 1H); 1.05 (bs, 21H); 0.86 (s, 9H); 0.13 (s, 3H); 0.08 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C37H62O7Si2Na: 697.3932; found: 697.3921 
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Methyl-2-((1S,2R,3S)-2-((2R,3R)-2-((tert-butyldimethylsilyl)oxy)-3-(hydroxymethyl)pent-4-
en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-(2-methylpenta-1,4-dien-1-yl)furan-3-
carboxylate (247) 
 
NaBH4 (15.7 mg, 0.42 mmol, 6 eq.) was suspended in a 5/1 (1.5 mL) mixture of THF/water and the 
suspension was cooled to 0 °C. A solution of compound 246b (57.7 mg, 69.2 µmol, 1.0 eq.) in 
anhydrous THF (1ml) was added dropwise. The reaction mixture was allowed to stir for 3 days until 
it was quenched by the addition sat. aq. NH4Cl and Et2O. The layers were separated and the 
aqueous layer was acidified to pH=4. The two phases were recombined and mixed vigorously. The 
phases were separated and the organic phase was washed twice with water, before it was dried 
with brine and MgSO4. The solvent was removed under reduced pressure and silica gel 
chromatography (hexane/EtOAc = 15/1 to 10/1) yielded pure primary alcohol 247 (32 mg, 
48.5 µmol, 70%) as colorless viscous oil. 
1H-NMR (400MHz, CDCl3):  = 6.41 (s, 1H); 6.03 (m, 2H); 5.85 (m, 1H); 5.75 (m, 1H); 5.12 (m, 2H); 
5.01 (d, J = 17.5Hz, 1H); 4.65 (m, 1H); 4.00 (m, 1H); 3.81 (s, 3H); 3.49 (m, 2H); 2.91 (d, J = 6.6Hz, 
1H); 2.64 (m, 1H); 2.53 (m, 1H); 2.33 (m, 1H); 2.00 (s, 3H); 1.80 (m, 4H); 1.32 (m, 2H); 1.05 (bs, 
21H); 0.88 (s, 9H); 0.13 (s, 3H); 0.10 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C37H64O6Si2Na: 683.4139; found: 683.4127 
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Methyl-2-((1S,2R,3S)-2-((2R,3R)-3-(hydroxymethyl)-2-((triethylsilyl)oxy)pent-4-en-1-yl)-3-
((triisopropylsilyl)oxy)cyclobutyl)-5-(2-methylpenta-1,4-dien-1-yl)furan-3-carboxylate (402) 
 
Alcohol 246a (1.73 g, 2.4 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (15 mL) and the 
reaction mixture was cooled to 0 °C. After the addition of 2,6-lutidine (1.03 g, 79.6 mmol, 4 eq.) 
the solution was incubated at 0 °C for 5 minutes before TES-OTf (1.27 g, 4.8 mmol, 2 eq.) was 
added dropwise. The reaction mixture was stirred at 0 °C for 30 minutes and then quenched by the 
addition of sat. aq. NaHCO3. The phases were separated and the aqueous layer was extracted 
twice with CH2Cl2. The combined organic layers were washed with NH4Cl and brine. Drying with 
MgSO4, concentration in vacuo and purification by silica gel chromatography (hexane/EtOAc = 
10/1) yielded the TES-ether (2.03 g, 2.4 mmol, quant.) as colorless oil.  
The following reaction was performed according to an adapted protocol of Maier et al.[135] NaBH4 
(81.6 mg, 2.16 mmol, 6 eq.) was suspended in a 5/1 (6 mL) mixture of THF/water and the 
suspension was cooled to 0 °C. A solution of the previously prepared TES-ether (300 mg, 
0.36 mmol, 1.0 eq.) in anhydrous THF (5ml) was added dropwise. The reaction mixture was 
allowed to stir for 3 days until it was quenched by the addition sat. aq. NH4Cl and Et2O. The layers 
were separated and the aqueous layer was acidified to pH=4. The two phases were recombined 
and mixed vigorously. The phases were separated and the organic phase was washed twice with 
water, before it was dried with brine and MgSO4. The solvent was removed under reduced 
pressure and silica gel chromatography (hexane/EtOAc = 15/1 to 10/1) yielded pure primary 
alcohol 402 (154 mg, 0.23 mmol, 65%) as colorless viscous oil. 
1H-NMR (400MHz, CDCl3):  = 6.40 (s, 1H); 6.03 (s, 1H); 5.81 (m, 2H); 5.75 (m, 1H); 5.12 (m, 3H); 
5.02 (d, J = 17.4Hz, 1H); 4.66 (m, 1H); 4.01 (m, 2H); 3.80 (s, 3H); 3.55 (m, 1H); 3.50 (m, 1H); 3.17 
(m, 1H); 2.90 (d, J = 6.7Hz, 1H); 2.66 (m, 1H); 2.52 (m, 1H); 2.34 (m, 1H); 2.00 (s, 3H); 1.98 (m, 2H); 
1.86 (m, 1H); 1.06 (bs, 21H); 0.97 (t, J = 7.9Hz, 9H); 0.63 (q, J = 7.9Hz, 6H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C37H64O6Si2Na: 683.4139; found: 683.4132 
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Methyl-5-(2-methylpenta-1,4-dien-1-yl)-2-((1S,2R,3S)-2-((2R,3R)-2-((triethylsilyl)oxy)-3-
(((trimethylsilyl)oxy)methyl)pent-4-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-
carboxylate (248) 
 
Primary alcohol 402 (100 mg, 0.15 mmol, 1.0 eq.) was dissolved in anhydrous DMF (2 mL) and 
imidazole (62 mg, 0.91 mmol, 6 eq.) was added in one portion. Under an Ar-atmosphere, the 
mixture was cooled to 0 °C and a solution of trimethylsilyl-chloride (TMS-Cl, 58 µL, 0.45 mmol, 
3 eq.) in anhydrous DMF (200 µL) was slowly added at 0 °C. The reaction mixture was allowed to 
warm to r.t. overnight. 3 mL of hexane/Et2O (1/1) and 100 mL of saturated aqueous NH4Cl were 
added and the phases separated. The organic phase was extracted with water twice. The 
combined aqueous phases were twice back-extracted with a 1/1 mixture of hexane/Et2O and the 
combined organic layers were dried over MgSO4. Evaporation of the solvent and short filtration 
(product is of moderate stability on silica gel!) through a pad of silica gel yielded tri-silylether 248 
(105 mg, 0.14 mmol, 95%) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 6.40 (s, 1H); 6.03 (s, 1H); 5.85 (m, 1H); 5.72 (m, 1H); 5.07 (m, 4H); 
4.64 (m, 1H); 4.02 (m, 1H); 3.89 (m, 1H); 3.80 (s, 3H); 3.50 (m, 1H); 3.41 (m, 1H); 3.17 (d, J = 6.6Hz, 
1H); 2.90 (d, J = 6.6Hz, 1H); 2.73 (m, 1H); 2.43 (m, 1H); 2.32 (m, 1H); 2.01 (m, 1H); 2.00 (s, 3H); 1.86 
(m, 1H); 1.77 (m, 1H); 1.06 (bs, 21H); 0.95 (t, J = 8.0Hz, 9H); 0.60 (q, J = 8.0Hz, 6H); -0.01 (s, 9H) 
13C-NMR (100MHz, CDCl3):  = 164.2; 162.3; 151.3; 150.9; 149.4; 137.3; 135.8; 135.7; 135.0; 120.5; 
117.6; 116.8; 116.0; 114.5; 114.2; 108.5; 69.1; 67.0; 63.4; 51.1; 51.0; 44.9; 43.5; 38.3; 36.6; 34.2; 
33.4; 29.7; 24.4; 18.7; 18.0; 12.1; 7.0; 5.2; 0.2; -0.6 
HRMS (ESI) (m/z): [M]+ calcd. for C40H72O6Si3: 732.4637; found: 732.4631 
 
  
134 
 
Methyl-2-((1S,2R,3S)-2-((2R,3R)-2-hydroxy-3-(hydroxymethyl)pent-4-en-1-yl)-3-
((triisopropylsilyl)oxy)cyclobutyl)-5-(2-methylpenta-1,4-dien-1-yl)furan-3-carboxylate (403) 
 
Primary alcohol 402 (115 mg, 0.17 mmol, 1.0 eq.) was dissolved in a 1/10 mixture of anhydrous 
CH2Cl2/MeOH (=2 mL). Camphor sulphonic acid (CSA, 2 mg, 8.7 µmol, 0.05 eq.) was added and 
the reaction was allowed to stir overnight. The reaction was quenched by the addition of sat. aq. 
NaHCO3 and the phases were separated. The aqueous layer was extracted twice with CH2Cl2 and 
the combined organic layers were dried with brine and Na2SO4. Removal of the solvent under 
reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 2/1) yielded pure 
diol 403 (95 mg, 0.17 mmol, quant.) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 6.40 (s, 1H); 6.02 (s, 1H); 5.88 (m, 2H); 5.15 (m, 4H); 4.72 (m, 1H); 
4.00 (m, 2H); 3.80 (s, 3H); 3.75 (m, 2H); 3.25 (bs, 1H); 3.17 (d, J = 6.8Hz, 1H); 2.90 (d, J = 6.8Hz, 1H); 
2.76 (m, 1H); 2.62 (m, 1H); 2.43 (m, 1H); 2.25 (m, 1H); 2.00 (s, 3H); 1.88 (m, 2H); 1.60 (bs, 1H); 1.06 
(bs, 21H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C31H50O6SiNa: 569.3274; found: 569.3268 
 
Methyl-2-((1S,2R,3S)-2-(((4R,5R)-2,2-dimethyl-5-vinyl-1,3-dioxan-4-yl)methyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)-5-(2-methylpenta-1,4-dien-1-yl)furan-3-carboxylate (254) 
 
Diol 403 (95 mg, 0.17 mmol, 1.0 eq.) was dissolved in anhydrous dimethoxyethane (2 mL), 
dimethoxypropane (43 µL, 0.35 mmol, 2 eq.) and CSA (4 mg, 0.02 mmol, 0.1 eq.) were added. The 
reaction mixture was stirred at r.t. for one hour. The reaction was quenched by the addition of sat. 
aq. NaHCO3 and the phases were separated.  
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The organic layer was washed with water and dried with brine and MgSO4. The solvents were 
removed under reduced pressure and the crude product was purified by silica gel chromatography 
(hexane/EtOAc = 7/1) yielding pure acetal 254 (9.6 mg, 16.3 mmol, 96%) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 6.41 (s, 1H); 6.20 (ddd, J = 17.4, 9.9, 9.9Hz, 1H); 6.03 (s, 1H); 5.86 (m, 
1H); 5.13 (m, 1H); 5.10 (m, 1H); 5.06 (d, J = 1.8Hz, 1H); 5.01 (d, J = 1.8Hz, 1H); 4.68 (m, 1H); 4.09 
(m, 1H); 4.02 (m, 1H); 3.97 (m, 1H); 3.80 (s, 3H); 3.62 (dd, J = 11.2, 1.8Hz, 1H); 3.18 (d, J = 6.6Hz, 
1H); 2.90 (d, J = 6.6Hz, 1H); 2.77 (m, 1H); 2.47 (m, 2H); 2.36 (m, 1H); 2.23 (m, 1H); 2.00 (s, 3H); 1.74 
(m, 1H); 1.38 (s, 3H); 1.34 (s, 3H); 1.06 (bs, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C34H54O6Si: 586.3690; found: 586.3687 
 
4.2.4 11,12 Metathesis Approach (cBu) 
 
(S)-ethyl 3,4-dihydroxybutanoate (260) 
 
(-)-Malic acid dimethyl ester (8.5 g, 52.5 mmol, 1.0 eq.) was dissolved in anhydrous THF (120 mL) 
and the solution was cooled to 0 °C. BH3
.DMS (4.38 g, 54.2 mmol, 1.03 eq.) was added dropwise 
and the reaction mixture was allowed to stir for one hour before NaBH4 (100 mg, 2.6 mmol, 
0.05 eq.) was added. The reaction mixture was allowed to warm to r.t. and stirring was continued 
for one hour. MeOH (50 mL) and pTsOH (500 mg, 2.6 mmol, 0.05 eq.) were added and solvents 
were removed in vacuo. The crude mixture was again dissolved in MeOH (100 mL) and the solvent 
was removed under reduced pressure. The crude reaction mixture was dissolved in Et2O and sat. 
aq. NaHCO3 was added. The phases were separated and the organic phase was dried with brine 
and Na2SO4. The solvents were removed in vacuo yielding pure diol 260 (5.79 g, 43.2 mmol, 82%) 
as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 4.14 (m, 1H); 3.73 (s, 3H); 3.69 (m, 1H); 3.53 (dd, J = 11.4, 6.1Hz, 
1H); 2.55 (m, 2H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C5H10O4Na: 157.0477; found: 157.0472 
  
136 
 
(S)-ethyl 3,4-bis((tert-butyldimethylsilyl)oxy)butanoate (404) 
 
Diol 260 (5.11 g, 38.1 mmol, 1 eq.) was dissolved in anhydrous DMF (75 mL). Imidazole (11.68 g, 
171.6 mmol, 4.5 eq.) was added to the solution and it was cooled to 0 °C. A solution of TBS-Cl 
(12.65 g, 83.9 mmol, 2.2 eq.) in anhydrous DMF (20 mL) was added. The reaction mixture was 
allowed to stir at 0 °C for one hour, and then it was quenched by the addition of sat. aq. NH4Cl. 
Et2O and hexane  were added and the phases were separated. The organic layer was washed with 
NH4Cl before it was dried with brine and MgSO4. Purification by silica gel chromatography 
(hexane/EtOAc = 10/1) yielded pure bis-silylether 404 (13.1 g, 36.4 mmol, 95%) as colorless liquid.  
1H-NMR (400 MHz, CDCl3):  = 4.14 (m, 1H); 3.66 (s, 3H); 3.59 (dd, J = 10.0, 5.1Hz, 1H); 3.53 (dd, J = 
10.0, 7.2Hz, 1H); 2.64 (dd, J = 15.0, 4.4Hz, 1H); 2.37 (dd, J = 15.0, 8.0Hz, 1H); 0.89 (s, 9H); 0.85 (s, 
9H); 0.05 (bs, 12H) 
HRMS (ESI) (m/z): [M]+ calcd. for C17H38O4Si2: 362.2309; found: 362.2301 
 
(S)-4,5-bis((tert-butyldimethylsilyl)oxy)pentan-2-one (261) 
 
Bis silyl ether 404 (13.1 g, 36.4 mmol, 1 eq.) and Weinreb amine hydrochloride (5.32 g, 54.6 mmol, 
1.5 eq.) were dissolved in anhydrous THF (75 mL) and the solution was cooled to -20 °C. iPrMgBr 
(2M in Et2O; 54.6 mL, 109.1 mmol, 3 eq.) was added dropwise and the solution was allowed to 
warm to 0 °C where it was stirred for 30 minutes. The reaction was quenched by the addition of 
sat. aq. NH4Cl and Et2O was added. The phases were separated and the pH of the aqueous phase 
was adjusted to 5. The layers were recombined and the organic layer was washed twice with 0.1M 
HCl. The organic phase was dried with brine and MgSO4 and the solvent was removed under 
reduced pressure yielding pure Weinreb amide 404a (14.26 g, 36.4 mmol, quant.) as colorless oil.  
Weinreb amide 404a (14.26 g, 36.4 mmol, 1.0 eq.) was dissolved in anhydrous THF (150 mL) and 
the solution was cooled to -78 °C. A solution of MeMgCl (3M in Et2O; 14.6 mL, 43.7 mmol, 1.2 eq.) 
was added dropwise and the reaction mixture was allowed to warm to -20 °C within two hours. 
The reaction was quenched by the addition of sat. aq. NH4Cl. Et2O was added and the phases were 
separated.  
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The organic layer was washed with NH4Cl before it was dried with brine and MgSO4. Purification by 
silica gel chromatography (hexane/EtOAc = 10/1) yielded pure methyl ketone 261 (9.4 g, 
27.1 mmol, 75%) as colorless liquid.  
1H-NMR (400 MHz, CDCl3):  = 4.16 (m, 1H); 3.57 (dd, J = 10.0, 5.0Hz, 1H); 3.39 (dd, J = 10.0, 6.8Hz, 
1H); 2.66 (dd, J = 15.3, 4.8Hz, 1H); 2.37 (dd, J = 15.3, 7.3Hz, 1H); 2.16 (s, 3H); 0.88 (s, 9H); 0.86 (s, 
9H); 0.05 (m, 12H) 
HRMS (ESI) (m/z): [M]+ calcd. for C17H38O3Si2: 346.2359; found: 346.2348 
 
(6S)-6,7-bis((tert-butyldimethylsilyl)oxy)-1-((4-methoxybenzyl)oxy)-4-methylhept-2-yn-4-yl 
benzoate (262) 
 
DIPA (4.4 mL, 31.2 mmol, 1.15 eq.) was dissolved in anhydrous THF (50 mL) and the mixture was 
cooled to -10 °C when n-BuLi (2.5M in hexane; 11.9 mL, 29.8 mmol, 1.1 eq.) was added. The 
mixture was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
propargylic ether 222a (5 g, 28.5 mmol, 1.05 eq.) in anhydrous THF (20 mL) was added dropwise. 
Upon completion, the reaction mixture was allowed to stir for 30 minutes. A solution of methyl 
ketone 261 (9.4 g, 27.1 mmol, 1.0 eq.) in anhydrous THF (30 mL) was added and the reaction 
mixture was stirred for one hour. The reaction was quenched by the addition of sat. aq. NH4Cl. 
After addition of Et2O, phases were separated and the aqueous phase was neutralized by the 
addition of 0.5M KHSO4. The aqueous layer was extracted twice with Et2O and the combined 
organic phases were dried with MgSO4. Purification by silica gel chromatography (hexane/EtOAc = 
7/1) yielded tertiary alcohol as colorless viscous oil (10.3 g, 19.7 mmol, 73%) as an inconsequential 
mixture of diastereoisomers. 
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Tertiary alcohol (10.3 g, 19.7 mmol, 1.0 eq.) was dissolved in anhydrous THF (100 mL), NEt3 
(8.24 mL, 59.1 mmol, 3 eq.) and benzoic acid anhydride (8.91 g, 39.4 mmol, 2 eq.) were added at 
r.t. The reaction mixture was cooled to 0 °C and MgBr2
.OEt2 (10.17 g, 39.4 mmol, 2 eq.) was added 
portionwise. The solution was allowed to warm to r.t. within 30 minutes. Water and Et2O were 
added and the phases were separated. The organic phase was washed with water and the 
combined aqueous phases were back-extracted with Et2O. The combined organic layers were dried 
with MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 7/1) yielded tertiary benzoate 262 (10.4 g, 16.6 mmol, 84%) as 
colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 8.02 (m, 2H); 7.55 (m, 1H); 7.42 (m, 2H); 7.29 (d, J = 8.5Hz, 2H); 6.85 
(d, J = 8.5Hz, 2H); 4.55 (s, 2H); 4.19 (s, 2H); 3.79 (s, 3H); 3.66 (m, 1H); 3.60 (m, 1H); 2.50 (m, 1H); 
2.02 (m, 2H); 1.90 (s, 3H); 0.88 (bs, 18H); 0.09 (s, 6H); 0.03 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C35H54O6Si2: 626.3459; found: 626.3448 
 
(6S)-6,7-bis((tert-butyldimethylsilyl)oxy)-1-hydroxy-4-methylhept-2-yn-4-yl benzoate (405) 
 
To a solution of benzoate 262 (10.4 g, 16.6 mmol, 1.0 eq.) in CH2Cl2 (150 mL) were added 15 mL of 
a pH=7-buffer (50mM KH2PO4). The vigorously stirred suspension was cooled to 0 °C and DDQ 
(5.65 g, 24.9 mmol, 1.5 eq.) was added portionwise. The suspension was allowed to stir overnight 
while it warmed to r.t. After addition of sat. aq. NaHCO3, the phases were separated and the 
organic phase was washed 6 times with H2O. The organic phase was dired with brine and MgSO4, 
and removal of the solvent in vacuo gave crude propargylic alcohol. Purification by silica gel 
chromatography (hexane/EtOAc = 5/1) gave alcohol 405 in quantitative yield (8.41 g, 16.6 mmol, 
quant.) 
1H-NMR (400 MHz, CDCl3):  = 8.00 (m, 2H); 7.54 (m, 1H); 7.42 (m, 2H); 4.32 (s, 2H); 4.15 (dddd, J = 
10.8, 10.8, 5.4, 5.4Hz, 1H); 3.65 (m, 2H); 2.49 (dd, J = 14.9, 5.8Hz, 1H); 2.13 (bs, 1H); 1.98 (dd, J = 
14.1, 5.6 Hz, 1H); 1.87 (s, 3H); 0.89 (s, 18H); 0.09 (s, 6H); 0.04 (s, 6H) 
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13C-NMR (100MHz, CDCl3):  = 164.7; 132.8; 130.9; 129.6; 128.3; 85.5; 84.7; 74.9; 71.2; 67.7; 51.1; 
45.5; 27.9; 26.00; 25.9; 18.4; 18.1; -4.0; -4.5; -5.2 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C27H46O5Si2Na: 529.2781; found: 529.2772 
 
(6S)-6,7-bis((tert-butyldimethylsilyl)oxy)-1-iodo-4-methylhept-2-yn-4-yl benzoate (259) 
 
Imidazole (1.2 g, 17.8 mmol, 3 eq.), PPh3 (3.1 g, 11.8 mmol, 2 eq.) and iodine (3.0 g, 11.8 mmol, 
2 eq.) were added to 35 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension was stirred at 
0 °C for 20 minutes while it turned yellow. To this suspension a solution of propargylic alcohol 405 
(3.0 g, 5.9 mmol, 1.0 eq.) in anhydrous CH2Cl2 (25 mL) was rapidly added. The reaction mixture was 
stirred for one hour. Then it was quenched by the addition of 60 mL hexane. The precipitating 
triphenylphosphineoxide was filtered through a pad of celite and a sat. aq. solution of Na2S2O3 and 
NaHCO3 was added to the filtrate. The phases were separated and the organic phase was washed 
with Na2S2O3, NaHCO3 and brine before it was dried with MgSO4. After removal of the solvent 
under reduced pressure, purification by silica gel chromatography (hexane/EtOAc = 7/1) yielded 
propargylic iodide 259 (2.58 g, 4.18 mmol, 71%) as slightly yellow liquid.  
1H-NMR (400 MHz, CDCl3):  = 8.01 (m, 2H); 7.53 (m, 1H); 7.41 (m, 2H); 4.15 (m, 1H); 3.74 (s, 2H); 
3.64 (m, 2H); 2.50 (dd, J = 14.3, 5.9Hz, 1H); 1.97 (dd, J = 14.3Hz, 5.9Hz, 1H); 1.84 (s, 3H); 0.89 (m, 
18H); 0.13 (m, 6H); 0.05 (s, 6H) 
13C-NMR (100 MHz, CDCl3):  = 164.5; 132.9; 131.0; 129.7; 128.4; 84.8; 83.2; 74.8; 71.0; 67.5; 45.7; 
27.7; 26.0; 18.4; 18.0; -3.9; -4.4; -5.2 
HRMS (ESI) (m/z): [M]+ calcd. for C27H45IO4Si2: 616.1901; found: 616.1894 
 
  
140 
 
(2S)-1,2-bis((tert-butyldimethylsilyl)oxy)-9-methoxy-8-((1S,2R,3S)-2-(2-((4-
methoxyphenyl)diphenylmethoxy)ethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)-4-
methyl-9-oxonon-5-yn-4-yl benzoate (263) 
 
NaH (60% in mineral oil, 168 mg, 4.18 mmol, 1.0 eq.) was suspended in anhydrous THF (22 mL). 
The reaction mixture was cooled to 0 °C and a solution of -keto ester 195 (2.7 g, 4.18 mmol, 
1.0 eq.) in anhydrous THF (10 mL) was added. The reaction was stirred at 0 °C for 20 minutes and 
then warmed to r.t. within 10 minutes. Then it was re-cooled to 0 °C and a solution of propargylic 
iodide 259 (2.58 g, 4.18 mmol, 1.0 eq.) was added uninterruptedly at 0 °C. The reaction mixture 
was stirred at this temperature for 20 minutes and then warmed to r.t. within 20 minutes before it 
was quenched with saturated aqueous NH4Cl. Et2O was added and the phases separated. The pH 
of the aqueous phase was adjusted to 6 with 0.5M KHSO4 and it was extracted twice with Et2O. 
The combined organic layers were dried with MgSO4 and the solvent was removed under reduced 
pressure. Silica gel column chromatography (hexane/EtOAc = 10/1 to 7/1) yielded alkylated -keto 
ester 263 as slightly yellow oil (3.5 g, 3.1 mmol, 74%). 
1H-NMR (400 MHz, CDCl3):  = 7.97 (m, 2H); 7.51 (m, 1H); 7.39 (m, 6H); 7.28 (m, 8H); 7.19 (m, 2H); 
6.81 (m, 2H); 4.40 (m, 1H); 4.02 (m, 1H); 3.78 (m, 3H); 3.57 (m, 6H); 3.13 (m, 2H); 2.85 (m, 2H); 
2.62 (m, 1H); 2.42 (m, 2H); 2.11 (m, 1H); 1.94 (m, 2H); 1.80 (m, 3H); 0.96 (m, 18H); 0.88 (m, 21H); 
0.05 (m, 12H) 
13C-NMR (100 MHz, CDCl3):  = 168.5; 158.3; 144.8; 135.8; 132.7; 130.6; 129.4; 128.4; 128.2; 
127.7; 126.7; 112.9; 71.1; 67.7; 65.5; 61.6; 55.1; 52.4; 46.1; 45.4; 44.8; 42.2; 33.9; 33.0; 29.1; 28.9; 
28.1; 25.9; 18.4; 18.0; 11.9; -4.0; -5.3 
HRMS (ESI) (m/z): [M]+ calcd. for C66H96O10Si3: 1132.6311; found: 1132.6303 
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Methyl-5-((S)-4,5-bis((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-2-((1S,2R,3S)-2-
(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-
carboxylate (258) 
 
Alkylated -keto ester 263 (3.5 g, 3.1 mmol, 1.0 eq.) was dissolved in anhydrous DMF (30 mL) 
under an Ar-atmosphere and finely ground anhydrous K2CO3 (2.77 g, 20.1 mmol, 6.5 eq.) was 
added. The reaction flask was sealed and the reaction mixture was heated to 90 °C (oil bath 
temperature 100 °C) for two hours. The suspension was allowed to cool to r.t. and the suspended 
K2CO3 was allowed to settle down. The supernatant was decanted and remaining K2CO3 was 
washed four times with Et2O (4x40 mL). The combined organic layers were quenched with 0.5M 
KHSO4 and the pH was adjusted to 6. The phases were separated and the aqueous phase was 
washed 4 times with Et2O/hexane (1/1). The combined organic layers were dried with MgSO4 and 
the solvents were removed under reduced pressure. The crude product was purified by silica gel 
chromatography (hexane/EtOAc = 10/1) yielding pure vinyl furan 258 (2.8 g, 2.8 mmol, 89%) as a 
mixture of double bond isomers (E/Z = 4/1). 
(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 7.36 (m, 4H); 7.20 (m, 8H); 6.75 (m, 2H); 6.37 (s, 1H); 6.03 (s, 1H); 
4.68 (dd, J = 12.6, 6.1Hz, 1H); 3.82 (m, 2H); 3.77 (s, 3H); 3.67 (s, 3H); 3.56 (dd, J = 9.8, 5.1Hz, 1H); 
3.42 (dd, J = 9.8, 6.8Hz, 1H); 3.08 (dd, J = 13.0, 6.2Hz, 2H); 2.92 (m, 1H); 2.44 (m, 2H); 2.32 (m, 1H); 
2.17 (dd, J = 13.1, 7.6Hz, 1H); 2.10 (m, 1H); 1.99 (s, 3H); 1.89 (m, 1H); 1.01 (s, 21H); 0.90 (s, 9H); 
0.84 (s, 9H); 0.05 (s, 6H); 0.02 (s, 3H); -0.04 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 164.3; 162.5; 158.4; 151.1; 144.9; 136.1; 130.2; 128.4; 127.6; 
126.6; 116.4; 113.5; 112.8; 108.1; 72.1; 67.2; 66.5; 61.7; 55.1; 45.9; 44.9; 36.3; 32.9; 29.2; 26.0; 
19.6; 18.3; 17.9; -4.5; -4.8 
HRMS (ESI) (m/z): [M]+ calcd. for C59H90O8Si3: 1010.5943; found: 1010.5940 
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Methyl-5-((S,E)-4-((tert-butyldimethylsilyl)oxy)-2-methylhexa-1,5-dien-1-yl)-2-((1S,2R,3S)-
2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-
3-carboxylate (265) 
 
Bis TBS-ether 258 (1.0 g, 1.0 mmol, 1.0 eq.) was dissolved in anhydrous THF (3 mL) and the 
reaction mixture was cooled to 0 °C. 7%HF in pyridine (2.6 mL, 10.0 mmol, 10 eq.) was added 
dropwise and the reaction mixture was allowed to stir until TLC indicated complete consumption 
of the starting material (approx. 30 minutes). The reaction was quenched by the careful addition 
of sat. aq. NaHCO3. The phases were separated and the organic layer was extracted twice with 
NaHCO3. The combined organic layers were back-extracted twice with CH2Cl2 and the combined 
organic layers were dried with brine and MgSO4. After removal of the solvent under reduced 
pressure silica gel chromatography (hexane/EtOAc = 1/1) yielded pure diol (712 mg, 0.91 mmol, 
91%) as colorless oil. 
The previously prepared diol (705 mg, 0.9mol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (10 mL). 
NEt3 (253 µL, 1.8 mmol, 2 eq.), DMAP (5.5 mg, 0.05 mmol, 0.05 eq.) and dibutyl tin oxide (247 mg, 
1.0 mmol, 1.1 eq.) were added. The solution was cooled to 0 °C and kept under an Ar-atmosphere. 
After a period of 30 minutes, tosyl-chloride (163 mg, 0.86 mmol, 0.95 eq.) was dissolved in 
anhydrous CH2Cl2 (10 mL) and was added dropwise to the reaction mixture. The suspension was 
stirred for 90 minutes, before it was quenched by the addition of 0.5M KHSO4. The phases were 
separated and the aqueous layer was extracted with CH2Cl2. The combined organic extracts were 
dried with brine and MgSO4 and the solvent was removed under reduced pressure. Purification by 
silica gel column chromatography (hexane/EtOAc = 3/1 to 2/1) yielded mono tosylate 264 (793 mg, 
0.85 mmol, 94%). 
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Trimethylsulfonium iodide (510 mg, 2.5 mmol, 3 eq.) was suspended in anhydrous THF (5 mL) and 
the suspension was cooled to -20 °C. n-BuLi (2.5M in hexane; 0.97 mL, 2.41 mmol, 2.9 eq.) was 
added dropwise and the reaction mixture was allowed to stir for 30 minutes. A solution of the 
previously prepared mono tosylate (780 mg, 0.83 mmol, 1.0 eq.) in anhydrous THF (5 mL) was 
slowly added and the mixture turned milky. The reaction mixture was stirred at -20 °C for two 
hours, then it was allowed to warm to r.t. within one hour and finally it was stirred at r.t. for 
another two hours before it was quenched with water at 0 °C. Et2O was added and the phases 
were separated. The pH of the aqueous phase was carefully neutralized with 0.5M KHSO4 and it 
was extracted two more times with Et2O. The combined organic layers were dried with brine and 
MgSO4 and the solvent was removed under reduced pressure. Silica gel chromatography 
(hexane/EtOAc = 5/1 to 4/1) yielded pure secondary allylic alcohol (457 mg, 0.59 mmol, 69%) as 
colorless oil. 
Previously prepared allylic alcohol (450 mg, 0.58 mmol, 1.0 eq.) was dissolved in anhydrous DMF 
(4 mL) and imidazole (98.3 mg, 1.44 mmol, 2.5 eq.) was added. The reaction mixture was cooled to 
0 °C and TBS-Cl (96 mg, 0.64 mmol, 1.1 eq.) was added. The solution was allowed to stir at 0 °C for 
one hour, before it was quenched by the addition of sat. aq. NH4Cl. Et2O and hexane were added 
and the phases were separated. The organic layer was washed with NH4Cl and afterwards dried 
with brine and MgSO4. The solvents were removed under reduced pressure. The resulting crude 
product was purified by silica gel chromatography (hexane/EtOAc = 7/1 to 5/1) and TBS-ether 264 
was obtained as colorless viscous oil (508 mg, 0.57 mmol, 98%). 
HRMS (ESI) (m/z): [M]+ calcd. for C54H76O7Si2: 892.5130; found: 892.5124 
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Methyl-5-((S,E)-4-((tert-butyldimethylsilyl)oxy)-2-methylhexa-1,5-dien-1-yl)-2-((1S,2R,3S)-
2-((R)-2-hydroxy-3-(((triethylsilyl)oxy)methyl)but-3-en-1-yl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (267a) 
 
Allylic TBS-ether 264 (500 mg, 0.56 mmol, 1.0 eq.) was dissolved in 5.6 mL of a 10/1 mixture 
CH2Cl2/MeOH. PPTS (28.1 mg, 0.11 mmol, 0.2 eq.) was added and the reaction mixture was 
allowed to stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. 
three hours). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases 
were separated and the aqueous layer was extracted two times with Et2O. The combined organic 
layers were dried with MgSO4 and the solvent was removed under reduced pressure. Purification 
by silica gel chromatography (hexane/EtOAc = 5/1 to 3/1) yielded the free alcohol as colorless 
viscous oil (344 mg, 0.55 mmol, 99%). 
Previously prepared primary alcohol (340 mg, 0.55 mmol, 1.0 eq.) was dissolved in anhydrous 
EtOAc (6 mL) and IBX (463 mg, 1.6 mmol, 3 eq.) was added. The suspension was heated to reflux 
for three hours. Now the suspension was cooled to r.t. and 6 mL of hexane were added. The 
suspension was filtered through a pad of celite and the solvents were removed under reduced 
pressure. The crude product was used without further purification. 
Anhydrous NiCl2 (142 mg, 1.1 mmol, 2 eq.) and anhydrous CrCl2 (336 mg, 2.74 mmol, 5 eq.) were 
suspended in anhydrous, degassed DMF (5 pump & freeze cycles, 3 mL) in a flame dried Schlenk 
tube, giving a dark green solution. The solution was cooled to 0 °C and solutions of aldehyde 
(340 mg, 0.55 mmol, 1.0 eq.) in anhydrous, degassed DMF (5 pump & freeze cycles, 3 mL) and 
vinylbromide 407b (275 mg, 1.1 mmol, 2 eq.) in anhydrous, degassed DMF (5 pump & freeze 
cycles, 3 mL) were added dropwise isochronally. The reaction mixture was allowed to warm to r.t. 
overnight. NH4Cl and EtOAc were added and the phases were separated. The organic layer was 
washed with water twice and dried with brine and MgSO4. The solvent was removed in vacuo and 
purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded pure NHK-product 267a 
(433 mg, 0.55 mmol, quant.) as colorless oil (d.r. = 2.3/1). 
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1H-NMR (400MHz, CDCl3):  = 6.37 (s, 1H); 6.00 (s, 1H); 5.84 (ddd, J = 17.1, 10.5, 5.9Hz, 1H); 5.18 
(d, J = 17.1Hz, 1H); 5.05 (m, 2H); 4.92 (s, 1H); 4.75 (dd, J = 12.9, 6.1Hz, 1H); 4.27 (m, 3H); 4.14 (m, 
1H); 4.00 (m, 1H); 3.80 (s, 3H); 3.10 (d, J = 5.2Hz, 1H); 2.76 (m, 1H); 2.53 (m, 1H); 2.34 (m, 3H); 2.15 
(m, 1H); 2.01 (s, 3H); 1.97 (m, 1H); 1.07 (s, 21H); 0.94 (t, J = 7.8Hz, 9H); 0.87 (s, 9H); 0.60 (q, J = 
7.8Hz, 6H); 0.02 (s, 3H); 0.01 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C43H78O7Si3: 790.5055; found: 790.5048 
 
Methyl-5-((S,E)-4-((tert-butyldimethylsilyl)oxy)-2-methylhexa-1,5-dien-1-yl)-2-((1S,2R,3S)-
2-((R)-2-hydroxy-3-(hydroxymethyl)but-3-en-1-yl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (267b) 
 
Primary TES-ether 267a (150 mg, 0.19 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (4 mL) 
and finely ground NH4F (351 mg, 9.5 mmol, 50 eq.) was added. The reaction mixture was stirred at 
r.t. for 2 days. Water and Et2O were added and the phases were separated. The organic layer was 
washed two times with water and dried with brine and MgSO4. Silica gel chromatography 
(hexane/EtOAc = 2/1 to 0/1) yielded diol 267b (119 mg, 0.18 mmol, 93%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 6.37 (s, 1H); 6.01 (s, 1H); 5.84 (ddd, J = 17.1, 10.5, 5.9Hz, 1H); 5.19 
(d, J = 17.1Hz, 1H); 5.05 (m, 2H); 4.98 (s, 1H); 4.75 (dd, J = 12.9, 6.1Hz, 1H); 4.41 (m, 1H); 4.27 (m, 
2H); 3.98 (m, 1H); 4.00 (m, 1H); 3.81 (s, 3H); 3.30 (m, 1H); 2.76 (m, 1H); 2.61 (m, 1H); 2.45 (m, 1H); 
2.32 (m, 3H); 2.18 (m, 1H); 2.02 (s, 3H); 1.08 (s, 21H); 0.88 (s, 9H); 0.02 (s, 3H); 0.01 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 162.5; 151.3; 150.1; 141.3; 135.8; 116.2; 113.8; 111.9; 108.2; 74.5; 
72.8; 72.5; 66.8; 64.3; 51.5; 49.8; 45.7; 35.6; 35.0; 32.5; 27.5; 25.8; 19.6; 18.0; 17.9; 12.2; -4.5; -5.0 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C37H64O7Si2Na: 699.4088; found: 699.4082 
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2-bromoprop-2-en-1-ol (406) 
 
Anhydrous HBr was prepared according the procedure of Duncan using tetraline (10.6 mL, 
77.4 mmol, 1.0 eq.) and bromine (16 mL, 309.6 mmol, 4 eq.).[136] NEt4Br (26.0 g, 123.8 mmol, 
1.6 eq.) was suspended in anhydrous CH2Cl2 (80 mL) and the solution was cooled to 0 °C when 
anhydrous HBr was bubbled through the suspension. The reaction mixture turned yellow and 
stirring was continued for 20 minutes at 0 °C and for 10 minutes at r.t. A solution of propargyl 
alcohol (4.16 mL, 77.4 mmol, 1.0 eq.) in anhydrous CH2Cl2 (10 mL) was added slowly. The solution 
was stirred at r.t for one hour and then heated to reflux for two hours. 
The reaction mixture was allowed to cool to r.t. and water was added. The phases were separated 
and the organic phase was washed twice with water. The organic layer was dried with MgSO4 and 
the solvent was removed in vacuo. Purification by distillation yielded pure vinyl bromide 406 (9 g, 
65.8 mmol, 85%) as colorless liquid. 
1H-NMR (400MHz, CDCl3):  = 5.93 (m, 1H); 5.58 (m, 1H); 4.23 (t, J = 1.1Hz, 2H); 2.42 (bs, 1H) 
HRMS (ESI) (m/z): [M]+ calcd. for C3H5BrO: 135.9524; found: 135.9518 
 
((2-bromoallyl)oxy)(tert-butyl)dimethylsilane (407a) 
 
Vinyl bromide 406 (5 g, 36.5 mmol, 1.0 eq.) was dissolved in anhydrous DMF (100 mL) and 
imidazole (4.97 g, 73 mmol, 2 eq.) was added in one portion. Under Ar-atmosphere, the mixture 
was cooled to 0 °C and a solution of TBS-Cl (6.6 g, 43.8 mmol, 1.2 eq.) in anhydrous DMF (15 mL) 
was slowly added at 0 °C. The reaction mixture was allowed to warm to r.t. and stirring was 
continued for two hours. 100 mL of hexane/Et2O (1/1) and 100 mL of saturated aqueous NH4Cl 
were added and the phases were separated. The organic phase was extracted with water twice. 
The combined aqueous phases were twice back-extracted with a 1/1 mixture of hexane/Et2O and 
the combined organic layers were dried over MgSO4. Evaporation of the solvent yielded silylether 
407a (8.62 g, 34.3 mmol, 94%) as colorless oil, which was purified by silica gel column 
chromatography (hexane). 
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1H-NMR (400MHz, CDCl3):  = 5.95 (d, J = 1.8Hz, 1H); 5.58 (d, J = 1.8Hz, 1H); 4.21 (t, J = 1.6Hz, 2H); 
0.92 (s, 9H); 0.10 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C9H19BrOSi: 250.0389; found: 250.0382 
 
((2-bromoallyl)oxy)triethylsilane (407b) 
 
Vinyl bromide 406 (5 g, 36.5 mmol, 1.0 eq.) was dissolved in anhydrous DMF (100 mL) and 
imidazole (4.97 g, 73 mmol, 2 eq.) was added in one portion. Under Ar-atmosphere, the mixture 
was cooled to 0 °C and a solution of TES-Cl (6.6 g, 43.8 mmol, 1.2 eq.) in anhydrous DMF (15 mL) 
was slowly added at 0 °C. 
The reaction mixture was allowed to warm to r.t. and stirring was continued for two hours. 100 mL 
of hexane/Et2O (1/1) and 100 mL of saturated aqueous NH4Cl were added and the phases were 
separated. The organic phase was extracted with water twice. The combined aqueous phases were 
twice back-extracted with a 1/1 mixture of hexane/Et2O and the combined organic layers were 
dried over MgSO4. Evaporation of the solvent yielded silylether 407b (8.34 g, 33.2 mmol, 91%) as 
colorless oil, which was purified by silica gel column chromatography (hexane). 
1H-NMR (400MHz, CDCl3):  = 5.98 (q, J = 1.8Hz, 1H); 5.53 (q, J = 1.6Hz, 1H); 4.21 (dd, J = 1.7, 1.7Hz, 
2H); 0.98 (t, J = 8.0Hz, 9H); 0.64 (q, J = 8.0Hz, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C9H19BrOSi: 250.0389; found: 250.0384 
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4.2.5 11,12 Horner Wadsworth Emmons Approach (cBu) 
 
Methyl-5-((S)-4,5-bis((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-2-((1S,2R,3S)-2-
(2-hydroxyethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (408) 
 
Vinylfuran 258 (2.8 g, 2.8 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (5 mL) and 
hexafluoroisopropanol (HFIP, 5 mL) was added. The solution was allowed to stir at r.t. for 15 
minutes during which time it turned yellow. Anhydrous MeOH was added until the color 
disappeared and the solution was allowed to stir at r.t. for 3 days. Solvents were removed in vacuo 
and purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded pure primary alcohol 
408 (1.73 g, 2.3 mmol, 84%) as colorless viscous oil. 
(Z)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.53 (s, 1H); 6.05 (s, 1H); 4.68 (dd, J = 12.6, 6.3Hz, 1H); 3.92 (m, 1H); 
3.78 (s, 3H); 3.69 (m, 2H); 3.59 (dd, J = 10.0, 5.2Hz, 1H); 3.44 (dd, J = 9.8, 6.6Hz, 1H); 2.78 (m, 1H); 
2.60 (m, 3H); 2.37 (m, 1H); 2.24 (m, 1H); 2.05 (m, 1H); 1.92 (s, 3H); 1.86 (m, 1H); 1.07 (s, 21H); 0.89 
(s, 9H); 0.81 (s, 9H); 0.05 (s, 6H); 0.03 (s, 3H); -0.03 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 164.7; 162.1; 137.6; 116.1; 113.3; 108.2; 71.8; 68.0; 67.0; 61.2; 
51.2; 45.9; 38.8; 35.7; 32.9; 31.8; 26.0; 18.1; 12.3; -4.4; -4.8; -5.3 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C39H74O7Si3Na: 761.4640; found: 761.4632 
[]D
20: +23.4 (c=0.19; CHCl3) 
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(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.36 (s, 1H); 6.03 (s, 1H); 4.76 (q, J = 6.9Hz, 1H); 3.88 (m, 1H); 3.81 
(m, 1H); 3.79 (s, 3H); 3.72 (m, 2H); 3.56 (dd, J = 9.9, 5.3Hz, 1H); 3.42 (dd, J = 9.9, 6.9Hz, 1H); 2.75 
(m, 1H); 2.59 (m, 1H); 2.45 (m, 2H); 2.18 (dd, J = 13.2, 7.7Hz, 1H); 2.07 (m, 1H); 2.02 (s, 3H); 1.92 
(m, 2H); 1.06 (s, 21H); 0.90 (s, 9H); 0.85 (s, 9H); 0.05 (s, 6H); 0.03 (s, 3H); -0.02 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 164.7; 162.5; 151.4; 140.9; 136.3; 116.2; 113.4; 112.7; 108.0; 71.9; 
67.1; 66.6; 61.1; 51.3; 46.4; 45.8; 35.7; 32.0; 31.8; 25.9; 25.8; 19.5; 18.0; 17.9; 12.0; -4.5; -4.9; -5.3; 
-5.4 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C39H74O7Si3Na: 761.4640; found: 761.4629 
[]D
20: -10.1 (c=0.35; CHCl3) 
 
Methyl-5-((S)-4,5-bis((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-2-((1S,2R,3S)-2-
(3-(dimethoxyphosphoryl)-2-hydroxypropyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-
carboxylate (409) 
 
Primary alcohol 408 (1.73 g, 2.3 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (25 mL) and IBX 
(1.93 g, 6.9 mmol, 3 eq.) was added. The suspension was heated to reflux for three hours. Now the 
suspension was cooled to r.t. and 25 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed in vacuo. The crude product was purified 
by silica gel column chromatography (hexane/EtOAc = 7/1). The aldehyde was obtained as viscous 
oil (1.55 g, 2.1 mmol, 90%). 
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Dimethyl methylphosphonate (251 µL, 1.1 mmol, 1.0 eq.) was dissolved in anhydrous THF (10 mL) 
and the solution was cooled to -78 °C before n-BuLi (1.6M in hexane; 1.51 mL, 2.4 mmol, 1.15 eq.) 
was added dropwise. The reaction mixture was stirred for 30 minutes, and then a solution of the 
previously prepared aldehyde (1.55 g, 2.1 mmol, 1.0 eq.) in anhydrous THF (15 mL) was added 
dropwise. Stirring was continued for one hour. The reaction mixture was quenched by the addition 
of sat. aq. NH4Cl. After the addition of Et2O, the phases were separated and the neutralized 
aqueous layer was extracted twice with Et2O. The combined organic layers were dried with MgSO4 
and the solvent was removed in vacuo. Purification by silica gel chromatography (hexane/EtOAc = 
2/1) resulted -hydroxy phosphonate 409 (1.5 g, 1.75 mmol, 83%) as colorless oil. 
(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.36 (s, 1H); 6.03 (s, 1H); 4.76 (m, 1H); 4.11 (m, 1H); 3.94 (m, 1H); 
3.80 (s, 3H); 3.69 (m, 7H); 3.57 (m, 2H); 3.44 (m, 2H); 2.86 (m, 1H); 2.54 (m, 3H); 2.37 (m, 1H); 2.18 
(dd, J = 13.3, 7.5Hz, 1H); 2.01 (s, 3H); 1.89 (m, 2H); 1.07 (bs, 21H); 0.91 (s, 9H); 0.86 (s, 9H); 0.06 (s, 
6H); 0.04 (s, 3H); -0.01 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C42H81O10PSi3Na: 883.4773; found: 883.4762 
 
Methyl-5-((S)-4,5-bis((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-2-((1S,2R,3S)-2-
(3-(dimethoxyphosphoryl)-2-oxopropyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-
carboxylate (271) 
 
-hydroxy phosphonate 409 (1.5 g, 1.75 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (20 mL) 
and IBX (1.47 g, 5.25 mmol, 3 eq.) was added. The suspension was heated to reflux for four hours. 
Now the suspension was cooled to r.t. and 20 mL of hexane were added. The suspension was 
filtered through a pad of celite and the solvents were removed under reduced pressure. The crude 
product was purified by silica gel column chromatography (hexane/EtOAc = 2/1). -keto 
phosphonate 271 was obtained as viscous oil (1.25 g, 1.45 mmol, 83%). 
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1H-NMR (400 MHz, CDCl3):  = 6.39 (s, 1H); 6.07 (s, 1H); 4.47 (dd, J = 14.9, 7.4Hz, 1H); 3.90 (m, 1H); 
3.80 (s, 3H); 3.69 (d, J = 5.6Hz, 3H); 3.68 (d, J = 6.0Hz, 3H); 3.56 (dd, J = 10.0, 5.2Hz, 1H); 3.52 (m, 
1H); 3.42 (dd, J = 9.8, 6.8Hz, 1H); 2.91 (m, 3H); 2.58 (m, 2H); 2.50 (m, 3H); 2.19 (dd, J = 13.6, 7.5Hz, 
1H); 2.01 (s, 3H); 1.04 (s, 21H); 0.91 (s, 9H); 0.86 (s, 9H); 0.06 (s, 3H); 0.05 (s, 3H); 0.04 (s, 3H); 0.00 
(s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 200.6; 164.2; 158.4; 152.1; 137.1; 116.2; 115.4; 108.2; 71.8; 67.1; 
64.4; 52.7; 51.4; 45.8; 44.1; 41.7; 41.0; 39.3; 34.9; 27.1; 25.9; 19.7; 18.0; 12.1; -4.2; -4.8; -5.3 
HRMS (ESI) (m/z): [M]+ calcd. for C42H79O10PSi3: 858.4719; found: 858.4708 
[]D
20: -43.3 (c=0.51; CHCl3) 
 
Methyl-5-((S)-4-((tert-butyldimethylsilyl)oxy)-5-hydroxy-2-methylpent-1-en-1-yl)-2-
((1S,2R,3S)-2-(3-(dimethoxyphosphoryl)-2-oxopropyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (410) 
 
-keto phosphonate 271 (320 mg, 0.37 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (4 mL) 
and finely ground NH4F (690 mg, 18.62 mmol, 50 eq.) was added. The reaction mixture was stirred 
at r.t. for 2 days. Water and Et2O were added and the phases were separated. The organic layer 
was washed two times with water and dried with brine and MgSO4. Silica gel chromatography (2/1 
to 1/1) yielded primary alcohol 410 (248 mg, 0.33 mmol, 90%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 6.39 (s, 1H); 6.04 (s, 1H); 4.71 (m, 1H); 3.98 (m, 2H); 3.77 (m, 7H); 
3.64 (m, 2H); 3.59 (m, 1H); 3.10 (m, 3H); 2.86 (m, 1H); 2.68 (m, 1H); 2.54 (m, 2H); 2.33 (m, 3H); 
2.02 (s, 3H); 1.89 (m, 1H); 1.05 (s, 21H); 0.90 (s, 9H); 0.10 (s, 3H); 0.06 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C36H65O10PSi2Na: 767.3752; found: 767.3748 
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(2S,4S,5R,8E,10S)-methyl 10-((tert-butyldimethylsilyl)oxy)-12-methyl-7-oxo-4-
((triisopropylsilyl)oxy)-17-oxatricyclo[12.2.12,5]heptadeca-1(16),8,12,14-tetraene-16-
carboxylate (273) 
 
Primary alcohol 410 (175 mg, 0.23 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (3 mL) and IBX 
(131 mg, 0.47 mmol, 2 eq.) was added. The suspension was heated to reflux for three hours. Now 
the suspension was cooled to r.t. and hexane (3 mL) was added. The suspension was filtered 
through a pad of celite and the solvents were removed under reduced pressure. The crude 
product was used without further purification. 
HFIP (5 mL) was mixed with anhydrous THF (70 mL) and the solution was cooled to 0 °C. n-BuLi 
(2.5M in hexane; 161 µL, 0.4 mmol, 3 eq.) was added dropwise and the reaction mixture was 
incubated for one hour at 0 °C. A solution of the seco aldehyde (100 mg, 0.13 mmol, 1.0 eq.) in 
anhydrous THF (20 mL) was added using a syringe pump over a period of time of 16 hours. The 
reaction mixture was quenched by the addition of sat. aq. NH4Cl and Et2O was added. The phases 
were separated and the organic layer was dried with brine and MgSO4. Removal of the solvents 
under reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 7/1 to 4/1) 
yielded pure (E)-macrocycle 273 (42 mg, 0.07 mmol, 52%) as colorless semi-solid.  
(Z)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.61 (dd, J = 15.7, 3.7Hz, 1H); 6.53 (dd, J = 15.7, 3.7Hz, 1H); 6.36 (s, 
1H); 5.94 (s, 1H); 4.56 (dd, J = 5.6, 5.6Hz, 1H); 4.41 (m, 1H); 4.07 (ddd, J = 9.6, 9.6, 9.6Hz, 1H); 3.77 
(s, 3H); 3.28 (ddt, J = 10.4, 5.9, 4.6Hz, 1H); 3.15 (dd, J = 12.0, 9.8Hz, 1H); 2.74 (dd, J = 12.2, 4.5Hz, 
1H); 2.69 (dd, J = 12.2, 10.6Hz, 1H); 2.39 (m, 1H); 2.35 (m, 1H); 2.20 (ddd, J = 11.9, 10.1, 5.5Hz, 1H); 
1.96 (s, 3H); 1.09 (m, 21H); 0.94 (s, 9H); 0.10 (s, 3H); -0.12 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 202.3; 163.8; 162.0; 150.2; 149.1; 131.8; 126.8; 115.9; 113.9; 
111.3; 70.2; 69.0; 51.3; 45.4; 43.3; 42.5; 37.8; 37.2; 26.1; 25.9; 18.4; 18.0; 12.1; -4.7; -5.0 
HRMS (ESI) (m/z): [M]+ calcd. for C34H56O6Si2: 616.3615; found: 616.3612 
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(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.53 (dd, J = 15.3, 5.5Hz, 1H); 6.35 (s, 1H); 6.10 (dd, J = 15.3, 1.5Hz, 
1H); 5.92 (s, 1H); 4.53 (dd, J = 5.5, 5.5Hz, 1H); 4.33 (m, 1H); 4.03 (ddd, J = 8.4, 8.4, 8.4Hz, 1H); 3.71 
(s, 3H); 3.24 (m, 1H); 2.94 (dd, J = 17.9, 8.2Hz, 1H); 2.51 (dd, J = 17.9, 5.8Hz, 1H); 2.46 (dd, J = 12.8, 
5.3Hz, 1H); 2.29 (m, 1H); 2.23 (dd, J = 12.8, 9.5Hz, 1H); 2.13 (m, 1H); 1.82 (s, 3H); 0.96 (m, 21H); 
0.84 (s, 9H); 0.00 (s, 3H); -0.02 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 198.7; 164.4; 161.2; 150.8; 146.3; 133.7; 127.8; 117.3; 113.4; 
108.3; 70.5; 67.7; 51.3; 50.2; 41.0; 40.1; 36.9; 34.4; 25.8; 19.1; 18.2; 18.0; 12.1; -4.7; -4.9 
HRMS (ESI) (m/z): [M]+ calcd. for C34H56O6Si2: 616.3615; found: 616.3613 
[]D
20: -76.4 (c=0.16; CHCl3) 
 
4.2.6 12,13 Horner Wadsworth Emmons Approach (cBu) 
 
Methyl-5-((S)-4-((tert-butyldimethylsilyl)oxy)-5-hydroxy-2-methylpent-1-en-1-yl)-2-
((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (278) 
 
Compound 285 (286 mg, 0.32 mmol, 1.0 eq.) was dissolved in a 6/1 mixture of anhydrous CH2Cl2 
(0.5 mL) and MeOH (3 mL) and finely ground NH4F (590 mg, 15.9 mmol, 50 eq.) was added. The 
reaction mixture was stirred at r.t. for 2 days. Water and Et2O were added and the phases were 
separated. The organic layer was washed two times with water and dried with brine and MgSO4. 
Silica gel chromatography (4/1 to 3/1) yielded pure primary alcohol 278 (266 mg, 0.3 mmol, 93%) 
as colorless oil. 
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1H-NMR (400 MHz, CDCl3):  = 7.41 (m, 1H); 7.33 (m, 3H); 7.21 (m, 8H); 6.76 (d, J = 8.7Hz, 2H); 6.48 
(s, 1H); 6.04 (s, 1H); 4.57 (m, 1H); 4.02 (m, 1H); 3.94 (m, 1H); 3.78 (s, 3H); 3.69 (s, 3H); 3.56 (m, 1H); 
3.48 (m, 1H); 3.02 (m, 2H); 2.81 (m, 1H); 2.71 (dd, J = 13.4, 7.3Hz, 1H); 2.55 (dd, J = 13.4, 5.9Hz, 
1H); 2.47 (m, 2H); 2.25 (m, 1H); 2.06 (m, 1H); 1.93 (s, 3H); 1.81 (m, 1H); 1.02 (s, 21H); 0.86 (s, 9H); 
0.06 (s, 3H); 0.03 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C53H76O8Si2Na: 919.4976; found: 919.4971 
 
Methyl-5-((S)-4-((tert-butyldimethylsilyl)oxy)-5-iodo-2-methylpent-1-en-1-yl)-2-
((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (279) 
 
Imidazole (146 mg, 2.15 mmol, 3 eq.), PPh3 (376 mg, 1.43 mmol, 2 eq.) and iodine (363 mg, 
1.43 mmol, 2 eq.) were added to 4 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension was 
stirred at 0 °C for 20 minutes while it turned yellow. To this suspension a solution of primary 
alcohol 278 (530 mg, 0.72 mmol, 1.0 eq.) in anhydrous CH2Cl2 (3 mL) was added rapidly. The 
reaction mixture was stirred for one hour. Then it was quenched by the addition of 60 mL hexane. 
The precipitating triphenylphosphineoxide was filtered through a pad of celite and a sat. aq. 
solution of Na2S2O3 and NaHCO3 was added to the filtrate. The phases were separated and the 
organic phase was washed with Na2S2O3, NaHCO3 and brine before it was dried with MgSO4. After 
removal of the solvent under reduced pressure, purification by silica gel chromatography 
(hexane/EtOAc = 20/1) yielded iodide 279 (550 mg, 0.55 mmol, 76%) as slightly yellow liquid.  
1H-NMR (400 MHz, CDCl3):  = 7.34 (m, 4H); 7.20 (m, 8H); 6.75 (d, J = 9.0Hz, 2H); 6.40 (s, 1H); 6.07 
(s, 1H); 4.66 (ddd, J = 12.2, 6.5, 6.5Hz, 1H); 3.86 (m, 1H); 3.77 (s, 3H); 3.71 (m, 1H); 3.68 (s, 3H); 
3.21 (m, 2H); 3.08 (m, 2H); 2.96 (m, 2H); 2.47 (m, 2H); 2.35 (m, 2H); 2.10 (m, 1H); 2.01 (s, 3H); 1.88 
(m, 1H); 1.76 (m, 1H); 1.02 (s, 21H); 0.88 (s, 9H); 0.08 (s, 3H); 0.00 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 162.8; 158.5; 150.9; 145.1; 134.6; 130.3; 128.4; 127.6; 126.6; 116.9; 
112.8; 95.6; 70.2; 66.7; 61.5; 55.1; 51.1; 48.2; 44.6; 36.3; 33.2; 29.2; 25.8; 18.0; 13.7; 12.1; -4.4 
 155 
 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C53H75IO7Si2Na: 1029.3994; found: 1029.3989 
 
Methyl-5-((4S)-4-((tert-butyldimethylsilyl)oxy)-6-(dimethoxyphosphoryl)-7-ethoxy-2-
methyl-7-oxohept-1-en-1-yl)-2-((1S,2R,3S)-2-(2-((4-
methoxyphenyl)diphenylmethoxy)ethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-
carboxylate (277) 
 
NaH (60% in mineral oil; 26 mg, 0.66 mmol, 3 eq.) was suspended in anhydrous DMSO (700 µL) 
and the reaction mixture was cooled to 0 °C. Triethylphosphonoacetate (130 µL, 0.66 mmol, 3 eq.) 
was added dropwise and the solution was allowed to stir for 30 minutes at 0 °C. A solution of 
iodide 279 (220 mg, 0.22 mmol, 1.0 eq.) in anhydrous DMSO (1 mL) was added dropwise and the 
reaction mixture was allowed to warm to r.t. within one hour. Stirring was continued at r.t. for 
another hour before the reaction was quenched by the addition of sat. aq. NH4Cl. Et2O was added 
and the phases were separated. The organic phase was washed twice with water and the 
combined aqueous layers were back-extracted once with Et2O. The combined organic layers were 
dried with brine and MgSO4. Purification by silica gel chromatography yielded pure phosphonate 
277 (110 mg, 0.1 mmol, 46%) as colorless oil. Furthermore, starting material 279 (75 mg, 74 µmol, 
79% borsm.) was recovered. 
Major: 
1H-NMR (400 MHz, CDCl3):  = 7.34 (m, 4H); 7.20 (m, 8H); 6.75 (d, J = 8.7Hz, 2H); 6.38 (s, 1H); 6.01 
(s, 1H); 4.66 (m, 1H); 4.22 (m, 2H); 4.11 (m, 5H); 3.86 (m, 1H); 3.77 (s, 3H); 3.68 (s, 3H); 3.25 (ddd, J 
= 12.4, 11.7, 1.8Hz, 1H); 3.07 (m, 2H); 2.93 (m, 1H); 2.44 (m, 1H); 2.33 (m, 1H); 2.23 (m, 2H); 2.09 
(m, 2H); 1.98 (s, 3H); 1.81 (m, 2H); 1.29 (m, 9H); 1.02 (s, 21H); 0.88 (s, 9H); 0.04 (s, 3H); 0.02 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C61H91O12PSi2: 1102.5787; found: 1102.5783 
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Minor: 
1H-NMR (400 MHz, CDCl3):  = 7.34 (m, 4H); 7.20 (m, 8H); 6.75 (d, J = 8.7Hz, 2H); 6.37 (s, 1H); 6.00 
(s, 1H); 4.66 (m, 1H); 4.22 (m, 2H); 4.11 (m, 5H); 3.86 (m, 1H); 3.77 (s, 3H); 3.67 (s, 3H); 3.16 (ddd, J 
= 9.8, 9.8, 3.7Hz, 1H); 3.07 (m, 2H); 2.93 (m, 1H); 2.44 (m, 1H); 2.33 (m, 1H); 2.23 (m, 2H); 2.09 (m, 
2H); 1.97 (s, 3H); 1.81 (m, 2H); 1.29 (m, 9H); 1.02 (s, 21H); 0.85 (s, 9H); 0.06 (s, 3H); -0.05 (s, 3H) 
 
Methyl-5-((4S)-4-((tert-butyldimethylsilyl)oxy)-6-(dimethoxyphosphoryl)-7-ethoxy-2-
methyl-7-oxohept-1-en-1-yl)-2-((1S,2R,3S)-2-(2-hydroxyethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (411) 
 
Phosphonate 277 (200 mg, 0.18 mmol, 1.0 eq.) was dissolved in 2.2 mL of a 10/1 mixture 
CH2Cl2/MeOH. PPTS (7 mg, 36 µmol, 0.2 eq.) was added and the reaction mixture was allowed to 
stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. three 
hours). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were 
separated and the aqueous layer was extracted two times with Et2O. The combined organic layers 
were dried with MgSO4 and the solvent was removed under reduced pressure. Purification by silica 
gel chromatography (hexane/EtOAc = 3/1 to 0/1) yielded free alcohol 411 as colorless viscous oil 
(150 mg, 0.18 mmol, quant.). 
Major: 
1H-NMR (400 MHz, CDCl3):  = 6.40 (s, 1H); 6.02 (s, 1H); 4.74 (ddd, J = 13.5, 6.6, 6.6Hz, 1H); 4.25 
(m, 2H); 4.12 (m, 5H); 3.91 (m, 1H); 3.80 (s, 3H); 3.72 (m, 2H); 3.24 (ddd, J = 12.5, 11.5, 2.4Hz, 1H); 
2.77 (m, 1H); 2.57 (m, 1H); 2.43 (m, 2H); 2.21 (m, 2H); 2.06 (m, 2H); 2.00 (s, 3H); 1.92 (m, 1H); 1.81 
(m, 1H); 1.29 (m, 9H); 1.07 (s, 21H); 0.88 (s, 9H); 0.04 (s, 6H) 
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13C-NMR (100 MHz, CDCl3):  = 169.0; 164.6; 162.7; 151.1; 135.4; 116.3; 113.5; 108.5; 89.6; 69.1; 
68.7; 66.7; 62.6; 61.3; 61.1; 51.4; 49.4; 48.1; 46.1; 42.3; 41.0; 35.7; 33.7; 32.4; 31.8; 25.8; 19.2; 
18.0; 16.314.1; 12.1; -4.1; -4.9 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C41H75O11PSi2Na: 853.4483; found: 853.4476 
Minor: 
1H-NMR (400 MHz, CDCl3):  = 6.38 (s, 1H); 6.00 (s, 1H); 4.74 (ddd, J = 13.5, 6.6, 6.6Hz, 1H); 4.25 
(m, 2H); 4.12 (m, 5H); 3.91 (m, 1H); 3.80 (s, 3H); 3.72 (m, 2H); 3.12 (ddd, J = 13.7, 9.8, 4.0Hz, 1H); 
2.77 (m, 1H); 2.57 (m, 1H); 2.43 (m, 2H); 2.21 (m, 2H); 2.06 (m, 2H); 1.99 (s, 3H); 1.92 (m, 1H); 1.81 
(m, 1H); 1.29 (m, 9H); 1.07 (s, 21H); 0.86 (s, 9H); 0.07 (s, 3H); -0.02 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 169.5; 164.6; 162.7; 151.0; 135.1; 116.4; 113.5; 108.7; 89.6; 69.0; 
68.8; 66.7; 62.8; 61.5; 51.4; 49.4; 48.1; 46.2; 42.5; 41.2; 35.7; 34.2; 32.2; 31.8; 25.8; 19.3; 17.9; 
16.3; 14.1; 12.1; -4.6; -4.7 
 
Methyl-5-((4S)-4-((tert-butyldimethylsilyl)oxy)-6-(dimethoxyphosphoryl)-7-ethoxy-2-
methyl-7-oxohept-1-en-1-yl)-2-((1S,2R,3S)-2-(2-oxoethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (281) 
 
Primary alcohol 411 (150 mg, 0.18 mmol, 1.0 eq.) was dissolved in anhydrous DMSO (2 mL) and 
IBX (101 mg, 0.36 mmol, 2 eq.) was added. The reaction mixtures was stirred at r.t. for 90 minutes 
or until all starting material was consumed. Now 2 mL of hexane and 2 mL of EtOAc were added 
and the suspension was filtered through a pad of celite 545 coarse. The filtrate was transferred to 
a separatory funnel and water was added. The phases were separated and the organic phase was 
washed twice with fresh water. The combined aqueous layers were back-extracted twice with 
EtOAc. The combined organic layers were dried with brine and MgSO4 and the solvents were 
removed in vacuo. Purification by silica gel chromatography yielded aldehyde 281 (145 mg, 
0.17 mmol, 97%) as colorless oil.   
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Major: 
1H-NMR (400 MHz, CDCl3):  = 9.78 (s, 1H); 6.40 (s, 1H); 6.03 (s, 1H); 4.73 (ddd, J = 11.8, 6.4, 6.4Hz, 
1H); 4.21 (m, 3H); 3.98 (m, 2H); 3.78 (s, 3H); 3.24 (ddd, J = 12.3, 11.8, 2.0Hz, 1H); 3.15 (m, 1H); 2.95 
(m, 1H); 2.63 (m, 2H); 2.39 (m, 2H); 2.23 (m, 2H); 2.16 (m, 1H); 2.04 (m, 1H); 1.99 (s, 3H); 1.81 (m, 
2H); 1.29 (m, 9H); 1.04 (s, 21H); 0.87 (s, 9H); 0.03 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C41H73O11PSi2: 828.4429; found: 828.4422 
Minor: 
1H-NMR (400 MHz, CDCl3):  = 9.78 (s, 1H); 6.38 (s, 1H); 6.01 (s, 1H); 4.73 (ddd, J = 11.8, 6.4, 6.4Hz, 
1H); 4.21 (m, 3H); 3.90 (m, 2H); 3.78 (s, 3H); 3.15 (m, 1H); 3.09 (ddd, J = 9.6, 9.6, 3.7Hz, 1H); 2.95 
(m, 1H); 2.63 (m, 2H); 2.39 (m, 2H); 2.23 (m, 2H); 2.16 (m, 1H); 2.04 (m, 1H); 1.97 (s, 3H); 1.81 (m, 
2H); 1.29 (m, 9H); 1.04 (s, 21H); 0.85 (s, 9H); 0.07 (s, 3H); 0.03 (s, 3H) 
 
4.2.7 Furan-Butenolide-12,13 Approach (cBu) 
 
(S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)oxirane (284) 
 
(R)-glycidol (186, 3.0 g, 40.5 mmol, 1.0 eq.) was dissolved in 200 mL anhydrous CH2Cl2, DMAP 
(247 mg, 2.0 mmol, 0.05 eq.) and pyridine (3.9 mL, 48.6 mmol, 1.2 eq.) were added. The reaction 
mixture was cooled to 0 °C. A solution of MMTr-Cl (13.76 g, 44.5 mmol, 1.1 eq.) in 100 mL of 
anhydrous CH2Cl2 was added dropwise at low temperature. The reaction mixture was stirred for 
two hours at 0 °C and then quenched by the addition of sat. aq. NH4Cl solution and the phases 
were separated. The aqueous phase was extracted twice with 100 mL CH2Cl2. The combined 
organic layers were dried with brine and MgSO4 and the solvent was removed under reduced 
pressure. Purification by silica gel chromatography (hexane/EtOAc = 10/1 to 7/1) yielded pure 
MMTr-glycidol 284 (13.6 g, 39.3 mmol, 97%) as slightly orange solid. 
1H-NMR (400 MHz, CDCl3):  = 7.46 (m, 3H); 7.31 (m, 7H); 7.20 (m, 2H); 6.84 (m, 2H); 3.80 (s, 3H); 
3.32 (dd, J = 9.3, 2.0Hz, 1H); 3.14 (m, 2H); 2.77 (m, 1H); 2.62 (dd, J = 5.1, 2.3Hz, 1H) 
HRMS (ESI) (m/z): [M]+ calcd. for C23H22O3: 346.1569; found: 346.1562 
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(S)-1-((4-methoxyphenyl)diphenylmethoxy)-4-methylpent-4-en-2-ol (412) 
 
CuI (152 mg, 0.8 mmol, 0.2 eq.) was suspended in a flame dried three neck round bottom flask in 
anhydrous THF (3 mL) and the suspension was cooled to -78 °C. 16.7 mL of a 0.5M solution of 
isopropenylmagnesium bromide (8.4 mmol, 2.1 eq.) in anhydrous THF were added and the 
suspension turned to a yellow solution. The reaction mixture was allowed to stir for 45 minutes at 
-78 °C until 5 mL of a solution of MMTr-glycidol 284 (1.38 g, 3.98 mmol, 1.0 eq.) in anhydrous THF 
were added dropwise. The reaction mixture was allowed to stir at -78 °C for two hours until it was 
quenched with NH4Cl. The biphasic mixture was allowed to warm to r.t. and Et2O and 25% aqueous 
NH3 were added. The phases were separated and the organic layer was repeatedly washed with a 
3/1 mixture of NH4Cl/NH3. The combined aqueous extracts were back-extracted once with Et2O 
and the combined organic layers were dried with MgSO4. The solvent was removed under reduced 
pressure and the crude product was purified by silica gel column chromatography (hexane/EtOAc 
= 10/1 to 7/1) yielding compound 412 (1.5 g, 3.86 mmol, 97%). 
1H-NMR (400 MHz, CDCl3):  = 7.45 (d, J = 7.8Hz, 4H); 7.33 (d, J = 8.9Hz, 2H); 7.26 (m, 4H); 7.18 (m, 
2H); 6.81 (d, J = 8.9Hz, 2H); 4.77 (s, 1H); 4.71 (s, 1H); 3.91 (m, 1H); 3.72 (s, 3H); 3.14 (m, 2H); 2.34 
(d, J = 3.0Hz, 1H); 2.16 (s, 1H); 2.15 (d, J = 2.2Hz, 1H); 1.69 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 158.5; 144.3; 142.1; 135.5; 130.2; 128.3; 127.7; 126.8; 113.0; 
112.9; 86.3; 68.5; 67.4; 55.0; 42.1; 22.3 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C26H28O3Na: 411.1936; found: 411.1930 
 
(S)-2-((tert-butyldimethylsilyl)oxy)-4-methylpent-4-en-1-ol (413) 
 
Compound 412 (1.5 g, 3.86 mmol, 1.0 eq.) was dissolved in anhydrous DMF (15 mL) and imidazole 
(657 mg, 9.65 mmol, 2.5 eq.) was added. The reaction mixture was cooled to 0 °C and TBS-Cl 
(640 mg, 4.25 mmol, 1.1 eq.) was added. 
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The solution was allowed to stir at 0 °C for one hour, before it was quenched by the addition of 
sat. aq. NH4Cl. Et2O and hexane were added and the phases were separated. The organic layer was 
washed with NH4Cl and afterwards dried with brine and MgSO4. The solvents were removed under 
reduced pressure. The resulting crude product was subsequently subjected to MMTr-
deprotection. 
The crude (1.94 g) product was dissolved in a 2/1 mixture of anhydrous CH2Cl2 (20 mL) and 
anhydrous MeOH (10 mL). The reaction mixture was cooled to 0 °C and CSA (90 mg, 0.39 mmol, 
0.1 eq.) was added. The solution was allowed to stir for 30 minutes before it was quenched by the 
addition of sat. aq. NaHCO3. The phases were separated and the aqueous layer was extracted 
twice with CH2Cl2. The combined organic layers were dried with brine and MgSO4 and the solvent 
was removed in vacuo. Purification by silica gel chromatography (hexane/EtOAc = 10/1) yielded 
pure primary alcohol 413 (600 mg, 2.6 mmol, 67%) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 4.80 (s, 1H); 4.74 (s, 1H); 3.90 (m, 1H); 3.57 (m, 1H); 3.45 (m, 1H); 
2.23 (d, J = 6.8Hz, 2H); 1.75 (s, 3H); 0.90 (s, 9H); 0.10 (s, 3H); 0.09 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C12H26O2SiNa: 253.1600; found: 253.1594 
 
(S,E)-ethyl 2-bromo-4-((tert-butyldimethylsilyl)oxy)-6-methylhepta-2,6-dienoate (414) 
 
Primary alcohol 413 (600 mg, 2.6 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (25 mL) and IBX 
(2.19 g, 7.8 mmol, 3 eq.) was added. The suspension was heated to reflux for three hours. Now the 
suspension was cooled to r.t. and 25 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed in vacuo. The crude product was of 
sufficient purity. In this way, the aldehyde was obtained as viscous oil (594 mg, 2.6 mmol, quant.). 
A suspension of NaH (60% in mineral oil, 111 mg, 2.77 mmol, 1.0 eq.) in anhydrous THF (10 mL) 
was cooled to 0 °C and a solution of ethyl 2-bromo-2-(diphenoxyphosphoryl)acetate (1.15 g, 
2.77 mmol, 1.0 eq.) in anhydrous THF (10 mL) was added dropwise. Upon completion of the 
addition the reaction mixture was stirred for 30 minutes. 
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A solution of the previously prepared aldehyde (594 mg, 2.6 mmol, 0.94 eq.) in anhydrous THF 
(10 mL) was added dropwise and the solution was allowed to stir at 0 °C for 30 minutes 
(precipitation of a solid). The reaction was quenched by the addition of water. The phases were 
separated and the aqueous layer was extracted twice with Et2O. 
The combined organic layers were dried with brine and MgSO4 and the solvents were removed 
under reduced pressure. Purification by silica gel chromatography yielded pure (E)-bromo-enone 
414 (450 mg, 1.19 mmol, 46%) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 6.59 (d, J = 8.5Hz, 1H); 5.14 (ddd, J = 16.0; 4.9, 0.9Hz, 1H); 4.81 (m, 
1H); 4.73 (m, 1H); 4.28 (dq, J = 7.1, 2.2Hz, 2H); 2.24 (m, 2H); 1.77 (s, 3H); 1.35 (t, J = 7.1Hz, 3H); 
0.87 (s, 9H); 0.03 (s, 3H); 0.01 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C16H29BrO3Si: 376.1069; found: 376.1058 
 
(S)-3-bromo-5-(2-methylallyl)furan-2(5H)-one (283) 
 
(E)-Bromo-enone 414 (450 mg, 1.19 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (12 mL) and 
pTsOH (11.34 mg, 59.6 µmol, 0.05 eq.) was added. The reaction mixture was heated to reflux for 
two hours before it was allowed to cool to r.t. and sat. aq. NaHCO3 and Et2O was added. The 
phases were separated and the organic phase was dried with brine and MgSO4. All solvents were 
removed in vacuo and purification by silica gel chromatography (hexane/EtOAc = 4/1) yielded pure 
bromo-butenolide 283 (227 mg, 1.05 mmol, 88%) as colorless oil. 
 
1H-NMR (400 MHz, CDCl3):  = 7.53 (d, J = 1.8Hz, 1H); 5.10 (ddd, J = 7.0, 7.0, 1.8Hz, 1H); 4.96 (m, 
1H); 4.84 (bs, 1H); 2.51 (m, 1H); 2.39 (m, 1H); 1.81 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C8H9BrO2: 215.9786; found: 215.9779 
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Methyl-5-((E)-3-((S)-4-bromo-5-oxo-2,5-dihydrofuran-2-yl)-2-methylprop-1-en-1-yl)-2-
((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (282) 
 
Bromo-butenolide 283 (67 mg, 0.31 mmol, 4 eq.) and vinylfuran 200 (52 mg, 75 µmol, 1.0 eq.) 
were dissolved in anhydrous, degassed (5 pump and freeze cycles) toluene (3 mL). The solution 
was heated to reflux overnight and a solution of Grubbs 2nd generation catalyst (17.5 mg, 20 µmol, 
0.2 eq.) in anhydrous, degassed toluene (2 mL) was added slowly via a syringe pump within 
10hours. After that period of time, the solvent was removed under reduced pressure. Purification 
by silica gel chromatography (hexane/EtOAc = 5/1 to 4/1) yielded pure compound 282 (14 mg, 
16 µmol, 21%) as colorless semi-solid.  
1H-NMR (400 MHz, CDCl3):  = 7.53 (d, J = 1.8Hz, 1H); 7.34 (m, 4H); 7.20 (m, 8H); 6.75 (m, 2H); 6.47 
(s, 1H); 6.08 (s, 1H); 5.11 (ddd, J = 6.9, 6.9, 1.8Hz, 1H); 4.64 (m, 1H); 3.90 (m, 1H); 3.77 (s, 3H); 3.70 
(s, 3H); 3.05 (m, 3H); 2.63 (m, 1H); 2.48 (m, 2H); 2.31 (m, 1H); 2.07 (s, 3H); 1.89 (m, 2H); 1.02 (s, 
21H) 
13C-NMR (100 MHz, CDCl3):  = 164.0; 163.2; 158.3; 152.1; 150.0; 145.0; 144.9; 136.2; 130.9; 130.2; 
128.4; 127.6; 126.6; 126.5; 117.8; 113.8; 112.8; 110.0; 85.9; 81.3; 66.8; 61.5; 55.1; 51.2; 44.4; 44.3; 
36.3; 33.5; 29.2; 19.2; 18.0; 12.2; 12.1 
HRMS (ESI) (m/z): [M]+ calcd. for C49H59BrO8Si: 882.3163; found: 882.3158 
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Methyl-5-((E)-3-((S)-4-bromo-5-oxo-2,5-dihydrofuran-2-yl)-2-methylprop-1-en-1-yl)-2-
((1S,2R,3S)-2-(2-hydroxyethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate 
(415) 
 
Compound 282 (14 mg, 15.8 µmol, 1.0 eq.) was dissolved in 1 mL of a 4/1 mixture CH2Cl2/MeOH. 
PPTS (0.4 mg, 1.6 µmol, 0.1 eq.) was added and the reaction mixture was allowed to stir at r.t. until 
TLC analysis indicated full consumption of the starting material (approx. one hour). The reaction 
mixture was quenched with saturated aqueous NaHCO3. The phases were separated and the 
aqueous layer was extracted two times with CH2Cl2. The combined organic layers were dried with 
MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 2/1) yielded free alcohol 415 as colorless viscous oil (7.5 mg, 
12.3 µmol, 78%). 
1H-NMR (600 MHz, CDCl3):  = 7.55 (d, J = 1.7Hz, 1H); 6.48 (s, 1H); 6.11 (s, 1H); 5.15 (ddd, J = 6.7, 
6.7, 1.8Hz, 1H); 4.75 (m, 1H); 3.93 (m, 1H); 3.81 (s, 3H); 3.72 (m, 2H); 2.79 (m, 1H); 2.60 (m, 2H); 
2.44 (m, 1H); 2.23 (m, 2H); 2.10 (s, 3H); 1.91 (m, 2H); 1.07 (m, 21H) 
13C-NMR (150 MHz, CDCl3):  = 164.4; 163.4; 153.4; 152.0; 150.2; 131.1; 117.7; 113.7; 110.0; 105.2; 
81.2; 66.6; 61.1; 55.1; 51.5; 46.2; 44.3; 35.7; 32.3; 31.7; 19.7; 19.2; 18.0; 17.9; 12.1 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C29H43BrO7SiNa: 633.1859; found: 633.1857 
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4.2.8 Furan-12,13 Approach (cBu) 
 
Methyl-5-((S,5E)-6-bromo-4-((tert-butyldimethylsilyl)oxy)-7-ethoxy-2-methyl-7-oxohepta-
1,5-dien-1-yl)-2-((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutyl)furan-3-carboxylate (289) 
 
Primary alcohol 278 (266 mg, 0.3 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (3 mL) and IBX 
(249 mg, 0.89 mmol, 3 eq.) was added. The reaction mixtures was refluxed for two hours or until 
all starting material was consumed. Now 3 mL of hexane were added and the suspension was 
filtered through a pad of celite 545 coarse. Removal of the solvents gave the aldehyde (260 mg, 
0.29 mmol, 98%) as colorless oil.  
A suspension of NaH (60% in mineral oil, 260 mg, 0.32 mmol, 1.1 eq.) in anhydrous THF (1 mL) was 
cooled to 0 °C and a solution of ethyl 2-bromo-2-(diphenoxyphosphoryl)acetate (139 mg, 
0.35 mmol, 1.2 eq.) in anhydrous THF (1 mL) was added dropwise. Upon completion of the 
addition the reaction mixture was stirred for 30 minutes. A solution of the previously prepared 
aldehyde (260 mg, 0.29 mmol, 1.0 eq.) in anhydrous THF (1 mL) was added dropwise and the 
solution was allowed to stir at 0 °C for 30 minutes (precipitation of a solid). The reaction was 
quenched by the addition of water. The phases were separated and the aqueous layer was 
extracted twice with Et2O. The combined organic layers were dried with brine and MgSO4 and the 
solvents were removed under reduced pressure. Purification by silica gel chromatography 
(hexane/EtOAc = 5/1) yielded pure (E)-bromo-enone 289 (80 mg, 76.6 µmol, 26%) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 7.42 (m, 1H); 7.34 (m, 3H); 7.21 (m, 8H); 6.76 (d, J = 8.7Hz, 2H); 6.67 
(d, J = 8.5Hz, 1H); 6.50 (s, 1H); 6.06 (s, 1H); 5.27 (m, 1H); 4.60 (m, 1H); 4.26 (m, 2H); 3.94 (m, 1H); 
3.78 (s, 3H); 3.69 (s, 3H); 3.04 (m, 2H); 2.75 (m, 1H); 2.49 (m, 2H); 2.31 (m, 2H); 2.09 (m, 1H); 1.95 
(s, 3H); 1.90 (m, 1H); 1.32 (m, 3H); 1.03 (s, 21H); 0.79 (s, 9H); 0.00 (s, 3H); -0.04 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C57H79BrO9Si2: 1042.4446; found: 1042.4438 
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Methyl-5-((S,5E)-6-bromo-4-((tert-butyldimethylsilyl)oxy)-7-ethoxy-2-methyl-7-oxohepta-
1,5-dien-1-yl)-2-((1S,2R,3S)-2-(2-oxoethyl)-3-((triisopropylsilyl)oxy)cyclobutyl)furan-3-
carboxylate (290) 
 
Bromo-enone 289 (80 mg, 76.6 µmol, 1.0 eq.) was dissolved in 1 mL of a 4/1 mixture 
CH2Cl2/MeOH. PPTS (1.5 mg, 7.7 µmol, 0.1 eq.) was added and the reaction mixture was allowed 
to stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. one 
day). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were 
separated and the aqueous layer was extracted two times with CH2Cl2. The combined organic 
layers were dried with MgSO4 and the solvent was removed under reduced pressure. Purification 
by silica gel chromatography (hexane/EtOAc = 4/1 to 3/1) yielded the free primary alcohol as 
colorless viscous oil (58 mg, 75.1 µmol, 98%). 
The previously prepared primary alcohol (58 mg, 75 µmol, 1.0 eq.) was dissolved in anhydrous 
EtOAc (2 mL) and IBX (42 mg, 0.15 mmol, 2 eq.) was added. The reaction mixtures was refluxed for 
two hours or until all starting material was consumed. Now 2 mL of hexane were added and the 
suspension was filtered through a pad of celite 545 coarse. Removal of the solvents and 
purification by silica gel chromatography (hexane/EtOAc = 5/1) gave aldehyde 290 (44 mg, 
57.1 µmol, 76%.) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 9.78 (t, J = 1.5Hz, 1H); 6.67 (d, J = 8.6Hz, 1H); 6.54 (s, 1H); 6.08 (s, 
1H); 5.27 (ddd, J = 8.4, 8.4, 4.5Hz, 1H); 4.69 (m, 1H); 4.27 (m, 2H); 4.03 (m, 1H); 3.79 (s, 3H); 3.19 
(ddd, J = 7.1, 7.1, 7.1Hz, 1H); 2.97 (m, 2H); 2.66 (m, 2H); 2.34 (m, 2H); 1.95 (s, 3H); 1.33 (m, 3H); 
1.05 (s, 21H); 0.80 (s, 9H); -0.01 (s, 3H); -0.04 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C57H61BrO9Si2: 768.3088; found: 768.3074 
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4.2.9 12,13 Approach (cBu) 
 
(S)-tert-butyl((1-((4-methoxyphenyl)diphenylmethoxy)pent-4-en-2-yl)oxy)dimethylsilane 
(416) 
 
CuI (381 mg, 2 mmol, 0.2 eq.) was suspended in a flame dried three neck round bottom flask in 
anhydrous THF (30 mL) and the suspension was cooled to -78 °C. 21 mL of a 1M solution of 
vinylmagnesium bromide (21.0 mmol, 2.1 eq.) in anhydrous THF were added and the suspension 
turned to a yellow solution. The reaction mixture was allowed to stir for 45 minutes at -78 °C until 
30 mL of a solution of MMTr-glycidol 284 (3.46 g, 10 mmol, 1.0 eq.) in anhydrous THF were added 
dropwise. The reaction mixture was allowed to stir at -78 °C for two hours until it was quenched 
with NH4Cl. The biphasic mixture was allowed to warm to r.t. and Et2O and 25% aqueous NH3 were 
added. The phases were separated and the organic layer was repeatedly washed with a 3/1 
mixture of NH4Cl/NH3. The combined aqueous extracts were back-extracted once with Et2O and 
the combined organic layers were dried with MgSO4. The solvent was removed under reduced 
pressure and the crude product was purified by silica gel column chromatography (hexane/EtOAc 
= 4/1) yielding the secondary homo allylic alcohol (3.74 g, 10 mmol, quant.). 
The previously prepared secondary homo allylic alcohol (3.74 g, 10 mmol, 1.0 eq.) was dissolved in 
anhydrous DMF (15 mL) and imidazole (1.5 g, 22.0 mmol, 2.2 eq.) was added in one portion. Under 
Ar-atmosphere, the mixture was cooled to 0 °C and a solution of TBS-Cl (1.58 g, 10.5 mmol, 
1.05 eq.) in anhydrous DMF (5 mL) was slowly added at 0 °C. The reaction mixture was allowed to 
warm to r.t. overnight. 50 mL of hexane/Et2O (1/1) and 10 mL of saturated aqueous NH4Cl were 
added and the phases separated. The organic phase was extracted with water twice. The 
combined aqueous phases were back-extracted twice with a 1/1 mixture of hexane/Et2O and the 
combined organic layers were dried over MgSO4. Evaporation of the solvent yielded silylether 416 
(13.4 g, 50.2 mmol, 85%) as colorless oil, which was purified by silica gel column chromatography 
(hexane/EtOAc = 20/1). 
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1H-NMR (400 MHz, CDCl3):  = 7.46 (m, 4H); 7.34 (m, 2H); 7.28 (m, 4H); 7.21 (m, 2H); 6.82 (m, 2H); 
5.74 (ddt, J = 7.2, 7.2, 7.1Hz, 1H); 5.01 (d, J = 17.2Hz, 1H); 4.96 (d, J = 10.3Hz, 1H); 3.80 (m, 1H); 
3.79 (s, 3H); 3.03 (ddd, J = 17.6, 5.9, 5.2Hz, 2H); 2.44 (m, 1H); 2.25 (m, 1H); 0.86 (s, 9H); 0.03 (s, 
3H); -0.01 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C31H40O3Si: 488.2747; found: 488.2741 
 
(S)-4-((tert-butyldimethylsilyl)oxy)-5-((4-methoxyphenyl)diphenylmethoxy)pentan-2-one 
(417) 
 
Olefin 146 (100 mg, 0.2 mmol, 1.0 eq.) was dissolved in DMF (1.5 mL) and THF (125 µL) and water 
(125 µL) were added. The final ratio of the three solvents was 6/1/1. Cu(I)Cl (8.1 mg, 0.08 mmol, 
0.4 eq.) and PdCl2 (7.26 mg, 0.02 mmol, 0.2 eq.) were added. Oxygen (O2) was bubbled through 
the solution for three hours at r.t. Et2O and sat. aq. NaHCO3 were added and the phases were 
separated. The organic phase was washed once with water, before it was dried with brine and 
MgSO4. The solvents were removed in vacuo and silica gel chromatography (hexane/EtOAc = 5/1) 
yielded pure methyl ketone 417 (100 mg, 0.2 mmol, 99%) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 7.43 (m, 4H); 7.29 (m, 6H); 7.22 (m, 2H); 6.83 (m, 2H); 4.28 (m, 1H); 
3.80 (s, 3H); 3.10 (m, 1H); 2.97 (m, 1H); 2.77 (m, 1H); 2.61 (m, 1H); 2.13 (s, 3H); 0.81 (s, 9H); -0.01 
(s, 3H); -0.07 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C31H40O4Si: 504.2696; found: 504.2691 
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(6S)-6-((tert-butyldimethylsilyl)oxy)-1-((4-methoxybenzyl)oxy)-7-((4-
methoxyphenyl)diphenylmethoxy)-4-methylhept-2-yn-4-yl benzoate (418) 
 
PMB ether 222a (3.13 g, 17.8 mmol, 1.3 eq.) was dissolved in anhydrous THF (100 mL) and the 
solution was cooled to -78 °C. After dropwise addition of LiHMDS (1M, 16.4 mL, 16.4 mmol, 
1.2 eq.) the reaction mixture was allowed to stir for one hour. A solution of methyl ketone 417 
(6.9 g, 13.7 mmol, 1.0eq) in anhydrous THF (40 mL) was added dropwise. The reaction mixture was 
allowed to stir at -78 °C for two hours until it was quenched by the addition of sat. aq. NH4Cl. After 
the addition of Et2O the phases were separated and the pH of the aqueous phase adjusted to 5. 
The aqueous phase was extracted twice with Et2O and the combined organic layers were dried 
with MgSO4. Removal of the solvent under reduced pressure yielded the tertiary alcohol, which 
was used without further purification.  
The previously prepared tertiary alcohol (136 mg, 0.2 mmol, 1.0 eq.) was dissolved in anhydrous 
THF (2 mL) and NEt3 (84 µL, 0.6 mmol, 3 eq.) and benzoic acid anhydride (104 mg, 0.4 mmol, 2 eq.) 
were added at r.t. The reaction mixture was cooled to 0 °C and MgBr2
.OEt2 (91 mg, 0.4 mmol, 
2 eq.) was added. The solution was allowed to warm to r.t. within 30 minutes. Water and Et2O 
were added and the phases were separated. The organic phase was washed with water and the 
combined aqueous phases were back-extracted with Et2O. The combined organic layers were dried 
with MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 5/1) yielded tertiary benzoate 418 (157 mg, 0.2 mmol, quant.) 
as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 8.01 (m, 2H); 7.55 (m, 1H); 7.45 (m, 4H); 7.40 (m, 2H); 7.26 (m, 
10H); 6.84 (m, 2H); 6.78 (d, J = 8.9Hz, 2H); 4.54 (s, 2H); 4.26 (m, 1H); 4.12 (s, 2H); 3.78 (s, 3H); 3.77 
(s, 3H); 3.19 (m, 1H); 3.16 (d, J = 5.8Hz, 1H); 2.64 (m, 1H); 2.25 (dd, J = 14.7, 6.6Hz, 1H); 1.83 (s, 
3H); 0.83 (s, 9H); 0.01 (s, 3H); -0.06 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 164.5; 159.3; 158.4; 144.6; 135.9; 132.9; 131.0; 130.3; 129.9; 129.6; 
129.2; 128.5; 128.2; 127.9; 127.8; 127.7; 127.1; 126.7; 113.8; 113.2; 113.0; 87.2; 86.3; 82.4; 81.7; 
75.0; 74.4; 70.8; 69.7; 69.0; 67.8; 56.8; 55.2; 46.1; 28.0; 27.5; 25.9; 18.0; -4.2; -4.4 
HRMS (ESI) (m/z): [M]+ calcd. for C49H56O7Si: 784.3795; found: 784.3782  
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(6S)-6-((tert-butyldimethylsilyl)oxy)-7-hydroxy-1-((4-methoxybenzyl)oxy)-4-methylhept-2-
yn-4-yl benzoate (419) 
 
Tertiary benzoate 418 (157 mg, 0.2 mmol, 1.0 eq.) was dissolved in 2 mL of a 4/1 mixture 
CH2Cl2/MeOH. PPTS (10 mg, 40 µmol, 0.2 eq.) was added and the reaction mixture was allowed to 
stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. one hour). 
The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were separated 
and the aqueous layer was extracted two times with Et2O. The combined organic layers were dried 
with MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 4/1) yielded free alcohol 419 as colorless viscous oil (64 mg, 
0.12 mmol, 62%). 
1H-NMR (400 MHz, CDCl3):  = 8.01 (m, 2H); 7.56 (m, 1H); 7.44 (m, 2H); 7.28 (d, J = 8.8Hz, 2H); 6.85 
(d, J = 8.8Hz, 2H); 4.54 (s, 2H); 4.18 (s, 2H); 4.17 (m, 1H); 3.79 (s, 3H and m, 1H); 3.68 (m, 1H); 2.43 
(m, 1H); 2.31 (m, 1H); 1.89 (s, 3H); 1.62 (bs, 1H); 0.91 (s, 9H); 0.12 (s, 6H) 
13C-NMR (100 MHz, CDCl3):  = 164.7; 159.4; 132.9; 130.8; 129.9; 129.8; 129.6; 129.4; 128.3; 113.8; 
86.6; 82.3; 73.9; 71.1; 69.7; 66.6; 64.4; 56.9; 55.3; 45.2; 27.8; 25.8; 18.0; -4.4; -4.5 
HRMS (ESI) (m/z): [M]+ calcd. for C29H40O6Si: 512.2594; found: 512.2586 
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(6S,E)-8-bromo-6-((tert-butyldimethylsilyl)oxy)-9-ethoxy-1-((4-methoxybenzyl)oxy)-4-
methyl-9-oxonon-7-en-2-yn-4-yl benzoate (297) 
 
Oxalyl chloride (20 µL, 0.23 mmol, 2 eq.) was dissolved in anhydrous CH2Cl2 (1 mL) and the solution 
was cooled to -78 °C. A solution of anhydrous DMSO (33 µL, 0.47 mmol, 4 eq.) in anhydrous CH2Cl2 
(200 µL) was added dropwise. The reaction mixture was allowed to stir at -78 °C for 45 minutes. A 
solution of alcohol 419 (60 mg, 0.12 mmol, 1.0 eq.) in anhydrous CH2Cl2 (1 mL) was added 
dropwise. The reaction mixture was allowed to stir for 90 minutes, before NEt3 (98 µL, 0.7 mmol, 
6 eq.) was added and the solution was allowed to warm to -20 °C within one hour. Sat. aq. NH4Cl 
was added and the phases were separated. The aqueous layer was extracted twice with CH2Cl2 and 
the combined organic layers were dried with brine and MgSO4. The solvent was removed under 
reduced pressure and the aldehyde (60 mg, 0.12 mmol, quant.) was used without further 
purification. 
A suspension of NaH (60% in mineral oil, 7 mg, 0.18 mmol, 1.5 eq.) in anhydrous THF (500 µL) was 
cooled to 0 °C and a solution of ethyl 2-bromo-2-(diphenoxyphosphoryl)acetate (84 mg, 
0.18 mmol, 1.5 eq.) in anhydrous THF (500 µL) was added dropwise. Upon completion of the 
addition the reaction mixture was stirred for 30 minutes. A solution of the previously prepared 
aldehyde (60 mg, 0.12 mmol, 1.0 eq.) in anhydrous THF (500 µL) was added dropwise and the 
solution was allowed to stir at 0 °C for 30 minutes (precipitation of a solid). The reaction was 
quenched by the addition of water. The phases were separated and the aqueous layer was 
extracted twice with Et2O. The combined organic layers were dried with brine and MgSO4 and the 
solvents were removed under reduced pressure. Purification by silica gel chromatography 
(hexane/EtOAc = 5/1) yielded pure (E)-bromo-enone 297 (79 mg, 0.12 mmol, quant.) as colorless 
oil.  
1H-NMR (400 MHz, CDCl3):  = 8.02 (m, 2H); 7.55 (m, 1H); 7.43 (m, 2H); 7.29 (m, 2H); 6.85 (d, J = 
8.6Hz, 2H); 6.65 (d, J = 8.8Hz, 1H); 5.51 (m, 1H); 4.56 (s, 2H); 4.21 (s, 2H); 4.18 (q, J = 7.2Hz, 2H); 
3.79 (s, 3H); 2.38 (m, 2H); 1.92 (s, 3H); 1.25 (t, J = 7.2Hz, 3H); 0.86 (s, 9H); 0.06 (s, 3H); 0.02 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C33H43BrO7Si: 658.1961; found: 658.1954 
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1-((S)-4-bromo-5-oxo-2,5-dihydrofuran-2-yl)-5-hydroxy-2-methylpent-3-yn-2-yl benzoate 
(420) 
 
(E)-bromo-enone 297 (3.76 g, 5.7 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (60 mL) and 
pTsOH (217 mg, 1.14mol, 0.2 eq.) was added. The reaction mixture was heated to reflux for four 
hours before it was allowed to cool to r.t. and sat. aq. NaHCO3 and Et2O was added. The phases 
were separated and the organic phase was dried with brine and MgSO4. All solvents were removed 
in vacuo and purification by silica gel chromatography (hexane/EtOAc = 2/1) yielded pure bromo-
butenolide 420 (2.05 g, 5.4mol, 95%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 8.00 (m, 2H); 7.65 (d, J = 1.8Hz, 1H); 7.59 (m, 1H); 7.46 (m, 2H); 5.42 
(dt, J = 7.4, 3.8Hz, 1H); 4.35 (s, 2H); 2.62 (dd, J = 14.3, 5.6Hz, 1H); 2.49 (m, 1H); 2.30 (dd, J = 14.3, 
7.5Hz, 1H); 1.91 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 167.9; 164.6; 152.9; 133.4; 130.1; 129.7; 129.5; 128.6; 113.2; 86.5; 
83.5; 79.9; 73.5; 50.9; 44.3; 27.6 
HRMS (ESI) (m/z): [M]+ calcd. for C17H15BrO5: 378.0103; found: 378.0097 
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1-((S)-4-bromo-5-oxo-2,5-dihydrofuran-2-yl)-5-iodo-2-methylpent-3-yn-2-yl benzoate 
(298) 
 
Imidazole (350 mg, 5.14 mmol, 3 eq.), PPh3 (899 mg, 3.43 mmol, 2 eq.) and iodine (870 mg, 
3.43 mmol, 2 eq.) were added to 15 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension was 
stirred at 0 °C for 20 minutes while it turned yellow. To this suspension a solution of propargylic 
alcohol 420 (650 mg, 1.71 mmol, 1.0 eq.) in anhydrous CH2Cl2 (5 mL) was added rapidly. The 
reaction mixture was stirred for one hour. Then it was quenched by the addition of hexane 
(20 mL). The precipitating triphenylphosphineoxide was filtered through a pad of celite and a sat. 
aq. solution of Na2S2O3 and NaHCO3 was added to the filtrate. The phases were separated and the 
organic phase was washed with Na2S2O3, NaHCO3 and brine before it was dried with MgSO4. After 
removal of the solvent under reduced pressure, purification by silica gel chromatography yielded 
propargylic iodide 298 (836 g, 1.71 mmol, quant.) as slightly yellow liquid.  
1H-NMR (400 MHz, CDCl3):  = 8.01 (m, 2H); 7.65 (d, J = 1.8Hz, 1H); 7.58 (m, 1H); 7.46 (m, 2H); 5.42 
(dt, J = 7.4, 3.8Hz, 1H); 3.71 (s, 2H); 2.62 (dd, J = 14.3, 5.6Hz, 1H); 2.48 (m, 1H); 2.31 (dd, J = 14.2, 
7.4Hz, 1H); 1.91 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C17H14BrIO4: 487.9120; found: 487.9115 
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1-((S)-4-bromo-5-oxo-2,5-dihydrofuran-2-yl)-7-methoxy-6-((1S,2R,3S)-2-(2-((4-
methoxyphenyl)diphenylmethoxy)ethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)-2-
methyl-7-oxohept-3-yn-2-yl benzoate (293) 
 
NaH (60% in mineral oil, 68 mg, 1.71 mmol, 1.0 eq.) was suspended in anhydrous THF (5 mL). The 
reaction mixture was cooled to 0 °C and a solution of -keto ester 195 (1.1 g, 1.71 mmol, 1.0 eq.) 
in anhydrous THF (5 mL) was added. 
The reaction was stirred at 0 °C for 20 minutes and then warmed to r.t. within 10 minutes. Then it 
was re-cooled to 0 °C and a solution of propargylic iodide 298 (836 mg, 1.71 mmol, 1.0 eq.) was 
added uninterruptedly at 0 °C. The reaction mixture was stirred at this temperature for 20 minutes 
and then warmed to r.t. within 20 minutes before it was quenched with saturated aqueous NH4Cl. 
Et2O was added and the phases separated. The pH of the aqueous phase was adjusted to 6 with 
0.5M KHSO4 and it was extracted twice with Et2O. The combined organic layers were dried with 
MgSO4 and the solvent was removed under reduced pressure. Silica gel column chromatography 
(hexane/EtOAc = 4/1) yielded alkylated -keto ester 293 as slightly yellow oil (1.7 g, 1.7 mmol, 
99%). 
1H-NMR (400 MHz, CDCl3):  = 7.98 (m, 2H); 7.57 (m, 2H); 7.41 (m, 7H); 7.26 (m, 5H); 7.19 (m, 2H); 
6.80 (m, 2H); 5.30 (m, 1H); 4.41 (m, 1H); 4.22 (m, 1H); 3.77 (s, 3H); 3.57 (m, 3H); 3.13 (m, 3H); 2.97 
(m, 1H); 2.78 (m, 2H); 2.64 (m, 1H); 2.47 (m, 2H); 2.26 (m, 2H); 2.12 (m, 1H); 1.80 (m, 3H); 0.97 (m, 
21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C56H65BrO10Si: 1004.3530; found: 1004.3525 
 
  
174 
 
1-((S)-4-bromo-5-oxo-2,5-dihydrofuran-2-yl)-6-((1S,2R,3S)-2-(2-hydroxyethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarbonyl)-7-methoxy-2-methyl-7-oxohept-3-yn-2-yl 
benzoate (421) 
 
Alkylated -keto ester 293 (1.7 g, 1.7 mmol, 1.0 eq.) was dissolved in a mixture of anhydrous 
CH2Cl2 (15 mL) and anhydrous MeOH (1.5 mL). The solution was cooled to 0 °C and CSA (42 mg, 
0.17 mmol, 0.1 eq.) was added. The reaction mixture was allowed to stir for two hours before it 
was quenched by the addition of sat. aq. NaHCO3. Phases were separated and the organic phase 
was dried with brine and MgSO4. After removal of the solvent, purification by silica gel 
chromatography (hexane/EtOAc = 2/1) yielded pure primary alcohol 421 (600 mg, 0.82 mmol, 
48%) as colorless viscous oil. 
1H-NMR (400 MHz, CDCl3):  = 8.03 (m, 1H); 7.94 (m, 1H); 7.66 (d, J = 1.8Hz, 1H); 7.59 (m, 1H); 7.46 
(m, 2H); 5.38 (m, 1H); 4.45 (m, 1H); 3.85 (m, 1H); 3.71 (m, 3H); 3.68 (m, 2H); 3.25 (m, 1H); 2.80 (m, 
3H); 2.53 (m, 1H); 2.45 (m, 1H); 2.38 (m, 1H); 2.28 (dd, J = 13.6, 7.5Hz, 1H); 2.14 (m, 1H); 1.96 (m, 
1H); 1.85 (s, 3H); 1.80 (m, 1H); 1.03 (m, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C36H49BrO9Si: 732.2329; found: 732.2322 
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1-((S)-4-bromo-5-oxo-2,5-dihydrofuran-2-yl)-7-methoxy-2-methyl-7-oxo-6-((1S,2R,3S)-2-
(2-oxoethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)hept-3-yn-2-yl benzoate (299) 
 
Primary alcohol 421 (100 mg, 0.14 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (2 mL) and IBX 
(76 mg, 0.27 mmol, 2 eq.) was added. The reaction mixtures was refluxed for two hours or until all 
starting material was consumed. Now 2 mL of hexane were added and the suspension was filtered 
through a pad of celite 545 coarse. Removal of the solvents and purification by silica gel 
chromatography (hexane/EtOAc = 3/1 to 2/1) gave aldehyde 299 (41 mg, 56 µmol, 41%) as 
colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 9.76 (m, 1H); 8.02 (m, 1H); 7.93 (m, 1H); 7.69 (d, J = 1.8Hz, 1H); 7.67 
(m, 1H); 7.44 (m, 2H); 5.38 (m, 1H); 4.50 (m, 1H); 3.91 (m, 1H); 3.69 (s, 3H); 3.14 (m, 2H); 2.81 (m, 
2H); 2.66 (m, 1H); 2.52 (m, 2H); 2.32 (m, 2H); 2.12 (m, 1H); 1.84 (m, 3H); 1.01 (s, 21H) 
13C-NMR (100 MHz, CDCl3):  = 203.9; 201.4; 168.5; 164.5; 164.2; 153.3; 133.3; 130.3; 129.6; 129.5; 
129.4; 128.5; 125.5; 112.8; 85.0; 84.8; 80.1; 79.6; 73.6; 73.1; 65.4; 56.3; 55.6; 52.7; 45.0; 44.6; 
42.8; 39.1; 33.8; 30.3; 27.6; 22.2; 17.9; 12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C36H47BrO9Si: 730.2173; found: 730.2168 
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(6S,E)-8-bromo-6-((tert-butyldimethylsilyl)oxy)-9-ethoxy-1-hydroxy-4-methyl-9-oxonon-7-
en-2-yn-4-yl benzoate (422) 
 
To a solution of benzoate 297 (2.8 g, 4.2 mmol, 1.0 eq.) in CH2Cl2 (20 mL) were added 4 mL of a 
pH=7-buffer (50mM KH2PO4). The vigorously stirred suspension was cooled to 0 °C and DDQ 
(1.06 g, 4.7 mmol, 1.1 eq.) was added portionwise. The suspension was allowed to stir overnight 
while it warmed to r.t. After addition of sat. aq. NaHCO3, the phases were separated and the 
organic phase was washed 6 times with H2O. The organic phase was dried with brine and MgSO4, 
and removal of the solvent in vacuo gave crude propargylic alcohol. Purification by silica gel 
chromatography (hexane/EtOAc = 3/1 to 2/1) gave alcohol 422 in quantitative yield (2.29 g, 
4.2 mmol, quant.). 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C25H35BrO6SiNa: 561.1284; found: 561.1278 
 
(6S,E)-8-bromo-6-((tert-butyldimethylsilyl)oxy)-9-ethoxy-1-iodo-4-methyl-9-oxonon-7-en-
2-yn-4-yl benzoate (300) 
 
Imidazole (468 mg, 6.87 mmol, 3 eq.), PPh3 (1.2 g, 4.58 mmol, 2 eq.) and iodine (1.16 g, 4.58 mmol, 
2 eq.) were added to 30 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension was stirred at 
0 °C for 20 minutes while it turned yellow. To this suspension a solution of propargylic benzoate 
422 (2.29 g, 4.2 mmol, 1.0 eq.) in anhydrous CH2Cl2 (10 mL) was added rapidly. The reaction 
mixture was stirred for one hour. Then it was quenched by the addition of hexane (60 mL). The 
precipitating triphenylphosphineoxide was filtered through a pad of celite and a sat. aq. solution of 
Na2S2O3 and NaHCO3 was added to the filtrate. The phases were separated and the organic phase 
was washed with Na2S2O3, NaHCO3 and brine before it was dried with MgSO4. 
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After removal of the solvent under reduced pressure, purification by silica gel chromatography 
(hexane/EtOAc = 4/1) yielded propargylic iodide 300 (2.45 g, 3.77 mmol, 82%) as slightly yellow 
liquid.  
HRMS (ESI) (m/z): [M]+ calcd. for C25H34BrIO5Si: 648.0404; found: 648.0400 
 
(4S,E)-1-ethyl 11-methyl 6-(benzoyloxy)-2-bromo-4-((tert-butyldimethylsilyl)oxy)-10-
((1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarbonyl)-6-methylundec-2-en-7-ynedioate (295) 
 
NaH (60% in mineral oil, 151 mg, 3.77 mmol, 1.0 eq.) was suspended in anhydrous THF (20 mL). 
The reaction mixture was cooled to 0 °C and a solution of -keto ester 195 (2.43 g, 3.77 mmol, 
1.0 eq.) in anhydrous THF (10 mL) was added. The reaction was stirred at 0 °C for 20 minutes and 
then warmed to r.t. within 10 minutes. Then it was re-cooled to 0 °C and a solution of propargylic 
iodide 300 (2.45 g, 3.77 mmol, 1.0 eq.) in anhydrous THF (10 mL) was added uninterruptedly at 
0 °C. The reaction mixture was stirred at this temperature for 20 minutes and then warmed to r.t. 
within 20 minutes before it was quenched with saturated aqueous NH4Cl. Et2O was added and the 
phases separated. The pH of the aqueous phase was adjusted to 6 with 0.5M KHSO4 and it was 
extracted twice with Et2O. The combined organic layers were dried with MgSO4 and the solvent 
was removed under reduced pressure. Silica gel column chromatography (hexane/EtOAc = 4/1) 
yielded alkylated -keto ester 295 as slightly yellow oil (3.78 g, 3.24 mmol, 86%). 
1H-NMR (400 MHz, CDCl3):  = 7.97 (m, 2H); 7.51 (m, 1H); 7.40 (m, 6H); 7.24 (m, 6H); 7.19 (m, 2H); 
6.80 (m, 2H); 6.60 (m, 1H); 5.42 (m, 1H); 4.38 (m, 1H); 4.22 (m, 1H); 4.12 (m, 1H); 3.78 (s, 3H); 3.53 
(m, 3H); 3.10 (m, 3H); 2.92 (m, 1H); 2.77 (m, 1H); 2.64 (m, 1H); 2.44 (m, 1H); 2.30 (m, 2H); 2.10 (m, 
2H); 1.78 (m, 3H); 1.28 (m, 3H); 1.21 (m, 2H); 0.96 (s, 21H); 0.85 (s, 9H); 0.02 (m, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C64H85BrO11Si2: 1164.4814; found: 1164.4808 
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(4S,E)-1-ethyl 11-methyl 6-(benzoyloxy)-2-bromo-4-((tert-butyldimethylsilyl)oxy)-10-
((1S,2R,3S)-2-(2-hydroxyethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)-6-
methylundec-2-en-7-ynedioate (423) 
 
Alkylated -keto ester 295 (250 mg, 0.21 mmol, 1.0 eq.) was dissolved in 10 mL of a 4/1 mixture 
CH2Cl2/MeOH. PPTS (2.7 mg, 0.01.0 mmol, 0.05 eq.) was added and the reaction mixture was 
allowed to stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. 
three days). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases 
were separated and the aqueous layer was extracted two times with CH2Cl2. The combined organic 
layers were dried with MgSO4 and the solvent was removed under reduced pressure. Purification 
by silica gel chromatography (hexane/EtOAc = 5/1 to 2/1) yielded free primary alcohol 423 as 
colorless viscous oil (100 mg, 0.14 mmol, 67%). 
1H-NMR (400 MHz, CDCl3):  = 7.98 (m, 2H); 7.53 (m, 1H); 7.41 (m, 2H); 6.60 (m, 1H); 5.45 (m, 1H); 
4.44 (m, 1H); 4.22 (m, 1H); 4.11 (m, 1H); 3.90 (m, 1H); 3.72 (m, 2H); 3.69 (m, 3H); 3.27 (m, 1H); 
2.88 (m, 2H); 2.76 (m, 2H); 2.56 (m, 2H); 2.29 (m, 2H); 2.13 (m, 1H); 1.96 (m, 1H); 1.81 (s, 3H); 1.25 
(m, 3H);  1.02 (s, 21H); 0.85 (s, 9H); 0.03 (m, 6H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C44H69BrO10Si2Na: 915.3510; found: 915.3502 
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(4S,E)-1-ethyl 11-methyl 6-(benzoyloxy)-2-bromo-4-((tert-butyldimethylsilyl)oxy)-6-
methyl-10-((1S,2R,3S)-2-(2-oxoethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)undec-
2-en-7-ynedioate (301) 
 
Primary alcohol 423 (100 mg, 0.14 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (2 mL) and IBX 
(96 mg, 0.34 mmol, 2.5 eq.) was added. The reaction mixtures was refluxed for two hours or until 
all starting material was consumed. Now 2 mL of hexane were added and the suspension was 
filtered through a pad of celite 545 coarse. Removal of the solvents gave aldehyde 301 (100 mg, 
0.14 mmol, quant.) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 7.98 (m, 2H); 7.53 (m, 1H); 7.41 (m, 2H); 6.60 (m, 1H); 5.45 (m, 1H); 
4.44 (m, 1H); 4.22 (m, 1H); 4.11 (m, 1H); 3.90 (m, 1H); 3.72 (m, 2H); 3.69 (m, 3H); 3.27 (m, 1H); 
2.88 (m, 2H); 2.76 (m, 2H); 2.56 (m, 2H); 2.29 (m, 2H); 2.13 (m, 1H); 1.96 (m, 1H); 1.81 (s, 3H); 1.25 
(m, 3H);  1.02 (s, 21H); 0.85 (s, 9H); 0.03 (m, 6H) 
13C-NMR (100 MHz, CDCl3):  = 204.1; 201.4; 168.6; 164.4; 162.3; 149.9; 132.8; 130.9; 129.7; 129.6; 
128.2; 125.5; 111.2; 82.9; 82.6; 81.9; 74.4; 73.8; 67.9; 67.1; 65.3; 62.4; 56.2; 55.8; 52.6; 47.7; 47.6; 
45.2; 44.9; 42.8; 39.0; 38.8; 33.7; 33.5; 30.3; 29.7; 27.9; 25.7; 18.0; 17.9; 14.0; 11.9; -4.5; -4.8 
HRMS (ESI) (m/z): [M]+ calcd. for C44H67BrO10Si2: 890.3456; found: 890.3447 
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(6S,E)-2-bromo-4-((tert-butyldimethylsilyl)oxy)-9-((4-methoxybenzyl)oxy)-6-methylnon-2-
en-7-yne-1,6-diol (424) 
 
Tertiary benzoate 297 (530 mg, 0.9 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (8 mL) and 
the solution was cooled to -78 °C. A solution of DIBAL-H (1.5M in toluene; 2.35 mL, 3.52 mmol, 
4.4 eq.) was added dropwise and the reaction mixture was allowed to stir at -78°c for two hours. 
The reaction was quenched by the addition of sat. aq. K/Na-tartrate and it was allowed to warm to 
r.t. under vigorous stirring. The phases were separated and the aqueous phase was extracted 
twice with CH2Cl2. The combined organic layers were dried with brine and MgSO4 and the solvent 
was removed under reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 
3/1) yielded pure primary allylic alcohol 424 (480 mg, 0.78 mmol, 97%) as colorless oil. 
Major: 
1H-NMR (400 MHz, CDCl3):  = 7.28 (d, J = 8.8Hz, 2H); 6.89 (d, J = 8.8Hz, 2H); 6.18 (d, J = 9.1Hz, 1H); 
4.93 (m, 1H); 4.70 (d, J = 5.6Hz, 2H); 4.52 (s, 2H); 4.27 (m, 1H); 4.18 (s, 2H); 3.81 (s, 3H); 2.01 (m, 
2H); 1.67 (m, 1H); 1.54 (s, 3H); 0.88 (s, 9H); 0.10 (s, 3H); 0.08 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C24H37BrO5SiNa: 535.1491; found: 535.1482 
Minor: 
1H-NMR (400 MHz, CDCl3):  = 7.28 (d, J = 8.8Hz, 2H); 6.89 (d, J = 8.8Hz, 2H); 6.02 (d, J = 9.1Hz, 1H); 
5.19 (m, 1H); 4.70 (d, J = 5.6Hz, 2H); 4.52 (s, 2H); 4.27 (m, 1H); 4.19 (d, J = 1.3Hz, 2H); 3.81 (s, 3H); 
2.01 (m, 2H); 1.67 (m, 1H); 1.49 (s, 3H); 0.90 (s, 9H); 0.17 (s, 3H); 0.11 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C24H37BrO5SiNa: 535.1491; found: 535.1485 
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(6S,E)-8-bromo-6,9-bis((tert-butyldimethylsilyl)oxy)-1-((4-methoxybenzyl)oxy)-4-
methylnon-7-en-2-yn-4-yl benzoate (303) 
 
Primary alcohol 424 (480 mg, 0.78 mmol, 1.0 eq.) was dissolved in anhydrous DMF (5 mL) and 
imidazole (132 mg, 1.94 mmol, 2.5 eq.) was added in one portion. Under Ar-atmosphere, the 
mixture was cooled to 0 °C and a solution ofs TBS-Cl (129 mg, 0.85 mmol, 1.1 eq.) in anhydrous 
DMF (3 mL) was slowly added at 0 °C. The reaction mixture was allowed to warm to r.t. and stirring 
was continued for two hours. 10 mL of hexane/Et2O (1/1) and 10 mL of saturated aqueous NH4Cl 
were added and the phases separated. The organic phase was extracted with water twice. 
The combined aqueous phases were twice back-extracted with a 1/1 mixture of hexane/Et2O and 
the combined organic layers were dried over MgSO4. Evaporation of the solvent yielded the 
desired silylether (557 mg, 0.76 mmol, 89%) as colorless oil. 
The previously prepared tertiary alcohol (780 mg, 1.06 mmol, 1.0 eq.) was dissolved in anhydrous 
THF (10 mL) and NEt3 (446 µL, 3.2 mmol, 3 eq.) and benzoic acid anhydride (482 mg, 2.13 mmol, 
2 eq.) were added at r.t. The reaction mixture was cooled to 0 °C and MgBr2
.OEt2 (551 mg, 
2.13 mmol, 2 eq.) was added portionwise. The solution was allowed to warm to r.t. within 30 
minutes. Water and Et2O were added and the phases were separated. The organic phase was 
washed with water and the combined aqueous phases were back-extracted with Et2O. The 
combined organic layers were dried with MgSO4 and the solvent was removed under reduced 
pressure. Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded tertiary benzoate 
303 (645 mg, 0.88 mmol, 83%) as colorless oil. 
Major: 
1H-NMR (400 MHz, CDCl3):  = 8.02 (m, 2H); 7.56 (m, 1H); 7.44 (m, 2H); 7.28 (d, J = 8.7Hz, 2H); 6.85 
(d, J = 8.7Hz, 2H); 6.05 (d, J = 9.1Hz, 1H); 4.93 (ddd, J = 9.1, 6.2, 6.2Hz, 1H); 4.55 (s, 2H); 4.19 (s, 
2H); 4.04 (m, 2H); 3.80 (s, 3H); 2.38 (m, 2H); 1.89 (s, 3H); 0.88 (s, 9H); 0.85 (s, 9H); 0.09 (s, 3H); 0.07 
(s, 3H); 0.02 (s, 3H); 0.00 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C37H55BrO6Si2: 730.2721; found: 730.2711 
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Minor:  
1H-NMR (400 MHz, CDCl3):  = 8.02 (m, 2H); 7.56 (m, 1H); 7.44 (m, 2H); 7.28 (d, J = 8.7Hz, 2H); 6.85 
(d, J = 8.7Hz, 2H); 6.00 (d, J = 9.2Hz, 1H); 4.80 (m, 1H); 4.54 (s, 2H); 4.19 (s, 2H); 4.04 (m, 2H); 3.80 
(s, 3H); 2.23 (m, 2H); 1.88 (s, 3H); 0.86 (s, 9H); 0.83 (s, 9H); 0.10 (s, 3H); 0.04 (s, 3H); 0.03 (s, 3H); -
0.04 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C37H55BrO6Si2: 730.2721; found: 730.2713 
 
(6S,E)-8-bromo-6,9-bis((tert-butyldimethylsilyl)oxy)-1-hydroxy-4-methylnon-7-en-2-yn-4-yl 
benzoate (425) 
 
To a solution of benzoate 303 (640 mg, 0.87 mmol, 1.0 eq.) in CH2Cl2 (4 mL) were added 2 mL of a 
pH=7-buffer (50mM KH2PO4). The vigorously stirred suspension was cooled to 0 °C and DDQ 
(298 mg, 1.31 mmol, 1.5 eq.) was added portionwise. The suspension was allowed to stir for 2 days 
while it warmed to r.t. After addition of sat. aq. NaHCO3, the phases were separated and the 
organic phase was washed 6 times with H2O. The organic phase was dried with brine and MgSO4, 
and removal of the solvent in vacuo gave crude propargylic alcohol. Purification by silica gel 
chromatography (hexane/EtOAc = 3/1) gave alcohol 425 in quantitative yield (530 mg, 0.87 mmol, 
quant.). 
Major: 
1H-NMR (400 MHz, CDCl3):  = 8.01 (m, 2H); 7.55 (m, 1H); 7.42 (m, 2H); 6.05 (d, J = 9.0Hz, 1H); 4.92 
(m, 1H); 4.19 (bs, 2H); 4.04 (m, 2H); 2.38 (m, 2H); 1.89 (s, 3H); 0.88 (s, 9H); 0.85 (s, 9H); 0.09 (s, 
3H); 0.07 (s, 3H); 0.02 (s, 3H); 0.00 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C29H47BrO5Si2Na: 633.2043; found: 633.2037 
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(6S,E)-8-bromo-6,9-bis((tert-butyldimethylsilyl)oxy)-1-iodo-4-methylnon-7-en-2-yn-4-yl 
benzoate (304) 
 
Imidazole (179 mg, 2.62 mmol, 3 eq.), PPh3 (459 mg, 1.75 mmol, 2 eq.) and iodine (444 mg, 
1.75 mmol, 2 eq.) were added to 6 mL anhydrous CH2Cl2 and cooled to 0 °C. The suspension was 
stirred at 0 °C for 20 minutes while it turned yellow. To this suspension a solution of propargylic 
benzoate 425 (530 mg, 0.87 mmol, 1.0 eq.) in anhydrous CH2Cl2 (3 mL) was added rapidly. The 
reaction mixture was stirred for one hour. Then it was quenched by the addition of 60 mL hexane. 
The precipitating triphenylphosphineoxide was filtered through a pad of celite and a sat. aq. 
solution of Na2S2O3 and NaHCO3 was added to the filtrate. The phases were separated and the 
organic phase was washed with Na2S2O3, NaHCO3 and brine before it was dried with MgSO4. After 
removal of the solvent under reduced pressure, purification by silica gel chromatography 
(hexane/EtOAc = 5/1) yielded propargylic iodide 304 (628 mg, 0.87 mmol, quant.) as slightly yellow 
liquid.  
HRMS (ESI) (m/z): [M]+ calcd. for C29H46BrIO4Si2: 720.1163; found: 720.1158 
 
(4S,E)-2-bromo-1,4-bis((tert-butyldimethylsilyl)oxy)-11-methoxy-10-((1S,2R,3S)-2-(2-((4-
methoxyphenyl)diphenylmethoxy)ethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)-6-
methyl-11-oxoundec-2-en-7-yn-6-yl benzoate (294) 
 
NaH (60% in mineral oil, 34.8 mg, 0.87 mmol, 1.0 eq.) was suspended in anhydrous THF (3 mL). The 
reaction mixture was cooled to 0 °C and a solution of -keto ester 195 (561 mg, 0.87 mmol, 
1.0 eq.) in anhydrous THF (3 mL) was added. The reaction was stirred at 0 °C for 20 minutes and 
then warmed to r.t. within 10 minutes.  
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Then it was re-cooled to 0 °C and a solution of propargylic iodide 304 (628 mg, 0.87 mmol, 1.0 eq.) 
was added uninterruptedly at 0 °C. The reaction mixture was stirred at this temperature for 20 
minutes and then warmed to r.t. within 20 minutes before it was quenched with saturated 
aqueous NH4Cl. Et2O was added and the phases separated. The pH of the aqueous phase was 
adjusted to 6 with 0.5M KHSO4 and it was extracted twice with Et2O. The combined organic layers 
were dried with MgSO4 and the solvent was removed under reduced pressure. Silica gel column 
chromatography (hexane/EtOAc = 5/1 to 3/1) yielded alkylated -keto ester 294 as slightly yellow 
oil (740 mg, 0.6 mmol, 69%). 
1H-NMR (400 MHz, CDCl3):  = 7.96 (m, 2H); 7.52 (m, 1H); 7.40 (m, 6H); 7.26 (m, 6H); 7.19 (m, 2H); 
6.80 (m, 2H); 6.00 (m, 1H); 4.83 (m, 1H); 4.53 (m, 1H); 4.39 (m, 1H); 4.03 (m, 1H); 3.78 (s, 3H); 3.54 
(m, 4H); 3.13 (m, 3H); 2.81 (m, 2H); 2.65 (m, 1H); 2.44 (m, 1H); 2.27 (m, 1H); 2.13 (m, 3H); 1.75 (m, 
4H); 0.97 (s, 21H); 0.88 (m, 18H); 0.05 (m, 12H) 
13C-NMR (100 MHz, CDCl3):  = 204.1; 168.6; 164.3; 158.4; 144.8; 137.3; 136.0; 132.8; 130.8; 130.3; 
129.6; 128.4; 128.3; 127.7; 126.7; 125.7; 113.0; 86.1; 82.7; 74.5; 67.4; 66.7; 65.5; 63.2; 61.7; 55.1; 
52.4; 48.9; 46.0; 42.1; 33.8; 29.1; 27.9; 25.8; 17.9; 12.0; -4.2; -4.8 
HRMS (ESI) (m/z): [M]+ calcd. for C68H97BrO10Si3: 1236.5573; found: 1236.5568 
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(4S,E)-2-bromo-1,4-bis((tert-butyldimethylsilyl)oxy)-10-((1S,2R,3S)-2-(2-hydroxyethyl)-3-
((trisopropylsilyl)oxy)cyclobutanecarbonyl)-11-methoxy-6-methyl-11-oxoundec-2-en-7-yn-
6-yl benzoate (426) 
 
Vinyl bromide 294 (160 mg, 0.13 mmol, 1.0 eq.) was dissolved in 6.6 mL of a 10/1 mixture 
CH2Cl2/MeOH. PPTS (3.3 mg, 13 µmol, 0.1 eq.) was added and the reaction mixture was allowed to 
stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. two hours). 
The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were separated 
and the aqueous layer was extracted two times with Et2O. The combined organic layers were dried 
with MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 4/1) yielded free primary alcohol 426 as colorless viscous oil 
(90 mg, 93 µmol, 72%). 
1H-NMR (400 MHz, CDCl3):  = 7.97 (m, 2H); 7.54 (m, 1H); 7.42 (m, 2H); 6.03 (m, 1H); 4.86 (m, 1H); 
4.46 (m, 2H); 4.07 (m, 1H); 3.87 (m, 1H); 3.72 (m, 3H); 3.69 (m, 3H); 3.28 (m, 1H); 2.87 (m, 1H); 
2.77 (m, 2H); 2.52 (m, 2H); 2.27 (m, 1H); 2.16 (m, 2H); 2.02 (m, 1H); 1.78 (m, 3H); 1.04 (m, 21H); 
0.87 (m, 18H); 0.05 (m, 12H) 
13C-NMR (100 MHz, CDCl3):  = 204.1; 168.5; 164.3; 137.6; 133.0; 129.7; 129.6; 128.4; 125.6; 115.9; 
86.1; 82.6; 67.4; 66.0; 60.7; 55.7; 52.7; 49.3; 46.0; 42.4; 33.4; 31.3; 25.8; 17.9; 12.0; -4.2; -5.4 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C48H81BrO9Si3Na: 987.4269; found: 987.4262 
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(4S,E)-2-bromo-1,4-bis((tert-butyldimethylsilyl)oxy)-11-methoxy-6-methyl-11-oxo-10-
((1S,2R,3S)-2-(2-oxoethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarbonyl)undec-2-en-7-yn-
6-yl benzoate (305) 
 
Primary alcohol 426 (80 mg, 83 µmol, 1.0 eq.) was dissolved in anhydrous DMSO (2 mL) and IBX 
(35 mg, 124 µmol, 1.5 eq.) was added. The reaction mixtures was stirred at r.t. for two hours or 
until all starting material was consumed. Now 2 mL of hexane and 2 mL of EtOAc were added and 
the suspension was filtered through a pad of celite 545 coarse. The filtrate was transferred to a 
separatory funnel and water was added. The phases were separated and the organic phase was 
washed twice with fresh water. The combined aqueous layers were back-extracted twice with 
EtOAc. The combined organic layers were dried with brine and MgSO4 and the solvents were 
removed in vacuo. Aldehyde 305 (80 mg, 83 µmol, quant.) was obtained as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 9.79 (m, 1H); 7.97 (m, 2H); 7.54 (m, 1H); 7.42 (m, 2H); 6.02 (dd, J = 
9.1, 5.2Hz, 1H); 4.86 (m, 1H); 4.51 (m, 2H); 4.06 (m, 1H); 3.89 (m, 1H); 3.70 (m, 3H); 3.20 (m, 2H); 
2.83 (m, 3H); 2.66 (m, 1H); 2.53 (m, 1H); 2.28 (m, 1H); 2.14 (m, 2H); 1.78 (m, 3H); 1.02 (s, 21H); 
0.87 (m, 18H); 0.05 (m, 12H) 
HRMS (ESI) (m/z): [M]+ calcd. for C48H79BrO9Si3: 962.4215; found: 962.4212 
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4.2.10 Northern Lactone-Butenolide Approach (cBu) 
 
7-methoxy-2-methyl-7-oxohept-2-en-5-yn-4-yl cyclobutanecarboxylate (309) 
 
Methyl propiolate (1.9 mL, 22 mmol, 1.1 eq.) was dissolved in anhydrous THF (70 mL) and the 
reaction mixture was cooled to -78 °C. LiHMDS (1M in THF, 22 mL, 22 mmol, 1.1 eq.) was added 
dropwise and the solution was allowed to stir for 30 minutes. A solution of 3-methylbut-2-enal 
(1.68 g, 20 mmol, 1.0 eq.) in anhydrous THF (10 mL) was added dropwise. The reaction mixture 
was allowed to stir for 30 minutes until it was quenched by the addition of sat. aq. NH4Cl. The 
phases were separated and the aqueous phase was carefully acidified and extracted twice with 
Et2O. The combined organic phases were dried with MgSO4 and the solvents were removed under 
reduced pressure. The resulting allylic alcohol 308 (3.44 g, 20 mmol, quant.) was of satisfying 
purity for further conversion.  
Allylic alcohol 308 (3.44 g, 20 mmol, 1.0 eq.), cyclobutane carboxylic acid (2.08 mL, 22 mmol, 
1.1 eq.) and DMAP (489 mg, 4 mmol, 0.2 eq.) were dissolved in anhydrous CH2Cl2 (80 mL) in an Ar-
atmosphere. DIC (3.4 mL, 22 mmol, 1.1 eq.) was added to the reaction mixture and the solution 
was allowed to stir at r.t. overnight. The reaction mixture was quenched by the addition of sat. aq. 
NaHCO3 and the phases were separated. The organic phase was extracted two more times with 
NaHCO3 and the combined organic layers were dried with brine and MgSO4. The solvent was 
removed under reduced pressure and the crude reaction mixture was purified by silica gel 
chromatography (hexane/EtOAc = 5/1) yielding pure ester 309 (4.6 g, 18.4 mmol, 92%) as colorless 
oil. 
1H-NMR (250 MHz, CDCl3):  = 6.13 (d, J = 8.9Hz, 1H); 5.30 (m, 1H); 3.77 (s, 3H); 3.15 (m, 1H); 2.24 
(m, 4H); 1.96 (m, 2H); 1.77 (s, 3H); 1.76 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C14H18O4: 250.1205; found: 250.1194 
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Methyl-2-cyclobutyl-5-(2-methylprop-1-en-1-yl)furan-3-carboxylate (310) 
 
A solution of propargylic ester 309 (100 mg, 0.4 mmol, 1.0 eq.) in EtOAc (5 mL) was degassed with 
Ar for 3 minutes prior to use. Tri-nbutyl phosphine (120 µL, 0.48 µL, 1.2 eq.) was added to the 
solution of substrate. The reaction vessel was sealed, heated to 110 °C, and allowed to stir for two 
hours. The reaction mixture was removed in vacuo onto silica gel and subjected to purification by 
flash chromatography (hexane/EtOAc = 1/0 – 50/1 – 20/1 – 10/1) to yield furan 310 (58 mg, 
0.25 mmol, 62%). 
1H-NMR (250 MHz, CDCl3):  = 6.36 (s, 1H); 6.02 (bs, 1H); 4.21 (m, 1H); 3.79 (s, 3H); 2.32 (m, 6H); 
2.00 (s, 3H); 1.91 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C14H18O3: 234.1256; found: 234.1250 
 
(E)-3-(tributylstannyl)but-2-en-1-ol (427) 
 
The preparation of 427 was performed according to Betzer et al.[111] Hexabutylditin (Bu6Sn2; 37.6 g, 
65 mmol, 7.6 eq.) was dissolved in anhydrous THF (50 mL) and the solution was cooled to -78 °C 
before n-BuLi (2.5M in hexane; 26 mL, 65 mmol, 7.6 eq.) was added dropwise. The reaction 
mixture was allowed to stir at -40 °C for 30  and then transferred via a cannula to a -78 °C pre 
cooled suspension of dry CuCN (2.9 g, 32.4 mmol, 3.8 eq.) in anhydrous THF (50 mL). The 
suspension was stirred at -40 °C until it turned yellow (approx. 30 min). 21 mL of anhydrous MeOH 
were added and the reaction mixture was stirred at -10 °C for 30 minutes when it turned red. The 
reaction mixture was re-cooled to -78 °C and a solution of but-2-yn-1-ol (600 mg, 8.5 mmol, 
1.0 eq.) in anhydrous THF (21 mL) was added dropwise. The solution was allowed to warm to -
10 °C and stirred at this temperature overnight. 21 mL of anhydrous MeOH were added at -20 °C 
and the reaction mixture was stirred for another 15 minutes before 21 mL of H2O were added.  
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After 15 minutes Et2O was added and the phases were separated. The organic phase was extracted 
twice with NH4Cl and the combined aqueous phases were back-extracted once with Et2O. The 
combined organic layers were dried with brine and MgSO4 and the solvent was removed under 
reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 7/1) yielded vinyl-
stannane 427 (2.92 g, 8.1 mmol, 95%) as colorless liquid. 
1H-NMR (250 MHz, CDCl3):  = 5.75 (m, 1H); 4.26 (dd, J = 5.6, 5.6Hz, 2H); 1.89 (t, J = 22.1Hz, 3H); 
1.48 (m, 6H); 1.31 (m, 8H); 0.89 (t, J = 7.1Hz, 14H) 
HRMS (ESI) (m/z): [M]+ calcd. for C16H34OSn: 362.1632; found: 362.1621 
 
(E)-3-iodobut-2-en-1-ol (315) 
 
Iodine (786 mg, 2.77 mmol, 2 eq.) and Na2CO3 (294 mg, 2.77 mmol. 2 eq.) were suspended in 
anhydrous CH2Cl2 (6 mL) and cooled to 0 °C. A solution of vinyl-stannane 427 (2.92 g, 8.1 mmol, 
1.0 eq.) in anhydrous CH2Cl2 (4 mL) was added dropwise over a period of 20 minutes. After stirring 
for one hour the reaction was quenched by the addition of sat. aq. Na2S2O3 solution. The phases 
were separated and the aqueous layer was extracted three times with Et2O. The combined organic 
layers were dried with MgSO4 and the solvent was removed in vacuo. Silica gel chromatography 
(hexane/EtOAc = 1/0 to 4/1) yielded pure vinyliodide 315 (250 mg, 1.27 mmol, 92%) as colorless 
oil.  
1H-NMR (250 MHz, CDCl3):  = 6.40 (m, 1H); 4.09 (d, J = 6.2, 6.2Hz, 2H); 2.45 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C4H7IO: 197.9542; found: 197.9537 
 
  
190 
 
(E)-tert-butyl((3-iodobut-2-en-1-yl)oxy)dimethylsilane (428) 
 
Vinyl iodide 315 (2.5 g, 12.6 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (100 mL). Pyridine 
(5.11 mL, 63 mmol, 5 eq.) and DMAP (154 mg, 1.3 mmol, 0.1 eq.) were added to the solution and it 
was cooled to 0 °C. A solution of TBS-Cl (2.28 g, 15.1 mmol, 1.2 eq.) in anhydrous CH2Cl2 (20 mL) 
was added. The reaction mixture was allowed to stir at 0 °C for one hour, and then it was 
quenched by the addition of sat. aq. NH4Cl. The phases were separated and the organic layer was 
washed with NH4Cl. The organic layer was dried with brine and MgSO4. Purification by silica gel 
chromatography (hexane/EtOAc = 10/1) yielded pure silyl ether 428 (3.7 g, 11.8 mmol, 94%) as 
colorless liquid.  
1H-NMR (250MHz, CDCl3):  = 6.30 (t, J = 6.5Hz, 1H); 4.12 (d, J = 6.5Hz, 1H); 2.41 (s, 3H); 0.89 (s, 
9H); 0.07 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H21IOSi: 312.0406; found: 312.0394 
 
(S,E)-tert-butyldimethyl((3-methyl-4-(oxiran-2-yl)but-2-en-1-yl)oxy)silane (314) 
 
TBS-protected vinyl iodide 428 (312 mg, 1.0 mmol, 1.0 eq.) was dissolved in anhydrous Et2O (5 mL) 
and the solution was cooled to -78 °C. t-BuLi (1.6M in pentane; 1.3 mL, 2.1 mmol, 2.1 eq.) was 
added dropwise. After completion of the addition stirring was continued for 30 minutes. Freshly 
prepared 2-thienyl-Cu(CN)Li (0.5M in THF; 2 mL, 1.0 mmol, 1.0 eq.) was added via cannula to the 
reaction mixture.[112] The solution turned yellow and stirring was continued for one hour at -78 °C. 
A solution of tosylated (R)-glycidol 393 (274 mg, 1.2 mmol, 1.2 eq.) in 3 mL anhydrous Et2O was 
added dropwise. Stirring was continued at -78 °C for two hours and then at r.t. for one hour (the 
solution turned dark). The reaction mixture was quenched by the addition of a 3/1 mixture of sat. 
aq. NH4Cl/25% aq. NH4OH. The phases were separated and the organic layer was extracted twice 
with NH4Cl before it was dried with brine and MgSO4. Removal of the solvent under reduced 
pressure and purification by silica gel chromatography (hexane/EtOAc = 10/1) yielded pure 
epoxide 314 (120 mg, 0.5 mmol, 50%) as colorless oil.  
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1H-NMR (400MHz, CDCl3):  = 5.44 (ddd, J = 6.3, 6.3, 1.3Hz, 1H); 4.22 (dd, J = 6.3, 1.0Hz, 2H); 3.00 
(m, 1H); 2.77 (m, 1H); 2.49 (dd, J = 2.3, 2.3Hz, 1H); 2.22 (m, 1H); 1.71 (s, 3H); 0.91 (s, 9H); 0.08 (s, 
6H) 
13C-NMR (100MHz, CDCl3):  = 133.1; 126.9; 60.1; 51.2; 46.8; 42.4; 26.0; 18.4; 17.0; -5.1 
HRMS (ESI) (m/z): [M]+ calcd. for C13H26O2Si: 242.1702; found: 242.1698 
 
(5S)-5-((E)-4-((tert-butyldimethylsilyl)oxy)-2-methylbut-2-en-1-yl)-3-
(phenylselanyl)dihydrofuran-2(3H)-one (313) 
 
DIPA (220 µL, 1.58 mmol, 3.15 eq.) was mixed with anhydrous THF (5 mL) and the mixture was 
cooled to -10 °C when n-BuLi (2.5M in hexane; 600 µL, 1.5 mmol, 3 eq.) was added. The mixture 
was allowed to stir at -10 °C for 30 minutes. Then, a solution of phenylselanyl acetic acid (397, 
269 mg, 1.25 mmol, 2.5 eq.) in anhydrous THF (5 mL) was added. The reaction mixture was stirred 
at -10 °C for 20 min, then the cooling bath was removed and it was allowed to stir at r.t for 90 
minutes (formation of dianion, precipitating). The suspension of the dianion was cooled to -78 °C 
and a solution of epoxide 314 (120 mg, 0.5 mmol, 1.0 eq.) was added dropwise to the dianion. The 
reaction mixture was allowed to warm to r.t. slowly overnight. The reaction was quenched by the 
addition of NH4Cl and water. Et2O was added and the phases were separated. The aqueous phase 
was extracted twice with Et2O and the combined organic layers were dried with MgSO4. The 
solvent was removed under reduced pressure. The crude product was of sufficient purity for 
further conversion. 
The crude product was dissolved in anhydrous CH2Cl2 (50 mL) and DMAP (6.1 mg, 0.05 mmol, 
0.1 eq.) was added. The reaction was cooled to 0 °C and DIC (85.2 µL, 0.55 mmol, 1.1 eq.) was 
added. The reaction mixture was stirred at 0 °C for 90 minutes. The solvent was removed under 
reduced pressure und the crude product was purified using silica gel chromatography 
(hexane/EtOAc = 7/1). Selenolactone 313 was obtained as orange oil (195 mg, 0.45 mmol, 89%) as 
an inconsequential mixture of diastereo isomers.  
  
192 
 
1H-NMR (400MHz, CDCl3):  = 7.66 (m, 2H); 7.34 (m, 3H); 5.30 (dd, J = 6.2, 1.1Hz, 1H); 4.52 (m, 1H); 
4.15 (d, J = 6.1Hz, 2H); 4.00 (dd, J = 9.6, 9.6Hz, 1H); 2.70 (m, 1H); 2.33 (m, 1H); 2.09 (m, 1H); 1.97 
(m, 1H); 1.60 (s, 3H); 0.90 (s, 9H); 0.06 (s, 6H) 
13C-NMR (100MHz, CDCl3):  = 175.6; 135.7; 131.2; 129.4; 128.9; 128.7; 127.0; 77.6; 59.9; 45.1; 
37.3; 36.9; 35.5; 26.0; 18.4; 16.8; -5.1 
HRMS (ESI) (m/z): [M]+ calcd. for C21H32O3SeSi: 440.1286; found: 440.1272 
 
(1S,2R,3S)-2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylic acid (318) 
 
Aldehyde 194 (2 g, 3.5 mmol, 1.0 eq.) was dissolved in t-BuOH (22 mL) and 3.5 mL of 2-methyl-but-
2-ene was added. The reaction mixture was cooled to 0 °C and an aqueous solution (13 mL) of 
NaClO2 (4.74 g, 52.4 mmol, 15 eq.) and NaH2PO4.H2O (4.74 g, 34.4 mmol, 9.8 eq.) was added at 
once. The reaction mixture was stirred at 0 °C for one hour and Et2O and water were added. The 
phases were separated and the organic layer was washed twice with water before it was dried 
with MgSO4. Removal of the solvent under reduced pressure yielded pure carboxylic acid 318 (2 g, 
3.5 mmol, quant.) as colorless oil.  
1H-NMR (250MHz, CDCl3):  = 7.44 (m, 4H); 7.27 (m, 8H); 6.84 (d, J = 8.8Hz, 2H); 5.25 (bs, 1H); 4.54 
(m, 1H); 3.80 (s, 3H); 3.78 (m, 1H); 2.97 (m, 1H); 2.82 (m, 1H); 2.59 (m, 1H); 2.20 (m, 1H); 1.92 (m, 
2H); 1.29 (m, 1H); 1.05 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C36H48O5Si: 588.3271; found: 588.3264 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-hydroxyethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (429a) 
 
Carboxylic acid 318 (225 mg, 0.38 mmol, 1.0 eq.) and PMB-OH (106 mg, 0.76 mmol, 2 eq.) were 
dissolved in anhydrous CH2Cl2 (600 mL) and DMAP (4.6 mg, 38 µmol, 0.1 eq.) was added. The 
reaction was cooled to 0 °C and DIC (89 µL, 0.57 mmol, 1.5 eq.) was added. The reaction mixture 
was stirred at 0 °C for 90 minutes. The solvent was removed under reduced pressure und the 
crude product was purified using silica gel chromatography (hexane/EtOAc = 7/1). The PMB-ester 
was obtained as slightly yellow oil (264 mg, 0.37 mmol, 98%). 
The previously prepared PMB-ester (264 mg, 0.37 mmol, 1.0 eq.) was dissolved in 5 mL of a 4/1 
mixture CH2Cl2/MeOH. PPTS (9.3 mg, 37 µmol, 0.1 eq.) was added and the reaction mixture was 
allowed to stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. 
one hour). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were 
separated and the aqueous layer was extracted two times with Et2O. The combined organic layers 
were dried with MgSO4 and the solvent was removed under reduced pressure. Purification by silica 
gel chromatography (hexane/EtOAc = 4/1) yielded free alcohol 429a as colorless viscous oil 
(153 mg, 0.35 mmol, 95%). 
1H-NMR (250MHz, CDCl3):  = 7.28 (d, J = 8.5Hz, 2H); 6.89 (d, J = 8.5Hz, 2H); 5.06 (s, 2H); 4.54 (m, 
1H); 3.81 (s, 3H); 3.67 (m, 2H); 2.91 (m, 1H); 2.79 (m, 1H); 2.48 (m, 1H); 2.18 (m, 1H); 1.87 (m, 3H); 
1.03 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C24H40O5Si: 436.2645; found: 436.2629 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-oxoethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (319a) 
 
Primary alcohol 429a (153 mg, 0.35 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (4 mL) and 
IBX (196 mg, 0.70 mmol, 2 eq.) was added. The reaction mixtures was refluxed for two hours or 
until all starting material was consumed. Now hexane (4 mL) was added and the suspension was 
filtered through a pad of celite 545 coarse. Removal of the solvents gave aldehyde 319a (g, 
0.35 mmol, quant.) as colorless oil.  
1H-NMR (250MHz, CDCl3):  = 9.80 (t, J = 1.8Hz, 1H); 7.28 (d, J = 8.5Hz, 2H); 6.89 (d, J = 8.5Hz, 2H); 
5.06 (s, 2H); 4.54 (m, 1H); 3.81 (s, 3H); 2.89 (m, 1H); 2.59 (m, 1H); 2.50 (m, 1H); 2.32 (m, 2H); 2.25 
(m, 1H); 1.04 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C24H38O5Si: 434.2489; found: 434.2489 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-acetoxy-2-((5S)-5-((E)-4-((tert-butyldimethylsilyl)oxy)-2-
methylbut-2-en-1-yl)-2-oxo-3-(phenylselanyl)tetrahydrofuran-3-yl)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (430) 
 
DIPA (21.7 µL, 0.16 mmol, 1.3 eq.) was dissolved in anhydrous THF (1 mL) and the mixture was 
cooled to -10 °C when n-BuLi (1.6M in hexane; 90 µL, 0.14 mmol, 1.2 eq.) was added. The mixture 
was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
selenolactone 313 (106 mg, 0.24 mmol, 2 eq.) in anhydrous THF (1 mL) was added dropwise. Upon 
completion, the reaction mixture was allowed to stir for 30 minutes. A solution of aldehyde 319a 
(52.2 mg, 0.12 mmol, 1.0 eq.) in anhydrous THF (1 mL) was added and the reaction mixture was 
stirred for one hour. The reaction was quenched by the addition of sat. aq. NH4Cl. After addition of 
Et2O, phases were separated and the aqueous phase was neutralized by the addition of 0.5M 
KHSO4. The aqueous layer was extracted twice with Et2O and the combined organic phases were 
dried with MgSO4. Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded the aldol 
product as colorless viscous oil (81.8 mg, 94 µmol, 78%). 
The aldol product (81 mg, 94 µmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (2 mL) and DIPEA 
(15 µL, 0.1 mmol, 1.1eq) and DMAP (1.1 mg, 9,4 µmol, 0.1 eq.) were added. The reaction mixture 
was cooled to 0 °C and Ac2O (9.3 µL, 99 µmol, 1.05 eq.) was added. The solution was allowed to 
stir at 0 °C for 45 min, and then it was quenched by the addition of sat. aq. NH4Cl. Phases were 
separated and the aqueous phase was extracted twice with CH2Cl2. The combined organic layers 
were dried with MgSO4 and the solvent was removed under reduced pressure. Purification by silica 
gel chromatography yielded acetate 430 (83 mg, 91 µmol, 96%).  
1H-NMR (250MHz, CDCl3):  = 7.71 (m, 2H); 7.29 (m, 4H); 6.88 (d, J = 8.6Hz, 2H); 5.31 (m, 2H); 5.01 
(m, 2H); 4.55 (m, 1H); 4.18 (d, J = 6.2Hz, 2H); 3.81 (s, 3H); 2.79 (m, 1H); 2.58 (m, 2H); 2.41 (m, 3H); 
2.18 (m, 3H); 1.94 (m, 2H); 1.90 (s, 3H); 1.67 (m, 1H); 1.62 (s, 3H); 1.05 (s, 21H); 0.91 (s, 9H); 0.08 
(s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C47H72O9SeSi2: 916.3880; found: 916.3869 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-acetoxy-2-((5S)-5-((E)-4-hydroxy-2-methylbut-2-en-1-yl)-
2-oxo-3-(phenylselanyl)tetrahydrofuran-3-yl)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (431) 
 
Compound 430 (83 mg, 90 µmol, 1.0 eq.) was dissolved in anhydrous THF (1 mL) and the reaction 
mixture was cooled to 0 °C. 7% HF in pyridine (53 µL, 0.18 mmol, 2 eq.) was added dropwise and 
the reaction mixture was allowed to stir for 15 minutes. The reaction was quenched by the careful 
addition of sat. aq. NaHCO3. The phases were separated and the organic layer was extracted twice 
with NaHCO3. The combined organic layers were back-extracted twice with CH2Cl2 and the 
combined organic layers were dried with brine and MgSO4. After removal of the solvent under 
reduced pressure silica gel chromatography (hexane/EtOAc = 4/1) yielded pure allylic alcohol 431 
(55 mg, 68 µmol, 76%) as colorless oil. 
1H-NMR (250MHz, CDCl3):  = 7.67 (m, 2H); 7.34 (m, 4H); 6.88 (d, J = 8.6Hz, 2H); 5.34 (m, 1H); 5.25 
(m, 1H); 5.03 (m, 2H); 4.57 (m, 1H); 4.36 (m, 1H); 4.14 (m, 2H); 3.81 (s, 3H); 2.78 (m, 1H); 2.59 (m, 
2H); 2.41 (m, 3H); 2.18 (m, 3H); 2.00 (m, 2H); 1.94 (s, 3H); 1.67 (m, 1H); 1.68, 1.57 (s, 3H); 1.04 (m, 
21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C41H58O9SeSi: 802.3015; found: 802.3002 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-acetoxy-2-((S)-5-((E)-4-hydroxy-2-methylbut-2-en-1-yl)-2-
oxo-2,5-dihydrofuran-3-yl)ethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarboxylate (432) 
 
Compound 431 (50 mg, 62 µmol, 1.0 eq.) was dissolved in CH2Cl2 (2 mL) and sat. aq. NH4Cl (500 µL) 
was added. The biphasic mixture was cooled to 0 °C and 30% H2O2 (19.2 µL, 0.19 mmol, 3 eq.) was 
added. The reaction was stirred at 0 °C for one hour and then quenched by the addition of sat. aq. 
Na2S2O3. Phases were separated and the organic phase was extracted 4 times with water. The 
organic layer was dried with MgSO4 and the solvent was removed under reduced pressure. After 
silica gel chromatography (hexane/EtOAc = 2/1 to 1/1) butenolide 432 was obtained as colorless 
oil (40 mg, 62 µmol, quant.) as an inseparable mixture of diastereo isomers. 
Major: 
1H-NMR (250MHz, CDCl3):  = 7.28 (d, J = 8.0Hz, 2H); 6.98 (s, 1H); 6.88 (d, J = 8.0Hz, 2H); 5.56 (m, 
2H); 5.02 (m, 2H); 4.55 (m, 1H); 4.14 (m, 2H); 3.80 (s, 3H); 2.79 (m, 2H); 2.28 (m, 6H); 2.00 (s, 3H); 
1.85 (m, 1H); 1.67 (s, 3H); 1.02 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C35H52O9Si: 644.3381; found: 644.3372 
Minor: 
1H-NMR (250MHz, CDCl3):  = 7.28 (d, J = 8.0Hz, 2H); 7.11 (s, 1H); 6.88 (d, J = 8.0Hz, 2H); 5.42 (m, 
2H); 4.93 (m, 2H); 4.55 (m, 1H); 4.14 (m, 2H); 3.80 (s, 3H); 2.79 (m, 2H); 2.28 (m, 6H); 1.98 (s, 3H); 
1.85 (m, 1H); 1.70 (s, 3H); 1.02 (s, 21H) 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-acetoxy-2-((S)-5-((E)-2-methyl-4-oxobut-2-en-1-yl)-2-oxo-
2,5-dihydrofuran-3-yl)ethyl)-3-((triisopropylsilyl)oxy)cyclobutanecarboxylate (433) 
 
Allylic alcohol 432 (40 mg, 62 µmol, 1.0 eq.) was dissolved in anhydrous EtOAc (2 mL) and IBX 
(52 mg, 0.19 mmol, 3 eq.) was added. The reaction mixtures was refluxed for two hours or until all 
starting material was consumed. Now hexane (2 mL) was added and the suspension was filtered 
through a pad of celite 545 coarse. Removal of the solvents gave aldehyde 433 (40 mg, 62 µmol, 
quant.) as colorless oil.  
Major & minor: 
1H-NMR (400MHz, CDCl3):  = 10.0, 9.98 (d, J = 7.6Hz, 1H); 7.30 (d, J = 8.0Hz, 2H); 7.08, 7.01 (s, 1H); 
6.90 (d, J = 8.0Hz, 2H); 5.95, 5.88 (d, J = 7.8Hz, 1H); 5.60 (m, 1H); 4.99 (m, 1H); 4.56 (m, 1H); 3.80 
(s, 3H); 2.92, 2.78 (m, 1H); 2.69 (m, 1H); 2.46 (m, 3H); 2.31 (m, 1H); 2.23, 2.19 (s, 3H); 2.09 (m, 1H); 
1.99 (s, 3H); 1.67 (m, 3H); 1.02 (s, 21H) 
13C-NMR (100MHz, CDCl3):  = 190.5; 175.1; 170.0; 169.8; 169.7; 159.7; 156.1; 156.0; 149.1; 148.8; 
134.2; 133.8; 130.1; 129.9; 129.8; 128.1; 114.0; 113.9; 78.7; 68.0; 67.3; 66.6; 66.4; 66.2; 55.3; 43.6; 
42.1; 41.1; 39.3; 39.1; 34.6; 34.5; 31.1; 30.9; 29.7; 24.7; 20.8; 20.7; 18.1; 17.9; 12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C35H50O9Si: 642.3224; found: 642.3213 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-((S)-5-((E)-4-((tert-butyldimethylsilyl)oxy)-2-methylbut-2-
en-1-yl)-2-oxo-2,5-dihydrofuran-3-yl)-2-hydroxyethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (320a) 
 
DIPA (0.21 mL, 1.60 mmol, 1.3 eq.) was dissolved in anhydrous THF (10 mL) and the mixture was 
cooled to -10 °C when n-BuLi (1.6M in hexane; 0.90 mL, 1.40 mmol, 1.2 eq.) was added. The 
mixture was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
selenolactone 313 (1.06 g, 2.40 mmol, 2 eq.) in anhydrous THF (10 mL) was added dropwise. Upon 
completion, the reaction mixture was allowed to stir for 30 minutes. A solution of aldehyde 319a 
(522 mg, 1.2 mmol, 1.0 eq.) in anhydrous THF (10 mL) was added and the reaction mixture was 
stirred for one hour. The reaction was quenched by the addition of sat. aq. NH4Cl. After addition of 
Et2O, phases were separated and the aqueous phase was neutralized by the addition of 0.5M 
KHSO4. The aqueous layer was extracted twice with Et2O and the combined organic phases were 
dried with MgSO4. The solvent was removed under reduced pressure to yield seleno ether as 
slightly orange oil (860 mg, 0.98 mmol, 82%). 
Previously prepared seleno ether (500 mg, 0.57 mmol, 1.0 eq.) was dissolved in CH2Cl2 (6 mL) and 
sat. aq. NH4Cl (1 mL) was added. The biphasic mixture was cooled to 0 °C and 30% H2O2 (177 µL, 
1.72 mmol, 3 eq.) was added. The reaction was stirred at 0 °C for one hour and then quenched by 
the addition of sat. aq. Na2S2O3. Phases were separated and the organic phase was extracted 4 
times with water. The organic layer was dried with MgSO4 and the solvent was removed under 
reduced pressure. After silica gel chromatography (hexane/EtOAc = 2/1) butenolide 320a was 
obtained as colorless oil (402 mg, 0.56 mmol, 98%) as a separable mixture of diastereo isomers. 
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Major: 
1H-NMR (400MHz, CDCl3):  = 7.29 (d, J = 8.5Hz, 2H); 7.24 (s, 1H); 6.89 (d, J = 8.5Hz, 2H); 5.43 (t, J = 
6.2Hz, 1H); 5.06 (s, 2H); 5.92 (m, 1H); 4.59 (m, 1H); 4.46 (m, 1H); 4.20 (d, J = 6.2Hz, 2H); 3.87 (m, 
1H); 3.81 (s, 3H); 2.90 (m, 2H); 2.50 (m, 1H); 2.36 (m, 2H); 2.21 (m, 2H); 1.92 (m, 1H); 1.70 (s, 3H); 
1.05 (s, 21H); 0.90 (s, 9H); 0.07 (s, 6H) 
13C-NMR (100MHz, CDCl3):  = 175.6; 172.0; 159.7; 148.3; 137.4; 130.9; 130.1; 130.0; 129.1; 127.9; 
114.0; 80.3; 66.8; 66.5; 65.9; 65.7; 60.4; 60.0; 55.3; 43.3; 43.2; 39.2; 38.9; 35.1; 34.2; 26.0; 18.4; 
17.9; 17.8; 17.0; 14.2; 12.1; -5.1 
HRMS (ESI) (m/z): [M]+ calcd. for C39H64O8Si2: 716.4140; found: 716.4134 
 
(1S,2R,3S)-4-methoxybenzyl 2-(2-((S)-5-((E)-4-((tert-butyldimethylsilyl)oxy)-2-methylbut-2-
en-1-yl)-2-oxo-2,5-dihydrofuran-3-yl)-2-(tert-butyldiphenylsilyl)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (433a) 
 
Secondary allylic alcohol 320a (125 mg, 0.17 mmol, 1.0 eq.) was dissolved in anhydrous DMF 
(2 mL) and imidazole (35.5 mg, 0.52 mmol, 3 eq.) was added in one portion. Under Ar-atmosphere, 
the mixture was cooled to 0 °C and TBDPS-Cl (54.2 µL, 0.21 mmol, 1.2 eq.) was slowly added at 
0 °C. The reaction mixture was allowed to warm to r.t. overnight and stirring was continued for 2 
days. 4 mL of hexane/Et2O (1/1) and 4 mL of saturated aqueous NH4Cl were added and the phases 
were separated. The organic phase was extracted with water twice. The combined aqueous phases 
were twice back-extracted with a 1/1 mixture of hexane/Et2O and the combined organic layers 
were dried over MgSO4. Evaporation of the solvent yielded silylether 433a (155 mg, 0.16 mmol, 
93%) as colorless oil, which was purified by silica gel column chromatography (hexane/EtOAc = 
5/1). 
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1H-NMR (400MHz, CDCl3):  = 7.58 (m, 4H); 7.38 (m, 6H); 7.32 (d, J = 8.5Hz, 2H); 7.25 (s, 1H); 6.87 
(d, J = 8.5Hz, 2H); 5.35 (t, J = 6.2Hz, 1H); 5.00 (m, 2H); 4.77 (m, 1H); 4.57 (m, 1H); 4.48 (m, 1H); 4.18 
(d, J = 6.2Hz, 2H); 3.81 (s, 3H); 2.95 (m, 1H); 2.78 (m, 1H); 2.38 (m, 1H); 2.33 (m, 1H); 2.26 (m, 1H); 
2.17 (m, 1H); 2.04 (m, 2H); 1.63 (s, 3H); 1.06 (s, 9H); 1.00 (s, 21H); 0.91 (s, 9H); 0.08 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C55H82O8Si3: 954.5317; found: 954.5302 
 
(1S,2R,3S)-4-methoxybenzyl 2-(2-(tert-butyldiphenylsilyl)-2-((S)-5-((E)-4-hydroxy-2-
methylbut-2-en-1-yl)-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (321a) 
 
Compound 433a (180 mg, 0.19 mmol, 1.0 eq.) was dissolved in anhydrous THF (3 mL) and the 
reaction mixture was cooled to 0 °C. 7%HF in pyridine (96 µL, 0.37 mmol, 2 eq.) was added 
dropwise and the reaction mixture was allowed to stir for 15 minutes. The reaction was quenched 
by the careful addition of sat. aq. NaHCO3. The phases were separated and the organic layer was 
extracted twice with NaHCO3. The combined organic layers were back-extracted twice with CH2Cl2 
and the combined organic layers were dried with brine and MgSO4. After removal of the solvent 
under reduced pressure silica gel chromatography (hexane/EtOAc = 4/1) yielded pure allylic 
alcohol 321a (106 mg, 0.13 mmol, 67%) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 7.58 (m, 4H); 7.38 (m, 6H); 7.25 (d, J = 8.5Hz, 2H); 6.94 (m, 1H); 6.87 
(d, J = 8.5Hz, 2H); 5.41 (m, 1H); 5.03 (m, 2H); 4.83 (m, 1H); 4.62 (m, 1H); 4.52 (m, 2H); 4.16 (m, 2H); 
3.80 (s, 3H); 3.04 (m, 1H); 2.76 (m, 1H); 2.35 (m, 1H); 2.15 (m, 2H); 2.05 (m, 1H); 1.89 (m, 2H); 1.66 
(s, 3H); 1.05 (s, 9H); 0.99 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C49H68O8Si2: 840.4453; found: 840.4447 
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(1S,2R,3S)-4-methoxybenzyl 2-(2-(tert-butyldiphenylsilyl)-2-((S)-5-((E)-2-methyl-4-oxobut-
2-en-1-yl)-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (434a) 
 
Primary alcohol 321a (66 mg, 78 µmol, 1.0 eq.) was dissolved in anhydrous EtOAc (2 mL) and IBX 
(65.9 mg, 0.24 mmol, 3 eq.) was added. The suspension was heated to reflux for three hours. The 
suspension was cooled to r.t. and hexane (2 mL) was added. The suspension was filtered through a 
pad of celite and the solvents were removed under reduced pressure. The crude product was 
purified by silica gel column chromatography (hexane/EtOAc = 5/1). Aldehyde 434a was obtained 
as viscous oil (66 mg, 78 µmol, quant.). 
Major: 
1H-NMR (400MHz, CDCl3):  = 9.97 (d, J = 7.5Hz, 1H); 7.58 (m, 4H); 7.38 (m, 6H); 7.24 (d, J = 8.5Hz, 
2H); 6.87 (d, J = 8.5Hz, 2H); 6.84 (m, 1H); 5.86 (dd, J = 7.8, 1.0Hz, 1H); 5.03 (m, 2H); 4.78 (m, 1H); 
4.53 (m, 2H); 3.80 (s, 3H); 2.99 (m, 1H); 2.72 (m, 1H); 2.40 (m, 1H); 2.29 (m, 2H); 2.15 (d, J = 1.3Hz, 
3H); 2.03 (m, 3H); 1.06 (s, 9H); 0.99 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C49H66O8Si2: 838.4296; found: 838.4287 
Minor: 
1H-NMR (400MHz, CDCl3):  = 9.96 (d, J = 7.5Hz, 1H); 7.58 (m, 4H); 7.38 (m, 6H); 7.24 (d, J = 8.5Hz, 
2H); 6.87 (d, J = 8.5Hz, 2H); 6.84 (m, 1H); 5.80 (dd, J = 7.8, 1.0Hz, 1H); 5.03 (m, 2H); 4.68 (m, 1H); 
4.53 (m, 2H); 3.79 (s, 3H); 2.99 (m, 1H); 2.81 (m, 1H); 2.40 (m, 1H); 2.29 (m, 2H); 2.13 (d, J = 1.3Hz, 
3H); 2.03 (m, 3H); 1.06 (s, 9H); 0.99 (s, 21H) 
 
  
 203 
 
(1S,2R,3S)-4-methoxybenzyl 2-(2-((tert-butyldiphenylsilyl)oxy)-2-((5S)-5-((E)-4-hydroxy-7-
methoxy-2-methyl-7-oxohept-2-en-5-yn-1-yl)-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (312a) 
 
Methyl propiolate (7.2 µL, 80 µmol, 1.5 eq.) was dissolved in anhydrous THF (300 µL) and the 
reaction mixture was cooled to -78 °C. LiHMDS (1M in THF, 80 µL, 80 µmol, 1.5 eq.) was added 
dropwise and the solution was allowed to stir for 30 minutes. A solution of aldehyde 434a (45 mg, 
54 µmol, 1.0 eq.) in anhydrous THF (1 mL) was added dropwise. The reaction mixture was allowed 
to stir for 30 minutes until it was quenched by the addition of sat. aq. NH4Cl. The phases were 
separated and the aqueous phases was carefully acidified and extracted twice with Et2O. The 
combined organic phases were dried with MgSO4 and the solvents were removed under reduced 
pressure. The resulting allylic alcohol 312a (48 mg, 52 µmol, 98%) was of satisfying purity for 
further conversion.  
1H-NMR (400MHz, CDCl3):  = 7.57 (m, 4H); 7.36 (m, 6H); 7.25 (m, 2H); 7.05 (s, 1H); 6.87 (m, 2H); 
5.41 (m, 1H); 5.13 (m, 2H); 4.94 (m, 2H); 4.54 (m, 2H); 3.81 (s, 3H); 3.77 (m, 3H); 3.10 (m, 1H); 2.75 
(m, 1H); 2.35 (m, 2H); 2.18 (m, 1H); 2.03 (m, 2H); 1.77, 1.70 (s, 3H); 1.63 (m, 1H); 1.06 (s, 9H); 0.99 
(s, 21H) 
13C-NMR (100MHz, CDCl3):  = 176.4; 170.8; 159.6; 150.7; 150.2; 149.4; 137.0; 136.3; 136.1; 135.9; 
135.8; 135.7; 133.5; 133.1; 132.8; 130.0; 129.9; 129.8; 128.6; 128.0; 127.7; 127.0; 126.9; 114.0; 
87.3; 87.0; 79.7; 79.5; 79.0; 75.7; 68.4; 68.3; 66.5; 66.4; 66.3; 66.2; 58.7; 58.6; 58.5; 55.3; 52.7; 
43.7; 42.4; 42.2; 41.0; 40.0; 39.3; 38.9; 38.6; 38.4; 35.6; 35.5; 34.7; 34.1; 32.9; 32.7; 29.7; 19.0; 
17.9; 17.4; 17.1; 16.9; 11.9 
HRMS (ESI) (m/z): [M]+ calcd. for C53H70O10Si2: 922.4508; found: 922.4492 
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(1S,2R,3S)-2-(2-((tert-butyldiphenylsilyl)oxy)-2-((5S)-5-((E)-4-hydroxy-7-methoxy-2-methyl-
7-oxohept-2-en-5-yn-1-yl)-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylic acid (322a) 
 
Propargylic alcohol 312a (8 mg, 8.7 µmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (100 µL) and 
the solution was cooled to 0 °C. TFA (10 µL, 0.13 mmol, 15 eq.) was added dropwise and the 
reaction mixture was allowed to stir at 0 °C for 5 hours. The reaction was quenched by the 
addition of sat. aq. NaHCO3 and the phases were separated. The organic layer was washed two 
times with NaHCO3 and afterwards dried with MgSO4. The solvent was removed under reduced 
pressure. Purification by silica gel chromatography yielded seco acid 322a (6 mg, 7.6 µmol, 88%) as 
colorless semi-solid. 
Major: 
1H-NMR (600MHz, CDCl3):  = 7.63 (m, 2H); 7.58 (m, 2H); 7.44 (m, 1H); 7.39 (m, 3H); 7.32 (m, 2H); 
7.20 (t, J = 1.5Hz, 1H); 5.47 (d, J = 8.5Hz, 1H); 5.20 (d, J = 8.7Hz, 1H); 4.95 (m, 1H); 4.68 (m, 1H); 
4.54 (m, 1H); 3.79 (s, 3H); 3.31 (m, 1H); 2.61 (m, 1H); 2.51 (m, 1H); 2.43 (m, 1H); 2.24 (m, 2H); 2.12 
(m, 2H); 1.97 (m, 2H); 1.79 (d, J = 1.1Hz, 3H); 1.10 (s, 9H); 0.99 (m, 21H) 
13C-NMR (150MHz, CDCl3):  = 179.6; 170.4; 160.0; 151.1; 135.8; 135.5; 130.1; 127.8; 127.7; 126.8; 
109.7; 90.1; 86.5; 79.5; 78.9; 75.8; 68.8; 66.6; 58.6; 53.0; 41.5; 38.5; 34.4; 27.0; 19.1; 17.9; 11.9 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C45H62O9Si2Na: 825.3830; found: 825.3817 
Minor: 
1H-NMR (600MHz, CDCl3):  = 7.63 (m, 2H); 7.58 (m, 2H); 7.44 (m, 1H); 7.39 (m, 3H); 7.32 (m, 2H); 
7.10 (t, J = 1.5Hz, 1H); 5.47 (d, J = 8.5Hz, 1H); 5.16 (d, J = 8.0Hz, 1H); 4.90 (m, 1H); 4.64 (m, 1H); 
4.54 (m, 1H); 3.79 (s, 3H); 3.18 (m, 1H); 2.68 (m, 1H); 2.61 (m, 1H); 2.51 (m, 1H); 2.24 (m, 2H); 2.12 
(m, 2H); 1.97 (m, 2H); ); 1.74 (d, J = 1.5Hz, 3H); 1.10 (s, 9H); 0.99 (m, 21H) 
13C-NMR (150MHz, CDCl3):  = 179.6; 170.4; 160.0; 151.1; 135.8; 135.5; 130.0; 127.8; 127.7; 126.8; 
109.7; 90.1; 86.5; 79.5; 78.9; 75.8; 68.8; 66.5; 58.6; 52.9; 41.1; 38.5; 34.4; 27.0; 19.1; 17.9; 11.9  
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(1S,2R,3S)-tert-butyl 2-(2-((4-methoxyphenyl)diphenylmethoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (316b) 
 
Carboxylic acid 318 (500 mg, 0.85 mmol, 1.0 eq.) was dissolved in anhydrous benzene (4 mL). NEt3 
(131 µL, 0.94 mmol, 1.1 eq.) and DMAP (208 mg, 1.7 mmol, 2 eq.) were added to the solution. 
Now, 2,4,6-trichlorbenzoyl chloride (133 µL, 0.85 mmol, 1.0 eq.) was added and the reaction 
mixture was allowed to stir for one hour. A solution of anhydrous t-BuOH (162 µL, 1.7 mmol, 2 eq.) 
in anhydrous CH2Cl2 (4 mL) was added dropwise. After completion of the addition stirring was 
continued for two hours. The reaction was quenched by the addition of sat. aq. NH4Cl. Phases 
were separated and the aqueous layer was extracted twice with CH2Cl2. The combined organic 
layers were dried with MgSO4 and the solvent was removed in vacuo. Purification by silica gel 
chromatography yielded pure t-butyl ester 316b (548 mg, 0.85 mmol, quant.) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 7.43 (m, 4H); 7.28 (m, 6H); 7.21 (m, 2H); 6.81 (m, 2H); 4.50 (m, 1H); 
3.79 (s, 3H); 3.11 (m, 2H); 2.65 (m, 2H); 2.40 (m, 1H); 2.10 (m, 2H); 1.79 (m, 1H); 1.38 (s, 9H); 0.98 
(s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C40H56O5Si: 644.3897; found: 644.3879 
 
  
206 
 
(1S,2R,3S)-tert-butyl 2-(2-((5S)-5-((E)-4-((tert-butyldimethylsilyl)oxy)-2-methylbut-2-en-1-
yl)-2-oxo-3-(phenylselanyl)tetrahydrofuran-3-yl)-2-hydroxyethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (435b) 
 
tert-Butyl ester 316b (548 mg, 0.85 mmol, 1.0 eq.) was dissolved in 10 mL of a 4/1 mixture 
CH2Cl2/MeOH. PPTS (22 mg, 85 µmol, 0.1 eq.) was added and the reaction mixture was allowed to 
stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. 1.5h). The 
reaction mixture was quenched with saturated aqueous NaHCO3. The phases were separated and 
the aqueous layer was extracted two times with CH2Cl2. The combined organic layers were dried 
with MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 5/1) yielded the free primary alcohol as colorless viscous oil 
(272 mg, 0.73 mmol, 86%). The previously prepared primary alcohol (320 mg, 0.86 mmol, 1.0 eq.) 
was dissolved in anhydrous EtOAc (9 mL) and IBX (722 mg, 2.58 mmol, 3 eq.) was added. The 
suspension was heated to reflux for three hours. Now the suspension was cooled to r.t. and 9 mL 
of hexane were added. The suspension was filtered through a pad of celite and the solvents were 
removed under reduced pressure. The crude product (318 mg, 0.86 mmol, quant.) was used 
without further purification. 
DIPA (146 µL, 1.03 mmol, 1.2 eq.) was dissolved in anhydrous THF (3 mL) and the mixture was 
cooled to -10 °C when n-BuLi (1.6M in hexane; 591 µL, 0.95 mmol, 1.1 eq.) was added. The mixture 
was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
selenolactone 313 (399 mg, 0.91 mmol, 1.05 eq.) in anhydrous THF (4 mL) was added dropwise. 
Upon completion, the reaction mixture was allowed to stir for 30 minutes. A solution of the 
previously prepared aldehyde (320 mg, 0.86 mmol, 1.0 eq.) in anhydrous THF (3 mL) was added 
and the reaction mixture was stirred for one hour. The reaction was quenched by the addition of 
sat. aq. NH4Cl. After addition of Et2O, phases were separated and the aqueous phase was 
neutralized by the addition of 0.5M KHSO4. The aqueous layer was extracted twice with Et2O and 
the combined organic phases were dried with MgSO4. Purification by silica gel chromatography 
(hexane/EtOAc = 5/1) yielded 435b as colorless viscous oil (697 mg, 0.86 mmol, quant.). 
HRMS (ESI) (m/z): [M]+ calcd. for C41H70O7SeSi2: 810.3825; found: 810.3814  
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(1S,2R,3S)-tert-butyl 2-(2-((S)-5-((E)-4-((tert-butyldimethylsilyl)oxy)-2-methylbut-2-en-1-
yl)-2-oxo-2,5-dihydrofuran-3-yl)-2-hydroxyethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (320b) 
 
tert-Butyl ester 435b (360 mg, 0.44 mmol, 1.0 eq.) was dissolved in CH2Cl2 (25 mL) and sat. aq. 
NH4Cl (4 mL) was added. The biphasic mixture was cooled to 0 °C and 30% H2O2 (137 µL, 
1.33 mmol, 3 eq.) was added. The reaction was stirred at 0 °C for one hour and then quenched by 
the addition of sat. aq. Na2S2O3. The phases were separated and the organic phase was extracted 4 
times with water. The organic layer was dried with MgSO4 and the solvent was removed under 
reduced pressure. After silica gel chromatography (hexane/EtOAc = 4/1) butenolide 320b was 
obtained as colorless oil (242 mg, 0.37 mmol, 83%) as a separable mixture of diastereo isomers. 
Major: 
1H-NMR (400MHz, CDCl3):  = 7.27 (t, J = 1.5Hz, 1H); 5.45 (t, J = 6.0Hz, 1H); 5.04 (t, J = 6.3Hz, 1H); 
4.61 (m, 1H); 4.55 (m, 1H); 4.25 (m, 1H); 4.10 (d, J = 6.0Hz, 2H); 2.88 (m, 1H); 2.73 (m, 1H); 2.38 (m, 
4H); 2.20 (m, 1H); 1.92 (m, 1H); 1.72 (s, 3H); 1.45 (s, 9H); 1.05 (s, 21H); 0.90 (s, 9H); 0.07 (s, 6H) 
13C-NMR (100MHz, CDCl3):  = 175.3; 172.0; 156.0; 148.6; 136.9; 131.1; 128.9; 127.8; 80.9; 80.4; 
67.1; 66.1; 65.8; 60.0; 43.2; 42.9; 40.3; 34.4; 34.3; 28.0; 26.0; 18.4; 17.9; 17.0; 12.1; -5.1 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C35H64O7Si2Na: 675.4088; found: 675.4082 
Minor: 
1H-NMR (400MHz, CDCl3):  = 7.29 (t, J = 1.5Hz, 1H); 5.44 (t, J = 6.1Hz, 1H); 5.13 (t, J = 6.9Hz, 1H); 
4.59 (m, 1H); 4.48 (m, 1H); 4.20 (d, J = 6.1Hz, 2H); 4.18 (m, 1H); 2.79 (m, 1H); 2.41 (m, 3H); 2.21 (m, 
1H); 1.89 (m, 1H); 1.71 (s, 3H); 1.57 (m, 1H); 1.45 (s, 9H); 1.05 (s, 21H); 0.90 (s, 9H); 0.07 (s, 6H) 
13C-NMR (100MHz, CDCl3):  = 175.3; 172.0; 156.0; 148.3; 137.6; 130.9; 130.7; 129.3; 129.1; 121.7; 
82.1; 80.9; 80.3; 66.8; 65.8; 60.0; 43.3; 43.1; 40.3; 35.2; 34.3; 28.0; 26.0; 18.4; 17.9; 17.0; 12.1; -5.1 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C35H64O7Si2Na: 675.4088; found: 675.4079  
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(1S,2R,3S)-tert-butyl 2-(2-((S)-5-((E)-4-((tert-butyldimethylsilyl)oxy)-2-methylbut-2-en-1-
yl)-2-oxo-2,5-dihydrofuran-3-yl)-2-((2-methoxyethoxy)methoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (433b) 
 
Secondary allylic alcohol 320b (400 mg, 0.61 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 
(6 mL) and the solution was cooled to 0 °C. DIPEA (1.6 mL, 9.2 mmol, 15 eq.) was added and the 
reaction mixture was stirred for 15 minutes. A solution of MEM-Cl (700 µL, 6.1 mmol, 10 eq.) in 
anhydrous CH2Cl2 (2 mL) was added dropwise. The reaction mixture was allowed to warm to r.t. 
overnight, then it was quenched with sat. aq. NH4Cl and the phases were separated. The aqueous 
phase was extracted twice with CH2Cl2 and the combined organic layers were dried with MgSO4. 
The solvent was removed under reduced pressure. Purification by silica gel chromatography 
(hexane/EtOAc = 4/1) yielded pure compound 433b (300 mg, 0.41 mmol, 66%) as colorless oil.  
Major: 
1H-NMR (400MHz, CDCl3):  = 7.22 (m, 1H); 5.44 (m, 1H); 5.02 (m, 1H); 4.72 (s, 2H); 4.55 (m, 2H); 
4.20 (m, 2H); 3.56 (m, 1H); 3.67 (m, 2H); 3.50 (m, 2H); 3.37 (s, 3H); 2.70 (m, 2H); 2.38 (m, 3H); 2.19 
(m, 2H); 2.02 (m, 1H); 1.71 (s, 3H); 1.43 (s, 9H); 1.03 (s, 21H); 0.90 (s, 9H); 0.07 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C39H72O9Si2: 740.4715; found: 740.4703 
Minor: 
1H-NMR (400MHz, CDCl3):  = 7.22 (m, 1H); 5.44 (m, 1H); 5.02 (m, 1H); 4.72 (s, 2H); 4.55 (m, 2H); 
4.20 (m, 2H); 3.73 (m, 1H); 3.67 (m, 2H); 3.50 (m, 2H); 3.35 (s, 3H); 2.70 (m, 2H); 2.38 (m, 3H); 2.19 
(m, 2H); 2.02 (m, 1H); 1.71 (s, 3H); 1.44 (s, 9H); 1.03 (s, 21H); 0.90 (s, 9H); 0.07 (s, 6H) 
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(1S,2R,3S)-tert-butyl-2-(2-((S)-5-((E)-4-hydroxy-2-methylbut-2-en-1-yl)-2-oxo-2,5-
dihydrofuran-3-yl)-2-((2-methoxyethoxy)methoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (321b) 
 
Compound 433b (300 mg, 0.41 mmol, 1.0 eq.) was dissolved in anhydrous THF (5 mL) and the 
reaction mixture was cooled to 0 °C. 7%HF in pyridine (1.6 mL, 6.15 mmol, 15 eq.) was added 
dropwise and the reaction mixture was allowed to stir overnight. The reaction was quenched by 
the careful addition of sat. aq. NaHCO3. The phases were separated and the organic layer was 
extracted twice with NaHCO3. The combined organic layers were back-extracted twice with CH2Cl2 
and the combined organic layers were dried with brine and MgSO4. After removal of the solvent 
under reduced pressure silica gel chromatography (hexane/EtOAc = 1/1) yielded pure allylic 
alcohol 321b (255 mg, 0.41 mmol, quant.) as slightly yellow oil. 
Major: 
1H-NMR (400MHz, CDCl3):  = 7.22 (t, J = 1.1Hz, 1H); 5.51 (t, J = 6.6Hz, 1H); 5.07 (m, 1H); 4.71 (m, 
2H); 4.55 (m, 2H); 4.16 (d, J = 6.6Hz, 2H); 3.67 (m, 2H); 3.51 (m, 2H); 3.36 (s, 3H); 2.70 (m, 2H); 2.41 
(m, 3H); 2.20 (m, 3H); 1.74 (s, 3H); 1.44 (s, 9H); 1.03 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C33H58O9SiNa: 649.3748; found: 649.3735 
Minor: 
1H-NMR (400MHz, CDCl3):  = 7.27 (t, J = 1.1Hz, 1H); 5.56 (t, J = 6.6Hz, 1H); 5.07 (m, 1H); 4.71 (m, 
2H); 4.55 (m, 2H); 4.18 (d, J = 6.6Hz, 2H); 3.67 (m, 2H); 3.51 (m, 2H); 3.37 (s, 3H); 2.70 (m, 2H); 2.41 
(m, 3H); 2.00 (m, 3H); 1.74 (s, 3H); 1.43 (s, 9H); 1.03 (s, 21H) 
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(1S,2R,3S)-tert-butyl 2-(2-((5S)-5-((E)-4-hydroxy-7-methoxy-2-methyl-7-oxohept-2-en-5-
yn-1-yl)-2-oxo-2,5-dihydrofuran-3-yl)-2-((2-methoxyethoxy)methoxy)ethyl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (312b) 
 
Allylic alcohol 321b (150 mg, 0.24 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (3 mL) and IBX 
(200 mg, 0.72 mmol, 3 eq.) was added. The reaction mixtures was refluxed for two hours or until 
all starting material was consumed. Hexane (3 mL) was added and the suspension was filtered 
through a pad of celite 545 coarse. Removal of the solvents gave crude aldehyde (150 mg, 
0.24 mmol, quant.) as colorless oil.  
Methyl propiolate (23.5 µL, 0.26 mmol, 1.1 eq.) was dissolved in anhydrous THF (2 mL) and the 
reaction mixture was cooled to -78 °C. LiHMDS (1M in THF, 0.26 mL, 0.26 mmol, 1.1 eq.) was 
added dropwise and the solution was allowed to stir for 30 minutes. A solution of the previously 
prepared aldehyde (150 mg, 0.24 mmol, 1.0 eq.) in anhydrous THF (2 mL) was added dropwise. 
The reaction mixture was allowed to stir for 30 minutes until it was quenched by the addition of 
sat. aq. NH4Cl. The phases were separated and the aqueous phases was carefully acidified and 
extracted twice with Et2O. The combined organic phases were dried with MgSO4 and the solvents 
were removed under reduced pressure. The resulting allylic alcohol 312b (168 mg, 0.24 mmol, 
99%) was of satisfying purity for further conversion.  
Major & minor: 
1H-NMR (400MHz, CDCl3):  = 7.20 (m, 1H); 5.45 (m, 1H); 5.17 (d, J = 8.0Hz, 1H); 5.03 (m, 1H); 4.72 
(s, 2H); 4.56 (m, 2H); 3.77 (s, 3H); 3.67 (m, 2H); 3.51 (m, 2H); 3.37 (s, 3H); 2.72 (m, 1H); 2.62 (m, 
1H); 2.35 (m, 3H); 2.21 (m, 2H); 2.02 (m, 2H); 1.80 (s, 3H); 1.43 (s, 9H); 1.03 (m, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C37H60O11SiNa: 731.3803; found: 731.3794 
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4.2.11 Northern Lactone-Horner Wadsworth Emmons Approach (cBu) 
 
(E)-triethyl((3-iodobut-2-en-1-yl)oxy)silane (436) 
 
Vinyl iodide 315 (2.4 g, 12.2 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (100 mL). Pyridine 
(4.95 mL, 61.0 mmol, 5 eq.) and DMAP (147 mg, 1.2 mmol, 0.1 eq.) were added to the solution and 
it was cooled to 0 °C. A solution of TES-Cl (5.12 mL, 30.5 mmol, 2.5 eq.) in anhydrous CH2Cl2 
(20 mL) was added. The reaction mixture was allowed to stir at 0 °C for one hour, and then it was 
quenched by the addition of sat. aq. NH4Cl. The phases were separated and the organic layer was 
washed with NH4Cl. The organic layer was dried with brine and MgSO4. Purification by silica gel 
chromatography (hexane/EtOAc = 10/1) yielded pure silyl ether 436 (3.35 g, 10.7 mmol, 88%) as 
colorless liquid.  
1H-NMR (250 MHz, CDCl3):  = 6.32 (t, J = 6.6Hz, 1H); 4.11 (d, J = 6.6Hz, 2H); 2.42 (s, 3H); 0.96 (t, J = 
8.0Hz, 9H); 0.61 (q, J = 8.0Hz, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H21IOSi: 312.0406; found: 312.0397 
 
(S,E)-1-((4-methoxyphenyl)diphenylmethoxy)-4-methyl-6-((triethylsilyl)oxy)hex-4-en-2-ol 
(326) 
 
TES-protected vinyl iodide 436 (4.73 g, 15.15 mmol, 1.0 eq.) was dissolved in anhydrous Et2O 
(100 mL) and the solution was cooled to -78 °C. t-BuLi (1.67M in pentane; 19 mL, 31.8 mmol, 
2.1 eq.) was added dropwise. After completion of the addition stirring was continued for 30 
minutes. Freshly prepared 2-thienyl-Cu(CN)Li (0.5M in THF; 36.4 mL, 18.18 mmol, 1.2 eq.) was 
added via cannula to the reaction mixture.[112] The solution turned yellow and stirring was 
continued for one hour at -78 °C. A solution of MMTr-protected (R)-glycidol 284 (6.3 g, 18.2 mmol, 
1.2 eq.) in 20 mL anhydrous Et2O was added dropwise. Stirring was continued at -78 °C for two 
hours and then at r.t. for one hour (the solution turned dark). The reaction mixture was quenched 
by the addition of a 3/1 mixture of sat. aq. NH4Cl/25% aq. NH4OH.  
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The phases were separated and the organic layer was extracted twice with NH4Cl before it was 
dried with brine and MgSO4. Removal of the solvent under reduced pressure and purification by 
silica gel chromatography (hexane/EtOAc = 10/1 to 5/1) yielded pure secondary alcohol 326 (5.5 g, 
10.3 mmol, 68%) as slightly yellow, viscous oil.  
1H-NMR (400MHz, CDCl3):  = 7.44 (d, J = 7.5Hz, 4H); 7.30 (m, 6H); 7.23 (m, 2H); 6.84 (d, J = 8.8Hz, 
2H); 5.37 (dt, J = 6.3, 1.2Hz, 1H); 4.15 (d, J = 6.3Hz, 2H); 3.89 (m, 1H); 3.80 (s, 3H); 3.12 (m, 2H); 
2.17 (m, 2H); 1.62 (s, 3H); 0.95 (t, J = 7.9Hz, 9H); 0.60 (q, J = 7.9Hz, 6H) 
13C-NMR (100MHz, CDCl3):  = 158.6; 144.4; 135.6; 133.6; 130.3; 129.2; 128.4; 127.9; 127.8; 127.5; 
127.2; 126.9; 113.2; 86.4; 68.8; 67.4; 59.5; 55.2; 43.9; 16.4; 6.8; 4.5 
HRMS (ESI) (m/z): [M]+ calcd. for C33H44O4Si: 532.3009; found: 532.3000 
 
(S,E)-5-((tert-butyldimethylsilyl)oxy)-6-((4-methoxyphenyl)diphenylmethoxy)-3-methylhex-
2-enal (437) 
 
Secondary alcohol 326 (1 g, 1.88 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (20 mL) and 
2,6-lutidine (1.1 mL, 9.4 mmol, 5 eq.) was added. The reaction mixture was cooled to 0 °C and TBS-
OTf (603 µL, 2.6 mmol, 1.4 eq.) was added dropwise. The solution was allowed to stir for one hour. 
It was quenched by the addition of sat. aq. NaHCO3 and the phases were separated. The aqueous 
phase was extracted twice with CH2Cl2 and the combined organic phases were washed with brine 
and dried with MgSO4. After removal of the solvent under reduced pressure, purification by silica 
gel chromatography yielded pure tri-ether (1.21 g, 1.88 mmol, quant.) as slightly yellow viscous oil. 
The previously prepared tri-ether (1.2 g, 1.86 mmol, 1.0 eq.) was dissolved in anhydrous THF 
(20 mL) and the reaction mixture was cooled to 0 °C. 7% HF in pyridine (1.08 mL, 3.7 mmol, 2 eq.) 
was added dropwise and the reaction mixture was allowed to stir for 15 minutes. The reaction was 
quenched by the careful addition of sat. aq. NaHCO3. The phases were separated and the organic 
layer was extracted twice with NaHCO3. The combined organic layers were back-extracted twice 
with CH2Cl2 and the combined organic layers were dried with brine and MgSO4. After removal of 
the solvent under reduced pressure silica gel chromatography (hexane/EtOAc = 4/1) yielded the 
pure allylic alcohol (971 mg, 1.82 mmol, 98%) as slightly yellow oil.  
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The previously prepared primary alcohol (971 mg, 1.82 mmol, 1.0 eq.) was dissolved in anhydrous 
EtOAc (20 mL) and IBX (1.53 g, 5.47 mmol, 3 eq.) was added. The suspension was heated to reflux 
for three hours. Now the suspension was cooled to r.t. and 20 mL of hexane were added. The 
suspension was filtered through a pad of celite and the solvents were removed under reduced 
pressure. The crude product was purified by silica gel column chromatography (hexane/EtOAc = 
5/1). Aldehyde 437 was obtained as viscous oil (966 mg, 1.82 mmol, quant.). 
1H-NMR (250MHz, CDCl3):  = 9.92 (d, J = 8.0Hz, 1H); 7.44 (d, J = 7.5Hz, 4H); 7.30 (m, 6H); 7.23 (m, 
2H); 6.83 (d, J = 8.8Hz, 2H); 5.86 (d, J = 8.0Hz, 1H); 3.92 (m, 1H); 3.80 (s, 3H); 3.11 (m, 1H); 2.98 (m, 
1H); 2.63 (m, 1H); 2.35 (m, 1H); 2.14 (s, 3H); 0.82 (s, 9H); -0.04 (s, 3H); -0.08 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C33H42O4Si: 530.2852; found: 530.2843 
 
(8S,E)-methyl-8-((tert-butyldimethylsilyl)oxy)-4-hydroxy-9-((4-
methoxyphenyl)diphenylmethoxy)-6-methylnon-5-en-2-ynoate (329) 
 
Methyl propiolate (161 µL, 1.81 mmol, 1.5 eq.) was dissolved in anhydrous THF (7 mL) and the 
reaction mixture was cooled to -78 °C. LiHMDS (1M in THF, 1.87 mL, 1.87 mmol, 1.55 eq.) was 
added dropwise and the solution was allowed to stir for 30 minutes. A solution of aldehyde 437 
(640 mg, 1.21 mmol, 1.0 eq.) in anhydrous THF (3 mL) was added dropwise. The reaction mixture 
was allowed to stir for 30 minutes until it was quenched by the addition of sat. aq. NH4Cl. The 
phases were separated and the aqueous phase was carefully acidified and extracted twice with 
Et2O. The combined organic phases were dried with MgSO4 and the solvents were removed under 
reduced pressure. The resulting allylic alcohol 329 (744 mg, 1.2 mmol, 99%) was purified by silica 
gel chromatography (hexane/EtOAc = 4/1), whereupon two inseparable, inconsequential 
diastereoisomers (d.r. = 2/1) were obtained. 
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Major: 
1H-NMR (400MHz, CDCl3):  = 7.45 (m, 4H); 7.30 (m, 6H); 7.22 (m, 2H); 6.83 (d, J = 9.0Hz, 2H); 5.30 
(dt, J = 8.4, 0.9Hz, 1H); 5.07 (m, 1H); 3.88 (m, 1H); 3.80 (s, 3H); 3.78 (s, 3H); 3.07 (m, 1H); 2.98 (m, 
1H); 2.45 (m, 1H); 2.18 (m, 1H); 1.70 (m, 3H); 0.84 (s, 9H); 0.00 (s, 3H); -0.05 (s, 3H) 
13C-NMR (100MHz, CDCl3):  = 158.5; 153.8; 144.5; 139.8; 135.9; 132.6; 130.3; 128.5; 128.4; 128.3; 
128.0; 127.7; 127.1; 126.8; 124.9; 113.3; 113.1; 87.3; 87.2; 86.3; 70.5; 70.2; 70.1; 66.8; 58.8; 55.2; 
52.7; 45.0; 44.5; 25.8; 25.1; 18.0; 17.8; 17.4; -4.5; -4.8 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C37H46O6SiNa: 637.2961; found: 637.2947 
Minor: 
1H-NMR (400MHz, CDCl3):  = 7.45 (m, 4H); 7.30 (m, 6H); 7.22 (m, 2H); 6.83 (d, J = 9.0Hz, 2H); 5.30 
(dt, J = 8.4, 0.9Hz, 1H); 5.07 (m, 1H); 3.88 (m, 1H); 3.80 (s, 3H); 3.77 (s, 3H); 3.07 (m, 1H); 2.98 (m, 
1H); 2.45 (m, 1H); 2.18 (m, 1H); 1.70 (m, 3H); 0.85 (s, 9H); 0.00 (s, 3H); -0.04 (s, 3H) 
13C-NMR (100MHz, CDCl3):  = 158.5; 153.8; 144.6; 139.7; 135.9; 132.6; 130.4; 128.5; 128.4; 128.3; 
128.0; 127.7; 127.1; 126.8; 125.0; 113.3; 113.1; 87.3; 87.2; 86.3; 70.5; 70.2; 70.1; 67.0; 58.7; 55.2; 
52.7; 45.0; 44.5; 25.8; 25.1; 18.0; 17.8; 17.4; -4.5; -4.8 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C37H46O6SiNa: 637.2961; found: 637.2949 
 
(8S,E)-methyl-8-((tert-butyldimethylsilyl)oxy)-9-((4-methoxyphenyl)diphenylmethoxy)-6-
methyl-4-(((2,2,2-trichloroethoxy)carbonyl)oxy)non-5-en-2-ynoate (325a) 
 
Allylic alcohol 329 (369 mg, 0.6 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (6 mL), pyridine 
(145 µL, 1.8 mmol, 3 eq.) and DMAP (7.3 mg, 60 µmol, 0.1 eq.) were added. The reaction mixture 
was cooled to 0 °C and Troc-Cl (127 mg, 0.6 mmol, 1.0 eq.) was added dropwise. The solution was 
allowed to stir for one hour. It was quenched by the addition of sat. aq. NaHCO3 and the phases 
were separated. The aqueous phase was extracted twice with CH2Cl2 and the combined organic 
phases were washed with brine and dried with MgSO4.  
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After removal of the solvent under reduced pressure, purification by silica gel chromatography 
(hexane/EtOAc = 5/1) yielded pure compound 325a (412 mg, 0.52 mmol, 87%) as slightly yellow 
viscous oil. 
1H-NMR (400MHz, CDCl3):  = 7.44 (d, J = 8.0Hz, 4H); 7.30 (m, 6H); 7.21 (m, 2H); 6.83 (d, J = 8.9Hz, 
2H); 6.01 (d, J = 9.0Hz, 1H); 5.38 (d, J = 9.0Hz, 1H); 4.76 (m, 2H); 3.83 (m, 1H); 3.79 (s, 3H); 3.77 (s, 
3H); 3.09 (m, 1H); 2.97 (m, 1H); 2.51 (m, 1H); 2.19 (m, 1H); 1.78 (m, 3H); 0.81 (s, 9H); -0.05 (m, 3H); 
-0.10 (s, 3H) 
13C-NMR (100MHz, CDCl3):  = 158.5; 153.3; 153.0; 144.5; 143.4; 143.3; 135.9; 130.3; 128.4; 127.8; 
126.8; 119.8; 113.1; 86.4; 82.3; 82.2; 77.5; 77.0; 70.3; 70.2; 67.2; 65.8; 65.1; 65.0; 55.2; 52.8; 45.1; 
45.0; 25.8; 17.9; 17.8; 15.3; -4.5; -5.0 
HRMS (ESI) (m/z): [M]+ calcd. for C40H47Cl3O8Si: 788.2106; found: 788.2105 
 
(8S,E)-methyl-8-((tert-butyldimethylsilyl)oxy)-6-methyl-9-oxo-4-(((2,2,2-
trichloroethoxy)carbonyl)oxy)non-5-en-2-ynoate (330a) 
 
Compound 325a (490 mg, 0.62 mmol, 1.0 eq.) was dissolved in 10 mL of a 4/1 mixture 
CH2Cl2/MeOH. PPTS (15.6 mg, 62 µmol, 0.1 eq.) was added and the reaction mixture was allowed 
to stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. two 
hours). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were 
separated and the aqueous layer was extracted two times with Et2O. The combined organic layers 
were dried with MgSO4 and the solvent was removed under reduced pressure. Purification by silica 
gel chromatography (hexane/EtOAc = 4/1) yielded the free primary alcohol as colorless viscous oil 
(317 mg, 0.61 mmol, 99%). 
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The previously prepared primary alcohol (317 mg, 0.61 mmol, 1.0 eq.) was dissolved in anhydrous 
EtOAc (6 mL) and IBX (512 mg, 1.83 mmol, 3 eq.) was added. The suspension was heated to reflux 
for three hours. Now the suspension was cooled to r.t. and 6 mL of hexane were added. The 
suspension was filtered through a pad of celite and the solvents were removed in vacuo. The crude 
product was purified by silica gel column chromatography (hexane/EtOAc = 5/1). Aldehyde 330a 
was obtained as viscous oil (315 mg, 0.61 mmol, quant.). 
1H-NMR (250MHz, CDCl3):  = 9.61 (d, J = 1.2Hz, 1H); 6.04 (d, J = 8.9Hz, 1H); 5.48 (d, J = 8.9Hz, 1H); 
4.76 (m, 2H); 4.09 (m, 1H); 3.78 (s, 3H); 2.36 (m, 2H); 1.82 (s, 3H); 0.90 (s, 9H); 0.06 (s, 3H); 0.03 (s, 
3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C20H29Cl3O7Si: 514.0748; found: 514.0738 
 
(8S,E)-methyl-8-((tert-butyldimethylsilyl)oxy)-9-((4-methoxyphenyl)diphenylmethoxy)-6-
methyl-4-((triethylsilyl)oxy)non-5-en-2-ynoate (325b) 
 
Allylic alcohol 329 (120 mg, 0.2 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (5 mL). Pyridine 
(50 µL, 0.59 mmol, 3 eq.) and DMAP (1.2 mg, 10 µmol, 0.05 eq.) were added to the solution and it 
was cooled to 0 °C. A solution of TES-Cl (66 µL, 0.39 mmol, 2 eq.) in anhydrous CH2Cl2 (1 mL) was 
added. The reaction mixture was allowed to stir at 0 °C for one hour, and then it was quenched by 
the addition of sat. aq. NH4Cl. The phases were separated and the organic layer was washed with 
NH4Cl. The organic layer was dried with brine and MgSO4. Purification by silica gel chromatography 
(hexane/EtOAc = 10/1) yielded pure silyl ether 325b (116 mg, 0.16 mmol, 80%) as colorless liquid.  
1H-NMR (250MHz, CDCl3):  = 7.43 (m, 4H); 7.24 (m, 8H); 6.81 (m, 2H); 5.33 (m, 1H); 5.11 (m, 1H); 
3.84 (m, 1H); 3.76 (s, 3H); 3.73 (s, 3H); 3.48 (m, 1H); 3.00 (m, 1H); 2.14 (m, 2H); 1.69 (m, 3H); 0.95 
(m, 12H); 0.81 (m, 6H); 0.63 (m, 6H); 0.08 (s, 3H); -0.06 (m, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C43H60O6Si2: 728.3928; found: 728.3914 
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(8S,E)-methyl-8-((tert-butyldimethylsilyl)oxy)-9-hydroxy-6-methyl-4-((triethylsilyl)oxy)non-
5-en-2-ynoate (438) 
 
Bis-silylether 325b (116 mg, 0.16 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (2 mL) and 
hexafluoroisopropanol (HFIP, 2 mL) was added. The solution was allowed to stir at r.t. for 15 
minutes during which time it turned yellow. Anhydrous MeOH was added until the color 
disappeared and the solution was allowed to stir at r.t. for 2 days. Solvents were removed in vacuo 
and purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded pure primary alcohol 
438 (50 mg, 0.11 mmol, 68%) as colorless viscous oil. 
1H-NMR (250MHz, CDCl3):  = 5.37 (d, J = 8.1Hz, 1H); 5.14 (d, J = 8.1Hz, 1H); 3.87 (m, 1H); 3.76 (s, 
3H); 3.53 (m, 1H); 3.43 (m, 1H); 2.22 (d, J = 6.6Hz, 2H); 1.85 (t, J = 6.3Hz, 1H); 1.72 (s, 3H); 0.95 (t, J 
= 7.7Hz, 9H); 0.89 (s, 9H); 0.64 (q, J = 7.7Hz, 6H); 0.08 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C23H44O5Si2: 456.2727; found: 456.2721 
 
(8S,E)-methyl-8-((tert-butyldimethylsilyl)oxy)-6-methyl-9-oxo-4-((triethylsilyl)oxy)non-5-
en-2-ynoate (330b) 
 
Oxalyl chloride (8.9 µL, 105 µmol, 2 eq.) was dissolved in anhydrous CH2Cl2 (1 mL) and the solution 
was cooled to -78 °C. A solution of anhydrous DMSO (14.9 µL, 0.21 mmol, 4 eq.) in anhydrous 
CH2Cl2 (200 µL) was added dropwise. The reaction mixture was allowed to stir at -78 °C for 45 
minutes. A solution of alcohol 438 (24 mg, 53 µmol, 1.0 eq.) in anhydrous CH2Cl2 (1 mL) was added 
dropwise. 
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The reaction mixture was allowed to stir for 90 minutes, before NEt3 (43.9 µL, 0.32 mmol, 6 eq.) 
was added and the solution was allowed to warm to -20 °C within one hour. Sat. aq. NH4Cl was 
added and the phases were separated. The aqueous layer was extracted twice with CH2Cl2 and the 
combined organic layers were dried with brine and MgSO4. The solvent was removed under 
reduced pressure and silica gel chromatography (hexane/EtOAc = 7/1) yielded pure aldehyde 330b 
(20 mg, 44 µmol, 84%) as colorless oil.  
1H-NMR (400MHz, CDCl3):  = 9.61 (d, J = 1.6Hz, 1H); 5.41 (d, J = 8.1Hz, 1H); 5.14 (d, J = 8.1Hz, 1H); 
4.08 (m, 1H); 3.76 (s, 3H); 2.32 (m, 2H); 1.73 (s, 3H); 0.96 (t, J = 7.7Hz, 9H); 0.90 (s, 9H); 0.65 (q, J = 
7.7Hz, 6H); 0.06 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C23H42O5Si2: 454.2571; found: 454.2562 
 
Dimethyl-(2-hydroxy-3-((1R,2R,4S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)propyl)phosphonate (331) 
 
Primary alcohol 193 (1.0 g, 1.74 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (20 mL) and IBX 
(975 mg, 3.5 mmol, 2 eq.) was added. The suspension was heated to reflux for four hours. Now the 
suspension was cooled to r.t. and 20 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed in vacuo. The crude product (997 mg, 
1.74 mmol, quant.) was used without further purification. 
An adapted procedure of Genov and Tebby was used.[101] Dimethyl methylphosphonate (216 mg, 
1.74 mmol, 1.0 eq.) was dissolved in anhydrous THF (12 mL) and the solution was cooled to -78 °C 
before n-BuLi (2.5M in hexane; 730 µL, 1.83 mmol, 1.05 eq.) was added dropwise. The reaction 
mixture was stirred for 30 minutes, then a solution of the previously prepared aldehyde (997 mg, 
1.74 mmol, 1.0 eq.) in anhydrous THF (5 mL) was added dropwise. Stirring was continued for one 
hour. The reaction mixture was quenched by the addition of sat. aq. NH4Cl. After the addition of 
Et2O, the phases were separated and the neutralized aqueous layer was extracted twice with Et2O. 
The combined organic layers were dried with MgSO4 and the solvent was removed in vacuo.  
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The resulting -hydroxy phosphonate 331 (1.2 g, 1.74 mmol, quant.) was of sufficient purity for 
further conversion. 
1H-NMR (250MHz, CDCl3):  = 7.42 (m, 4H); 7.27 (m, 8H); 6.82 (d, J = 8.8Hz, 2H); 4.35 (d, J = 7.0Hz, 
1H); 4.02 (m, 1H); 3.79 (s, 3H); 3.64 (m, 6H); 3.03 (m, 2H); 2.79 (m, 1H); 2.32 (m, 2H); 1.62 (m, 3H); 
1.43 (m, 1H); 1.26 (m, 1H); 1.02 (bs, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C39H57O7PSi: 696.3611; found: 696.3604 
 
Dimethyl-(3-((1R,2R,4S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)-2-oxopropyl)phosphonate (439) 
 
-hydroxy phosphonate 331 (1.2 g, 1.74 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (20 mL) 
and IBX (1.46 g, 5.22 mmol, 3 eq.) was added. The suspension was heated to reflux for four hours. 
Now the suspension was cooled to r.t. and 20 mL of hexane were added. The suspension was 
filtered through a pad of celite and the solvents were removed in vacuo. The crude product was 
purified by silica gel column chromatography (hexane/EtOAc = 1/1). -keto phosphonate 439 was 
obtained as viscous oil (1.1 g, 1.58 mmol, 91%). 
1H-NMR (400MHz, CDCl3):  = 7.40 (m, 4H); 7.27 (m, 6H); 7.21 (m, 2H); 6.82 (d, J = 9.0Hz, 2H); 4.34 
(m, 1H); 3.79 (s, 3H); 3.70 (d, JPH=11.3Hz, 3H); 3.65 (d, JPH=11.3Hz, 3H); 3.17 (m, 1H); 3.01 (m, 1H); 
2.93 (m, 2H); 2.75 (m, 1H); 2.59 (m, 1H); 2.37 (m, 2H); 1.65 (m, 1H); 0.98 (s, 21H) 
13C-NMR (100MHz, CDCl3):  = 201.2; 158.5; 144.8; 144.6; 135.8; 130.3; 128.4; 128.3; 127.7; 126.8; 
113.0; 86.1; 65.8; 65.6; 64.1; 55.2; 52.8; 52.7; 42.2; 40.9; 39.1; 38.5; 35.0; 29.6; 17.9; 17.8; 12.0 
31P-NMR (162MHz, CDCl3):  = 24.59 
HRMS (ESI) (m/z): [M]+ calcd. for C39H55O7Si: 694.3455; found: 694.3442 
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(E)-Enone (324a) 
 
-keto phosphonate 439 (296 mg, 0.43 mmol, 1.1 eq.) was dissolved in anhydrous THF (2 mL) and 
the reaction mixture was cooled to -78 °C. LiHMDS (1M in THF; 470 µL, 0.47 mmol, 1.2 eq.) was 
added dropwise and the reaction mixture was stirred at -78 °C for one hour until a solution of 
aldehyde 330a (200 mg, 0.39 mmol, 1.0 eq.) in anhydrous THF (2 mL) was added dropwise. The 
solution was stirred 30 minutes at -78 °C, then it was allowed to warm to -10 °C with a rate of 
approx. 1 °C/minute. The reaction was quenched by the addition of sat. aq. NH4Cl and Et2O was 
added. The phases were separated and the aqueous layer was extracted twice with Et2O. The 
combined organic layers were dried with MgSO4 and the solvent was removed under reduced 
pressure. Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded pure enone 324a 
(230 mg, 0.21 mmol, 55%) as colorless oil.  
1H-NMR (400MHz, CDCl3):  = 7.41 (m, 4H); 7.27 (m, 6H); 7.21 (m, 2H); 6.82 (d, J = 8.9Hz, 2H); 6.55 
(dd, J = 15.4, 5.4Hz, 1H); 6.12 (d, J = 15.4Hz, 1H); 6.04 (d, J = 8.9Hz, 1H); 5.42 (d, J = 8.9Hz, 1H); 4.77 
(m, 2H); 4.34 (m, 2H); 3.79 (s, 3H); 3.78 (s, 3H); 3.23 (m, 1H); 3.04 (m, 2H); 2.86 (m, 1H); 2.39 (m, 
3H); 2.14 (m, 2H); 1.81, 1.80 (s, 3H); 1.68 (m, 1H); 0.96 (s, 21H); 0.86 (m, 9H); -0.01, -0.07 (m, 6H) 
13C-NMR (100MHz, CDCl3):  = 199.2; 158.4; 146.4; 144.8; 144.7; 142.0; 141.9; 136.1; 130.2; 128.8; 
128.7; 128.4; 128.3; 127.7; 126.7; 120.8; 113.0; 86.0; 82.0; 81.9; 77.1; 70.5; 70.4; 65.9; 64.9; 64.2; 
60.4; 55.1; 52.9; 52.8; 47.2; 38.6; 34.9; 29.8; 25.8; 25.7; 21.0; 17.9; 17.7; 14.2; 12.0; -4.5; -5.0 
HRMS (ESI) (m/z): [M]+ calcd. for C57H77Cl3O10Si2: 1082.4121; found: 1082.4115 
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(5E,8S,9E)-methyl 8-((tert-butyldimethylsilyl)oxy)-11-hydroxy-12-((1R,2R,4S)-2-(((4-
methoxyphenyl)diphenylmethoxy)methyl)-4-((triisopropylsilyl)oxy)cyclobutyl)-6-methyl-4-
(((2,2,2-trichloroethoxy)carbonyl)oxy)dodeca-5,9-dien-2-ynoate (440) 
 
Enone 324a (123 mg, 0.11 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (2 mL) and CeCl3.7H2O 
(127 mg, 0.24 mmol, 3 eq.) was added. The reaction mixture was cooled to -78 °C and NaBH4 
(10.7 mg, 0.28 mmol, 2.5 eq.) was added portionwise in an Ar-stream. The reaction was allowed to 
stir for one hour and then quenched by the addition of sat. aq. NH4Cl. Et2O was added and the 
phases were separated. The aqueous phase was carefully acidified to pH 5-6. The layers were 
recombined and mixed vigorously. Separation, pH adjusting and mixing cycle was repeated 3 
times, then the separated organic layer was dried with MgSO4 and the solvent was removed under 
reduced pressure giving pure allylic alcohol 440 (81 mg, 75 µmol, 68%) as colorless viscous oil.  
1H-NMR (400MHz, CDCl3):  = 7.40 (m, 4H); 7.25 (m, 8H); 6.80 (d, J = 8.9Hz, 2H); 6.03 (d, J = 8.9Hz, 
1H); 5.51 (m, 2H); 5.41 (d, J = 8.9Hz, 1H); 4.75 (m, 2H); 4.35 (m, 1H); 4.16 (m, 1H); 4.00 (m, 1H); 
3.77 (s, 3H); 3.75 (s, 3H); 3.57 (m, 1H); 3.09 (m, 1H); 2.97 (m, 1H); 2.75 (m, 1H); 2.31 (m, 2H); 2.15 
(m, 2H); 1.79 (s, 3H); 1.67 (m, 2H); 1.02 (m, 21H); 0.83 (m, 9H); -0.03 (m, 6H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C57H79Cl3O10Si2Na: 1107.4175; found: 1107.4164 
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Dimethyl-(1-bromo-3-((1R,2R,4S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)-2-oxopropyl)phosphonate (334) 
 
To a suspension of NaH (60% in mineral oil; 17.3 mg, 0.43 mmol, 1.0 eq.) in anhydrous THF (2 mL) 
was added a solution of -keto phosphonate 439 (300 mg, 0.43 mmol, 1.0 eq.) in anhydrous THF 
(2 mL) dropwise at 0 °C. 
The reaction mixture was stirred for 30 minutes at 0 °C and 15 minutes at r.t. After re-cooling to 
0 °C bromine (15.5 µL, 0.3 mmol, 0.7 eq.) was added and the solution was allowed to stir for two 
hours at 0 °C. After quenching with aq. sat. Na2S2O3 and addition of Et2O, the phases were 
separated and the aqueous layer was extracted twice with Et2O. The combined organic layers were 
dried with MgSO4 and the solvent was removed in vacuo. Purification by silica gel chromatography 
yielded pure mono brominated -keto phosphonate 334 (190 mg, 0.25 mmol, 82%) as colorless oil 
and -keto phosphonate 439 (123 mg, 0.18 mmol, 98%borsm) with the same appearance. 
1H-NMR (400MHz, CDCl3):  = 7.40 (m, 4H); 7.25 (m, 8H); 6.80 (d, J = 8.9Hz, 2H); 4.35 (m, 2H); 4.16 
(m, 1H); 3.78 (s, 3H); 3.74 (m, 6H); 3.11 (m, 2H); 3.04 (m, 1H); 2.91 (m, 1H); 2.38 (m, 1H); 1.66 (m, 
2H); 0.99 (m, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C39H54BrO7PSi: 772.2560; found: 772.2554 
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(E)--bromo-enone (335b) 
 
A flame dried Schlenk tube was charged with anhydrous THF (500 µL) and LiHMDS (1M in THF, 
46 µL, 46 µmol, 1.05 eq.) was added. The solution was cooled to 0 °C. A solution of brominated 
-keto phosphonate 334 (38 mg, 48 µmol, 1.1 eq.) in anhydrous THF (500 µL) was added dropwise 
and the reaction mixture was allowed to stir for 30 minutes. A solution of aldehyde 330b (20 mg, 
44 µmol, 1.0 eq.) in anhydrous THF (500 µL) was added dropwise. The solution was stirred 30 
minutes at 0 °C and then was allowed to warm to r.t. overnight. The reaction was quenched by the 
addition of sat. aq. NH4Cl and Et2O was added. The phases were separated and the aqueous layer 
was extracted twice with Et2O. The combined organic layers were dried with MgSO4 and the 
solvent was removed in vacuo. Purification by silica gel chromatography (hexane/EtOAc = 5/1) 
yielded pure (E)-enone 335b (36 mg, 31 µmol, 70%) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 7.41 (m, 4H); 7.27 (m, 6H); 7.21 (m, 2H); 6.90 (d, J = 6.8Hz, 1H); 6.84 
(d, J = 8.9Hz, 2H); 5.49 (d, J = 7.7Hz, 1H); 5.20 (d, J = 8.1Hz, 1H); 4.67 (m, 1H); 4.37 (q, J = 6.9Hz, 
1H); 3.80 (s, 3H); 3.77 (s, 3H); 3.27 (m, 1H); 3.03 (m, 2H); 2.61 (m, 1H); 2.37 (m, 3H); 2.13 (m, 1H); 
1.97 (m ,1H); 1.80 (s, 3H); 1.69 (m, 1H); 1.04 (m, 9H); 0.96 (s, 21H); 0.67 (m, 6H) 
13C-NMR (100MHz, CDCl3):  = 192.2; 158.4; 144.9; 144.7; 144.5; 135.8; 135.0; 134.8; 130.5; 130.3; 
129.2; 128.3; 128.2; 127.9; 127.8; 127.2; 126.8; 126.7; 113.2; 113.1; 113.0; 87.3; 86.0; 75.5; 70.2; 
70.0; 65.6; 63.7; 59.2; 55.3; 52.7; 44.6; 44.5; 39.1; 34.6; 32.7; 29.7; 29.5; 17.9; 17.8; 16.6; 12.2; 
12.0; 6.7; 4.8 
HRMS (ESI) (m/z): [M]+ calcd. for C54H75BrO8Si2: 986.4184; found: 986.4167 
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2-((1R,2R,4S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)ethyl acetate (441) 
 
Mono MMTr-ether 193 (1 g, 1.75 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (20 mL), NEt3 
(728 µL, 5.24 mmol, 3 eq.), and DMAP (11 mg, 87.5 µmol, 0.05 eq.) were added and the reaction 
mixture was cooled to 0 °C before AcCl (186 µL, 2.62 mmol, 1.5 eq.) was added dropwise. The 
solution was allowed to stir at 0 °C for 30 minutes before it was quenched by the addition of sat. 
aq. NH4Cl. Phases were separated and the organic layer was dried with MgSO4. The solvent was 
removed under reduced pressure yielding 441 (1 g, 1.6 mmol, 93%) of satisfying purity as slightly 
yellow oil.  
1H-NMR (250MHz, CDCl3):  = 7.42 (m, 4H); 7.25 (m, 8H); 6.82 (d, J = 8.9Hz, 2H); 4.31 (m, 1H); 4.04 
(m, 2H); 3.80 (s, 3H); 3.11 (m, 1H); 2.99 (m, 1H); 2.72 (m, 1H); 2.59 (m, 1H); 2.31 (m, 2H); 1.99 (s, 
3H); 1.61 (m ,2H); 1.00 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C38H52O5Si: 616.3584; found: 616.3568 
 
2-((1R,2R,4S)-2-(hydroxymethyl)-4-((triisopropylsilyl)oxy)cyclobutyl)ethyl acetate (442) 
 
Crude 441 (1 g, 1.6 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (20 mL) and cooled to 0 °C. A 
solution of CSA (18.6 mg, 0.08 mmol, 0.05 eq.) in anhydrous MeOH (2 mL) was added dropwise 
and the reaction mixture was allowed to stir for one hour at 0 °C. The reaction was quenched by 
the addition of aq. sat. NaHCO3. The phases were separated and the aqueous phase was extracted 
twice with CH2Cl2. The combined organic layers were dried with MgSO4 and the solvent was 
removed in vacuo. Purification by silica gel chromatography (hexane/EtOAc = 4/1) yielded pure 
primary alcohol 442 (453 mg, 1.3 mmol, 81%) as colorless oil.  
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1H-NMR (250MHz, CDCl3):  = 4.33 (m, 1H); 4.13 (m, 2H); 3.67 (m, 2H); 2.58 (m, 1H); 2.32 (m, 1H); 
2.19 (m, 1H); 2.04 (s, 3H); 2.00 (m, 2H); 1.77 (m ,2H); 1.04 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C18H36O4Si: 344.2383; found: 344.2374 
 
2-((1R,2R,4S)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)ethanol (336) 
 
Primary alcohol 442 (453 mg, 1.3 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (10 mL). 
Pyridine (430 µL, 5.22 mmol, 4 eq.) and DMAP (16 mg, 0.13 mmol, 0.1 eq.) were added to the 
solution and it was cooled to 0 °C. A solution of TBDPS-Cl (718 mg, 2.61 mmol, 2 eq.) in anhydrous 
CH2Cl2 (3 mL) was added. The reaction mixture was allowed to stir at 0 °C for two hours, and then 
it was quenched by the addition of sat. aq. NH4Cl. The phases were separated and the organic 
layer was washed with NH4Cl. The organic layer was dried with brine and MgSO4. Purification by 
silica gel chromatography (hexane/EtOAc = 10/1) yielded the pure silyl ether (758 mg, 1.3 mmol, 
quant.) as colorless liquid.  
758 mg (1.3 mmol, 1.0 eq.) of the previously prepared silyl ether were dissolved in as little 
anhydrous CH2Cl2 as possible. 13 mL of anhydrous MeOH and 1.82 g (13.1 mmol, 10 eq.) of finely 
ground K2CO3 were added. The reaxtion mixture was stirred for one hour and then filtered through 
a pad of celite. Et2O (100 mL) was added to the resulting solution. 
The pH of the solution was adjusted to 7 by the addition of 0.5M KHSO4 solution and the phases 
were separated. The organic phase was extracted twice with water and the combined aqueous 
phases were back-extracted with Et2O/hexane (1/1). The combined organic layers were dried with 
MgSO4 and the solvent was removed under reduced pressure. Purification by silica gel 
chromatography (hexane/EtOAc = 5/1) yielded 600 mg (1.11 mmol, 84%) of primary alcohol 336 as 
colorless oil. 
1H-NMR (250MHz, CDCl3):  = 7.65 (m, 4H); 7.41 (m, 6H); 4.31 (m, 1H); 3.70 (m, 4H); 2.76 (m, 1H); 
2.66 (m, 1H); 2.17 (m, 2H); 1.97 (m, 1H); 1.80 (m, 1H); 1.66 (m, 1H); 1.04 (m, 30H) 
HRMS (ESI) (m/z): [M]+ calcd. for C32H52O3Si2: 540.3455; found: 540.3442  
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2-((1R,2R,4S)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)acetic acid (337) 
 
Mono-TBDPS-protected triol 336 (600 mg, 1.11 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc 
(11 mL) and IBX (931 mg, 3.33 mmol, 3 eq.) was added. The reaction mixtures was refluxed for two 
hours or until all starting material was consumed. Now hexane (11 mL) was added and the 
suspension was filtered through a pad of celite 545 coarse. Removal of the solvents gave the 
aldehyde (560 mg, 1.04 mmol, 94%) as colorless oil, which was used without further purification.  
The previously prepared aldehyde (560 mg, 1.04 mmol, 1.0 eq.) was dissolved in t-BuOH (5 mL) 
and 1 mL of 2-methyl-but-2-ene was added. The reaction mixture was cooled to 0 °C and an 
aqueous solution (3 mL) of NaClO2 (1.4 g, 15.59 mmol, 15 eq.) and NaH2PO4.H2O (1.4 g, 10.1 mmol, 
9.8 eq.) was added at once. The reaction mixture was stirred at 0 °C for one hour and Et2O and 
water were added. The phases were separated and the organic layer was washed twice with water 
before it was dried with MgSO4. Removal of the solvent under reduced pressure yielded pure 
carboxylic acid 337 (577 mg, 1.04 mmol, quant.) as colorless oil.  
1H-NMR (250MHz, CDCl3):  = 7.65 (m, 4H); 7.41 (m, 6H); 5.67 (bs, 1H); 4.39 (m, 1H); 3.65 (m, 2H); 
3.05 (1H); 2.76 (m, 1H); 2.63 (m, 1H); 2.22 (m, 2H); 1.77 (m, 1H); 1.03 (m, 30H) 
HRMS (ESI) (m/z): [M]+ calcd. for C32H50O4Si2: 554.3248; found: 554.3232  
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Bis(2,2,2-trifluoroethyl) (3-((1R,2R,4S)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)-2-oxopropyl)phosphonate (339) 
 
Carboxylic acid 337 (56 mg, 0.1 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (1 mL) and the 
solution was cooled to 0 °C. Ghosez’s reagent (1-Chloro-N,N,2-trimethyl-1-propenylamine; 134 mg, 
1.0 mmol, 10 eq.) was added and the reaction mixture was stirred a 0 °C for four hours. After that 
period of time the solvent was removed in vacuo and the crude acid chloride was used without 
further purification. 
Bis(2,2,2-trifluoroethyl) methylphosphonate (39 mg, 0.15 mmol, 1.5 eq.) was dissolved in 
anhydrous THF (1 mL) and the solution was cooled to -110 °C.[137] LiHMDS (1M in THF; 140 µL, 
0.14 mmol, 1.4 eq.) was added dropwise and the temperature was controlled carefully. The 
reaction mixture was allowed to stir at -110 °C for 10 min, then it was cooled to -150 °C, where the 
solvent (THF) got solid. A solution of the previously prepared acid chloride (57 mg, 0.1 mmol, 
1.0 eq.) in anhydrous THF (1 mL) was added dropwise to the solid THF. After the addition, the 
reaction mixture was allowed to warm to -110 °C again where it was stirred for 30 minutes. 
Afterwards it was again allowed to warm to -95 °C, where it was quenched by the addition of sat. 
aq. NH4Cl and Et2O. The phases were separated and the aqueous phase was extracted twice with 
Et2O. The combined organic layers were dried with MgSO4 and the solvent was removed in vacuo. 
Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded pure -keto phosphonate 
339 (59 mg, 0.08 mmol, 75%) as colorless oil.  
1H-NMR (250MHz, CDCl3):  = 7.63(m, 4H); 7.41 (m, 6H); 4.40 (m, 5H); 3.62 (d, J = 5.7Hz, 2H); 3.26 
(s, 1H); 3.18 (s, 1H); 3.12 (m, 1H); 2.91 (m, 1H); 2.68 (m, 1H); 2.21 (m, 2H); 1.71 (m, 1H); 1.05 (s, 
9H); 1.01 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C37H55F6O6PSi2: 796.3179; found: 796.3165 
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Bis(2,2,2-trifluoroethyl) (1-bromo-3-((1R,2R,4S)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)-2-oxopropyl)phosphonate (340) 
 
The following procedure was adapted from Tago and Kogen.[138] To a suspension of NaH (60% in 
mineral oil; 2.7 mg, 69 µmol, 1.0 eq.) in anhydrous THF (500 µL) was added a solution of -keto 
phosphonate 339 (55 mg, 69 µmol, 1.0 eq.) in anhydrous THF (500 µL) dropwise at 0 °C. The 
reaction mixture was stirred for 30 minutes at 0 °C and 15 minutes at r.t. After re-cooling to 0 °C 
bromine (2.5 µL, 48 µmol, 0.7 eq.) was added and the solution was allowed to stir for two hours at 
0 °C. After quenching with aq. sat. Na2S2O3 and addition of Et2O the phases were separated and 
the aqueous layers was extracted twice with Et2O. The combined organic layers were dried with 
MgSO4 and the solvent was removed in vacuo. Purification by silica gel chromatography 
(hexane/EtOAc = 5/1) yielded pure mono brominated -keto phosphonate 340 (50 mg, 57 µmol, 
83%) as colorless oil. 
1H-NMR (250MHz, CDCl3):  = 7.63(m, 4H); 7.41 (m, 6H); 4.47 (m, 5H); 3.62 (m, 2H); 3.10 (m, 3H); 
2.24 (m, 2H); 1.72 (m, 2H); 1.04 (s, 9H); 1.01 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C37H54BrF6O6PSi2: 854.2284; found: 854.2271 
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(E)--bromo-enone (341) 
 
A flame dried Schlenk tube was charged with anhydrous THF (500 µL) and KOtBu (3.4 mg, 
30.4 µmol, 0.95 eq.) and 18-crown-6 (9.3 mg, 35.2 µmol, 1.1 eq.) were added. The solution was 
cooled to -78 °C. A solution of brominated -keto phosphonate 340 (28 mg, 32 µmol, 1.0 eq.) in 
anhydrous THF (500 µL) was added dropwise and the reaction mixture was allowed to stir for 30 
minutes. A solution of aldehyde 330a (14.8 mg, 28.8 µmol, 1.0 eq.) in anhydrous THF (500 µL) was 
added dropwise. The solution was stirred for 30 minutes at -78 °C and then was allowed to warm 
to r.t. overnight. The reaction was quenched by the addition of sat. aq. NH4Cl and Et2O was added. 
The phases were separated and the aqueous layer was extracted twice with Et2O. The combined 
organic layers were dried with MgSO4 and the solvent was removed under reduced pressure. 
Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded pure (E)-enone 341 (20 mg, 
17.6 µmol, 61%) as colorless oil.  
1H-NMR (400MHz, CDCl3):  = 7.65 (m, 4H); 7.39 (m, 6H); 6.45 (d, J = 7.6Hz, 1H); 6.07 (d, J = 9.0Hz, 
1H); 5.46 (d, J = 9.0Hz, 1H); 4.97 (dt, J = 8.2, 2.7Hz, 1H); 4.78, 4.76 (s, 2H); 4.38 (m, 2H); 3.78 (s, 
3H); 3.67 (m, 2H); 3.14 (m, 1H); 2.79 (dd, J = 19.5, 3.9Hz, 1H); 2.25 (m, 3H); 1.88 (s, 3H); 1.46 (m, 
1H); 1.29 (m, 2H); 1.03 (s, 9H); 0.99 (s, 21H); 0.82 (s, 9H); -0.10 (m, 6H) 
13C-NMR (100MHz, CDCl3):  = 196.8; 153.0; 150.5; 142.5; 142.3; 135.6; 133.8; 133.7; 129.6; 127.7; 
127.6; 120.5; 117.9; 82.4; 82.2; 77.5; 77.1; 69.8; 69.7; 65.2; 65.1; 65.0; 64.7; 52.9; 52.8; 52.7; 45.9; 
45.8; 38.7; 36.0; 34.6; 31.1; 26.9; 25.8; 25.7; 19.2; 18.0; 17.9; 17.4; 13.7; 12.0; -4.8; -5.1 
HRMS (ESI) (m/z): [M]+ calcd. for C53H78BrCl3O9Si3: 1126.3203; found: 1126.3194 
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(E)--bromo-allylic alcohol (443) 
 
Enone 341 (17 mg, 15µmmol, 1.0 eq.) was dissolved in anhydrous MeOH (1 mL) and CeCl3.7H2O 
(17 mg, 45 µmol, 3 eq.) was added. The reaction mixture was cooled to -78 °C and NaBH4 (3.5 mg, 
90 µmol, 6 eq.) was added portionwise in an Ar-stream. The reaction was allowed to stir for one 
hour and then quenched by the addition of sat. aq. NH4Cl. Et2O was added and the phases were 
separated. The aqueous phase was carefully acidified to pH 5-6. The layers were recombined and 
vigorously mixed. Separation, pH adjusting and mixing cycle was repeated 3 times, then the 
separated organic layer was dried with MgSO4 and the solvent was removed under reduced 
pressure. Silica gel chromatography (hexane/EtOAc = 10/1) yielded pure allylic alcohol 443 
(13.5 mg, 12 µmol, 79%) as colorless viscous oil.  
1H-NMR (400MHz, CDCl3):  = 7.67 (m, 4H); 7.39 (m, 6H); 6.04 (d, J = 9.0Hz, 1H); 5.90 (d, J = 8.8Hz, 
1H); 5.41 (t, J = 9.0Hz, 1H); 4.77 (s, 2H); 4.68 (m, 2H); 4.40 (m, 1H); 4.30 (m, 1H); 3.78 (s, 3H); 3.70 
(m, 1H); 3.60 (m, 1H); 2.79 (m, 1H); 2.35 (m, 1H); 2.18 (m, 4H); 1.85 (m, 1H); 1.80, 1.78 (s, 3H); 1.46 
(m, 1H); 1.09 (m, 9H); 1.03 (m, 21H); 0.85 (m, 9H); 0.00 (m, 6H) 
13C-NMR (100MHz, CDCl3):  = 152.9; 142.1; 136.4; 135.6; 130.5; 129.8; 129.6; 127.7; 127.6; 120.5; 
97.5; 82.3; 77.1; 71.5; 71.4; 68.5; 68.4; 66.0; 65.0; 64.3; 63.9; 52.8; 43.2; 40.9; 35.0; 34.2; 32.3; 
30.6; 29.7; 29.3; 26.9; 26.8; 25.7; 19.2; 19.1; 18.0; 17.9; 12.3; 12.0 
HRMS (ESI) (m/z): [M]+ calcd. for C53H80BrCl3O9Si3: 1128.3359; found: 1128.3347 
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(S,E)-2,6-bis((tert-butyldimethylsilyl)oxy)-4-methylhex-4-en-1-ol (444) 
 
TBS-protected vinyl iodide 428 (2.81 g, 9.0 mmol, 1.0 eq.) was dissolved in anhydrous Et2O (90 mL) 
and the solution was cooled to -78 °C. t-BuLi (1.6M in pentane; 11.8 mL, 18.9 mmol, 2.1 eq.) was 
added dropwise. After completion of the addition stirring was continued for 30 minutes. Freshly 
prepared 2-thienyl-Cu(CN)Li (0.5M in THF; 18.0 mL, 9.0 mmol, 1.0 eq.) was added via cannula to 
the reaction mixture.[112] The solution turned yellow and stirring was continued for one hour at -
78 °C. A solution of MMTr-protected (R)-glycidol 284 (3.7 g, 10.8 mmol, 1.2 eq.) in 10 mL 
anhydrous Et2O was added dropwise. Stirring was continued at -78 °C for two hours and then at 
r.t. for one hour (the solution turned dark). The reaction mixture was quenched by the addition of 
a 3/1 mixture of sat. aq. NH4Cl/25% aq. NH4OH. The phases were separated and the organic layer 
was extracted twice with NH4Cl before it was dried with brine and MgSO4. Removal of the solvent 
under reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 10/1 to 
5/1) yielded the pure secondary alcohol (3.8 g, 7.1 mmol, 79%) as slightly yellow, viscous oil.  
The previously prepared secondary alcohol (300 mg, 0.56 mmol, 1.0 eq.) was dissolved in 
anhydrous CH2Cl2 (6 mL) and 2,6-lutidine (211 mg, 1.97 mmol, 3.5 eq.) was added. The reaction 
mixture was cooled to 0 °C and TBS-OTf (168 µL, 0.73 mmol, 1.3 eq.) was added dropwise. The 
solution was allowed to stir for one hour. It was quenched by the addition of sat. aq. NaHCO3 and 
the phases were separated. The aqueous phase was extracted twice with CH2Cl2 and the combined 
organic phases were washed with brine and dried with MgSO4.After removal of the solvent under 
reduced pressure, purification by silica gel chromatography yielded the pure bis-ether (353 mg, 
0.55 mmol, 97%) as slightly yellow viscous oil. 
The previously prepared bis-ether (353 mg, 0.55 mmol, 1.0 eq.) was dissolved in 5 mL of a 4/1 
mixture CH2Cl2/MeOH. PPTS (13.8 mg, 55 µmol, 0.1 eq.) was added and the reaction mixture was 
allowed to stir at r.t. until TLC analysis indicated full consumption of the starting material (approx. 
two hours). The reaction mixture was quenched with saturated aqueous NaHCO3. The phases were 
separated and the aqueous layer was extracted two times with Et2O. The combined organic layers 
were dried with MgSO4 and the solvent was removed under reduced pressure. Purification by silica 
gel chromatography (hexane/EtOAc = 4/1) yielded free primary alcohol 444 as colorless viscous oil 
(131 mg, 0.35 mmol, 64%).  
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1H-NMR (250MHz, CDCl3):  = 5.34 (t, J = 6.3Hz, 1H); 4.17 (m, 2H); 3.76 (m, 1H); 3.45 (m ,2H); 2.27 
(m, 1H); 2.04 (m ,1H); 1.64 (s, 3H); 0.89 (s, 9H); 0.86 (s, 9H); 0.06 (s, 6H); 0.04 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C19H42O3Si2: 374.2672; found: 374.2661 
 
(S,3E,7E)-5,9-bis((tert-butyldimethylsilyl)oxy)-1-((1R,2R,4S)-2-(((4-
methoxyphenyl)diphenylmethoxy)methyl)-4-((triisopropylsilyl)oxy)cyclobutyl)-7-
methylnona-3,7-dien-2-one (445) 
 
Primary alcohol 444 (131 mg, 0.35 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (4 mL) and IBX 
(197 mg, 0.70 mmol, 2 eq.) was added. The suspension was heated to reflux for three hours. Now 
the suspension was cooled to r.t. and 4 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed under reduced pressure. The crude 
product was of satisfying purity for further conversion. The aldehyde was obtained as viscous oil 
(131 mg, 0.35 mmol, quant.).
-keto phosphonate 439 (60 mg, 86 µmol, 1.0 eq.) was dissolved in anhydrous THF (500 µL) and 
the reaction mixture was cooled to -78 °C. LiHMDS (1M in THF; 90 µL, 90 µmol, 1.05 eq.) was 
added dropwise and the reaction mixture was stirred at -78 °C for one hour until a solution of the 
previously prepared aldehyde (32 mg, 86 µmol, 1.0 eq.) in anhydrous THF (500 µL) was added 
dropwise. The solution was stirred for 30 minutes at -78 °C, then it was allowed to warm to -10 °C 
with a rate of approx. 1 °C/minute. The reaction was quenched by the addition of sat. aq. NH4Cl 
and Et2O was added. The phases were separated and the aqueous layer was extracted twice with 
Et2O. The combined organic layers were dried with MgSO4 and the solvent was removed under 
reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded pure 
enone 445 (46 mg, 49 µmol, 57%) as colorless oil.  
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1H-NMR (250MHz, CDCl3):  = 7.40 (m, 4H); 7.23 (m, 8H); 6.80 (d, J = 8.8Hz, 2H); 6.59 (dd, J = 15.8, 
4.9Hz, 1H); 6.1 (dd, J = 15.8, 1.0Hz, 1H); 5.37 (m, 1H); 4.33 (m, 2H); 4.15 (d, J = 5.7Hz, 2H); 4.07 (m, 
1H); 3.78 (s, 3H); 3.21 (m, 1H); 3.02 (m, 2H); 2.86 (m, 1H); 2.38 (m, 4H); 2.10 (m, 2H); 1.61 (s, 3H); 
1.60 (m, 2H); 0.94 (s, 18H); 0.89 (s, 21H); 0.00 (m, 12H) 
HRMS (ESI) (m/z): [M]+ calcd. for C56H88O6Si3: 940.5889; found: 940.5876 
 
4.2.12 Southern Lactone Approach (cBu) 
 
(S,E)-7-((tert-butyldimethylsilyl)oxy)-5-methylhepta-1,5-dien-3-ol (446) 
 
Trimethylsulfonium iodide (631 mg, 3.1 mmol, 3 eq.) was suspended in anhydrous THF (3 mL) and 
the suspension was cooled to -20 °C. n-BuLi (2.5M in hexane; 1.2 mL, 2.99 mmol, 2.9 eq.) was 
added dropwise and the reaction mixture was allowed to stir for 30 minutes. A solution of epoxide 
314 (250 mg, 1.03 mmol, 1.0 eq.) in anhydrous THF (2 mL) was slowly added and the mixture 
turned milky. The reaction mixture was stirred at -20 °C for two hours, then it was allowed to 
warm to r.t. within one hour and finally it was stirred at r.t. for another two hours before it was 
quenched with water at 0 °C. Et2O was added and the phases were separated. The pH of the 
aqueous phase was carefully neutralized with 0.5M KHSO4 and it was extracted two more times 
with Et2O. The combined organic layers were dried with brine and MgSO4 and the solvent was 
removed under reduced pressure. Silica gel chromatography (hexane/EtOAc = 7/1 to 5/1) yielded 
pure secondary allylic alcohol 446 (195 mg, 0.76 mmol, 74%) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 5.87 (ddd, J = 17.2, 10.6, 5.8Hz, 1H); 5.44 (dt, J = 6.2, 1.0Hz, 1H); 5.27 
(dt, J = 17.2, 1.3Hz, 1H); 5.11 (dt, J = 10.6, 1.3Hz, 1H); 4.24 (m, 1H); 4.21 (d, J = 6.2Hz, 2H); 2.22 (m, 
2H); 1.68 (s, 3H); 0.90 (s, 9H); 0.07 (s, 6H) 
13C-NMR (100MHz, CDCl3):  = 140.5; 133.1; 128.7; 114.6; 70.2; 60.0; 47.6; 26.0; 18.4; 16.5; -5.1 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C14H28O2SiNa: 279.1756; found: 279.1748 
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(S,E)-tert-butyl((5-((4-methoxyphenyl)diphenylmethoxy)-3-methylhepta-2,6-dien-1-
yl)oxy)dimethylsilane (348) 
 
Allylic alcohol 446 (410 mg, 1.6 mmol, 1.0 eq.) was dissolved in 10 mL anhydrous CH2Cl2 and DMAP 
(20 mg, 0.16 mmol, 0.1 eq.) and pyridine (206 µL, 2.6 mmol, 1.6 eq.) were added. The reaction 
mixture was cooled to 0 °C. A solution of MMTr-Cl (741 mg, 2.4 mmol, 1.5 eq.) in anhydrous CH2Cl2 
(3 mL) was added dropwise to the solution. The reaction mixture was allowed to warm to r.t. 
within two hours. Then it was quenched by the addition of sat. aq. NH4Cl solution. Phases were 
separated and the aqueous phase was extracted twice with 100 mL CH2Cl2, respectively. The 
combined organic layers were dried with brine and MgSO4. Solvents were removed under reduced 
pressure and the crude product was purified using silica gel chromatography (hexane/EtOAc = 7/1) 
yielding pure compound 348 (835 mg, 1.6 mmol, quant.) as slightly orange oil.  
1H-NMR (400MHz, CDCl3):  = 7.52 (m, 4H); 7.39 (d, J = 8.9Hz, 2H); 7.23 (m, 6H); 6.80 (d, J = 8.9Hz, 
2H); 5.65 (m, 1H); 5.18 (dt, J = 6.4, 1.1Hz, 1H); 4.79 (m, 2H); 4.09 (d, J = 6.2Hz, 2H); 4.01 (m, 1H); 
3.79 (s, 3H); 1.85 (m, 2H); 1.36 (s, 3H); 0.88 (s, 9H); 0.03 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C34H44O3Si: 528.3060; found: 528.3051 
 
(S,E)-5-((4-methoxyphenyl)diphenylmethoxy)-3-methylhepta-2,6-dien-1-ol (447) 
 
Compound 348 (850 mg, 1.6 mmol, 1.0 eq.) was dissolved in anhydrous THF (15 mL) and the 
reaction mixture was cooled to 0 °C. 7%HF in pyridine (4.2 mL, 16 mmol, 10 eq.) was added 
dropwise and the reaction mixture was allowed to stir overnight. The reaction was quenched by 
the careful addition of sat. aq. NaHCO3. The phases were separated and the organic layer was 
extracted twice with NaHCO3. The combined organic layers were back-extracted twice with CH2Cl2 
and the combined organic layers were dried with brine and MgSO4. After removal of the solvent 
under reduced pressure silica gel chromatography (hexane/EtOAc = 4/1) yielded pure allylic 
alcohol 447 (656 mg, 1.57 mmol, 98%) as slightly yellow oil.  
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1H-NMR (400MHz, CDCl3):  = 7.52 (m, 4H); 7.39 (d, J = 8.9Hz, 2H); 7.23 (m, 6H); 6.80 (d, J = 8.9Hz, 
2H); 5.66 (m, 1H); 5.29 (t, J = 6.9Hz, 1H); 4.80 (m, 2H); 4.04 (m, 3H); 3.79 (s, 3H); 1.87 (m, 2H); 1.42 
(s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C28H30O3: 414.2195; found: 414.2183 
 
(8S,E)-methyl 4-hydroxy-8-((4-methoxyphenyl)diphenylmethoxy)-6-methyldeca-5,9-dien-
2-ynoate (351) 
 
Allylic alcohol 447 (600 mg, 1.45 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (15 mL) and IBX 
(1.22 g, 4.35 mmol, 3 eq.) was added. The reaction mixtures was refluxed for two hours or until all 
starting material was consumed. Hexane (15 mL) was added and the suspension was filtered 
through a pad of celite 545 coarse. Removal of the solvents gave the corresponding aldehyde 
(578 mg, 1.4 mmol, 97%) as colorless oil.  
Methyl propiolate (194 µL, 2.18 mmol, 1.5 eq.) was dissolved in anhydrous THF (10 mL) and the 
reaction mixture was cooled to -78 °C. LiHMDS (1M in THF, 2.33 mL, 2.33 mmol, 1.6 eq.) was 
added dropwise and the solution was allowed to stir for 30 minutes. A solution of the previously 
prepared aldehyde (578 mg, 1.4 mmol, 1.0 eq.) in anhydrous THF (10 mL) was added dropwise. 
The reaction mixture was allowed to stir for 30 minutes until it was quenched by the addition of 
sat. aq. NH4Cl. The phases were separated and the aqueous phase was carefully acidified and 
extracted twice with Et2O. The combined organic phases were dried with MgSO4 and the solvents 
were removed under reduced pressure. The resulting allylic alcohol 351 (695 mg, 1.4 mmol, 
quant.) was obtained as an inconsequential diastereomeric mixture (d.r. = 1.37/1) and was of 
satisfying purity for further conversion.  
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Major: 
1H-NMR (400MHz, CDCl3):  = 7.51 (m, 4H); 7.39 (d, J = 8.9Hz, 2H); 7.27 (m, 4H); 7.21 (d, J = 6.9Hz, 
2H); 6.81 (d, J = 8.9Hz, 2H); 5.67 (m, 1H); 5.18 (m, 1H); 5.05 (m, 1H); 4.83 (m, 2H); 4.03 (m, 1H); 
3.79 (s, 3H); 3.75 (s, 3H); 1.87 (m, 2H); 1.43 (s, 3H) 
13C-NMR (100MHz, CDCl3):  = 158.6; 153.9; 145.4; 139.1; 136.6; 136.0; 130.8; 128.9; 128.8; 127.6; 
127.5; 126.8; 126.4; 114.1; 112.9; 87.8; 87.2; 75.3; 74.0; 59.2; 55.2; 52.6; 46.0; 17.3 
HRMS (ESI) (m/z): [M]+ calcd. for C32H32O5Na: 519.2147; found: 519.2132 
Minor: 
1H-NMR (400MHz, CDCl3):  = 7.51 (m, 4H); 7.39 (d, J = 8.9Hz, 2H); 7.27 (m, 4H); 7.21 (d, J = 6.9Hz, 
2H); 6.81 (d, J = 8.9Hz, 2H); 5.67 (m, 1H); 5.18 (m, 1H); 5.05 (m, 1H); 4.83 (m, 2H); 4.03 (m, 1H); 
3.79 (s, 3H); 3.73 (s, 3H); 1.77 (m, 2H); 1.43 (s, 3H) 
13C-NMR (100MHz, CDCl3):  = 158.6; 153.9; 145.5; 139.5; 136.6; 136.2; 130.8; 128.9; 128.8; 127.6; 
127.5; 126.8; 126.3; 114.1; 112.9; 87.8; 87.1; 75.3; 74.0; 59.2; 55.2; 52.6; 46.2; 17.1 
HRMS (ESI) (m/z): [M]+ calcd. for C32H32O5Na: 519.2147; found: 519.2139 
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3-(((tert-butyldimethylsilyl)oxy)methyl)-1-((1R,2R,4S)-2-(((4-
methoxyphenyl)diphenylmethoxy)methyl)-4-((triisopropylsilyl)oxy)cyclobutyl)but-3-en-2-
ol (352) 
 
Primary alcohol 193 (1.0 g, 1.74 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (20 mL) and IBX 
(975 mg, 3.5 mmol, 2 eq.) was added. The suspension was heated to reflux for four hours. Now the 
suspension was cooled to r.t. and 20 mL of hexane were added. The suspension was filtered 
through a pad of celite and the solvents were removed under reduced pressure. The crude 
product (997 mg, 1.74 mmol, quant.) was used without further purification. 
Anhydrous NiCl2 (312 mg, 2.4 mmol, 2 eq.) and anhydrous CrCl2 (737 mg, 6 mmol, 5 eq.) were 
suspended in anhydrous, degassed DMF (5 pump & freeze cycles, 3 mL) in a flame dried Schlenk 
tube, giving a dark green solution. The solution was cooled to 0 °C and solutions of the previously 
prepared aldehyde (690 mg, 1.2 mmol, 1.0 eq.) in anhydrous, degassed DMF (5 pump & freeze 
cycles, 3 mL) and vinylbromide 407a (605 mg, 2.4 mmol, 2 eq.) in anhydrous, degassed DMF (5 
pump & freeze cycles, 3 mL) were added dropwise isochronally. The reaction mixture was allowed 
to warm to r.t. overnight. NH4Cl and EtOAc were added and the phases were separated. The 
organic layer was washed with water twice and dried with brine and MgSO4. The solvent was 
removed in vacuo and purification by silica gel chromatography (hexane/EtOAc = 7/1) yielded pure 
NHK-product 352 (934 mg, 1.2 mmol, quant.) as colorless oil (d.r. = 1.34/1).  
1H-NMR (400MHz, CDCl3):  = 7.42 (m, 4H); 7.28 (m, 6H); 7.21 (m, 2H); 6.82 (m, 2H); 5.02 (m, 2H); 
4.35 (m, 1H); 4.13 (m, 3H); 3.79 (s, 3H); 3.13 (m, 1H); 2.97 (m, 1H); 2.76 (m, 1H); 2.32 (m, 2H); 1.87 
(m, 1H); 1.62 (m, 2H); 1.04 (m, 21H); 0.88 (d, J = 2.28Hz, 9H); 0.01 (m, 6H) 
13C-NMR (100MHz, CDCl3):  = 158.5; 151.0; 150.4; 144.8; 144.6; 144.5; 135.9; 130.2; 128.4; 128.3; 
127.7; 126.8; 113.0; 109.4; 108.9; 86.0; 73.5; 71.5; 66.2; 66.1; 64.1; 64.0; 63.9; 63.3; 55.2; 42.8; 
40.0; 35.6; 35.3; 30.1; 30.0; 29.0; 28.6; 25.9; 18.0; 17.9; 12.1; -5.4 
HRMS (ESI) (m/z): [M]+ calcd. for C45H68O5Si2: 744.4605; found: 744.4594 
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8-(((1R,2R,4S)-2-(((4-methoxyphenyl)diphenylmethoxy)methyl)-4-
((triisopropylsilyl)oxy)cyclobutyl)methyl)-12,12,13,13-tetramethyl-9-methylene-2,5,7,11-
tetraoxa-12-silatetradecane (448) 
 
Secondary allylic alcohol 352 (930 mg, 1.2 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 
(13 mL) and the solution was cooled to 0 °C. DIPEA (2.2 mL, 12.5 mmol, 10 eq.) was added and the 
reaction mixture was stirred for 15 minutes. MEM-Cl (712 µL, 6.24 mmol, 5 eq.) was added 
dropwise. The reaction mixture was allowed to warm to r.t. overnight, and then it was quenched 
with sat. aq. NH4Cl and the phases were separated. The aqueous phase was extracted twice with 
CH2Cl2 and the combined organic layers were dried with MgSO4. The solvent was removed under 
reduced pressure. Purification by silica gel chromatography (hexane/EtOAc = 7/1) yielded pure 
compound 448 (811 mg, 0.97 mmol, 78%) as colorless oil.  
1H-NMR (400MHz, CDCl3):  = 7.41 (m, 4H); 7.28 (m, 6H); 7.21 (m, 2H); 6.81 (m, 2H); 5.02 (m, 2H); 
4.77 (s, 1H); 4.73 (s, 1H); 4.35 (m, 1H); 4.13 (m, 3H); 3.79 (s, 3H); 3.72 (m, 2H); 3.57 (m, 2H); 3.40 
(s, 3H); 3.13 (m, 1H); 2.97 (m, 1H); 2.76 (m, 1H); 2.32 (m, 2H); 1.87 (m, 1H); 1.58 (m, 2H); 1.03 (m, 
21H); 0.88 (m, 9H); 0.01 (m, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C49H76O7Si2: 832.5130; found: 832.5122 
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(1R,2R,3S)-2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-2-((2-methoxyethoxy)methoxy)but-
3-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutanecarbaldehyde (449) 
 
Bis allylic alcohol 448 (680 mg, 0.82 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (3 mL) and 
hexafluoroisopropanol (HFIP, 3 mL) was added. The solution was allowed to stir at r.t. for 15 
minutes during which time it turned yellow. Anhydrous MeOH was added until the color 
disappeared and the solution was allowed to stir at r.t. for 2 days. Solvents were removed under 
reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 4/1) yielded the 
pure primary alcohol (400 mg, 0.71 mmol, 87%) as colorless viscous oil. 
The previously prepared primary alcohol (400 mg, 0.71 mmol, 1.0 eq.) was dissolved in anhydrous 
EtOAc (7 mL) and IBX (500 g, 1.78 mmol, 2.5 eq.) was added. The reaction mixtures was refluxed 
for two hours or until all starting material was consumed. Now hexane (7 mL) was added and the 
suspension was filtered through a pad of celite 545 coarse. Removal of the solvents gave aldehyde 
449 (400 mg, 0.71 mmol, quant.) as colorless oil.  
Major:  
1H-NMR (400MHz, CDCl3):  = 9.88 (d, J = 2.5Hz, 1H); 5.25 (q, J = 2.0Hz, 1H); 5.05 (m, 1H); 4.66 (m, 
1H); 4.55 (m, 1H); 4.41 (m, 1H); 4.09 (m, 3H); 3.76 (m, 1H); 3.55 (m, 3H); 3.38 (s, 3H); 3.13 (m, 1H); 
2.84 (m, 1H); 2.40 (m, 1H); 2.26 (m, 1H); 1.95 (m, 1H); 1.80 (m, 1H); 1.04 (s, 21H); 0.90 (s, 9H); 0.05 
(s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C29H58O6Si2: 558.3772; found: 558.3764 
Minor: 
1H-NMR (400MHz, CDCl3):  = 9.80 (d, J = 2.8Hz, 1H); 5.28 (q, J = 2.0Hz, 1H); 5.05 (m, 1H); 4.66 (m, 
1H); 4.55 (m, 1H); 4.41 (m, 1H); 4.09 (m, 3H); 3.76 (m, 1H); 3.55 (m, 3H); 3.39 (s, 3H); 2.95 (m, 1H); 
2.84 (m, 1H); 2.40 (m, 1H); 2.26 (m, 1H); 1.95 (m, 1H); 1.80 (m, 1H); 1.04 (s, 21H); 0.90 (s, 9H); 0.05 
(s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C29H58O6Si2: 558.3772; found: 558.3762  
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(1S,2R,3S)-2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-2-((2-methoxyethoxy)methoxy)but-
3-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutanecarbaldehyde (354) 
 
400 mg (0.71 mmol, 1.0 eq.) of aldehyde 449 were dissolved in as little anhydrous CH2Cl2 as 
possible. Anhydrous MeOH (7 mL) and finely ground K2CO3 (1.0 g, 7.1 mmol, 10 eq.) were added. 
The reaction mixture was stirred for one hour and then filtered through a pad of celite. Et2O 
(10 mL) was added to the resulting solution. The pH of the solution was adjusted to neutral by the 
addition of 0.5M KHSO4 solution and the phases were separated. The organic phase was extracted 
twice with water and the combined aqueous phases were back-extracted with Et2O/hexane (1/1). 
The combined organic layers were dried with MgSO4 and the solvent was removed in vacuo giving 
400 mg (0.71 mmol, quant.) of inverted aldehyde 354 as colorless oil, which was of excellent 
purity. 
Major:  
1H-NMR (400MHz, CDCl3):  = 9.80 (d, J = 1.8Hz, 1H); 5.26 (q, J = 1.9Hz, 1H); 5.09 (d, J = 1.1Hz, 1H); 
4.70 (m, 1H); 4.59 (m, 1H); 4.40 (m, 1H); 4.15 (m, 3H); 3.75 (m, 1H); 3.55 (m, 3H); 3.38 (s, 3H); 2.92 
(m, 1H); 2.86 (m, 1H); 2.54 (m, 1H); 2.14 (m, 1H); 2.02 (m, 1H); 1.86 (m, 1H); 1.03 (s, 21H); 0.91 (s, 
9H); 0.06 (m, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C29H58O6Si2: 558.3772; found: 558.3763 
Minor: 
1H-NMR (400MHz, CDCl3):  = 9.77 (d, J = 2.1Hz, 1H); 5.29 (q, J = 2.0Hz, 1H); 5.05 (d, J = 1.5Hz, 1H); 
4.70 (m, 1H); 4.59 (m, 1H); 4.40 (m, 1H); 4.15 (m, 3H); 3.75 (m, 1H); 3.55 (m, 3H); 3.38 (s, 3H); 2.92 
(m, 1H); 2.82 (m, 1H); 2.54 (m, 1H); 2.14 (m, 1H); 2.02 (m, 1H); 1.86 (m, 1H); 1.03 (s, 21H); 0.91 (s, 
9H); 0.0m (m, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C29H58O6Si2: 558.3772; found: 558.3766 
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(1S,2R,3S)-2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-2-((2-methoxyethoxy)methoxy)but-
3-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutanecarboxylic acid (450) 
 
Aldehyde 354 (400 mg, 0.71 mmol, 1.0 eq.) was dissolved in t-BuOH (5 mL) and 2-methyl-but-2-
ene (1 mL) was added. The reaction mixture was cooled to 0 °C and an aqueous solution (3 mL) of 
NaClO2 (971 mg, 10.7 mmol, 15 eq.) and NaH2PO4.H2O (971 mg, 7.04 mmol, 9.8 eq.) was added at 
once. The reaction mixture was stirred at 0 °C for one hour and Et2O and water were added. The 
phases were separated and the organic layer was washed twice with water before it was dried 
with MgSO4. Removal of the solvent under reduced pressure and silica gel chromatography 
(EtOAc) yielded pure carboxylic acid 450 (411 mg, 0.71 mmol, quant.) as colorless oil.  
1H-NMR (400MHz, CDCl3):  = 5.28 (m, 1H); 5.09 (d, J = 15.5Hz, 1H); 4.71 (t, J = 6.4Hz, 1H); 4.60 (m, 
1H); 4.53 (m, 1H); 4.35 (m, 1H); 4.19 (m, 1H); 4.15 (m, 2H); 3.79 (m, 1H); 3.55 (m, 3H); 3.41, 3.38 (s, 
3H); 2.91 (m, 1H); 2.56 (m, 1H); 2.22, 2.10 (m, 1H); 1.99 (m, 1H); 1.88 (m, 1H); 1.03 (s, 21H); 0.91 
(s, 9H); 0.06 (m, 6H) 
13C-NMR (100MHz, CDCl3):  = 178.6; 147.4; 111.9; 93.1; 77.3; 75.3; 72.0; 67.4; 67.1; 66.4; 62.3; 
61.7; 59.0; 42.8; 39.6; 34.2; 33.2; 25.9; 18.4; 18.0; 12.0; -5.5 
HRMS (ESI) (m/z): [M]+ calcd. for C29H58O7Si2: 574.3721; found: 574.3714 
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(1S,2R,3S)-(8S,E)-1-methoxy-8-((4-methoxyphenyl)diphenylmethoxy)-6-methyl-1-oxodeca-
5,9-dien-2-yn-4-yl 2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-2-((2-
methoxyethoxy)methoxy)but-3-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutanecarboxylate 
(347) 
 
Carboxylic acid 450 (116 mg, 0.2 mmol, 1.0 eq.) and propargylic alcohol 351 (100 mg, 0.2 mmol, 
1.0 eq.) were dissolved in anhydrous CH2Cl2 (2 mL) and DMAP (2.5 mg, 0.02 mmol, 0.1 eq.) was 
added. The reaction was cooled to 0 °C and DIC (34 µL, 0.22 mmol, 1.1 eq.) was added. The 
reaction mixture was stirred at 0 °C for 90 minutes. The solvent was removed under reduced 
pressure und the crude product was purified using silica gel chromatography (hexane/EtOAc = 
7/1). Ester 347 was obtained as slightly yellow oil (100 mg, 0.09 mmol, 47%) as an inseparable 
mixture of diastereo isomers.  
1H-NMR (400MHz, CDCl3):  = 7.29 (m, 10H); 7.17 (m, 2H); 6.84 (m, 2H); 6.12 (m, 1H); 5.85 (m, 1H); 
5.41 (m, 1H); 5.27 (m, 2H); 5.11 (m, 2H); 4.69 (m, 1H); 4.59 (m, 2H); 4.26 (m, 1H); 4.15 (m, 3H); 
3.80 (s, 3H); 2.77 (s, 3H); 3.70 (m, 1H); 3.61 (m, 1H); 3.52 (m, 2H); 3.38 (m, 3H); 2.85 (m, 1H); 2.71 
(m, 1H); 2.45 (m, 1H); 2.24 (m, 3H); 2.00 (m, 1H); 1.82 (s, 3H); 1.78 (m, 1H); 1.04 (s, 21H); 0.92 (m, 
9H); 0.06 (m, 6H) 
13C-NMR (100MHz, CDCl3):  = 174.3; 159.0; 153.2; 147.3; 147.5; 140.6; 139.1; 129.6; 128.3; 128.2; 
127.5; 122.2; 115.5; 113.7; 111.9; 93.4; 84.0; 81.9; 76.8; 76.3; 72.2; 70.6; 67.6; 66.4; 62.6; 60.6; 
59.4; 55.7; 53.2; 47.4; 42.8; 39.3; 34.8; 33.6; 26.5; 18.7; 18.4; 12.5; -5.0 
HRMS (ESI) (m/z): [M]+ calcd. for C61H88O11Si2: 1052.5865; found: 1052.5853 
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Methyl-2-((1S,2R,3S)-2-(3-(((tert-butyldimethylsilyl)oxy)methyl)-2-((2-
methoxyethoxy)methoxy)but-3-en-1-yl)-3-((triisopropylsilyl)oxy)cyclobutyl)-5-((S,E)-4-((4-
methoxyphenyl)diphenylmethoxy)-2-methylhexa-1,5-dien-1-yl)furan-3-carboxylate (267c) 
 
A solution of propargylic ester 347 (10 mg, 9.5 µmol, 1.0 eq.) in benzene (100 µL) was degassed 
with Ar for 3 minutes prior to use. Tri-nbutyl phosphine (2.8 µL, 11.4 µmol, 1.2 eq.) was added to 
the solution of the substrate. The reaction vessel was sealed, heated to 110 °C, and allowed to stir 
for two hours. The reaction mixture was removed in vacuo onto silica gel and subjected to 
purification by flash chromatography (hexane/EtOAc = 7/1 to 5/1) to yield furan 267c (1.5 mg, 
1.5 µmol, 15%). 
1H-NMR (400MHz, CDCl3):  = 7.30 (m, 10H); 7.17 (m, 2H); 6.84 (m, 2H); 6.43 (s, 1H); 6.09 (s, 1H); 
5.92 (m, 1H); 5.25 (m, 1H); 5.14 (m, 1H); 4.70 (m, 1H); 4.63 (m, 2H); 4.58 (m, 1H); 4.32 (m, 1H); 
4.16 (m, 2H); 3.82 (s, 3H); 3.80 (s, 3H); 3.60 (m, 2H); 3.53 (m, 2H); 3.34 (m, 3H); 2.80 (m, 2H); 2.55 
(m, 2H); 2.10 (m, 2H); 2.06 (m, 3H); 1.04 (m, 21H); 0.90 (s, 9H); 0.06 (s, 6H) 
13C-NMR (100MHz, CDCl3):  = 164.2; 162.1; 158.5; 151.3; 147.4; 147.3; 139.4; 135.0; 129.2; 128.1; 
116.2; 114.0; 113.2; 111.8; 108.9; 92.7; 91.5; 76.8; 71.8; 66.5; 62.1; 58.9; 55.3; 51.4; 48.8; 33.6; 
25.9; 18.5; 17.9; 12.1; -5.1 
HRMS (ESI) (m/z): [M]+ calcd. for C61H88O10Si2: 1036.5916; found: 1036.5904 
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(1S,2R,3S)-(8S,E)-1-methoxy-8-((4-methoxyphenyl)diphenylmethoxy)-6-methyl-1-oxodeca-
5,9-dien-2-yn-4-yl 2-(3-(hydroxymethyl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (451) 
 
Ester 347 (50 mg, 47.5 µmol, 1.0 eq.) was dissolved in a 6/1 mixture of anhydrous CH2Cl2 (0.5 mL) 
and MeOH (3 mL) and finely ground NH4F (70.3 mg, 1.9 mmol, 40 eq.) was added. The reaction 
mixture was stirred at r.t. for 2 days. Water and Et2O were added and the phases were separated. 
The organic layer was washed two times with water and dried with brine and MgSO4. Silica gel 
chromatography (2/1 to 1/1) yielded pure allylic alcohol 451 (40 mg, 43 µmol, 90%) as colorless oil. 
1H-NMR (400MHz, CDCl3):  = 7.28 (m, 10H); 7.15 (m, 2H); 6.83 (m, 2H); 6.12 (m, 1H); 5.84 (m, 1H); 
5.40 (m, 1H); 5.26 (m, 2H); 5.11 (m, 2H); 4.68 (m, 1H); 4.60 (m, 2H); 4.25 (m, 1H); 4.14 (m, 3H); 
3.80 (s, 3H); 2.77 (s, 3H); 3.70 (m, 1H); 3.61 (m, 1H); 3.53 (m, 2H); 3.37 (m, 3H); 2.85 (m, 1H); 2.70 
(m, 1H); 2.45 (m, 1H); 2.23 (m, 3H); 1.99 (m, 1H); 1.82 (s, 3H); 1.77 (m, 1H); 1.04 (s, 21H) 
HRMS (ESI) (m/z): [M]+ calcd. for C55H74O11Si: 938.5000; found: 938.4985 
 
  
 245 
 
4-((1R,2S,4S)-2-((((8S,E)-8-hydroxy-1-methoxy-6-methyl-1-oxodeca-5,9-dien-2-yn-4-
yl)oxy)carbonyl)-4-((triisopropylsilyl)oxy)cyclobutyl)-3-((2-methoxyethoxy)methoxy)-2-
methylenebutanoic acid (452) 
 
Allylic alcohol 451 (40 mg, 43 µmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (3 mL) and MnO2 
(55.5 mg, 0.64 mmol, 15 eq.) was added in one portion. The reaction mixture was allowed to stir 
until TLC indicated full consumption of the starting material (approx. three days). The suspension 
was filtered through a pad of celite 545 coarse and the solvent was removed under reduced 
pressure, giving the pure corresponding aldehyde (40 mg, 43 µmol, quant.) as colorless oil. 
The previously prepared aldehyde (40 mg, 43 µmol, 1.0 eq.) was dissolved in t-BuOH (250 µL) and 
2-methyl-but-2-ene (50 µL) was added. The reaction mixture was cooled to 0 °C and an aqueous 
solution (150 µL) of NaClO2 (57.9 mg, 0.64 mmol, 15 eq.) and NaH2PO4.H2O (57.9 mg, 0.42 mmol, 
9.8 eq.) was added at once. The reaction mixture was stirred at 0 °C for one hour and Et2O and 
water were added. The phases were separated and the organic layer was washed twice with water 
before it was dried with MgSO4. Removal of the solvent under reduced pressure and silica gel 
chromatography (EtOAc) yielded the pure carboxylic acid (36 mg, 39 µmol, 90%) as colorless oil.  
The previously prepared ester (30 mg, 32 µmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 
(500 µL) and hexafluoroisopropanol (HFIP, 500 µL) was added. The solution was allowed to stir at 
r.t. for 15 minutes during which time it turned yellow. Anhydrous MeOH was added until the color 
disappeared and the solution was allowed to stir at r.t. for 2 days. Solvents were removed under 
reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 1/1) yielded pure 
seco compound 452 (20 mg, 28 µmol, 93%) as colorless viscous oil. 
1H-NMR (400MHz, CDCl3):  = 6.38 (m, 1H); 6.12 (m, 1H); 5.86 (m, 2H); 5.42 (m, 1H); 5.28 (m, 1H); 
5.14 (m, 1H); 4.69 (m, 2H); 4.62 (m, 1H); 4.54 (m, 1H); 4.47 (m, 1H); 4.33 (m, 1H); 3.78 (m, 3H); 
3.66 (m, 2H); 3.53 (m, 2H); 3.37 (m, 3H); 2.84 (m, 1H); 2.69 (m, 1H); 2.44 (m, 1H), 2.31 (m, 2H); 
2.10 (m, 3H); 1.85 (m, 4H); 1.03 (m, 21H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C35H56O11SiNa: 703.3490; found: 703.3478  
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4.2.13 11,12 Metathesis Approach (cBu) 
 
(1S,2R,3S)-(8S,E)-8-hydroxy-1-methoxy-6-methyl-1-oxodeca-5,9-dien-2-yn-4-yl 2-(3-(((tert-
butyldimethylsilyl)oxy)methyl)-2-((2-methoxyethoxy)methoxy)but-3-en-1-yl)-3-
((triisopropylsilyl)oxy)cyclobutanecarboxylate (357b) 
 
Ester 267c (30 mg, 28.5 µmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (500 µL) and 
hexafluoroisopropanol (HFIP, 500 µL) was added. The solution was allowed to stir at r.t. for 15 
minutes during which time it turned yellow. Anhydrous MeOH was added until the color 
disappeared and the solution was allowed to stir at r.t. for 2 days. Solvents were removed under 
reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 2/1) yielded pure 
primary alcohol 357b (20 mg, 26 µmol, 95%) as colorless viscous oil. 
1H-NMR (400MHz, CDCl3):  = 6.10 (m, 1H); 5.86 (m, 1H); 5.41 (m, 1H); 5.26 (m, 2H); 5.12 (m, 2H); 
4.69 (m, 1H); 4.60 (m, 2H); 4.24 (m, 1H); 4.14 (m, 3H); 2.76 (s, 3H); 3.69 (m, 1H); 3.60 (m, 1H); 3.52 
(m, 2H); 3.37 (m, 3H); 2.84 (m, 1H); 2.72 (m, 1H); 2.43 (m, 1H); 2.24 (m, 3H); 2.00 (m, 1H); 1.81 (s, 
3H); 1.78 (m, 1H); 1.04 (s, 21H); 0.91 (m, 9H); 0.06 (m, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C41H72O10Si2: 780.4664; found: 780.4653 
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4.2.14 7,8 Metathesis Approach (iPr) 
 
(1R,4R,6R)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1]heptan-2-one (Carvone oxide, 
453) 
 
(R)-(-)-Carvone (359, 20 g, 133 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (300 mL) and the 
solution was cooled to -20 °C. 10 mL of a 4M solution of NaOH (40 mmol, 0.3 eq.) and 18 mL of a 
30% (w/w) solution of H2O2 (175 mmol, 1.31 eq.) were added dropwise. The solution was allowed 
to warm to 0 °C within four hours. The reaction mixture was quenched by the addition of 10 mL 
4M HCl and sat. aq. Na2S2O3. Et2O and water were added and the phases were separated. The 
aqueous layer was extracted twice with Et2O and the combined organic layers were dried with 
brine and MgSO4. The solvent was removed under reduced pressure yielding pure carvone-oxide 
453 (22.1 g, 133 mmol, quant.) as colorless liquid. 
1H-NMR (400 MHz, CDCl3):  = 4.79 (m, 1H); 4.72 (d, J = 0.7Hz, 1H); 3.44 (dd, J = 3.0, 1.1Hz, 1H); 
2.72 (m, 1H); 2.59 (ddd, J = 12.8, 7.8, 1.4Hz, 1H); 2.37 (ddd, J = 14.8, 3.0, 1.2Hz, 1H); 2.02 (dd, J = 
17.7, 11.7Hz, 1H); 1.90 (ddd, J = 14.8, 11.1; 1.1Hz, 1H); 1.71 (s, 3H); 1.41 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H14O2: 166.0994; found: 166.0989 
 
(3R,5R)-2,3-dihydroxy-2-methyl-5-(prop-1-en-2-yl)cyclohexanone (363) 
 
Carvone-oxide 453 (22.1 g, 133 mmol, 1.0 eq.) was dissolved in THF (600 mL) and a solution of 
H2SO4 (98%; 652 mg, 6.65 mmol, 0.05 eq.) in water (60 mL) was added. The reaction mixture was 
heated to reflux until TLC indicated complete consumption of the starting material (approx. two 
days). Water, hexane and Et2O were added and the layers were separated. The aqueous layer was 
extracted twice with Et2O and the combined organic layers were washed twice with brine and 
dried with MgSO4. The solvent was removed under reduced pressure, yielding pure carvone-diol 
363 (22 g, 119 mmol, 90%) as colorless liquid.  
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1H-NMR (400 MHz, CDCl3):  = 4.82 (m, 1H); 4.77 (d, J = 0.7Hz, 1H); 4.26 (bs, 1H); 4.05 (dd, J = 2.8, 
2.8Hz, 1H); 3.00 (bs, 1H); 2.90 (m, 1H); 2.52 (m, 1H); 2.16 (m, 1H); 1.88 (m, 1H); 1.76 (s, 3H); 1.40 
(s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 212.8; 146.5; 110.3; 78.2; 75.8; 41.6; 40.0; 33.0; 23.4; 20.6 
HRMS (ESI) (m/z): [M]+ calcd. for C10H16O3Na: 207.0997; found: 207.0986 
 
(4R)-6-hydroxy-4-(prop-1-en-2-yl)tetrahydro-2H-pyran-2-one (454) 
 
An adapted procedure of Rueping et al. was used.[139] A solution of carvone-diol 363 (22 g, 
119 mmol, 1.0 eq.) in CH2Cl2 (200 mL) was added dropwise to a mechanically stirred slurry of 
800 mL CH2Cl2, 100 mL water, 76 g SiO2 and NaIO4 (76.6 g, 0.36mol, 3 eq.) at 0 °C. The reaction 
mixture was allowed to warm to r.t. overnight (TLC completeness). The reaction mixture was 
filtered over a plug of celite coarse 545 and the residue was washed with CH2Cl2. The phases were 
separated and the organic phase was dried with brine and Na2SO4. The solvent was removed 
under reduced pressure and silica gel chromatography (CH2Cl2/MeOH = 30/1) yielded pure acylale 
454 (14.4 g, 92.2 mmol, 78%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 9.61 (bs, 1H); 4.84 (s, 1H); 4.82 (s, 1H); 3.12 (m, 1H); 2.54 (d, J = 
7.2Hz, 2H); 2.47 (m, 2H); 1.73 (s, 3H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C8H12O3Na: 179.0684; found: 179.0679 
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(R)-methyl 3-(2,2-dimethoxyethyl)-4-methylpent-4-enoate (364) 
 
Acylale 454 (14.4 g, 92.2 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (500 mL) and trimethyl 
ortho formate (50.4 mL, 461.0 mmol, 5 eq.) was added. pTsOH (877 mg, 4.6 mmol, 0.05 eq.) was 
added and the reaction was stirred at r.t. for four hours before it was quenched by the addition of 
sat. aq. NaHCO3. The phases were separated and the organic phase was dried with brine and 
MgSO4. The solvents were removed under reduced pressure and purification by silica gel 
chromatography (hexane/EtOAc = 3/1) yielded pure methyl ester 364 (18.4 g, 85 mmol, 92%) as 
colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 4.78 (s, 2H); 4.31 (dd, J = 7.3, 4.3Hz, 1H); 3.63 (s, 3H); 3.29 (s, 3H); 
3.27 (s, 3H); 2.72 (m, 1H); 2.39 (s, 1H); 2.37 (d, J = 1.3Hz, 1H); 1.68 (s, 3H); 1.67 (m, 2H) 
HRMS (ESI) (m/z): [M]+ calcd. for C11H20O4: 216.1362; found: 216.1358 
 
(S)-3-(2,2-dimethoxyethyl)-4-methylpent-4-enal (455) 
 
Methyl ester 364 (7.5 g, 34.7 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (300 mL) and the 
solution was cooled to -78 °C. A solution of DIBAL-H (1.5M in toluene; 25.4 mL, 38.1 mmol, 1.1 eq.) 
was added dropwise (!) and the reaction mixture was allowed to stir at -78°c for two hours. The 
reaction was quenched by the addition of sat. aq. K/Na-tartrate and it was allowed to warm to r.t. 
under vigorous stirring. The phases were separated and the aqueous phase was extracted twice 
with CH2Cl2. The combined organic layers were dried with brine and MgSO4 and the solvent was 
removed under reduced pressure, yielding pure aldehyde 455 (6.46 g, 34.7 mmol, quant.) as 
colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 9.66 (t, J = 2.3Hz, 1H); 4.83 (s, 2H); 4.33 (dd, J = 5.7, 5.7Hz, 1H); 3.32 
(s, 3H); 3.29 (s, 3H); 2.85 (m, 1H); 2.47 (m, 1H); 2.45 (m, 1H); 1.70 (m, 2H); 1.69 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H18O3: 186.1256; found: 186.1252  
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(R)-methyl 5-(2,2-dimethoxyethyl)-6-methyl-3-oxohept-6-enoate (362) 
 
DIPA (7.4 mL, 52.1 mmol, 1.5 eq.) was dissolved in anhydrous THF (150 mL) and the mixture was 
cooled to -10 °C when n-BuLi (2.5M in hexane; 19.5 mL, 48.6 mmol, 1.4 eq.) was added. The 
mixture was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
methyl acetate (3.6 mL, 45.1 mmol, 1.3 eq.) in anhydrous THF (50 mL) was added dropwise. Upon 
completion, the reaction mixture was allowed to stir for 30 minutes. A solution of aldehyde 455 
(6.46 g, 34.7 mmol, 1.0 eq.) in anhydrous THF (50 mL) was added and the reaction mixture was 
stirred for one hour. The reaction was quenched by the addition of sat. aq. NH4Cl. After addition of 
Et2O, phases were separated and the aqueous phase was neutralized by the addition of 0.5M 
KHSO4. The aqueous layer was extracted twice with Et2O and the combined organic phases were 
dried with MgSO4. Removal of the solvent yielded the corresponding -hydroxy ester as colorless 
oil (9.0 g, 34.6 mmol, quant.). 
The previously prepared -hydroxy ester (5.37 g, 20.6 mmol, 1.0 eq.) was dissolved in anhydrous 
EtOAc (200 mL) and IBX (17.3 g, 61.9 mmol, 3 eq.) was added. The reaction mixtures was refluxed 
for two hours or until all starting material was consumed. Now 200 mL of hexane were added and 
the suspension was filtered through a pad of celite 545 coarse. Removal of the solvents and 
purification by silica gel chromatography (hexane/EtOAc = 4/1) gave aldehyde 362 (3.76 g, 
14.6 mmol, 71%) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 4.80 (s, 1H); 4.79 (s, 1H); 4.31 (dd, J = 7.3, 4.0Hz, 1H); 3.73 (s, 3H); 
3.43 (d, J = 2.3Hz, 2H); 3.30 (s, 3H); 3.28 (s, 3H); 2.80 (m, 1H); 2.63 (s, 1H); 2.62 (d, J = 1.7Hz, 1H); 
1.69 (s, 3H); 1.67 (m, 2H) 
HRMS (ESI) (m/z): [M]+ calcd. for C13H22O5: 258.1467; found: 258.1463 
[]D
20: -1.1 (c=1.55; CHCl3) 
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(5R)-methyl 5-(2,2-dimethoxyethyl)-2-(4-((ethoxycarbonyl)oxy)but-2-yn-1-yl)-6-methyl-3-
oxohept-6-enoate (366) 
 
NaH (60% in mineral oil, 582 mg, 14.6 mmol, 1.0 eq.) was suspended in anhydrous THF (80 mL). 
The reaction mixture was cooled to 0 °C and a solution of -keto ester 362 (3.76 g, 14.6 mmol, 
1.0 eq.) in anhydrous THF (30 mL) was added. The reaction was stirred at 0 °C for 20 minutes and 
then warmed to r.t. within 10 minutes. Then it was re-cooled to 0 °C and a solution of propargylic 
iodide 198 (3.9 g, 14.6 mmol, 1.0 eq.) was added uninterruptedly at 0 °C. The reaction mixture was 
stirred at this temperature for 20 minutes and then warmed to r.t. within 20 minutes before it was 
quenched with saturated aqueous NH4Cl. Et2O was added and the phases separated. The pH of the 
aqueous phase was adjusted to 6 with 0.5M KHSO4 and it was extracted twice with Et2O. The 
combined organic layers were dried with MgSO4 and the solvent was removed under reduced 
pressure. Silica gel column chromatography (hexane/EtOAc = 3/1 to 1/1) yielded alkylated -keto 
ester 366 as colorless oil (5.25 g, 13.2 mmol, 90%). 
1H-NMR (400 MHz, CDCl3):  = 4.78 (m, 2H); 4.65 (m, 2H); 4.30 (m, 1H); 4.21 (m, 2H); 3.73 (m, 3H); 
3.68 (m, 1H); 3.30 (m, 3H); 3.28 (m, 3H); 2.96 (m, 1H); 2.82 (m, 1H); 2.74 (m, 2H); 2.68 (m, 1H); 
1.68 (m, 4H); 1.56 (m, 1H); 1.31 (dt, J = 7.1, 1.8Hz, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C20H30O8: 398.1941; found: 398.1935 
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(S)-methyl 2-(2-(2,2-dimethoxyethyl)-3-methylbut-3-en-1-yl)-5-vinylfuran-3-carboxylate 
(367) 
 
Alkylated -keto ester 366 (600 mg, 1.51 mmol, 1.0 eq.) was dissolved in anhydrous DMF (15 mL) 
under an Ar-atmosphere and finely ground anhydrous K2CO3 (1.36 g, 9.8 mmol, 6.5 eq.) was 
added. The reaction flask was sealed and the reaction mixture was heated to 90 °C (oil bath 
temperature 100 °C) for two hours. 
The suspension was allowed to cool to r.t. and the suspended K2CO3 was allowed to settle down. 
The supernatant was decanted and remaining K2CO3 was washed four times with Et2O (4x20 mL). 
The combined organic layers were quenched with 0.5M KHSO4 and the pH was adjusted to 6. The 
phases were separated and the aqueous phase was washed 4 times with Et2O/hexane (1/1). The 
combined organic layers were dried with MgSO4 and the solvents were removed under reduced 
pressure. The crude product was purified by silica gel chromatography (hexane/EtOAc = 2/1) 
yielding pure vinylfuran 367 (452 mg, 1.47 mmol, 97%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 6.45 (s, 1H); 6.40 (dd, J = 17.5, 11.3Hz, 1H); 5.63 (dd, J = 17.5, 1.0Hz, 
1H); 5.17 (dd, J = 11.3, 1.0Hz, 1H); 4.73 (s, 1H); 4.71 (s, 1H); 4.31 (dd, J = 6.8, 4.8Hz, 1H); 3.80 (s, 
3H); 3.29 (s, 3H); 3.25 (s, 3H); 3.08 (m, 2H); 2.75 (m, 1H); 1.74 (m, 2H); 1.70 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 164.1; 160.7; 151.2; 145.9; 124.3; 115.3; 113.0; 112.5; 108.2; 102.9; 
53.0; 52.4; 51.3; 42.4; 35.4; 32.1; 18.5 
HRMS (ESI) (m/z): [M]+ calcd. for C17H24O5: 308.1624; found: 308.1620 
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(S)-methyl 2-(3-methyl-2-(2-oxoethyl)but-3-en-1-yl)-5-vinylfuran-3-carboxylate (361) 
 
Vinyl furan 367 (4.0 g, 13 mmol, 1.0 eq.) was dissolved in CHCl3 (65 mL) and the solution was 
cooled to 0 °C. 50% aqueous TFA (32 mL) was added and the solution was allowed to stir for three 
hours before it was quenched by the addition of sat. aq. NaHCO3. Phases were separated and the 
organic layer was washed with brine and dried with MgSO4. Removal of the solvent under reduced 
pressure yielded pure aldehyde 361 (3.4 g, 13 mmol, quant.) as colorless viscous oil. 
1H-NMR (400 MHz, CDCl3):  = 9.64 (dd, J = 2.5, 0.5Hz, 1H); 6.47 (s, 1H); 6.42 (dd, J = 17.5, 11.3Hz, 
1H); 5.65 (dd, J = 17.5, 1.0Hz, 1H); 5.21 (dd, J = 11.3, 1.0Hz, 1H); 4.80 (s, 1H); 4.76 (s, 1H); 3.82 (s, 
3H); 3.16 (m, 2H); 3.11 (m, 1H); 2.53 (m, 2H); 1.76 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C15H18O4: 262.1205; found: 262.1194 
 
Methyl-2-((2R)-2-(2-hydroxy-2-((S)-5-(2-methylallyl)-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-3-
methylbut-3-en-1-yl)-5-vinylfuran-3-carboxylate (368a) 
 
DIPA (181 µL, 1.28 mmol, 1.2 eq.) was dissolved in anhydrous THF (3 mL) and the mixture was 
cooled to -10 °C when n-BuLi (2.5M in hexane; 491 µL, 1.23 mmol, 1.15 eq.) was added. The 
mixture was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
selenolactone 185 (347 mg, 1.17 mmol, 1.1 eq.) in anhydrous THF (3 mL) was added dropwise. 
Upon completion, the reaction mixture was allowed to stir for 30 minutes. A solution of aldehyde 
361 (280 mg, 1.07 mmol, 1.0 eq.) in anhydrous THF (3 mL) was added and the reaction mixture 
was stirred for one hour. The reaction was quenched by the addition of sat. aq. NH4Cl. After 
addition of Et2O, phases were separated and the aqueous phase was neutralized by the addition of 
0.5M KHSO4.  
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The aqueous layer was extracted twice with Et2O and the combined organic phases were dried 
with MgSO4. Evaporation of the solvent under reduced pressure yielded the desired triene as 
colorless viscous oil (590 mg, 1.06 mmol, 99%). 
The previously prepared triene (590 mg, 1.07 mmol, 1.0 eq.) was dissolved in CH2Cl2 (50 mL) and 
10 mL of sat. aq. NH4Cl were added. The biphasic mixture was cooled to 0 °C and 30% H2O2 
(330 µL, 3.2 mmol, 3 eq.) was added. The reaction was stirred at 0 °C for one hour and then 
quenched by the addition of sat. aq. Na2S2O3. Phases were separated and the organic phase was 
extracted 4 times with water. The organic layer was dried with MgSO4 and the solvent was 
removed under reduced pressure. After silica gel chromatography (hexane/EtOAc = 2/1) 
butenolide 368a was obtained as colorless oil (307 mg, 0.77 mmol, 72%) as a mixture of diastereo 
isomers (2/1). 
Major: 
1H-NMR (400 MHz, CDCl3):  = 7.23 (dd, J = 1.4, 1.4Hz, 1H); 6.44 (s, 1H); 6.40 (dd, J = 17.6, 11.3Hz, 
1H); 5.62 (d, J = 17.6Hz, 1H); 5.17 (d, J = 11.3Hz, 1H); 5.07 (m, 1H); 4.91 (s, 1H); 4.82 (s, 1H); 4.78 (s, 
1H); 4.76 (s, 1H); 4.44 (d, J = 9.8Hz, 1H); 3.80 (s, 3H); 3.15 (m, 1H); 3.05 (m, 1H); 2.97 (m, 1H); 2.57 
(bs, 1H); 2.44 (m, 1H); 2.33 (m, 1H); 1.99 (m, 1H); 1.79 (s, 3H); 1.74 (s, 3H); 1.64 (m, 1H) 
13C-NMR (100 MHz, CDCl3):  = 172.1; 164.2; 160.6; 151.2; 147.9; 145.5; 139.6; 137.0; 124.3; 115.2; 
114.3; 113.5; 113.1; 108.1; 80.1; 65.2; 51.3; 43.0; 41.3; 38.0; 32.2; 22.9; 17.9 
HRMS (ESI) (m/z): [M]+ calcd. for C23H28O6Na: 423.1784; found: 423.1778 
Minor: 
1H-NMR (400 MHz, CDCl3):  = 7.25 (dd, J = 1.4, 1.4Hz, 1H); 6.45 (s, 1H); 6.40 (dd, J = 17.6, 11.3Hz, 
1H); 5.62 (d, J = 17.6Hz, 1H); 5.19 (d, J = 11.3Hz, 1H); 5.08 (m, 1H); 4.92 (s, 1H); 4.83 (s, 1H); 4.73 (s, 
1H); 4.68 (s, 1H); 4.59 (bs, 1H); 3.81 (s, 3H); 3.29 (d, J = 3.7Hz, 1H); 3.21 (dd, J = 14.4, 5.5Hz, 1H); 
3.03 (dd, J = 14.4, 9.4Hz, 1H); 2.77 (m, 1H); 2.44 (m, 1H); 2.35 (m, 1H); 2.00 (m, 1H); 1.80 (s, 3H); 
1.79 (m, 1H); 1.74 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 172.2; 164.5; 161.2; 151.2; 148.4; 146.6; 139.6; 136.3; 124.3; 114.8; 
114.4; 113.2; 112.7; 108.0; 80.2; 65.6; 51.5; 43.6; 41.3; 38.8; 31.1; 23.0; 18.6 
HRMS (ESI) (m/z): [M]+ calcd. for C23H28O6Na: 423.1784; found: 423.1775 
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Methyl-2-((2R)-2-(2-acetoxy-2-((S)-5-(2-methylallyl)-2-oxo-2,5-dihydrofuran-3-yl)ethyl)-3-
methylbut-3-en-1-yl)-5-vinylfuran-3-carboxylate (368b) 
 
Butenolide 368a (54 mg, 0.14 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (2 mL) and 
pyridine (33 µL, 0.41 mmol, 3eq) and DMAP (1.7 mg, 14 µmol, 0.1 eq.) were added. The reaction 
mixture was cooled to 0 °C and Ac2O (26 µL, 0.27 mmol, 2 eq.) was added. The solution was 
allowed to stir at 0 °C for 45 min, then it was quenched by the addition of sat. aq. NH4Cl. Phases 
were separated and the aqueous phase was extracted twice with CH2Cl2. The combined organic 
layers were dried with MgSO4 and the solvent was removed under reduced pressure. Purification 
by silica gel chromatography (hexane/EtOAc = 2/1) yielded acetate 368b (44 mg, 0.1 mmol, 71%).  
1H-NMR (400 MHz, CDCl3):  = 7.11 (dd, J = 1.4, 1.4Hz, 1H); 6.46 (s, 1H); 6.40 (dd, J = 17.5, 11.3Hz, 
1H); 5.63 (d, J = 17.5Hz, 1H); 5.45 (m, 1H); 5.19 (d, J = 11.3Hz, 1H); 5.04 (m, 1H); 4.91 (s, 1H); 4.79 
(m, 2H); 4.67 (s, 1H); 3.81 (s, 3H); 3.10 (m, 2H); 2.77 (m, 1H); 2.42 (m, 1H); 2.32 (m, 1H); 2.08 (m, 
1H); 2.07 (s, 3H); 1.84 (m, 1H); 1.77 (s, 3H); 1.74 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C25H30O7: 442.1992; found: 442.1989 
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(5S,11R,Z)-methyl 9-acetoxy-3-methyl-7-oxo-11-(prop-1-en-2-yl)-6,16-
dioxatricyclo[11.2.1.15,8]heptadeca-1(15),2,8(17),13-tetraene-14-carboxylate (369) 
 
Benzene was degassed with 5 pump and freeze cycles. Both diastereo isomers of acetate 368b 
(30 mg, 68 µmol, 1.0 eq.) were dissolved in degassed benzene (34 mL; [2.0mM]) in a flame dried 
Schlenk flask and the reaction mixture was heated to reflux. Grubbs’ second generation 
metathesis catalyst (11.5 mg, 14 µmol, 0.2 eq.) was dissolved in 2 mL degassed benzene and was 
added via a syringe over a period of 15h using a syringe pump. After the addition was completed 
the solvent was removed under reduced pressure. Purification by silica gel column 
chromatography yielded macrocycle 369 as colorless oil (12 mg, 29 µmol, 43%). 
Major: 
1H-NMR (400 MHz, CDCl3):  = 6.99 (s, 1H); 6.44 (s, 1H); 6.14 (s, 1H); 5.51 (dd, J = 7.5, 3.0Hz, 1H); 
5.00 (dd, J = 11.7, 5.0Hz, 1H); 4.83 (s, 1H); 4.81 (s, 1H); 3.83 (s, 3H); 3.42 (dd, J = 16.7, 9.7Hz, 1H); 
3.01 (dd, J = 11.8, 11.8Hz, 1H); 2.89 (dd, J = 16.7, 3.8Hz, 1H); 2.78 (dd, J = 12.0, 4.8Hz, 1H); 2.46 (m, 
2H); 2.05 (s, 3H); 2.01 (s, 3H); 1.80 (s, 3H); 1.67 (m, 1H) 
13C-NMR (100 MHz, CDCl3):  = 170.9; 170.1; 163.9; 160.0; 155.0; 150.2; 147.8; 131.1; 129.2; 117.1; 
115.6; 111.0; 110.6; 78.0; 68.2; 51.5; 41.0; 40.3; 36.9; 32.4; 25.8; 20.9; 20.4 
HRMS (ESI) (m/z): [M]+ calcd. for C23H26O7: 414.1679; found: 414.1673 
Minor: 
1H-NMR (600 MHz, CDCl3):  = 7.21 (s, 1H); 6.46 (s, 1H); 6.13 (s, 1H); 5.38 (dd, J = 12.1, 4.2Hz, 1H); 
5.08 (ddd, J = 12.0, 4.9, 1.6Hz, 1H); 4.98 (s, 1H); 4.96 (s, 1H); 3.83 (s, 3H); 3.53 (dd, J = 16.5, 12.9Hz, 
1H); 3.12 (dd, J = 11.8, 11.8Hz, 1H); 2.81 (dd, J = 12.2, 4.9Hz, 1H); 2.69 (dd, J = 16.6, 3.8Hz, 1H); 
2.32 (m, 1H); 2.13 (m, 1H); 2.02 (s, 3H); 1.95 (s, 3H); 1.80 (s, 3H); 1.26 (m, 1H) 
13C-NMR (150 MHz, CDCl3):  = 169.5; 169.4; 163.9; 153.9; 150.6; 129.9; 121.6; 116.9; 116.3; 113.8; 
111.0; 78.7; 65.2; 51.6; 41.0; 39.7; 37.4; 32.2; 25.7; 20.9; 19.2 
HRMS (ESI) (m/z): [M]+ calcd. for C23H26O7: 414.1679; found: 414.1671  
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(R)-5-(2-methylallyl)dihydrofuran-2(3H)-one (456) 
 
A mixture of sodium (1.31 g, 57.1 mmol, 8 eq.) and anhydrous EtOH (50 mL) was stirred at 0 °C 
until the evolution of dihydrogen has ceased. A solution of diethylmalonate (5.42 mL, 35.7 mmol, 
5 eq.) in anhydrous EtOH (10 mL) was added and the reaction mixture was allowed to stir at 0 °C 
for 30 minutes. In the meantime a solution of tosylate 202 (1.93 g, 7.14 mmol, 1.0 eq.) in 
anhydrous THF (35 mL) was treated with NaH (60% suspension in mineral oil, 285 mg, 7.14 mmol, 
1.0 eq.) at 0 °C for 30 minutes. After this period of time the suspension with the in situ generated 
epoxide was cannulated slowly to the solution of the sodium malonate. The reaction mixture was 
allowed to stir for four hours (TLC completeness) before it was quenched by the addition of 1M 
HCl. Et2O was added and the phases were separated. The pH of the aqueous phase was adjusted 
to slightly acidic and the aqueous phase was extracted twice with Et2O. The combined organic 
layers were dried with brine and MgSO4 and the solvents were removed under reduced pressure. 
The desired lactone was obtained as colorless oil (700 mg, 3.3 mmol, 46%) and the crude product 
was of satisfying purity for further conversion. 
The previously prepared lactone (700 mg, 3.3 mmol, 1.0 eq.) was dissolved in DMSO (6 mL), then 
LiCl (280 mg, 6.6 mmol, 2 eq.) and water (60 µL, 3.3 mmol, 1.0 eq.) were added. The reaction 
mixture was sealed and heated to 150 °C for two hours (Krapcho protocol).[140] Et2O, hexane and 
sat. aq. NH4Cl were added and the phases were separated. The organic phases was dried with 
brine and MgSO4 and the solvent was removed in vacuo. Silica gel chromatography (hexane/EtOAC 
= 3/1 to 2/1) yielded pure lactone 456 (365 mg, 2.6 mmol, 79%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 4.87 (s, 1H); 4.79 (s, 1H); 4.65 (m, 1H); 2.52 (m, 3H); 2.31 (m, 2H); 
1.91 (m, 1H); 1.78 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C8H12O2: 140.0837; found: 140.0834 
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Methyl-2-((S)-2-(2,2-dimethoxyethyl)-3-methylbut-3-en-1-yl)-5-((E)-2-methyl-3-((R)-5-
oxotetrahydrofuran-2-yl)prop-1-en-1-yl)furan-3-carboxylate (457) 
 
Lactone 456 (240 mg, 1.71 mmol, 2 eq.) and vinylfuran 367 (264 mg, 0.86 mmol, 1.0 eq.) were 
dissolved in anhydrous, degassed (5 pump and freeze cycles) benzene (160 mL). The solution was 
heated to reflux overnight and a solution of Grubbs-Hoveyda 2nd generation catalyst (108 mg, 
0.17 mmol, 0.2 eq.) in anhydrous, degassed benzene (10 mL) was added slowly via a syringe pump 
within 10 hours. After that period of time, the solvent was removed under reduced pressure. 
Purification by silica gel chromatography (hexane/EtOAc = 5/1 to 1/1) yielded pure compound 457 
(104 mg, 0.25 mmol, 29%) as colorless semi-solid.  
1H-NMR (400 MHz, CDCl3):  = 6.43 (s, 1H); 6.06 (s, 1H); 4.72 (s, 1H); 4.71 (s, 1H); 4.68 (m, 1H); 4.30 
(dd, J = 5.8, 5.8Hz, 1H); 3.81 (s, 3H); 3.28 (s, 3H); 3.26 (s, 3H); 3.06 (m, 2H); 2.74 (m, 1H); 2.62 (m, 
1H); 2.54 (m, 2H); 2.42 (m, 1H); 2.33 (m, 1H); 2.02 (s, 3H); 1.92 (m, 1H); 1.70 (s, 3H); 1.69 (m, 2H) 
HRMS (ESI) (m/z): [M]+ calcd. for C23H32O7: 420.2148; found: 420.2145 
 
Methyl-5-((E)-3-((2S)-4-bromo-5-oxotetrahydrofuran-2-yl)-2-methylprop-1-en-1-yl)-2-((S)-
3-methyl-2-(2-oxoethyl)but-3-en-1-yl)furan-3-carboxylate (459) 
 
Compound 457 (47 mg, 0.11 mmol, 1.0 eq.) was dissolved in anhydrous THF (2 mL) and the 
solution was cooled to 0 °C. Bu4NBr3 (81 mg, 0.17 mmol, 1.5 eq.) was added portionwise and the 
reaction mixture was allowed to warm to r.t. within one hour. Stirring was continued for another 
two hours before the reaction was quenched by the addition of sat. aq. Na2S2O3 solution. Et2O was 
added and the phases were separated.  
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The organic layer was dried with brine and MgSO4 and the solvents were removed under reduced 
pressure. The desired bromo-lactone 458 (49 mg, 98 µmol, 88%) was obtained as slightly yellow 
oil. 
The previously prepared bromo-lactone 458 (49 mg, 98 µmol, 1.0 eq.) was dissolved in CHCl3 
(3 mL) and the solution was cooled to 0 °C. 50% aqueous TFA (1.5 mL) were added and the 
solution was allowed to stir for three hours before it was quenched by the addition of sat. aq. 
NaHCO3. Phases were separated and the organic layer was washed with brine and dried with 
MgSO4. Removal of the solvent under reduced pressure yielded pure aldehyde 459 (44 mg, 
97 µmol, 99%) as colorless viscous oil. 
1H-NMR (400 MHz, CDCl3):  = 9.62 (m, 1H); 6.44 (s, 1H); 6.08 (s, 1H); 4.79 (s, 1H); 4.76 (s, 1H); 4.69 
(m, 1H); 4.64 (m, 1H); 3.83 (s, 3H); 3.44 (m, 2H); 3.19 (m, 2H); 2.55 (m, 3H); 2.32 (m, 2H); 2.03 (s, 
3H); 1.76 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C21H25BrO6: 452.0835; found: 452.0831 
 
4.2.15 11,12 Horner Wadsworth Emmons Approach (iPr) 
 
Methyl-5-((S)-4,5-bis((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-2-((S)-2-(2,2-
dimethoxyethyl)-3-methylbut-3-en-1-yl)furan-3-carboxylate (371) 
 
NaH (60% in mineral oil, 447 mg, 11.2 mmol, 1.0 eq.) was suspended in anhydrous THF (60 mL). 
The reaction mixture was cooled to 0 °C and a solution of -keto ester 362 (4.8 g, 11.2 mmol, 
1.0 eq.) in anhydrous THF (30 mL) was added. The reaction was stirred at 0 °C for 20 minutes and 
then warmed to r.t. within 10 minutes. Then it was re-cooled to 0 °C and a solution of propargylic 
iodide 259 (6.89 g, 11.2 mmol, 1.0 eq.) was added uninterruptedly at 0 °C. The reaction mixture 
was stirred at this temperature for 20 minutes and then warmed to r.t. within 20 minutes before it 
was quenched with saturated aqueous NH4Cl. Et2O was added and the phases separated. 
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The pH of the aqueous phase was adjusted to 6 with 0.5M KHSO4 and it was extracted twice with 
Et2O. The combined organic layers were dried with MgSO4 and the solvent was removed under 
reduced pressure. The desired alkylated -keto ester (6.9 g, 9.2 mmol, 83%) was obtained as 
slightly yellow oil. 
Previously prepared alkylated -keto ester (6.8 g, 9.1 mmol, 1.0 eq.) was dissolved in anhydrous 
DMF (100 mL) under an Ar-atmosphere and finely ground anhydrous K2CO3 (8.22 g, 59.2 mmol, 
6.5 eq.) was added. The reaction flask was sealed and the reaction mixture was heated to 90 °C (oil 
bath temperature 100 °C) for two hours. Stirring was stopped, the suspension was allowed to cool 
to r.t. and the suspended K2CO3 was allowed to settle down. The supernatant was decanted and 
remaining K2CO3 was washed four times with Et2O (4x40 mL). The combined organic layers were 
quenched with 0.5M KHSO4 and the pH was adjusted to 6. The phases were separated and the 
aqueous phase was washed 4 times with Et2O/hexane (1/1). The combined organic layers were 
dried with MgSO4 and the solvents were removed under reduced pressure. The crude product was 
purified by silica gel chromatography (hexane/EtOAc = 7/1 to 5/1) yielding vinylfuran 371 (5.05 g, 
8.1 mmol, 89%) as mixture of double bond isomers (E/Z = 2/1). 
(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.36 (s, 1H); 6.01 (s, 1H); 4.70 (s, 1H); 4.69 (s, 1H); 4.31 (m, 1H); 3.81 
(s, 3H); 3.79 (m, 1H); 3.55 (dd, J = 9.9, 5.2Hz, 1H); 3.40 (dd, J = 9.9, 6.7Hz, 1H); 3.28 (s, 3H); 3.25 (s, 
3H); 3.06 (m, 2H); 2.74 (m, 1H); 2.45 (m, 1H); 2.15 (dd, J = 13.3, 7.8Hz, 1H); 1.97 (s, 3H); 1.71 (m, 
2H); 1.69 (s, 3H); 0.90 (s, 9H); 0.85 (s, 9H); 0.05 (s, 6H); -0.02 (s, 6H);  
13C-NMR (100 MHz, CDCl3):  = 164.5; 159.2; 151.7; 151.2; 146.0; 137.7; 136.4; 116.2; 115.9; 115.0; 
112.4; 107.6; 102.9; 71.9; 68.8; 67.1; 53.0; 52.3; 51.2; 45.9; 42.4; 38.7; 35.4; 32.1; 25.8; 19.4; 18.5; 
18.0; -4.5; -5.4 
HRMS (ESI) (m/z): [M]+ calcd. for C33H60O7Si2: 624.3878; found: 624.3871 
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(Z)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.54 (s, 1H); 6.04 (s, 1H); 4.70 (s, 1H); 4.69 (s, 1H); 4.31 (m, 1H); 3.94 
(m, 1H); 3.79 (s, 3H); 3.60 (dd, J = 9.9, 5.2Hz, 1H); 3.45 (dd, J = 9.9, 6.7Hz, 1H); 3.28 (s, 3H); 3.24 (s, 
3H); 3.06 (m, 2H); 2.74 (m, 1H); 2.57 (m, 1H); 2.52 (m, 1H); 1.91 (s, 3H); 1.71 (m, 2H); 1.69 (s, 3H); 
0.89 (s, 9H); 0.83 (s, 9H); 0.05 (s, 6H); 0.03 (s, 3H); 0.02 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 164.5; 159.1; 151.7; 151.2; 146.1; 137.7; 136.4; 116.2; 115.9; 114.9; 
112.3; 107.7; 102.9; 71.8; 68.0; 67.1; 52.9; 52.2; 51.1; 45.9; 42.4; 38.7; 35.3; 32.1; 25.9; 19.4; 18.5; 
18.1; -4.8; -5.4 
HRMS (ESI) (m/z): [M]+ calcd. for C33H60O7Si2: 624.3878; found: 624.3869 
 
Methyl-5-((S)-4,5-bis((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-2-((S)-3-
methyl-2-(2-oxoethyl)but-3-en-1-yl)furan-3-carboxylate (460) 
 
LiBF4 (197 mg, 2.1 mmol, 1.1 eq.) was dissolved in a mixture of CH3CN/H2O (20 mL/0.4 mL) and the 
reaction mixture was cooled to 0 °C. A solution of dimethyl acetal 371 (1.19 g, 1.9 mmol, 1.0 eq.) in 
6 mL CH3CN was added dropwise. The solution was stirred at 0 °C for two hours before it was 
quenched by the addition of water and Et2O. Phases were separated and the organic layer was 
washed twice with water. After drying with brine and MgSO4 the solvent was removed in vacuo. 
Purification by silica gel chromatography (hexane/EtOAc = 5/1) yielded aldehyde 460 (880 mg, 
1.52 mmol, 80%) as colorless oil and a mixture of double bond isomers (2/1). 
(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 9.62 (dd, J = 2.5, 0.8Hz, 1H); 6.38 (s, 1H); 6.02 (s, 1H); 4.77 (s, 1H); 
4.74 (s, 1H); 3.82 (s, 3H); 3.81 (m, 1H); 3.55 (dd, J = 9.9, 5.2Hz, 1H); 3.40 (dd, J = 9.9, 6.7Hz, 1H); 
3.12 (m, 3H); 2.55 (m, 2H); 2.46 (m, 2H); 1.97 (s, 3H); 1.75 (s, 3H); 0.90 (s, 9H); 0.85 (s, 9H); 0.05 (s, 
6H); -0.02 (s, 6H) 
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13C-NMR (100 MHz, CDCl3):  = 201.5; 164.4; 158.1; 152.1; 151.6; 145.3; 138.2; 137.0; 129.8; 116.2; 
116.0; 115.7; 113.8; 112.5; 107.6; 102.9; 71.8; 68.0; 67.1; 51.3; 46.4; 45.9; 40.7; 38.7; 31.7; 25.8; 
19.4; 18.3; 18.0; -4.5; -4.8 
HRMS (ESI) (m/z): [M]+ calcd. for C31H54O6Si2: 578.3459; found: 578.3451 
(Z)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 9.60 (dd, J = 2.5, 0.8Hz, 1H); 6.55 (s, 1H); 6.04 (s, 1H); 4.78 (s, 1H); 
4.76 (s, 1H); 3.94 (m, 1H); 3.80 (s, 3H); 3.61 (dd, J = 9.9, 5.2Hz, 1H); 3.45 (dd, J = 9.9, 6.7Hz, 1H); 
3.12 (m, 3H); 2.55 (m, 2H); 2.45 (m, 2H); 1.92 (s, 3H); 1.75 (s, 3H); 0.89 (s, 9H); 0.83 (s, 9H); 0.05 (s, 
6H); 0.03 (s, 3H); 0.02 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 201.5; 164.4; 158.1; 152.1; 151.6; 145.4; 138.2; 137.0; 129.6; 116.2; 
116.0; 115.7; 113.8; 112.5; 107.7; 102.9; 71.8; 68.0; 67.1; 51.2; 46.4; 45.9; 40.7; 38.7; 31.7; 25.7; 
19.4; 18.3; 18.0; -4.8; -5.3 
HRMS (ESI) (m/z): [M]+ calcd. for C31H54O6Si2: 578.3459; found: 578.3453 
 
Methyl-5-((S)-4,5-bis((tert-butyldimethylsilyl)oxy)-2-methylpent-1-en-1-yl)-2-((S)-5-
(dimethoxyphosphoryl)-4-oxo-2-(prop-1-en-2-yl)pentyl)furan-3-carboxylate (373) 
 
Aldehyde 460 (880 mg, 1.52 mmol, 1.0 eq.) and dimethyl (diazomethyl)phosphonate (684 mg, 
4.56 mmol, 3 eq.) were dissolved in anhydrous CH2Cl2 (15 mL). Anhydrous SnCl2 (432 mg, 
2.28 mmol, 1.5 eq.) was added in one portion. The reaction mixture was stirred overnight at r.t. 
before it was quenched by the addition of sat. aq. NH4Cl. The phases were separated and the 
neutralized aqueous layer was extracted twice with CH2Cl2. The combined organic layers were 
dried with MgSO4 and the solvent was removed in vacuo. Purification by silica gel chromatography 
(hexane/EtOAc = 2/1 to 1/1) resulted -keto phosphonate 373 (677 mg, 1.32 mmol, 87%) as 
colorless oil. 
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(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.36 (s, 1H); 6.02 (s, 1H); 4.71 (s, 1H); 4.70 (s, 1H); 3.82 (s, 3H); 3.77 
(s, 3H); 3.74 (s, 3H); 3.55 (dd, J = 9.9, 5.2Hz, 1H); 3.40 (dd, J = 9.9, 6.7Hz, 1H); 3.12 (m, 3H); 3.03 (m, 
2H); 2.82 (m, 1H); 2.68 (m, 1H); 2.46 (dd, J = 13.3, 3.9Hz, 1H); 2.16 (dd, J = 13.3, 7.7Hz, 1H); 1.97 (s, 
3H); 1.73 (s, 3H); 0.90 (s, 9H); 0.85 (s, 9H); 0.05 (s, 6H); -0.02 (s, 6H) 
13C-NMR (100 MHz, CDCl3):  = 177.7; 164.4; 158.4; 152.0; 145.7; 136.8; 116.1; 112.1; 107.6; 71.9; 
67.1; 53.0; 51.3; 47.4; 45.9; 42.0; 41.2; 40.7; 31.6; 26.0; 19.7; 19.4; -4.5; -5.3 
HRMS (ESI) (m/z): [M]+ calcd. for C34H61O9PSi2: 700.3592; found: 700.3586 
 
Methyl-5-((S)-4-((tert-butyldimethylsilyl)oxy)-5-hydroxy-2-methylpent-1-en-1-yl)-2-((S)-5-
(dimethoxyphosphoryl)-4-oxo-2-(prop-1-en-2-yl)pentyl)furan-3-carboxylate (461) 
 
-keto phosphonate 373 (67 mg, 0.1 mmol, 1.0 eq.) was dissolved in anhydrous MeOH (3 mL) and 
finely ground NH4F (177 mg, 4.78 mmol, 50 eq.) was added. The reaction mixture was stirred at r.t. 
for 2 days. Water and Et2O were added and the phases were separated. The organic layer was 
washed two times with water and dried with brine and MgSO4. Silica gel chromatography 
(hexane/EtOAc = 1/1) yielded primary alcohol 461 (42 mg, 72 µmol, 72%) as colorless oil. 
(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 6.39 (s, 1H); 6.02 (s, 1H); 4.72 (s, 1H); 4.70 (s, 1H); 3.92 (m, 1H); 3.82 
(s, 3H); 3.77 (s, 3H); 3.74 (s, 3H); 3.57 (m, 1H); 3.12 (m, 2H); 3.03 (m, 1H); 2.84 (m, 2H); 2.68 (m, 
1H); 2.64 (m, 1H); 2.52 (m, 1H); 2.34 (d, J = 6.5Hz, 1H); 2.26 (m, 1H); 1.97 (s, 3H); 1.72 (s, 3H); 0.89 
(s, 9H); 0.08 (s, 3H); 0.04 (s, 3H) 
HRMS (ESI) (m/z): [M]+ calcd. for C28H47O9PSi: 586.2727; found: 586.2724 
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Methyl-5-((S)-4-((tert-butyldimethylsilyl)oxy)-2-methyl-5-oxopent-1-en-1-yl)-2-((S)-5-
(dimethoxyphosphoryl)-4-oxo-2-(prop-1-en-2-yl)pentyl)furan-3-carboxylate (374) 
 
Primary alcohol 461 (42 mg, 72 µmol, 1.0 eq.) was dissolved in anhydrous DMSO (1.5 mL) and IBX 
(40 mg, 0.14 mmol, 2 eq.) was added. The reaction mixture was stirred at r.t. for two hours or until 
all starting material was consumed. 2 mL of hexane and 2 mL of EtOAc were added and the 
suspension was filtered through a pad of celite 545 coarse. The filtrate was transferred to a 
separatory funnel and water was added. 
The phases were separated and the organic phase was washed twice with fresh water. The 
combined aqueous layers were back-extracted twice with EtOAc. The combined organic layers 
were dried with brine and MgSO4 and the solvents were removed in vacuo. Aldehyde 374 (42 mg, 
72 µmol, quant.) was obtained as colorless oil.  
(E)-isomer: 
1H-NMR (400 MHz, CDCl3):  = 9.63 (d, J = 1.5Hz, 1H); 6.40 (s, 1H); 6.04 (s, 1H); 4.71 (s, 1H); 4.70 (s, 
1H); 4.10 (ddd, J = 4.3, 4.1, 1.7Hz, 1H); 3.95 (m, 6H); 3.81 (s, 3H); 3.19 (m, 3H); 3.05 (m, 2H); 2.78 
(m, 1H); 2.64 (m, 1H); 2.48 (dd, J = 13.6, 3.9Hz, 1H); 2.16 (dd, J = 13.6, 8.3Hz, 1H); 1.99 (s, 3H); 1.73 
(s, 3H); 0.88 (s, 9H); -0.01 (s, 6H) 
13C-NMR (100 MHz, CDCl3):  = 203.6; 194.1; 164.2; 158.5; 151.4; 145.1; 135.0; 133.8; 117.3; 116.4; 
115.5; 112.5; 108.5; 76.9; 76.4; 56.2; 51.3; 43.9; 41.0; 40.2; 36.6; 31.4; 25.7; 19.8; 19.1; 18.1; -4.8; -
5.1 
31P-NMR (162MHz, CDCl3):  = 11.8 
HRMS (ESI) (m/z): [M]+ calcd. for C28H45O9PSi: 584.2570; found: 584.2564 
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(2E,5S,6E,10S)-methyl 5-((tert-butyldimethylsilyl)oxy)-3-methyl-8-oxo-10-(prop-1-en-2-yl)-
15-oxabicyclo[10.2.1]pentadeca-1(14),2,6,12-tetraene-13-carboxylate (370) 
 
HFIP (100 µL) was mixed with anhydrous THF (15 mL) and the solution was cooled to 0 °C. n-BuLi 
(2.2M in cyclohexane; 78 µL, 171 µmol, 5 eq.) was added dropwise and the reaction mixture was 
incubated for one hour at 0 °C. A solution of seco aldehyde 374 (20 mg, 0.34 µmol, 1.0 eq.) in 
anhydrous THF (5 mL) was added using a syringe pump over a period of time of 16 hours. The 
reaction mixture was quenched by the addition of sat. aq. NH4Cl and Et2O was added. The phases 
were separated and the organic layer was dried with brine and MgSO4. Removal of the solvents 
under reduced pressure and purification by silica gel chromatography (hexane/EtOAc = 7/1 to 4/1) 
yielded pure (E)-macrocycle 370 (11 mg, 24 µmol, 71%) as colorless semi-solid.  
1H-NMR (600 MHz, CDCl3):  = 6.80 (dd, J = 15.9, 3.0Hz, 1H); 6.39 (s, 1H); 6.25 (15.9, 1.9Hz, 1H); 
6.05 (s, 1H); 4.83 (s, 1H); 4.77 (s, 1H); 4.45 (m, 1H); 3.79 (s, 3H); 3.38 (dd, J = 15.1, 8.3Hz, 1H); 3.12 
(m, 1H); 3.07 (dd, J = 11.0, 1.5Hz, 1H); 2.89 (dd, J = 12.9, 9.0Hz, 1H); 2.75 (dd, J = 15.1, 3.8Hz, 1H); 
2.30 (m, 2H); 2.17 (m, 1H); 2.00 (s, 3H); 1.81 (s, 3H); 0.94 (s, 9H); 0.13 (s, 3H); 0.11 (s, 3H) 
13C-NMR (150 MHz, CDCl3):  = 202.5; 164.1; 158.6; 151.3; 146.6; 134.3; 126.2; 120.2; 116.6; 116.3; 
111.1; 109.9; 69.8; 65.9; 51.4; 44.7; 44.4; 41.3; 38.4; 29.7; 25.9; 25.6; 21.2; 15.3; -4.8; -4.9 
HRMS (ESI) (m/z): [M]+ calcd. for C26H38O5Si: 458.2489; found: 458.2486 
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4.3 Sarcofuranocembranolide A 
 
4-((tert-butyldimethylsilyl)oxy)butan-1-ol (462) 
 
1,4-butandiol (379, 23.9 g, 265 mmol, 4 eq.) was dissolved in anhydrous DMF (200 mL) and 
imidazole (9.0 g, 132 mmol, 2 eq.) was added in one portion. Under Ar-atmosphere, the mixture 
was cooled to 0 °C and a solution of TBS-Cl (10.0 g, 66 mmol, 1.0 eq.) in anhydrous DMF (50 mL) 
was added slowly at 0 °C. The reaction mixture was allowed to warm to r.t. overnight. 100 mL of 
hexane/Et2O (1/1) and 200 mL of saturated aqueous NH4Cl were added and the phases separated. 
The organic phase was extracted with water twice. The combined aqueous phases were back-
extracted twice with a 1/1 mixture of hexane/Et2O and the combined organic layers were dried 
over MgSO4. Evaporation of the solvent yielded mono silylether 462 (11.6 g, 57 mmol, 86%) as 
colorless oil, which was purified by silica gel column chromatography (hexane/EtOAc = 4/1). 
1H-NMR (400 MHz, CDCl3):  = 3.67(t, J = 5.6Hz, 2H); 3.65 (t, J = 5.8Hz, 2H); 2.19 (bs, 1H); 1.65 (m, 
4H); 0.90 (s, 9H); 0.07 (s, 6H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C10H24O2SiNa: 227.1443; found: 227.1439 
 
4-((tert-butyldimethylsilyl)oxy)butanal (380) 
 
Mono silyl-ether 462 (11.6 g, 57 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (250 mL) and IBX 
(32 g, 144 mmol, 2 eq.) was added. The reaction mixtures was refluxed for two hours or until all 
starting material was consumed. Hexane (250 mL) was added and the suspension was filtered 
through a pad of celite 545 coarse. Removal of the solvents gave aldehyde 380 (11.5 g, 57 mmol, 
quant.) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 9.79 (t, J = 1.8Hz, 1H); 3.65 (t, J = 6.0Hz, 2H); 2.50 (dt, J = 7.0, 1.8Hz, 
2H); 1.86 (m, 2H); 0.88 (s, 9H); 0.04 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C10H22O2Si: 202.1389; found: 202.1383 
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(R)-6-((tert-butyldimethylsilyl)oxy)hex-1-en-3-ol (381) 
 
Adehyde 380 (15 g, 74 mmol, 1.0 eq.) was dissolved in anhydrous THF (600 mL) and the solution 
was cooled to -78 °C. Vinyl-MgBr (1M in THF, 89 mL, 89 mmol, 1.2 eq.) was added slowly and the 
reaction mixture was allowed to stir for two hours warming to -40 °C. The reaction was quenched 
by the addition of sat. aq. NH4Cl and Et2O was added. The phases were separated and the pH of 
the aqueous phase was adjusted to neutral. The aqueous layer was extracted twice with Et2O and 
the combined organic layers were dried with brine and MgSO4. The solvent was removed under 
reduced pressure yielding the desired racemic secondary alcohol (17 g, 74 mmol, quant.) as 
colorless liquid.  
The racemate (17 g, 74 mmol, 1.0 eq.) was dissolved in DIPE (750 mL) and vinyl acetate (15.7 mL, 
170 mmol, 2.3 eq.) and Amano lipase PS (19.24 g, [260 mg/mmol]) were added. The reaction 
mixture was vigorously stirred at 35 °C until NMR measurements indicated a conversion of 52% 
(approx. two days). The suspension was filtered through a pad of celite coarse 545 and the filtrate 
was dried with MgSO4. Removal of the solvent under reduced pressure and silica gel 
chromatography (hexane/EtOAc = 4/1) yielded enantiomerically pure (R)-alcohol 381 (7.8 g, 
33.9 mmol, 46%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 5.86 (ddd, J = 17.2, 10.3, 5.9Hz, 1H); 5.21 (dt, J = 17.2, 1.6Hz, 1H); 
5.07 (ddd, J = 10.3, 1.7, 1.2Hz, 1H); 4.12 (dd, J = 5.8, 11.0Hz, 1H); 3.63 (t, J = 5.8Hz, 2H); 2.77 (bs, 
1H); 1.62 (m, 4H); 0.88 (s, 9H); 0.04 (s, 6H) 
13C-NMR (100 MHz, CDCl3):  = 141.2; 114.1; 72.6; 63.4; 34.2; 28.6; 25.8; 18.2; -4.5 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C12H26O2SiNa: 263.1600; found: 263.1594 
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(R)-6-((tert-butyldimethylsilyl)oxy)hex-1-en-3-yl acetate (463) 
 
Secondary alcohol 381 (5 g, 21.7 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (100 mL) and 
NEt3 (6.1 mL, 43.4 mmol, 2eq) and DMAP (133 mg, 1.1 mmol, 0.05 eq.) were added. The reaction 
mixture was cooled to 0 °C and Ac2O (2.46 mL, 26 mmol, 1.2 eq.) was added. The solution was 
allowed to stir at 0 °C for 45 min, and then it was quenched by the addition of sat. aq. NH4Cl. 
Phases were separated and the aqueous phase was extracted twice with CH2Cl2. The combined 
organic layers were dried with MgSO4 and the solvent was removed under reduced pressure. 
Purification by silica gel chromatography (hexane/EtOAc = 7/1) yielded acetate 463 (5.3 g, 
19.5 mmol, 90%) as colorless oil.  
1H-NMR (400 MHz, CDCl3):  = 5.78 (m, 1H); 5.20 (m, 3H); 3.61 (t, J = 6.1Hz, 2H); 2.04 (s, 3H); 1.59 
(m, 4H); 0.89 (s, 9H); 0.04 (s, 6H) 
HRMS (ESI) (m/z): [M]+ calcd. for C14H28O3Si: 272.1808; found: 272.1802 
 
(R)-6-hydroxyhex-1-en-3-yl acetate (382) 
 
Primary silyl ether 463 (5.3 g, 19.5mol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 (100 mL) and 
490 mg PPTS (1.95 mmol, 0.1 eq.) in 10 mL anhydrous MeOH was added dropwise. The reaction 
mixture was stirred for two hours at r.t. The reaction was quenched by the addition of sat. aq. 
NaHCO3. The phases were separated and the aqueous layer was extracted twice with CH2Cl2. The 
combined organic layers were dried with MgSO4. After removal of the solvent the crude product 
was purified by silica gel chromatography (hexane/EtOAc = 3/1), giving pure primary alcohol 382 
(2.5 g, 16 mmol, 82%) as colorless oil. 
1H-NMR (400 MHz, CDCl3):  = 5.78 (m, 1H); 5.27 (m, 1H); 5.25 (dd, J = 17.4, 1.3Hz, 1H); 5.18 (dd; J 
= 10.5, 1.3Hz, 1H); 3.66 (t, J = 6.3Hz, 2H); 2.06 (s, 3H); 1.71 (m, 2H); 1.60 (m, 2H); 1.44 (bs, 1H) 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C8H14O3Na: 181.0841; found: 181.0835 
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(R)-5-vinyldihydrofuran-2(3H)-one (384) 
 
Primary alcohol 382 (1.8 g, 11.4 mmol, 1.0 eq.) was dissolved in anhydrous EtOAc (100 mL) and IBX 
(6.4 g, 22.8 mmol, 2 eq.) was added. The reaction mixtures was refluxed for two hours or until all 
starting material was consumed. Hexane (100 mL) was added and the suspension was filtered 
through a pad of celite 545 coarse. Removal of the solvents gave the desired aldehyde (1.8 g, 
11.4 mmol, quant.) as colorless oil.  
The previously prepared aldehyde (1.8 g, 11.4 mmol, 1.0 eq.) was dissolved in t-BuOH (75 mL) and 
2-methyl-but-2-ene (scavenger; 12 mL) were added. The reaction mixture was cooled to 0 °C and 
an aqueous solution (45 mL) of NaClO2 (15.5 g, 171.0 mmol, 15 eq.) and NaH2PO4.H2O (15.5 g, 
112.0 mmol, 9.8 eq.) was added at once. The reaction mixture was stirred at 0 °C for one hour and 
Et2O and water were added. The phases were separated and the organic layer was washed twice 
with water before it was dried with MgSO4. Removal of the solvent under reduced pressure 
yielded pure carboxylic acid (2.1 g, 11.3 mmol, 99%) as colorless oil, which was subsequently 
subjected to the next reaction. 
1.8 g (9.7 mmol, 1.0 eq.) of the previously prepared carboxylic acid were dissolved in as little 
anhydrous CH2Cl2 as possible. 10 mL of anhydrous MeOH and 2.7 g (19.3 mmol, 2 eq.) of finely 
ground K2CO3 were added. The reaction mixture was stirred for one hour and then acidified by the 
addition of 1M HCl. CH2Cl2 was added and the phases were separated. The aqueous phase was 
extracted twice with CH2Cl2 and the combined organic layers were dried with Na2SO4. The solvent 
was removed in vacuo yielding 1.36 g (9 mmol, 93%) of the desired seco-acid as colorless oil. 
The previously prepared seco-acid (1.3 g, 9 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 
(20 mL) and DMAP (110 mg, 0.9 mmol, 0.1 eq.) was added. The reaction was cooled to 0 °C and 
DIC (1.8 mL, 11.7 mmol, 1.3 eq.) was added. The reaction mixture was stirred at 0 °C for 90 
minutes. The solvent was removed under reduced pressure und the crude product was purified 
using silica gel chromatography (hexane/EtOAc = 2/1 to 1/1). Vinyl lactone 384 was obtained as 
colorless oil (1.08 g, 8.55 mmol, 95%).  
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1H-NMR (400 MHz, CDCl3):  = 5.88 (m, 1H); 5.36 (dd, J = 17.2, 1.0Hz, 1H); 5.26 (dd; J = 10.6, 1.0Hz, 
1H); 4.94 (m, 1H); 2.54 (m, 2H); 2.41 (m, 1H); 2.01 (m, 1H) 
13C-NMR (100 MHz, CDCl3):  = 176.8; 135.5; 117.4; 80.4; 28.3; 28.2 
HRMS (ESI) (m/z): [M]+ calcd. for C6H8O2: 112.0524; found: 112.0520 
 
(5R)-3-(phenylselanyl)-5-vinyldihydrofuran-2(3H)-one (378) 
 
An adopted procedure of Pattenden et al. was used.[141] Vinyl lactone 384 (1 g, 8.9 mmol, 1.0 eq.) 
was dissolved in anhydrous THF (80 mL) and the solution was cooled to -78 °C. LiHMDS (1M in THF; 
10.7 mL, 10.7 mmol, 1.2 eq.) was added dropwise and the reaction mixture was allowed to stir for 
30 minutes. TMS-Cl (1.42 mL, 11.1 mmol, 1.25 eq.) was added dropwise and the reaction mixture 
was again allowed to stir for 30 minutes. A solution of PhSeBr (2.63 g, 11.1 mmol, 1.25 eq.) in 
anhydrous THF (15 mL) was added drop wise and the solution was allowed to stir for another 30 
minutes, before it was quenched by the addition of sat. aq. NH4Cl. The phases were separated and 
the pH of the aqueous layer was adjusted to 6 by the careful addition of aq. 0.5M KHSO4 solution. 
The aqueous phase was extracted twice with Et2O and the combined organic layers were dried 
with brine and MgSO4. The solvent was removed under reduced pressure and silica gel 
chromatography (hexane/EtOAc = 3/1 to 2/1) yielded pure selenolactone 378 (1.52 g, 5.7 mmol, 
64%) as an inconsequential mixture of diastereo isomers. 
Major: 
1H-NMR (400 MHz, CDCl3):  = 7.69 (m, 2H); 7.36 (m, 3H); 5.82 (m, 1H); 5.33 (dd, J = 17.2, 1.0Hz, 
1H); 5.25 (dd; J = 10.6, 1.0Hz, 1H); 4.77 (m, 1H); 3.97 (dd, J = 6.8, 4.8Hz, 1H); 2.43 (m, 2H) 
13C-NMR (100 MHz, CDCl3):  = 175.3; 135.9; 134.9; 129.5; 129.2; 118.2; 79.2; 36.8; 36.6; 29.7 
77Se-NMR (76 MHz, CDCl3):  = 622.9 
HRMS (ESI) (m/z): [M]+ calcd. for C12H12O2Se: 268.0003; found: 267.9994 
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Methyl-2-((2R)-2-(2-hydroxy-2-((S)-2-oxo-5-vinyl-2,5-dihydrofuran-3-yl)ethyl)-3-
methylbut-3-en-1-yl)-5-vinylfuran-3-carboxylate (377a) 
 
DIPA (1.02 mL, 7.3 mmol, 1.3 eq.) was dissolved in anhydrous THF (30 mL) and the mixture was 
cooled to -10 °C when n-BuLi (1.6M in hexane; 4.2 mL, 6.7 mmol, 1.2 eq.) was added. The mixture 
was allowed to stir at -10 °C for 30 min, before it was cooled to -78 °C. Then, a solution of 
selenolactone 378 (1.5 g, 5.6 mmol, 1.0 eq.) in anhydrous THF (10 mL) was added dropwise. Upon 
completion, the reaction mixture was allowed to stir for 30 minutes. A solution of aldehyde 361 
(1.55 g, 5.9 mmol, 1.05 eq.) in anhydrous THF (10 mL) was added and the reaction mixture was 
stirred for one hour. The reaction was quenched by the addition of sat. aq. NH4Cl. After addition of 
Et2O, phases were separated and the aqueous phase was neutralized by the addition of 0.5M 
KHSO4. The aqueous layer was extracted twice with Et2O and the combined organic phases were 
dried with MgSO4. Removal of the solvent under reduced pressure yielded the desired triene as 
colorless viscous oil (2.9 g, 5.5mol, 98%). 
The previously prepared triene (2.9 g, 5.5 mmol, 1.0 eq.) was dissolved in CH2Cl2 (55 mL) and 
20 mL of sat. aq. NH4Cl were added. The biphasic mixture was cooled to 0 °C and 30% H2O2 (2 mL, 
16.4 mmol, 3 eq.) was added. The reaction was stirred at 0 °C for one hour and then quenched by 
the addition of sat. aq. Na2S2O3. Phases were separated and the organic phase was extracted 4 
times with water. The organic layer was dried with MgSO4 and the solvent was removed under 
reduced pressure. After silica gel chromatography (hexane/EtOAc = 3/1 to 2/1) butenolide 377a 
was obtained as colorless oil (1.59 g, 4.3 mmol, 78%) as an inseparable mixture of diastereo 
isomers. 
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Major:  
1H-NMR (400 MHz, CDCl3):  = 7.16 (t, J = 1.6Hz, 1H); 6.46 (s, 1H); 6.41 (dd, J = 17.5, 11.3Hz, 1H); 
5.69 (m, 1H); 5.63 (d, J = 17.5Hz, 1H); 5.46 (d, J = 17.0Hz, 1H); 5.34 (m, 2H); 5.18 (d, J = 11.3Hz, 1H); 
4.80 (s, 1H); 4.78 (s, 1H); 4.46 (m, 1H); 3.81 (s, 3H); 3.11 (m, 2H); 2.98 (m, 1H); 2.47 (d, J = 5.6Hz, 
1H); 2.01 (m, 1H); 1.76 (s, 3H); 1.66 (m, 1H) 
13C-NMR (100 MHz, CDCl3):  = 172.0; 164.2; 160.6; 151.3; 146.7; 145.5; 136.9; 131.8; 124.4; 119.8; 
115.2; 113.6; 113.1; 108.2; 82.0; 65.3; 51.4; 43.1; 37.9; 32.2; 18.0 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C21H24O6Na: 395.1471; found: 395.1466 
Minor: 
1H-NMR (600 MHz, CDCl3):  = 7.19 (t, J = 1.5Hz, 1H); 6.45 (s, 1H); 6.40 (dd, J = 17.5, 11.3Hz, 1H); 
5.70 (m, 1H); 5.63 (d, J = 17.5Hz, 1H); 5.47 (d, J = 17.1Hz, 1H); 5.35 (s, 1H); 5.34 (s, 1H); 5.19 (d, J = 
11.3Hz, 1H); 4.73 (s, 1H); 4.68 (s, 1H); 4.62 (m, 1H); 3.81 (s, 3H); 3.30 (d, J = 5.3Hz, 1H); 3.22 (dd, J = 
14.4, 5.5Hz, 1H); 3.02 (dd, J = 14.4, 9.5Hz, 1H); 2.78 (m, 1H); 2.00 (m, 1H); 1.79 (m, 1H); 1.74 (s, 3H) 
13C-NMR (150 MHz, CDCl3):  = 172.1; 164.3; 160.6; 151.2; 147.2; 146.6; 136.8; 131.8; 124.3; 119.8; 
115.2; 113.2; 112.8; 108.0; 82.0; 65.6; 51.5; 43.6; 38.7; 31.0; 18.6 
HRMS (ESI) (m/z): [M+Na]+ calcd. for C21H24O6Na: 395.1471; found: 395.1464 
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Methyl-2-((2R)-2-(2-acetoxy-2-((S)-2-oxo-5-vinyl-2,5-dihydrofuran-3-yl)ethyl)-3-methylbut-
3-en-1-yl)-5-vinylfuran-3-carboxylate (377b) 
 
Secondary allylic alcohol 377a (100 mg, 0.27 mmol, 1.0 eq.) was dissolved in anhydrous CH2Cl2 
(3 mL) and pyridine (26 µL, 0.32 mmol, 1.2eq) and DMAP (3.3 mg, 27 µmol, 0.1 eq.) were added. 
The reaction mixture was cooled to 0 °C and Ac2O (30.5 µL, 0.32 mmol, 1.2 eq.) was added. The 
solution was allowed to stir at 0 °C for 45 min, then it was quenched by the addition of sat. aq. 
NH4Cl. Phases were separated and the aqueous phase was extracted twice with CH2Cl2. The 
combined organic layers were dried with MgSO4 and the solvent was removed under reduced 
pressure. Purification by silica gel chromatography (hexane/EtOAc = 4/1 to 3/1) yielded acetate 
377b (68 mg, 0.16 mmol, 61%).  
Major: 
1H-NMR (400 MHz, CDCl3):  = 7.03 (bs, 1H); 6.46 (s, 1H); 6.40 (m, 1H); 5.64 (m, 2H); 5.45 (m, 2H); 
5.33 (m, 2H); 5.19 (d, J = 11.4Hz, 1H); 4.78 (s, 1H); 4.67(s, 1H); 3.81 (s, 3H); 3.10 (m, 2H); 2.77 (m, 
1H); 2.11 (m, 1H); 2.08 (s, 3H); 1.81 (m, 1H); 1.74 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 170.6; 169.7; 164.1; 160.3; 151.3; 149.1; 147.8; 144.6; 133.7; 131.7; 
124.4; 120.4; 113.8; 113.1; 108.2; 81.7; 67.4; 51.3; 42.9; 35.2; 32.1; 20.8; 17.9 
HRMS (ESI) (m/z): [M]+ calcd. for C23H26O7: 414.1679; found: 414.1674 
Minor: 
1H-NMR (400 MHz, CDCl3):  = 7.13 (bs, 1H); 6.45 (s, 1H); 6.39 (m, 1H); 5.64 (m, 2H); 5.45 (m, 2H); 
5.33 (m, 2H); 5.18 (d, J = 11.4Hz, 1H); 4.69 (s, 1H); 4.61 (s, 1H); 3.80 (s, 3H); 3.07 (m, 2H); 2.68 (m, 
1H); 2.11 (m, 1H); 2.04 (s, 3H); 1.81 (m, 1H); 1.72 (s, 3H) 
13C-NMR (100 MHz, CDCl3):  = 170.6; 169.7; 164.1; 160.3; 151.3; 149.1; 147.8; 144.6; 132.8; 131.5; 
124.3; 120.0; 113.8; 112.9; 108.2; 81.6; 67.4; 51.3; 43.4; 34.9; 32.0; 20.9; 18.2 
HRMS (ESI) (m/z): [M]+ calcd. for C23H26O7: 414.1679; found: 414.1673  
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5 Appendices 
5.1 List of Abbreviations 
Ac  acetyl 
AIBN  2,2’-azobisisobutyronitrile 
aq.  aqueous 
Bn  benzyl 
Bu  butyl 
c  concentration 
cBu  cyclobutane/cyclobutyl 
CM  cross metathesis 
COSY  correlated spectroscopy 
CSA  camphorsulfonic acidd 
dba  dibenzylideneacetone 
dppf  1,1′-bis(diphenylphosphino) 
ferrocene 
DBU  1,8-diazabicyclo[5.4.0]undec- 
7-ene 
DCC  N,N′-dicyclohexylcarbo-
diimide 
CH2Cl2  dichloromethane 
DDQ  2,3-dichloro-5,6-dicyano-1,4- 
  benzoquinone 
DIBAL-H diisobutylaluminium hydride 
DIC  N,N′-diisopropylcarbodiimide 
DIPEA  N,N-diisopropylethylamine 
DMAP  4-(dimethylamino)pyridine 
DMAPP  dimethyl-allyl-pyrophophate 
DMF  N,N-dimethylformamide 
DMP  Dess-Martin periodinane 
DMS  dimethylsulfide 
DMSO  dimethylsulfoxide 
EDC  N-(3-Dimethylaminopropyl)- 
N′-ethylcarbodiimide 
eq.  equivalent 
et al.  latin: “et alii”, meaning 
“and others” 
etc.  latin: “et cetera”, meaning 
  “and so on” 
HMPA  hexamethylphosphoramide 
HSQC  heteronuclear single 
quantum 
coherence 
HRMS  high resolution mass 
spectroscopy 
HSQC  heteronuclear single 
quantum 
coherence 
HPLC  high pressure/performance 
liquid chromatography 
HWE  Horner-Wadsworth-Emmons 
Hz  Hertz 
IBX  o-iodoxybenzoic acid 
IC50  half maximal inhibitory 
  concentration 
IPP  isopentenyl-pyrophosphate 
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iPr  2-propenyl 
J  coupling constant 
KHMDS  potassium 
hexamethyldisilazide 
KOt-Bu potassium tert-butoxide 
LDA  lithium diisopropylamide 
LG  leaving group 
LiHMDS lithium hexamethyldisilazide 
mCPBA  meta-chloroperbenzoic acid 
MEM  (2-methoxyethoxy)methyl 
Ms  methansulfonyl 
MS  mass spectroscopy 
MVK  methyl vinyl ketone 
NaHMDS sodium 
hexamethyldisilazide 
NBS  N-bromosuccinimide 
NEt3  triethylamine 
NHK  Nozaki-Hiyama-Kishi 
NIS  N-iodosuccinimide 
NMR  nuclear magnetic resonance 
NOE  nuclear Overhauser effect 
NOESY  nuclear Overhauser effect 
spectroscopy 
PG  protecting group 
Ph  phenyl 
PMB  para-methoxybenzyl 
ppm  parts per million 
Py  pyridine 
R(1,2…n) any substituent (if not 
otherwise stated) 
RCM  ring closing metathesis 
Rf  ratio of fronts (TLC) 
r.t.  room temperature 
sat.  saturated 
SEM  (trimethylsilyl)ethoxymethyl 
TBAF  tetra-n-butylammonium 
fluoride 
TBAI  tetra-n-butylammonium 
iodide 
TBDPS  tert-butyldiphenylsilyl 
TBS  tert-butyldimethylsilyl 
TEA  triethylamine 
TES  triethylsilyl 
TFA  trifluoroacetic acid 
THF  tetrahydrofurane 
THP  tetrahydropyran 
Tf  trifluoromethanesulfonate 
TLC  thin layer chromatography 
TMS  trimethylsilyl 
Troc  2,2,2-trichloroethyl 
carbonate 
pTsOH  para-toluene-4-sulfonic acid 
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5.2 Single-Crystal Diffraction Data 
 
Chlorinated (Z)-Pentacycle (207a) 
 
Empirical formula: C31H44O9Cl2Si 
Formula weight (g/mol): 659.67 
Space group: P212121 
Cell symmetry: orthorhombic 
Temperature (K): 100 
a (Å): 12.6266 
b (Å): 12.6455 
c (Å): 20.9213 
V (Å3): 3340.50 
Z: 4 
hkl (min/max): -13 ≤ h ≤ 15, -15 ≤ k ≤ 14, -25 ≤ l ≤ 25 
 
Figure 50: ORTEP diagram of 207a with 50% ellipsoid probability 
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5.3 Selected NMR-Spectra 
5.3.1 7,8 Metathesis Approach (cBu) 
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5.3.2 9,10 Metathesis Approach (cBu) 
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.0
2
1
.0
0
5
.1
8
288 
 
 
 
 
  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0 ppm
2
8
.4
1
0
.8
5
2
.6
4
1
.1
5
2
.2
6
1
.0
9
1
.1
1
3
.5
1
1
.1
1
1
.0
5
1
.0
1
0
.9
8
0
.8
5
1
.1
8
0
.8
4
1
.0
0
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
3
.6
6
2
7
.7
3
2
.8
0
1
.2
6
1
.3
8
2
.5
4
1
.2
9
3
.3
9
0
.9
2
0
.9
1
3
.7
3
2
.2
9
1
.1
6
2
.2
2
2
.3
7
0
.9
4
2
.2
5
1
.0
3
1
.1
6
1
.0
7
2
.0
0
2
.4
9
3
.9
1
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
290 
 
5.3.3 10,11 Metathesis Approach (cBu) 
 
 
 
  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0
.2
6
1
.7
8
2
.0
7
1
8
.2
4
1
2
.4
8
0
.7
8
8
.5
5
0
.4
1
0
.7
0
1
.8
4
1
2
.4
5
5
.8
9
1
.0
7
0
.1
4
2
.8
4
1
8
.4
5
0
.2
4
1
1
.8
3
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
3
.8
6
2
1
.0
5
2
.5
0
1
.7
6
1
.3
7
0
.9
3
0
.9
6
1
.8
4
0
.5
1
0
.9
3
2
.8
7
0
.8
6
0
.8
1
0
.9
2
1
.8
4
1
.5
0
2
.0
3
0
.9
6
0
.7
4
1
.6
8
0
.6
3
1
.9
1
3
.0
0
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
9
.1
0
6
.2
4
9
.7
9
2
2
.6
0
1
.3
6
1
.3
3
2
.3
6
1
.9
0
2
.7
3
1
.0
4
1
.0
0
1
.0
4
1
.0
0
0
.7
6
1
.0
9
1
.0
3
3
.1
8
1
.0
5
1
.0
5
1
.0
1
4
.0
8
1
.0
7
0
.9
5
0
.8
9
0
.8
8
292 
 
 
 
 
  
220 200 180 160 140 120 100 80 60 40 20 0 ppm
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
2
6
.3
8
3
.0
0
3
.7
6
3
.5
0
3
.7
8
2
.3
2
1
.2
5
1
.1
4
1
.1
6
0
.9
1
0
.8
9
1
.1
8
3
.5
8
2
.3
8
1
.2
2
1
.1
5
2
.3
1
0
.7
6
1
.0
1
1
.2
6
1
.0
0
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5.3.4 11,12 Metathesis Approach (cBu) 
 
 
  
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
2
.7
8
1
9
.3
9
4
.3
6
2
.4
3
3
.0
0
2
.0
3
0
.9
8
0
.5
8
0
.6
5
1
.0
9
1
.5
2
0
.4
3
0
.4
4
1
.9
4
0
.4
2
0
.3
9
2
.9
0
1
.4
6
2
.7
9
294 
 
 
 
  
220 200 180 160 140 120 100 80 60 40 20 0 ppm
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
3
.0
0
2
.6
8
1
1
.4
9
2
5
.3
9
4
.9
1
1
.3
0
2
.8
8
1
.3
7
0
.8
8
1
.2
8
0
.7
0
3
.3
1
1
.8
5
0
.8
0
0
.6
9
3
.2
6
1
.0
3
0
.9
6
0
.9
5
0
.7
3
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5.3.5 11,12 Horner Wadsworth Emmons Approach (cBu) 
 
  
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
6
.0
4
1
1
.5
5
2
4
.1
6
2
.6
4
2
.6
3
3
.2
5
1
.1
2
2
.2
8
2
.1
1
1
.0
5
1
.0
5
3
.1
5
1
.1
1
1
.0
0
1
.0
7
1
.0
1
1
.0
4
1
.0
4
1
.0
0
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210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
5
.8
2
1
2
.4
5
2
0
.0
8
2
.7
1
1
.1
8
1
.4
0
1
.1
9
1
.1
4
1
.1
3
1
.1
3
1
.2
7
3
.2
0
1
.3
3
1
.1
2
1
.2
2
1
.0
1
1
.1
8
0
.9
4
1
.0
0
 297 
 
 
 
5.3.6 12,13 Horner Wadsworth Emmons Approach (cBu) 
 
  
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
0
.6
3
2
1
.5
7
2
8
.6
4
1
.1
9
1
.9
4
3
.4
2
1
.8
4
2
.5
2
2
.6
5
2
.1
2
2
.8
4
2
.4
7
0
.6
9
3
.3
9
1
.4
8
4
.9
3
1
.3
8
1
.0
0
1
.1
6
0
.9
4
2
.9
3
1
1
.4
1
6
.9
4
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200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
7
.2
1
1
1
.4
6
2
5
.5
4
1
1
.2
4
1
.0
3
1
.3
8
3
.0
8
1
.9
4
3
.0
6
1
.7
8
1
.1
8
1
.0
9
0
.3
2
0
.4
8
0
.6
0
2
.3
3
3
.4
8
1
.6
0
4
.8
1
2
.3
5
0
.9
8
1
.0
5
1
.0
0
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5.3.7 Furan-Butenolide-12,13 Approach (cBu) 
 
  
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
3
.0
0
1
.0
5
1
.0
2
0
.9
9
0
.9
9
0
.9
7
0
.8
8
300 
 
 
 
 
  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
1
7
.4
6
3
5
.3
2
2
.2
8
3
.0
0
2
.7
5
2
.5
7
1
.1
4
0
.8
2
2
.9
7
2
.1
3
0
.7
3
1
.5
0
2
.8
3
0
.8
4
0
.7
9
0
.3
0
0
.9
2
0
.6
3
0
.6
0
0
.5
9
0
.2
6
1
.9
1
8
.2
6
4
.3
9
0
.5
5
2030405060708090100110120130140150160170180190 ppm
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0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm
3
2
.8
8
2
.0
6
1
.3
3
3
.8
3
1
.8
2
1
.5
7
1
.7
1
4
.1
8
1
.6
9
4
.0
0
5
.1
0
1
.5
1
1
.2
9
1
.3
5
1
.0
8
1
.0
3
1
.0
0
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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5.3.8 Furan-12,13 Approach (cBu) 
 
5.3.9 12,13 Approach (cBu) 
 
 
10 9 8 7 6 5 4 3 2 1 0 ppm
7
.7
3
9
.9
5
2
9
.1
8
3
.7
5
3
.1
6
2
.7
0
2
.6
0
2
.0
3
1
.1
5
3
.8
1
1
.0
4
2
.5
4
0
.9
3
0
.9
1
1
.2
1
0
.7
1
1
.0
3
1
.0
0
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm
3
.4
9
0
.8
3
0
.6
0
0
.6
7
2
.0
1
0
.9
7
1
.9
5
1
.0
2
0
.9
4
2
.0
0
 303 
 
 
 
 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
10 9 8 7 6 5 4 3 2 1 0 ppm
8
.5
4
5
2
.3
7
5
.0
0
1
0
.9
9
2
.4
9
5
.1
8
2
.5
9
1
.2
1
1
.2
4
1
.1
3
5
.3
1
2
.6
5
1
.2
8
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210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
10 9 8 7 6 5 4 3 2 1 0 ppm
1
2
.8
3
2
0
.7
5
2
2
.7
4
3
.0
1
1
.8
6
1
.3
0
2
.1
0
2
.9
7
1
.9
7
3
.2
2
0
.9
8
1
.1
5
1
.6
0
0
.3
0
0
.5
6
0
.8
8
2
.0
5
0
.9
9
2
.0
0
0
.9
9
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5.3.10 Northern Lactone-Butenolide Approach (cBu) 
 
 
  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
6
.4
1
9
.8
7
3
.9
6
1
.4
1
0
.4
8
1
.4
3
0
.4
9
0
.6
0
1
.0
4
2
.2
0
0
.4
3
0
.6
2
1
.0
6
3
.5
7
2
.0
0
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
6
.1
7
1
0
.0
6
2
1
.8
8
3
.0
6
1
.0
3
1
.9
7
2
.0
6
2
.1
7
1
.0
5
1
.9
6
3
.2
0
0
.7
6
2
.0
0
0
.8
1
1
.2
1
1
.1
0
1
.9
4
0
.9
9
2
.0
6
1
.0
8
2
.0
0
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
8
.1
0
7
.3
5
1
.5
4
1
.6
4
1
.6
6
1
.8
1
1
.9
0
0
.7
5
1
.3
4
1
.2
1
0
.6
4
0
.5
3
0
.6
0
3
.0
1
1
.1
8
1
.1
9
1
.0
6
0
.4
7
0
.5
2
0
.9
5
0
.4
1
0
.5
0
2
.0
4
3
.1
5
1
.2
3
2
.0
7
2
.0
0
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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5.3.11 Northern Lactone-Horner Wadsworth Emmons Approach (cBu) 
 
 
 
  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
2
0
.7
8
0
.4
6
1
.0
2
1
.9
8
1
.0
0
1
.0
1
1
.4
3
2
.6
1
1
.0
3
5
.9
2
3
.0
1
0
.9
8
1
.9
9
2
.0
4
6
.5
2
4
.0
0
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
2
.8
0
2
.7
6
1
2
.3
0
2
0
.9
9
1
.1
5
2
.6
1
5
.0
3
1
.9
6
2
.9
9
1
.0
8
1
.9
3
0
.9
8
6
.6
6
0
.7
7
2
.0
2
1
.7
2
0
.8
7
0
.9
1
0
.9
3
1
.0
7
2
.0
2
2
.1
1
7
.2
8
4
.0
0
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
6
.3
7
2
0
.0
4
9
.8
5
1
.7
1
2
.6
4
0
.9
1
1
.0
5
3
.1
8
0
.8
3
1
.3
1
1
.3
9
0
.9
7
2
.8
4
3
.2
3
0
.9
5
0
.8
0
1
.0
7
0
.8
2
2
.0
0
0
.7
8
2
.3
6
7
.7
4
3
.8
6
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
7
.3
5
1
2
.7
7
2
8
.9
9
1
7
.0
1
2
.7
8
1
.8
3
3
.1
8
5
.5
5
1
.3
2
1
.3
5
4
.6
1
4
.0
9
1
.7
1
2
.0
0
1
.1
3
1
.0
4
1
.0
3
1
.1
3
9
.2
5
6
.0
8
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 ppm
312 
 
5.3.12 Southern Lactone Approach (cBu) 
 
 
 
  
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
5
.4
3
8
.2
9
8
.2
6
1
0
.5
4
2
.5
0
0
.9
7
1
.9
5
0
.9
1
1
.0
0
0
.9
9
0
.4
2
3
.5
9
2
.9
8
0
.8
9
1
.8
8
1
.9
2
2
.3
4
7
.4
5
4
.0
0
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
6
.4
4
1
0
.1
5
2
2
.9
7
1
.4
8
0
.6
8
0
.5
7
0
.4
9
0
.9
5
0
.6
5
1
.3
9
1
.3
9
1
.6
5
3
.2
4
1
.0
2
1
.9
4
0
.5
6
0
.6
1
1
.9
6
1
.0
0
1
.0
2
1
.0
0
220 200 180 160 140 120 100 80 60 40 20 0 ppm
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
5
.7
7
9
.6
6
2
0
.8
2
2
.0
1
3
.8
2
1
.1
7
2
.9
7
0
.9
9
0
.3
5
1
.1
5
1
.2
6
2
.8
5
1
.9
7
1
.0
0
0
.9
3
3
.1
3
3
.2
1
2
.6
5
1
.1
2
2
.0
6
0
.6
5
1
.7
4
2
.0
4
0
.9
7
0
.9
5
0
.9
6
2
.0
4
2
.0
0
1
2
.5
7
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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5.3.13 7,8 Metathesis Approach (iPr) 
 
 
  
1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
3
.2
6
1
.9
2
1
.0
2
2
.2
0
2
.9
2
2
.9
8
0
.7
0
2
.7
7
0
.9
5
0
.9
9
0
.9
4
1
.0
0
1
.0
6
1
.0
9
0
.8
4
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
1
.3
4
9
.0
6
1
.2
9
2
.8
5
1
.1
7
1
.1
8
1
.3
4
0
.9
3
3
.6
3
1
.2
2
2
.3
5
2
.8
0
1
.3
1
1
.0
0
1
.0
2
2
.0
0
1
.0
9
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
1
.3
1
3
.3
9
3
.4
4
1
.1
6
2
.4
7
0
.9
4
1
.1
2
2
.1
7
3
.3
4
1
.0
4
1
.1
0
1
.0
3
1
.1
3
1
.1
4
1
.0
9
1
.0
3
1
.0
0
1
.0
8
0
.8
5
1
.0
0
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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1.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
1
.1
6
1
.2
2
3
.2
0
3
.3
4
3
.1
0
2
.0
7
1
.0
7
1
.0
1
1
.0
4
1
.0
0
3
.2
4
2
.0
0
1
.1
0
1
.0
6
1
.0
5
1
.0
3
1
.0
0
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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5.3.14 11,12 Horner Wadsworth Emmons Approach (iPr) 
 
 
 
  
10 9 8 7 6 5 4 3 2 1 0 ppm
2
.8
9
3
.1
6
3
.5
1
2
.5
6
9
.9
2
1
0
.0
3
3
.0
0
1
.2
2
1
.8
0
0
.6
4
1
.7
1
1
.7
2
3
.0
0
0
.4
0
1
.1
3
1
.0
8
2
.0
7
1
.9
2
0
.4
2
1
.9
1
0
.9
7
0
.5
9
0
.3
8
0
.8
7
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
2
.9
8
1
9
.8
4
1
.6
9
3
.1
6
3
.0
3
0
.7
3
1
.3
3
1
.0
4
1
.0
4
2
.3
3
2
.3
0
5
.2
7
1
.0
3
1
.1
0
2
.8
8
3
.0
1
3
.4
9
2
.0
5
1
.0
0
0
.7
0
0
.2
8
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
6
.8
0
9
.8
1
4
.7
1
3
.4
9
2
.2
2
2
.0
7
1
.2
5
1
.2
4
1
.3
4
1
.2
5
1
.2
0
1
.5
6
1
.2
6
3
.6
8
0
.4
6
1
.1
3
1
.0
3
1
.1
0
0
.9
0
1
.0
5
1
.0
6
1
.0
0
1
.1
3
0
.3
7
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
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5.3.15 Sarcofuranocembranolide A 
 
 
 
  
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
1
.8
4
0
.8
7
0
.8
9
2
.0
0
0
.9
0
2
.9
8
1
.8
6
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
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1.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
1
.1
1
3
.0
8
0
.7
6
1
.9
4
2
.4
4
1
.0
3
2
.0
2
3
.0
9
0
.5
1
2
.0
8
0
.9
7
2
.0
4
1
.8
3
2
.3
0
0
.8
3
1
.0
6
1
.0
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